cid,cmpdname,cmpdsynonym,mw,mf,polararea,complexity,xlogp,heavycnt,hbonddonor,hbondacc,rotbonds,inchi,isosmiles,canonicalsmiles,inchikey,iupacname,exactmass,monoisotopicmass,charge,covalentunitcnt,isotopeatomcnt,totalatomstereocnt,definedatomstereocnt,undefinedatomstereocnt,totalbondstereocnt,definedbondstereocnt,undefinedbondstereocnt,pclidcnt,gpidcnt,gpfamilycnt,neighbortype,meshheadings,annothits,annothitcnt,aids,cidcdate,sidsrcname,depcatg,annotation
121280087,Almonertinib,"Almonertinib|HS-10296|1899921-05-1|Aumolertinib|Ameile|Egfr T790M inhibitor HS-10296|Aumolertinib [USAN]|HS-10297|N-(5-((4-(1-Cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide|CHEMBL4761468|EQ143|T4RS462G19|EQ-143|HS-10206|2-Propenamide, N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl)amino)-2-((2-(dimethylamino)ethyl)methylamino)-4-methoxyphenyl)-|N-[5-[[4-(1-cyclopropylindol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide|Aumolertinib [WHO-DD]|AUMOLERTINIB [INN]|UNII-T4RS462G19|SCHEMBL17683063|GTPL11136|GLXC-26972|EX-A3721|ZAD92105|HS 10296 [WHO-DD]|BDBM50557548|Hs 10296|s8817|WHO 11295|AKOS040758756|AT30756|HS10296|AS-84436|example 26 [WO2016054987A1]|HY-112823|CS-0066162",525.600,C30H35N7O2,87.600,823.000,4.200,39,2,7,11,"InChI=1S/C30H35N7O2/c1-6-29(38)32-24-17-25(28(39-5)18-27(24)36(4)16-15-35(2)3)34-30-31-14-13-23(33-30)22-19-37(20-11-12-20)26-10-8-7-9-21(22)26/h6-10,13-14,17-20H,1,11-12,15-16H2,2-5H3,(H,32,38)(H,31,33,34)",CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC,DOEOECWDNSEFDN-UHFFFAOYSA-N,N-[5-[[4-(1-cyclopropylindol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide,525.285,525.285,0,1,0,0,0,0,0,0,0,33,52,10,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Use and Manufacturing,9,1709312|1709313|1709314|1709315|1709316|1709317|1709318|1709319|1709320|1709321|1709322|1709323|1709324|1709325|1709326|1709327|1709328|1709329|1709330|1709331|1709338|1709339|1709340,20160806,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AKos Consulting & Solutions|Ambeed|AstaTech, Inc.|BenchChem|BindingDB|Biosynth|BOC Sciences|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|ChemShuttle|Cooke Chemical Co., Ltd|CymitQuimica|DC Chemicals|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|University of Kansas High Throughput Screening Laboratory|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
10184653,Afatinib,"Afatinib|439081-18-2|850140-72-6|Tovok|BIBW2992|Tomtovok|BIBW 2992|BIBW-2992|Afatinib (BIBW2992)|(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|Afatinib, Free Base|BIBW2992 (Tovok)|Afatinib free base|Afatinib [USAN]|Afatinib [USAN:INN]|(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|NSC-750691|UNII-41UD74L59M|(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide|CHEMBL1173655|CHEBI:61390|N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-Butenamide|41UD74L59M|850140-72-6 (free base)|NSC750691|(2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide|(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-oxolan-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide|(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide|S1011|(S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide.|2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-, (2E)-|afatinibum|MFCD12407405|Afatinib- Bio-X|(E)-4-dimethylamino-but-2-enoic acid-(4-(3-chloro-4-fluoro-phenylamino)-7-((S)-tetrahydrofuran-3-yloxy)-quinazolin-6-yl)-amide|(E)-4-Dimethylamino-but-2-enoic acid-[4-(3-chloro-4-fluoro-phenylamino)-7-((S)-tetrahydrofuran-3-yloxy)-quinazolin-6-yl]-amide|2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-|(E/Z)-Afatinib|Tovok (TN)|BIBW2992,Afatinib|Afatinib (USAN/INN)|AFATINIB [INN]|AFATINIB [MI]|Tovok, BIBW2992|AFATINIB [VANDF]|EGFR inhibitor 2nd gens|AFATINIB [MART.]|BIBW2992 - Afatinib|AFATINIB [WHO-DD]|D05UFG|MLS006010000|GTPL5667|CHEBI:94698|DTXSID20893451|EX-A065|BCPP000338|BCP01779|BDBM50322823|NSC799327|Afatinib(cis-trans isomerismtautomers)|AKOS015850681|AKOS015904219|AKOS025149636|BCP9000407|CCG-264776|DB08916|EX-8656|NSC-799327|NCGC00185000-01|(2e)-n-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3s)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-2-butenamide|(E)-N-[4-(3-chloro-4-fluoro-anilino)-7-[(3S)-tetrahydrofuran-3-yl]oxy-quinazolin-6-yl]-4-(dimethylamino)but-2-enamide|2-butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)- 6-quinazolinyl)-4-(dimethylamino)-, (2E)-|AC-26079|AC-27018|AM808098|AS-80916|BA164141|DS-14172|SMR004701084|CS-0020030|SW219248-1|A15572|D09724|AB01565886_02|EN300-6487482|EN300-19625328|SR-01000941576|J-500781|J-502300|Q4688818|SR-01000941576-1|BRD-K66175015-001-01-7|Z2568727518|(2E)-N-[4-(3-Chloro-4-fluoroanilino)-7-[[(3S)-oxolane-3-yl]oxy]quinazoline-6-yl]-4-(dimethylamino)-2-buteneamide|(E)-4-dimethylamino-but-2-enoic acid-(4-(3-chloro-4-fluoro-phenylamino)-7-((S)-tetrahydrofuran-3-yloxy)-quinazolin-6yl)-amide|(R,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|(S)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-|N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-oxolan-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide",485.900,C24H25ClFN5O3,88.600,702.000,3.600,34,2,8,8,"InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1",CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,ULXXDDBFHOBEHA-CWDCEQMOSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,485.163,485.163,0,1,0,1,1,0,1,1,0,3571,27666,5860,2D+3D,Afatinib,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,11,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|410943|410944|492109|492110|492111|624702|624703|624704|624705|624706|624707|624708|624709|624710|624711|624712|624713|624714|624715|624716|624717|624718|624719|624720|624721|624722|624723|624724|624725|624726|624727|624728|624729|624730|624731|624732|624733|624734|624735|624736|624737|624738|624739|624740|624741|624742|624743|624744|624745|624746|624747|624748|624749|624750|624751|624752|624753|624754|624755|624756|624757|624758|624759|624760|624761|624762|624763|624764|624765|624766|624767|624768|624769|624770|624771|624772|624773|624774|624775|624776|624777|624778|624779|624780|624781|624782|624783|624784|624785|624786|624787|624788|624789|624790|624791|624792|624793|624794|624795|624796|624797|624798|624799|624800|624801|624802|624803|624804|624805|624806|624807|624808|624809|624810|624811|624812|624813|624814|624815|624816|624817|624818|624819|624820|624821|624822|624823|624824|624825|624826|624827|624828|624829|624830|624831|624832|624833|624834|624835|624836|624837|624838|624839|624840|624841|624842|624843|624844|624845|624846|624847|624848|624849|624850|624851|624852|624853|624854|624855|624856|624857|624858|624859|624860|624861|624862|624863|624864|624865|624866|624867|624868|624869|624870|624871|624872|624873|624874|624875|624876|624877|624878|624879|624880|624881|624882|624883|624884|624885|624886|624887|624888|624889|624890|624891|624892|624893|624894|624895|624896|624897|624898|624899|624900|624901|624902|624903|624904|624905|624906|624907|624908|624909|624910|624911|624912|624913|624914|624915|624916|624917|624918|624919|624920|624921|624922|624923|624924|624925|624926|624927|624928|624929|624930|624931|624932|624933|624934|624935|624936|624937|624938|624939|624940|624941|624942|624943|624944|624945|624946|624947|624948|624949|624950|624951|624952|624953|624954|624955|624956|624957|624958|624959|624960|624961|624962|624963|624964|624965|624966|624967|624968|624969|624970|624971|624972|624973|624974|624975|624976|624977|624978|624979|624980|624981|624982|624983|624984|624985|624986|624987|624988|624989|624990|624991|624992|624993|624994|624995|624996|624997|624998|624999|625000|625001|625002|625003|625004|625005|625006|625007|625008|625009|625010|625011|625012|625013|625014|625015|625016|625017|625018|625019|625020|625021|625022|625023|625024|625025|625026|625027|625028|625029|625030|625031|625032|625033|625034|625035|625036|625037|625038|625039|625040|625041|625042|625043|625044|625045|625046|625047|625048|625049|625050|625051|625052|625053|625054|625055|625056|625057|625058|625059|625060|625061|625062|625063|625064|625065|625066|625067|625068|625069|625070|625071|625072|625073|625074|625075|625076|625077|625078|625079|625080|625081|625082|625083|625084|625085|625086|625087|625088|625089|625090|625091|625092|625093|625094|625095|625096|625097|625098|625099|625100|625101|625102|625103|625104|625105|625106|625107|625108|625109|625110|625111|625112|625113|625114|625115|625116|625117|625118|625119|625120|625121|625122|625123|625124|625125|625126|625127|625128|625129|625130|625131|625132|625133|625134|625135|625136|625137|625138|625139|625140|625141|625142|625143|708781|708783|718821|718822|718823|719885|719887|729594|729977|729978|741697|741698|741699|741701|741702|741703|741704|741705|741706|741708|741710|741711|741712|741713|741714|741718|741719|741720|741721|741722|741723|741725|741726|741728|741729|741731|741735|741736|741737|741738|741739|741740|741741|741742|741744|741745|741748|741750|741751|741752|741753|741754|741757|741758|741759|741761|741762|741763|741766|741767|741768|741770|741771|741774|741775|741777|741778|741779|741780|741781|741782|741783|741784|741785|741786|741787|741788|741789|741790|741791|741792|741793|741794|741795|741797|741798|741799|741800|741801|741802|741803|741805|741806|741807|741808|741809|741810|741812|741814|741815|741816|741817|741818|741820|741821|741822|741823|741826|741827|741828|741830|741831|741833|741834|741835|741837|741838|741840|741841|741842|741843|741844|741845|741846|741848|741849|741850|741852|741853|741854|741855|741856|741857|741860|741861|741863|741864|741865|741866|741867|741868|741869|741870|741871|741873|741876|741877|741878|741879|741880|741881|741882|741883|741885|741886|741888|741889|741890|741893|741898|741899|741900|741901|741902|741903|741904|741905|741906|741907|741908|741909|741910|741911|741912|741913|741914|741915|741916|741917|741918|741919|741920|741921|741922|741923|741924|741925|741928|741929|741930|741931|741932|741933|741934|741935|741936|741937|741938|741939|741940|741941|741942|741943|741944|741946|741947|741948|741949|741950|741951|741952|741953|741954|741955|741956|741957|741958|741959|741960|741961|741962|741963|741965|741966|741967|741968|741969|741970|741971|741974|741975|741976|741977|741978|741979|741980|741984|741985|741986|741987|741988|741989|741990|741991|741993|741994|741995|741996|741998|741999|742000|742002|742003|742004|742005|742006|742007|742008|742009|742010|742011|742012|742015|742016|742017|742018|742019|742020|742021|742024|742025|742028|742029|742030|742031|742033|742034|742035|742036|742037|742039|742040|742041|742042|742043|742044|742045|742047|742048|742049|742051|742052|742053|742054|742055|742056|742058|742060|742061|742062|742065|742068|742069|742070|742071|742072|742073|742074|742075|742076|742077|742078|742079|742080|742082|742083|742084|742088|742089|742090|742091|742092|742093|742095|742096|742099|742100|742101|742102|742103|742104|742105|742106|742107|742108|742109|742110|742111|742112|742114|742115|742116|742118|742120|742121|742122|742123|742124|742125|742127|742129|742130|742133|742134|742138|742139|742140|742141|742143|742144|742145|742146|742147|742148|742149|742150|742151|742152|742153|742154|742156|742157|742159|742160|742161|742162|742163|742164|742166|742167|742168|742169|742170|742171|742172|742173|742174|742175|742176|742178|742179|742180|742181|742182|742183|742184|742185|742186|742187|742188|742189|742191|742192|742193|742194|742196|742197|742198|742200|742201|742202|742203|742204|742205|742206|742207|742208|742209|742210|742211|742212|742213|742214|742215|742216|742217|742218|742219|742220|742221|742222|742223|742224|742225|742226|742227|742228|742229|742230|742231|742232|742233|742234|742235|742236|742237|742238|742239|742240|742241|742242|742243|742244|742245|742249|742250|742251|742253|742254|742255|742256|742257|742258|742260|742262|742263|742264|742266|742267|742268|742269|742270|742271|742272|742273|742274|742275|742277|742278|742279|742280|742281|742283|742284|742285|742286|742287|742288|742289|742290|742291|742292|742293|742294|742295|742296|742297|742298|742299|742300|742302|742303|742304|742305|742306|742307|742309|742310|742313|742315|742316|742317|742318|742319|742321|742323|742324|742325|742326|742327|742328|742329|742331|742332|742333|742334|742335|742336|742338|742339|742340|742342|742343|742344|742345|742346|742347|742349|742350|742351|742352|742354|742356|742357|742358|742360|742361|742362|742363|742364|742365|742366|742367|742368|742369|742370|742371|742372|742373|742374|742376|742378|742379|742380|742381|742382|742383|742384|742388|742389|742390|742391|742392|742393|742394|742395|742396|742397|742399|742400|742401|742403|742404|742405|742406|742409|770073|770078|770079|770080|770081|770082|770083|1057928|1057929|1057934|1057935|1128564|1128565|1128566|1128567|1128589|1128590|1137579|1137580|1137581|1137582|1137583|1137584|1137585|1137586|1137587|1137601|1137602|1159387|1159388|1167145|1167147|1167156|1167158|1167177|1167178|1167179|1167180|1171417|1171418|1171419|1171420|1171421|1171435|1171436|1171437|1171438|1171439|1171445|1171447|1171449|1171451|1171453|1171455|1171456|1171460|1171461|1175323|1175324|1176840|1176841|1239424|1250263|1250264|1250285|1250286|1250287|1250288|1250289|1250290|1250291|1250366|1250367|1250368|1250369|1250370|1250371|1250372|1250373|1259251|1259398|1259399|1259416|1259421|1259423|1279096|1279097|1279098|1279099|1279100|1279101|1301834|1301835|1301836|1301837|1301838|1301839|1301840|1321117|1321118|1321122|1321123|1321125|1341757|1341761|1341762|1345502|1345653|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347162|1347411|1347412|1365584|1365585|1365586|1368035|1368036|1409092|1409093|1409605|1420982|1420983|1420984|1420985|1420986|1421403|1421405|1421406|1421409|1421411|1421413|1421415|1421417|1421419|1421420|1424889|1424890|1424891|1424892|1424893|1424894|1424895|1424896|1424897|1424898|1424899|1424900|1424901|1424902|1424904|1424905|1424906|1424907|1424908|1424909|1424910|1424911|1424912|1424914|1424915|1424917|1424918|1424919|1424920|1424921|1424922|1424923|1424924|1424925|1424926|1424928|1424929|1424930|1424931|1424932|1424933|1424934|1424935|1424936|1424937|1424939|1424940|1424941|1424942|1424944|1424945|1424946|1424947|1424948|1424949|1424950|1424952|1424953|1424954|1424955|1424956|1424957|1424958|1424960|1424961|1424962|1424963|1424964|1424965|1424966|1424967|1424968|1424969|1424970|1424971|1424972|1424973|1424974|1424975|1424976|1424977|1424978|1424979|1424980|1424981|1424983|1424984|1424985|1424988|1424989|1424990|1424992|1424993|1424994|1424995|1424996|1424997|1424998|1424999|1425000|1425001|1425002|1425003|1425004|1425005|1425006|1425007|1425008|1425009|1425010|1425011|1425013|1425014|1425015|1425016|1425017|1425018|1425019|1425021|1425022|1425023|1425024|1425025|1425026|1425027|1425028|1425029|1425030|1425031|1425033|1425034|1425035|1425036|1425037|1425038|1425039|1425040|1425042|1425043|1425044|1425045|1425046|1425047|1425048|1425049|1425050|1425051|1425052|1425053|1425054|1425055|1425056|1425057|1425058|1425059|1425060|1425061|1425062|1425063|1425064|1425065|1425066|1425067|1425068|1425069|1425070|1425071|1425072|1425073|1425074|1425076|1425077|1425078|1425079|1425080|1425081|1425082|1425083|1425084|1425085|1,20061025,"001Chemical|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|AOBIOUS INC|ApexBio Technology|Apexmol|Arromax Pharmatech Co., Ltd|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BenchChem|BePharm Ltd.|BindingDB|BioChemPartner|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Broad Institute|CAPOT|CEGChem|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemFaces|Chemical Probes Portal|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|Clinivex|Collaborative Drug Discovery, Inc.|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Cure First|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Elsa Biotechnology|Enamine|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Founder Pharma|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|Hunan Huateng Pharmaceutical Co., Ltd.|iChemical Technology USA Inc|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LGC Standards|Matrix Scientific|MedChemexpress MCE|Metabolomics Workbench|MLSMR|Molepedia|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NCBI Structure|NextBio|NextMove Software|NIAID ChemDB|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|Novartis Institutes for BioMedical Research|Oakwood Products|OChem|OXCHEM CORPORATION|Paragos|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Prous Science Drugs of the Future|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|Santagata Laboratory - Brigham and Women's Hospital and Harvard Medical School|SCRIPDB|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Southern Research Institute|Springer Nature|Starshine Chemical|Sun-shine Chemical|SureChEMBL|Syntree|TargetMol|TCI (Tokyo Chemical Industry)|Tenova Pharmaceuticals Inc|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|The Scripps Research Institute Molecular Screening Center|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Thoreauchem|Tocris Bioscience|ToxPlanet|Tractus|Uchem Meditech|UCSC Chemical Screening Center|Up-Fluorochem|VladaChem|Wikidata|Win-Win Chemical|Wubei-Biochem|Wutech|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
176871,Erlotinib hydrochloride,"Erlotinib hydrochloride|183319-69-9|erlotinib HCl|Tarceva|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride|OSI-774|OSI 774|Erlotinib (Hydrochloride)|CP 358774|Erlotinib hydrochloride [USAN]|CP-358774|Erlotinib 13C6 HCl|C22H24ClN3O4|UNII-DA87705X9K|Tarceva (Erlotinib Hydrochloride)|NSC 718781|CP-358,774-01|DA87705X9K|Erlotinib hydrochloride [USAN:INN]|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride|CP-358|4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)|NSC-718781|6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride|183319-69-9 (HCl)|4-(m-Ethynylanilino)-6,7-bis(2-methoxyethoxy)quinazoline monohydrochloride|CP-358774-01|4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, monohydrochloride|6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hcl|[6,7-BIS-(2-METHOXY-ETHOXY)-QUINAZOLIN-4-YL]-(3-ETHYNYL-PHENYL)-AMINE HYDROCHLORIDE|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine Monohydrochloride.|CHEBI:53509|OSI-744|SMR002529980|NSC718781|183319-69-9 pound not183321-74-6|Erlotinib HCl (OSI-744)|Erlotinib, HCl|Tarceva (OSI)|MFCD07781272|Erlotinib hydrochlroide|Erlotinib(OSI-744)|erlotinib, hydrochloride salt|MLS003899192|MLS004774139|CHEMBL1079742|NSC 718781) HCl|DTXSID10171412|EX-A064|Erlotinib Hydrochloride (Tarceva)|BCPP000238|BCP02600|ERLOTINIB HYDROCHLORIDE [MI]|AC-400|ERLOTINIB HYDROCHLORIDE [JAN]|s1023|AKOS015849087|BCP9000658|CCG-269002|CS-0123|ERLOTINIB HYDROCHLORIDE [MART.]|KS-1202|PB30965|SB16917|ERLOTINIB HYDROCHLORIDE [USP-RS]|ERLOTINIB HYDROCHLORIDE [WHO-DD]|Ro-50-8231|BE164421|BP-30224|HY-12008|(CP358774|LS-184396|AM20090622|ERLOTINIB HYDROCHLORIDE [ORANGE BOOK]|FT-0651479|EC-000.2313|E-4007|EN300-123054|Q27124083|F0001-2385|Erlotinib Hydrochloride is known as a EGFR Kinase inhibitor.|Erlotinib Hydrochloride,CP-358774, OSI-774, NSC 718781|6,7-Bis-(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride|[6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl- phenyl)amine hydrochloride|N-(3-ETHENYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE HYDROCHLORIDE|N-(3-Ethynylphenyl)-6,7-bis(1-methoxyethoxy)-4-quinazolinamine hydrochloride|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, monohydrochloride|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-quinazolin-4-amine hydrochloride",429.900,C22H24ClN3O4,74.700,525.000,NULL,30,2,7,11,"InChI=1S/C22H23N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl,GTTBEUCJPZQMDZ-UHFFFAOYSA-N,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride",429.146,429.146,0,2,0,0,0,0,0,0,0,4510,31,15,2D,Erlotinib Hydrochloride,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,11,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|472048|472049|472050|472051|651821|651957|651958|652010|652017|652039|652067|652126|652257|686940|686964|687014|687016|720508|720509|720543|720582|720596|720648|720700|720702|720704|743126|743269|743445|1053197|1117264|1215757|1215758|1215759|1215760|1215761|1215762|1215763|1215764|1215765|1215766|1215767|1215768|1215769|1215770|1215771|1215772|1215773|1215774|1215775|1215776|1215777|1215778|1215779|1215780|1215781|1215782|1215783|1215784|1215785|1215786|1259318|1346378|1347120|1347162|1406661|1406663|1409598|1508598|1529834|1529835|1529836|1640020|1645758|1671463,20050326,"001Chemical|3WAY PHARM INC|4C Pharma Scientific Inc|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|Alfa Chemistry|Alsachim|AN PharmaTech|Angel Pharmatech Ltd.|AOBIOUS INC|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BenchChem|BerrChem|BindingDB|BioChemPartner|BioCrick|Biosynth|BOC Sciences|Boerchem|BroadPharm|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|Cure First|CymitQuimica|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|Exclusive Chemistry Ltd|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Founder Pharma|Glentham Life Sciences Ltd.|Hairui Chemical|Hangzhou APIChem Technology|iChemical Technology USA Inc|ISpharm|J&H Chemical Co.,ltd|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LeadScope|LEAPCHEM|LGC Standards|Life Chemicals|MassBank of North America (MoNA)|Matrix Scientific|Mcule|MedChemexpress MCE|MLSMR|MolCore BioPharmatech|Molepedia|MolPort|MuseChem|NextBio|NextMove Software|NORMAN Suspect List Exchange|Norris Pharm|NovoSeek|Oakwood Products|OChem|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|Prous Science Drugs of the Future|RR Scientific|Santa Cruz Biotechnology, Inc.|Santagata Laboratory - Brigham and Women's Hospital and Harvard Medical School|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sigma-Aldrich|Smolecule|Springer Nature|Starshine Chemical|Synblock Inc|Syntree|TargetMol|THE BioTek|Thieme Chemistry|Thomson Pharma|Thoreauchem|ToxPlanet|University of Kansas High Throughput Screening Laboratory|VladaChem|Wikidata|Wubei-Biochem|Wutech|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
117909640,"N-(3-(2-((2,3-Difluoro-4-(4-(2-hydroxyethyl)piperazin-1-yl)phenyl)amino)quinazolin-8-yl)phenyl)acrylamide","olafertinib|1660963-42-7|RX-518|N-(3-(2-((2,3-Difluoro-4-(4-(2-hydroxyethyl)piperazin-1-yl)phenyl)amino)quinazolin-8-yl)phenyl)acrylamide|CK-101|EGFR-IN-3|708TLB8J3Y|N-[3-[2-[2,3-difluoro-4-[4-(2-hydroxyethyl)piperazin-1-yl]anilino]quinazolin-8-yl]phenyl]prop-2-enamide|RX518(CK-101)|2-Propenamide, N-(3-(2-((2,3-difluoro-4-(4-(2-hydroxyethyl)-1-piperazinyl)phenyl)amino)-8-quinazolinyl)phenyl)-|N-(3-(2-(2,3-Difluoro-4-(4-(2-hydroxyethyl)piperazin-1-yl)phenylamino)quinazolin-8-yl)phenyl)acrylamide|2-Propenamide, N-[3-[2-[[2,3-difluoro-4-[4-(2-hydroxyethyl)-1-piperazinyl]phenyl]amino]-8-quinazolinyl]phenyl]-|N-[3-[2-[[2,3-difluoro-4-[4-(2-hydroxyethyl)piperazin-1-yl]phenyl]amino]quinazolin-8-yl]phenyl]acrylamide|OLAFERTINIB [INN]|UNII-708TLB8J3Y|OLAFERTINIB [WHO-DD]|GTPL9863|CHEMBL4297486|SCHEMBL16514522|C29H28F2N6O2|BDBM318916|CK101|RX518|BCP19075|EX-A1142|MFCD30345533|US10172868, Compound C151|AC-35884|DS-19272|HY-19815|CS-0016788|Example 153 [US20170050936A1]|F17404|A911365|J-690231|RX 518;RX518;EGFR-IN-3;CK101;CK-101;CK 101|[(6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetic acid|145379-14-2",530.600,C29H28F2N6O2,93.600,815.000,4.300,39,3,9,8,"InChI=1S/C29H28F2N6O2/c1-2-25(39)33-21-7-3-5-19(17-21)22-8-4-6-20-18-32-29(35-28(20)22)34-23-9-10-24(27(31)26(23)30)37-13-11-36(12-14-37)15-16-38/h2-10,17-18,38H,1,11-16H2,(H,33,39)(H,32,34,35)",C=CC(=O)NC1=CC=CC(=C1)C2=CC=CC3=CN=C(N=C32)NC4=C(C(=C(C=C4)N5CCN(CC5)CCO)F)F,C=CC(=O)NC1=CC=CC(=C1)C2=CC=CC3=CN=C(N=C32)NC4=C(C(=C(C=C4)N5CCN(CC5)CCO)F)F,IDRGFNPZDVBSSE-UHFFFAOYSA-N,"N-[3-[2-[2,3-difluoro-4-[4-(2-hydroxyethyl)piperazin-1-yl]anilino]quinazolin-8-yl]phenyl]prop-2-enamide",530.224,530.224,0,1,0,0,0,0,0,0,0,0,46,7,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents,7,1796605|1804410|1806453|1806454|1806455|1806456|1806457|1806458,20160223,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Activate Scientific|AEchem Scientific Corp., USA|Alichem|Amadis Chemical|Ambeed|Angel Pharmatech Ltd.|Ark Pharm, Inc.|AstaTech, Inc.|BenchChem|BindingDB|BioChemPartner|Biosynth|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Combi-Blocks|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Key Organics/BIONET|King Scientific|Lan Pharmatech|MedChemexpress MCE|MolCore BioPharmatech|MolPort|NextMove Software|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Thoreauchem|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
156538665,PA4Pth5HL9,"BLU-945|2660250-10-0|BLU945|PA4PTH5HL9|UNII-PA4PTH5HL9|Egfr mutant-selective inhibitor BLU-945|3-Isoquinolinamine, N-(2-((3S,4R)-3-fluoro-4-methoxy-1-piperidinyl)-4-pyrimidinyl)-5-(1-methylethyl)-8-((2R,3S)-2-methyl-3-((methylsulfonyl)methyl)-1-azetidinyl)-|N-[2-[(3S,4R)-3-fluoro-4-methoxypiperidin-1-yl]pyrimidin-4-yl]-8-[(2R,3S)-2-methyl-3-(methylsulfonylmethyl)azetidin-1-yl]-5-propan-2-ylisoquinolin-3-amine|CHEMBL5095169|SCHEMBL23579296|GTPL11948|BLU 945|GLXC-25704|EX-A6018|AKOS040759965|MS-30145|Compound 150 [WO2021133809A1]|HY-144680|CS-0433912|F78343|N-(2-((3S,4R)-3-Fluoro-4-methoxypiperidin-1-yl)pyrimidin-4-yl)-5-isopropyl-8-((2R,3S)-2-methyl-3-((methylsulfonyl)methyl)azetidin-1-yl)isoquinolin-3-amine",556.700,C28H37FN6O3S,109.000,922.000,4.600,39,1,10,8,"InChI=1S/C28H37FN6O3S/c1-17(2)20-6-7-24(35-14-19(18(35)3)16-39(5,36)37)22-13-31-27(12-21(20)22)32-26-8-10-30-28(33-26)34-11-9-25(38-4)23(29)15-34/h6-8,10,12-13,17-19,23,25H,9,11,14-16H2,1-5H3,(H,30,31,32,33)/t18-,19-,23+,25-/m1/s1",C[C@@H]1[C@H](CN1C2=C3C=NC(=CC3=C(C=C2)C(C)C)NC4=NC(=NC=C4)N5CC[C@H]([C@H](C5)F)OC)CS(=O)(=O)C,CC1C(CN1C2=C3C=NC(=CC3=C(C=C2)C(C)C)NC4=NC(=NC=C4)N5CCC(C(C5)F)OC)CS(=O)(=O)C,LIMFPAAAIVQRRD-BCGVJQADSA-N,"N-[2-[(3S,4R)-3-fluoro-4-methoxypiperidin-1-yl]pyrimidin-4-yl]-8-[(2R,3S)-2-methyl-3-(methylsulfonylmethyl)azetidin-1-yl]-5-propan-2-ylisoquinolin-3-amine",556.263,556.263,0,1,0,4,4,0,0,0,0,2,4,4,2D,NULL,Classification|Drug and Medication Information|Literature|Patents,5,NULL,20210821,"A2B Chem|AA BLOCKS|AbaChemScene|AbMole Bioscience|AKos Consulting & Solutions|Ambeed|AstaTech, Inc.|ChEMBL|ChemIDplus|CymitQuimica|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|IUPHAR/BPS Guide to PHARMACOLOGY|Key Organics/BIONET|MedChemexpress MCE|PATENTSCOPE (WIPO)|Probes & Drugs portal|Starshine Chemical|SureChEMBL|Thieme Chemistry",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
91668194,Mavelertinib,"Mavelertinib|1776112-90-3|PF-06747775|Mavelertinib [USAN]|Egfr T790M inhibitor PF-06747775|N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide|YXX2180047|PF06747775|UNII-YXX2180047|2-Propenamide, N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)-3-pyrrolidinyl)-|2-Propenamide, N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-9-methyl-9H-purin-2-yl]-3-pyrrolidinyl]-|N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methylpyrazol-4-yl)amino]-9-methylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide|Mavelertinib (USAN/INN)|MAVELERTINIB [INN]|MAVELERTINIB [WHO-DD]|GTPL9765|CHEMBL3989970|SCHEMBL16714537|EX-A4999|BDBM50450870|MFCD29079007|NSC788365|NSC-788365|compound 21 [PMID: 28287730]|AC-33593|HY-12972|MS-27202|PF6747775|CS-0012907|PF 6747775|J3.645.972G|PF 06747775|C92352|D11368|PF-06747775, >=98% (HPLC)|N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol -4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide|N-((3R,4R)-4-FLUORO-1-(6-((3-METHOXY-1-METHYL-PYRAZOL-4-YL)AMINO)-9-METHYL-PURIN-2-YL)PYRROLIDIN-3-YL)PROP-2-ENAMIDE",415.400,C18H22FN9O2,115.000,643.000,1.200,30,2,9,6,"InChI=1S/C18H22FN9O2/c1-5-13(29)21-11-8-28(6-10(11)19)18-23-15(14-16(24-18)26(2)9-20-14)22-12-7-27(3)25-17(12)30-4/h5,7,9-11H,1,6,8H2,2-4H3,(H,21,29)(H,22,23,24)/t10-,11-/m1/s1",CN1C=C(C(=N1)OC)NC2=C3C(=NC(=N2)N4C[C@H]([C@@H](C4)F)NC(=O)C=C)N(C=N3)C,CN1C=C(C(=N1)OC)NC2=C3C(=NC(=N2)N4CC(C(C4)F)NC(=O)C=C)N(C=N3)C,JYIUNVOCEFIUIU-GHMZBOCLSA-N,"N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methylpyrazol-4-yl)amino]-9-methylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide",415.188,415.188,0,1,0,2,2,0,0,0,0,4,282,69,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Safety and Hazards,8,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1345502|1364451|1364452|1364453|1364454|1364455|1364458|1364460|1364461|1364462|1364463|1364464|1364467|1364468|1364469|1364470|1364471|1364472|1364473|1364474|1364475|1364476|1364477|1364478|1364479|1364480|1364481|1364482|1364483|1364484|1364485|1364486|1364487|1364488|1364489|1364490|1364491|1364492|1364493|1364494|1364495|1364496|1364497|1364498|1364499|1364500|1364501|1364502|1364503|1364504|1364505|1364506|1364507|1364508|1364509|1364510|1364511|1364512|1364513|1364514|1364515|1364516|1364517|1364518|1364519|1364520|1364521|1364522|1364523|1364524|1364525|1364526|1364527|1364528|1364529|1364530|1364531|1364532|1364533|1364534|1364535|1364536|1364541|1364542|1364543|1364544|1364545|1364546|1364547|1364548|1364549|1364550|1364551|1364552|1364553|1364554|1364555|1364556|1671498,20150420,"A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|AstaTech, Inc.|BenchChem|BindingDB|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemShuttle|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DTP/NCI|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|NextMove Software|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sigma-Aldrich|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Thomson Pharma|Wikidata|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
25127713,Poziotinib,"Poziotinib|1092364-38-9|HM781-36B|NOV120101|UNII-OEI6OOU6IK|Poziotinib [INN]|NOV-120101|HM-781-36B|Poziotinib [USAN]|1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one|1-(4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one|OEI6OOU6IK|NOV-1201|HM-781-36|HM-78136B|MFCD28044290|1-[4-[[4-[(3,4-Dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-2-propen-1-one|HM 781-36B|2-Propen-1-one, 1-[4-[[4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-|1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one|1-[4-({4-[(3,4-DICHLORO-2-FLUOROPHENYL)AMINO]-7-METHOXYQUINAZOLIN-6-YL}OXY)PIPERIDIN-1-YL]PROP-2-EN-1-ONE|2-PROPEN-1-ONE, 1-(4-((4-((3,4-DICHLORO-2-FLUOROPHENYL)AMINO)-7-METHOXY-6-QUINAZOLINYL)OXY)-1-PIPERIDINYL)-|Poziotinib [USAN:INN]|D00YER|POZIOTINIB [WHO-DD]|C23H21Cl2FN4O3|Poziotinib (HM781-36B)|GTPL7903|SCHEMBL3391764|CHEMBL3545154|DTXSID80148853|EX-A528|HMS3673K03|AMY24248|BCP08270|WHO 9736|BDBM50468247|NSC783296|NSC800856|s7358|AKOS026674078|CCG-264748|CS-3942|DB12114|NOV 120101|NSC-783296|NSC-800856|SB16882|NCGC00386427-01|NCGC00386427-02|AC-29021|AS-74851|BP161454|HY-15730|Pan-Her/EGFR inhibitors (cancer), Hanmi|SY235762|HM 781-36|FT-0752903|A13044|J-690026|Q27088426|1-(4-((4-(3,4-DICHLORO-2-FLUOROANILINO)-7-METHOXYQUINAZOLIN-6-YL)OXY(PIPERIDIN-1-YL)PROP-2-EN-1-ONE|1-[4-[4-(3,4-Dichloro-2-fluorophenylamino)-7-methoxyquinazoline-6-yloxy]-1-piperidinyl]-2-propene-1-one",491.300,C23H21Cl2FN4O3,76.600,684.000,5.400,33,1,7,6,"InChI=1S/C23H21Cl2FN4O3/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26/h3-5,10-13H,1,6-9H2,2H3,(H,27,28,29)",COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C,COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C,LPFWVDIFUFFKJU-UHFFFAOYSA-N,"1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one",490.097,490.097,0,1,0,0,0,0,0,0,0,139,1557,380,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents,7,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1296008|1296009|1341757|1341758|1341759|1341760|1341761|1341762|1341763|1341764|1341765|1341766|1341767|1345084|1345502|1345572|1345653|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347159|1347160|1347411|1409598|1424365|1424366|1424369|1424370|1424371|1424373|1424376|1424381|1424889|1424890|1424891|1424892|1424894|1424895|1424896|1424899|1424900|1424901|1424902|1424904|1424905|1424907|1424908|1424909|1424910|1424911|1424912|1424915|1424917|1424919|1424920|1424921|1424922|1424923|1424924|1424925|1424926|1424928|1424929|1424930|1424931|1424933|1424934|1424937|1424939|1424940|1424941|1424942|1424944|1424945|1424946|1424947|1424948|1424949|1424950|1424951|1424952|1424953|1424954|1424955|1424957|1424960|1424961|1424962|1424963|1424964|1424966|1424967|1424969|1424970|1424971|1424972|1424973|1424975|1424977|1424978|1424979|1424980|1424981|1424983|1424984|1424985|1424986|1424988|1424989|1424990|1424991|1424992|1424993|1424994|1424995|1424996|1424997|1424998|1425000|1425001|1425002|1425003|1425004|1425006|1425007|1425008|1425009|1425010|1425011|1425012|1425013|1425014|1425016|1425017|1425018|1425021|1425022|1425023|1425026|1425027|1425028|1425029|1425030|1425033|1425034|1425035|1425036|1425037|1425038|1425039|1425040|1425042|1425043|1425044|1425045|1425046|1425047|1425048|1425049|1425050|1425051|1425052|1425053|1425054|1425055|1425056|1425057|1425058|1425059|1425060|1425061|1425062|1425063|1425064|1425065|1425067|1425068|1425069|1425070|1425071|1425072|1425073|1425074|1425076|1425077|1425078|1425081|1425082|1425083|1425085|1425086|1425087|1425089|1425090|1425093|1425094|1425095|1425096|1425097|1425098|1425099|1425100|1425101|1425103|1425104|1425105|1425106|1425108|1425110|1425111|1425114|1425115|1425116|1425117|1425118|1425121|1425122|1425123|1425124|1425125|1425126|1425127|1425129|1425130|1425131|1425132|1425133|1425135|1425136|1425137|1425138|1425140|1425141|1425142|1425143|1425144|1425145|1425146|1425147|1425148|1425149|1425150|1425151|1425152|1425153|1425154|1425155|1425156|1425157|1425158|1425159|1425160|1425161|1425162|1425163|1425164|1425165|1425166|1425167|1425168|1425169|1425170|1425171|1425172|1425173|1425174|1425175|1425176|1425177|1425178|1425179|1425180|1425181|1425182|1425183|1425184|1425185|1425186|1425187|1425188|1425189|1425190|1425191|1425192|1425193|1425194|1425195|1425196|1425197|1425199|1425200|1425201|1425202|1425203|1425204|1425206|1425207|1425208|1425209|1425210|1425211|1425212|1425213|1508601|1508620|1595616|1595617|1616559|1616560|1616561|1616562|1616563|1640020|1645758|1645759|1645760|1645761|1645840|1645841|1645842|1645844|1645845|1645846|1645847|1645851|1645870|1645876|1645877|1671188|1671193|1671498|1676503|1676504|1676505|1676506|1676507|1676508|1676509|1676510|1676528|1676529|1676530|1676531|1676533|1745853|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800|1806610,20090119,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Aceschem Inc|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AKos Consulting & Solutions|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|AstaTech, Inc.|Aurora Fine Chemicals LLC|Axon Medchem|B&C Chemical|BenchChem|BindingDB|BioChemPartner|Biosynth|BOC Sciences|Boerchem|Broad Institute|Cangzhou Enke Pharma Tech Co.,Ltd.|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Clearsynth|Cooke Chemical Co., Ltd|Cyclic PharmaTech|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|MedChemexpress MCE|MolCore BioPharmatech|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextMove Software|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|PATENTSCOPE (WIPO)|Probes & Drugs portal|Race Chemical|RR Scientific|SCRIPDB|Selleck Chemicals|Sinfoo Biotech|Smolecule|Springer Nature|Starshine Chemical|Sun-shine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|Therapeutic Target Database (TTD)|Thomson Pharma|ToxPlanet|TubePharm|Uchem Meditech|University of Kansas High Throughput Screening Laboratory|Up-Fluorochem|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
123631,Gefitinib,"Gefitinib|184475-35-2|Iressa|ZD1839|N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine|Irressat|gefitinib (zd1839)|ZD 1839|ZD-1839|Gefitinib [USAN]|N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine|C22H24ClFN4O3|Gefitinib (GMP)|Iressa(TM)|Iressa (TN)|N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine|N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine|CCRIS 9011|4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|MFCD04307832|CHEMBL939|NSC-759856|UNII-S65743JHBS|Gefitinib (JAN/USAN/INN)|Gefitinib [USAN:INN:BAN]|S65743JHBS|DTXSID8041034|CHEBI:49668|N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine|NCGC00159455-02|N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine|3-Chloro-4-Fluoro-N-[(4z)-7-Methoxy-6-(3-Morpholin-4-Ylpropoxy)quinazolin-4(1h)-Ylidene]aniline|CU-00000000396-1|DTXCID6021034|4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-|4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-4-morpholin)propoxy)-|6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine|IRE|CAS-184475-35-2|SR-00000000262|gefitinibum|Gefitini|Gefitini; Iressa|4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-|N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|gefitinib (iressa)|Gefitinib - Iressa|Iressa (AstraZeneca)|nchembio866-comp14|Kinome_3321|Kinome_3322|GEFITINIB [INN]|GEFITINIB [JAN]|GEFITINIB [MI]|GEFITINIB [VANDF]|D09XZB|GEFITINIB [MART.]|GEFITINIB [WHO-DD]|SCHEMBL7866|Gefitinib,Iressa, ZD1839|Gefitinib,ZD-1839,Iressa|GEFITINIB [EMA EPAR]|KBioSS_002241|MLS003899193|BDBM5447|cid_123631|GTPL4941|GEFITINIB [ORANGE BOOK]|ZD-1839, Iressa, Gefitinib|GEFITINIB [EP MONOGRAPH]|Gefitinib, >=98% (HPLC)|BCPP000221|HMS2089B19|HMS3244M21|HMS3244M22|HMS3244N21|HMS3295A21|HMS3413H08|HMS3654A07|HMS3677H08|HMS3714A05|HMS3748E17|Pharmakon1600-01502274|BCP01365|C22-H24-Cl-F-N4-O3|Tox21_111683|HY-50895G|NSC715055|NSC759856|NSC800105|s1025|STK621310|AKOS000280752|Tox21_111683_1|AB20814|AC-1556|BCP9000718|CCG-220642|CS-0124|DB00317|KS-1204|NSC 759856|NSC-715055|NSC-800105|4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-(3-morpholinopropoxy)quinazoline|N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide|NCGC00159455-03|NCGC00159455-04|NCGC00159455-05|NCGC00159455-06|NCGC00159455-08|NCGC00159455-09|NCGC00159455-14|BCB03_000781|BG164498|HY-50895|SMR002204119|SY002154|LS-139916|AM20090619|CS-0622782|FT-0602325|G0546|SW199108-4|EC-000.2409|D01977|EN300-123024|G-4408|K00240|AB01273954-01|AB01273954-02|AB01273954-03|AB01273954_04|A812870|Q417824|Q-201149|SR-00000000262-2|SR-00000000262-3|Gefitinib, EuropePharmacopoeia (EP) Reference Standard|Z1546610485|4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)-quinazoline|Gefitinib for system suitability, EuropePharmacopoeia (EP) Reference Standard|(3-CHLORO-4-FLUORO-PHENYL)-[7-METHOXY-6-(3-MORPHOLIN-4-YL-PROPOXY)-QUINAZOLIN-4-YL]-AMINE",446.900,C22H24ClFN4O3,68.700,545.000,4.100,31,1,8,8,"InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)",COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,XGALLCVXEZPNRQ-UHFFFAOYSA-N,N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine,446.152,446.152,0,1,0,0,0,0,0,0,0,15710,70461,19495,2D+3D,Gefitinib,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,14,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|393|514|880|881|894|1030|1379|1433|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1688|1726|1727|1728|1729|1731|1732|1742|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|2662|7892|66608|68106|69416|69565|69892|91107|94336|127927|127928|127929|201868|202680|256559|256560|256561|256562|256563|256564|256565|256566|256567|256568|256569|256570|256571|256572|256573|256574|256575|256576|256577|256578|256579|256580|256581|256582|256583|256584|256585|256586|256587|256588|256589|256590|256591|256592|256593|256594|256595|256596|256597|256598|256599|256600|256601|256602|256603|256604|256605|256606|256607|256608|256609|256610|256611|256612|256613|256614|256615|256616|256617|256618|256619|256620|256621|256622|256623|256624|256625|256626|256627|256628|256629|256630|256631|256632|256633|256634|256635|256636|256637|256638|256639|256640|256641|256642|256643|256644|256645|256646|256647|256648|256649|256650|256651|256652|256653|256654|256655|256656|256657|256658|256659|256660|256661|256662|256663|256664|256665|256666|256667|256668|256669|256670|256671|256672|256673|256674|256675|256676|256677|260895|260896|260898|260903|264807|264808|269265|271124|271125|271126|271127|271128|271129|271130|271131|271132|271133|271134|271135|271136|271137|271143|271144|271146|271147|271149|271150|271152|271153|271154|271155|295762|295765|295768|295769|295770|295771|295772|295773|310063|311524|345874|345876|360729|371183|394660|394661|394662|394664|394728|394729|394730|394731|394732|394882|394883|394884|395851|395852|404304|410943|410944|410945|410946|428424|428425|433870|433871|433872|435146|435147|435148|435149|435150|435151|435152|435153|435154|435155|435156|435157|435158|435159|435160|435161|435162|435163|435164|435165|435166|435167|435168|435169|435170|435171|435180|435181|435182|435183|435184|435188|435189|435190|435191|435192|435193|435194|435195|435196|435197|435198|435199|435200|435201|435202|435203|435204|435274|435275|435276|435277|435278|435279|435280|435281|435282|435283|435284|435285|435286|435287|435288|435289|435290|435291|435292|435293|435294|435295|435296|435297|435310|435311|435312|435318|435319|435320|435321|435322|435323|435324|435325|435326|435327|435328|435329|435393|435394|435395|435396|435397|435398|435399|435400|435401|435402|435403|435404|435405|435406|435407|435408|435409|435410|435411|435412|435413|435414|435415|435429|435430|435431|435432|435433|435434|435438|435439|435440|435441|435442|435443|435444|435445|435514|435515|435516|435517|435518|435519|435520|435521|435522|435523|435524|435525|435526|435527|435528|435529|435530|435531|435532|435533|435534|435545|435546|435551|435552|435553|435554|435555|435556|435557|435558|435559|435560|435561|435562|435563|435564|435644|435645|435646|435647|435648|435649|435650|435651|435652|435653|435654|435655|435656|435657|435658|435659|435660|435661|435662|435663|435664|435665|435666|435667|435674|435675|435676|435677|435678|435679|435687|435688|435689|435690|435691|435692|435693|435694|435775|435776|435777|435778|435779|435780|435781|435782|435783|435784|435785|435786|435787|435788|435789|435790|435791|435792|435793|435794|435795|435796|435797|435798|435799|435800|435801|435802|435803|435804|435805|435806|435807|435808|435821|435822|435823|435826|435827|435828|435829|435830|435831|435832|435833|435834|435835|435896|435897|435898|435899|435900|435901|435902|435903|435904|435905|435906|435907|435908|435909|435910|435911|435912|435924|435925|435926|435929|435930|435931|435932|435933|435934|435935|435936|435937|435938|435939|435940|435941|436004|436005|436006|436007|436008|436009|436010|436011|436012|436013|436014|436015|436016|436017|436018|436019|436020|436021|436022|436023|436024|436025|436032|436033|436034|436042|436043|436044|436045|436046|436047|436048|436049|436050|436051|436052|436053|436054|436055|449028|449029|451987|451988|456588|456589|456590|456591|456593|456903|456904|457035|457038|457039|457043|457044|463638|463639|477295|484274|484275|484280|484386|485281|485290|488708|488709|488710|488711|488712|488713|488715|488716|488717|488722|488724|488727|488728|488731|488734|488735|489609|489615|489616|489617|489618|489619|489620|492109|492110|492111|492961|493040|504327|504332|504749|504832|504834|504847|504865|507072|507073|507074|507075|507076|507077|507079|507080|507081|507082|507083|507084|507085|507421|507422|507423|507424|512580|512581|512582|528332|528338|528339|528340|537733|537734|537735|537736|540209|540210|540211|540212|540213|552132|552133|580189|580190|588210|588211|588212|588213|588579|588834|589039|589577|589578|589579|589580|589582|589662|599779|599780|599781|599957|599959|602332|611842|619785|619787|619789|619791|619792|619793|624030|624031|624032|624044|624170|624172|624173|624296|624297|624349|624392|624476|624478|624479|624702|624703|624704|624705|624706|624707|624708|624709|624710|624711|624712|624713|624714|624715|624716|624717|624718|624719|624720|624721|624722|624723|624724|624725|624726|624727|624728|624729|624730|624731|624732|624733|624734|624735|624736|624737|624738|624739|624740|624741|624742|624743|624744|624745|624746|624747|624748|624749|624750|624751|624752|624753|624754|624755|624756|624757|624758|624759|624760|624761|624762|624763|624764|624765|624766|624767|624768|624769|624770|624771|624772|624773|624774|624775|624776|624777|624778|624779|624780|624781|624782|624783|624784|624785|624786|624787|624788|624789|624790|624791|624792|624793|624794|624795|624796|624797|624798|624799|624800|624801|624802|624803|624804|624805|624806|624807|624808|624809|624810|624811|624812|624813|624814|624815|624816|624817|624818|624819|624820|624821|624822|624823|624824|624825|624826|624827|624828|624829|624830|624831|624832|624833|624834|624835|624836|624837|624838|624839|624840|624841|624842|624843|624844|624845|624846|624847|624848|624849|624850|624851|624852|624853|624854|624855|624856|624857|624858|624859|624860|624861|624862|624863|624864|624865|624866|624867|624868|624869|624870|624871|624872|624873|624874|624875|624876|624877|624878|624879|624880|624881|624882|624883|624884|624885|624886|624887|624888|624889|624890|624891|624892|624893|624894|624895|624896|624897|624898|624899|624900|624901|624902|624903|624904|624905|624906|624907|624908|624909|624910|624911|624912|624913|624914|624915|624916|624917|624918|624919|624920|624921|624922|624923|624924|624925|624926|624927|624928|624929|624930|624931|624932|624933|624934|624935|624936|624937|624938|624939|624940|624941|624942|624943|624944|624945|624946|624947|624948|624949|624950|624951|624952|624953|624954|624955|624956|624957|624958|624959|624960|624961|624962|624963|624964|624965|624966|624967|624968|624969|624970|624971|624972|624973|624974|624975|624976|624977|624978|624979|624980|624981|624982|624983|624984|624985|624986|624987|624988|624989|624990|624991|624992|624993|624994|624995|624996|624997|624998|624999|625000|625001|625002|625003|625004|625005|625006|625007|625008|625009|625010|625011|625012|625013|625014|625015|625016|625017|625018|625019|625020|625021|625022|625023|625024|625025|625026|625027|625028|625029|625030|625031|625032|625033|625034|625035|625036|625037|625038|625039|625040|625041|625042|625043|625044|625045|625046|625047|625048|625049|625050|625051|625052|625053|625054|625055|625056|625057|625058|625059|625060|625061|625062|625063|625064|625065|625066|625067|625068|625069|625070|625071|625072|625073|625074|625075|625076|625077|625078|625079|625080|625081|625082|625083|625084|625085|625086|625087|625088|625089|625090|625091|625092|625093|625094|625095|625096|625097|625098|625099|625100|625101|625102|625103|625104|625105|625106|625107|625108|625109|625110|625111|625112|625113|625114|625115|625116|625117|625118|625119|625120|625121|625122|625123|625124|625125|625126|625127|625128|625129|625130|625131|625132|625133|625134|625135|625136|625137|625138|625139|625140|625141|625142|625143|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|627040|627042|627045|627046|633730|633731|634927|634928|634930|638068|638084|644745|644746|651631|651632|651633|651634|651635|651645|651646|651696|651712|651713|651784|651789|651821|651828|651957|651958|652010|652017|652039|652048|652051|652067|652126|652257|661590|662510|662512|662578|662580|662596|662597|662598|662599|662600|662616|662617|666828|666829|666830|666831|670513|670514|670515|670516|670517|674789|674792|674793|674794|678801|679514|686940|686947|686950|686964|686978|686979|687014|687016|695418|695419|695420|708784|708790|708797|708798|708799|708800|708801|708802|708803|708980|708981|708982|708990|720508|720509|720516|720532|720533|720543|720552|720582|720596|720634|720635|720637|720641|720648|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720700|720702|720704|720717|720719|720725|729550|729551|729552|739693|739694|740935|740936|741697|741698|741699|741701|741702|741703|741704|741705|741706|741708|741710|741711|741712|741713|741714|741718|741719|741720|741721|741722|741723|741725|741726|741728|741729|741731|741735|741736|741737|741738|741739|741740|741741|741742|741744|741745|741748|741750|741751|741752|741753|741754|741757|741758|741759|741761|741762|741763|741766|741767|741768|741770|741771|741774|741775|741777|741778|741779|741780|741781|741782|741783|741784|741785|741786|741787|741788|741789|741790|741791|741792|741793|741794|741795|741797|741798|741799|741800|741801|741802|741803|741805|741806|741807|741808|741809|741810|741812|741814|741815|741816|741817|741818|741820|741821|741822|741823|741826|741827|741828|741830|741831|741833|741834|741835|741837|741838|741840|741841|741842|741843|741844|741845|741846|741848|741849|741850|741852|741853|741854|741855|741856|741857|741860|741861|741863|741864|74186,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Abbott Labs|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|Ambit Biosciences|AN PharmaTech|Angel Pharmatech Ltd.|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Arromax Pharmatech Co., Ltd|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BenchChem|BerrChem|BindingDB|BioChemPartner|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|CEGChem|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|Chemenu Inc.|ChemFaces|Chemical Carcinogenesis Research Information System (CCRIS)|Chemical Probes Portal|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemieTek|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemShuttle|ChemSpider|ChemTik|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Columbia University Molecular Screening Center|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|Crystallography Open Database|CSNpharm|Cure First|CymitQuimica|DAOGE BIOPHARMA|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|Ennopharm|eNovation Chemicals|EPA DSSTox|Exclusive Chemistry Ltd|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|ForeChem|Founder Pharma|Glentham Life Sciences Ltd.|Google Patents|Gulick Lab, Department of Structural Biology, University at Buffalo|Hairui Chemical|Hangzhou APIChem Technology|Hefei Hirisun Pharmatech Co., Ltd|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LeadScope|LGC Standards|MassBank of North America (MoNA)|Matrix Scientific|Mcule|MedChemexpress MCE|Metabolomics Workbench|Milbrandt Lab, Department of Genetics, Washington University School of Medicine|MLSMR|MolCore BioPharmatech|Molepedia|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NCBI Structure|NextBio|NextMove Software|NIAID ChemDB|NIH/NCATS RNAi|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|Norris Pharm|NovoSeek|Oakwood Products|OChem|Parchem|PATENTSCOPE (WIPO)|Phion Ltd|Pi Chemicals|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Prous Science Drugs of the Future|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|Santagata Laboratory - Brigham and Women's Hospital and Harvard Medical School|SCRIPDB|Selleck Chemicals|SGCOxCompounds|Shanghai Institute of Organic Chemistry|Shanghai Mathcon Pharmaceutical Co.,LTD.|Shanghai Send Pharmaceutical Technology Co., Ltd|Sigma-Aldrich|SLING Consortium|Smolecule|Southern Research Institute|Springer Nature|Starshine Chemical|SureChEMBL|Synblock Inc|Syntree|TargetMol|TCI (Tokyo Chemical Industry)|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|The Scripps Research Institute Molecular Screening Center|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Thoreauchem|Tocris Bioscience|Tox21|ToxPlanet|TripleBond|Uchem Meditech|UCSC Chemical Screening Center|University of Iowa High-Throughput Screening Core (UIHTS)|University of Kansas High Throughput Screening Laboratory|Vitas-M Laboratory|VladaChem|W&J PharmaChem|Wikidata|Wiley|Win-Win Chemical|Wolves R&D chemical|Wutech|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
22024915,Icotinib,"Icotinib|610798-31-7|Conmana|BPI-2009|N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine|UNII-9G6U5L461Q|CHEMBL2087361|BPI2009|9G6U5L461Q|N-(3-ethynylphenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.014,19]icosa-1(12),13,15,17,19-pentaen-18-amine|(1,4,7,10)Tetraoxacyclododecino(2,3-g)quinazolin-4-amine, N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-|N-(3-ethynylphenyl)-7H,8H,10H,11H,13H,14H-1,4,7,10-tetraoxacyclododeca[2,3-g]quinazolin-4-amine|Lcotinib|icotinib,BPI-2009H|ICOTINIB [WHO-DD]|GTPL7641|SCHEMBL5843603|DTXSID20209952|EX-A306|HMS3651F12|4-((3-ethynylphenyl)amino)-6,7-benzo-12-crown-4-quinazoline|BCP21716|BPI 2009|BDBM50391089|HY-15164A|MFCD22124501|NSC800770|s2922|AKOS030231301|CCG-264757|DB11737|NSC-800770|SB16602|NCGC00386224-06|AC-32044|AS-55948|FT-0701617|SW219698-1|D11251|A868809|Q16868421|(3-Ethynyl-phenyl)(7,8,10,11,13,14-hexahydro-6,9,12,15-tetraoxa-1,3-diazacyclododeca[b]naphthalen-4-yl)-amine|N-(3-ethynylphenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.0^{14,19]icosa-1(12),13,15,17,19-pentaen-18-amine",391.400,C22H21N3O4,74.700,553.000,3.100,29,1,7,3,"InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20/h1,3-5,12-15H,6-11H2,(H,23,24,25)",C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4,C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4,QQLKULDARVNMAL-UHFFFAOYSA-N,"N-(3-ethynylphenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.014,19]icosa-1(12),13,15,17,19-pentaen-18-amine",391.153,391.153,0,1,0,0,0,0,0,0,0,493,53,19,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Toxicity,9,683479|683480|683481|683482|683483|683484|683485|683486|683487|683488|683489|683490|683491|1159395|1159396|1259398|1259399|1259416|1259421|1259423|1345502|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347080|1347411|1409598|1409605|1424889|1424890|1424891|1424892|1424893|1424894|1424895|1424896|1424897|1424898|1424899|1424900|1424901|1424902|1424904|1424905|1424906|1424907|1424908|1424909|1424910|1424911|1424912|1424914|1424915|1424916|1424917|1424918|1424919|1424920|1424921|1424922|1424923|1424924|1424925|1424926|1424928|1424929|1424930|1424931|1424932|1424933|1424934|1424935|1424936|1424937|1424939|1424940|1424941|1424942|1424943|1424944|1424945|1424946|1424947|1424948|1424949|1424950|1424951|1424952|1424953|1424954|1424955|1424956|1424957|1424958|1424959|1424960|1424961|1424962|1424963|1424964|1424966|1424967|1424968|1424969|1424970|1424971|1424972|1424973|1424974|1424975|1424976|1424977|1424978|1424979|1424980|1424981|1424982|1424983|1424984|1424985|1424986|1424987|1424988|1424989|1424990|1424991|1424992|1424993|1424994|1424995|1424996|1424997|1424998|1424999|1425000|1425001|1425002|1425003|1425004|1425005|1425006|1425007|1425008|1425009|1425010|1425011|1425012|1425013|1425014|1425016|1425017|1425018|1425019|1425020|1425021|1425022|1425023|1425024|1425025|1425026|1425027|1425028|1425029|1425030|1425033|1425034|1425035|1425036|1425037|1425038|1425039|1425040|1425041|1425042|1425043|1425044|1425045|1425046|1425047|1425048|1425049|1425050|1425051|1425052|1425053|1425054|1425055|1425056|1425057|1425058|1425059|1425060|1425061|1425062|1425063|1425064|1425065|1425066|1425067|1425068|1425069|1425070|1425071|1425072|1425073|1425074|1425075|1425076|1425077|1425078|1425079|1425080|1425081|1425082|1425083|1425084|1425085|1425086|1425087|1425088|1425089|1425090|1425093|1425094|1425095|1425096|1425097|1425098|1425099|1425100|1425101|1425102|1425103|1425104|1425105|1425106|1425107|1425108|1425109|1425110|1425111|1425112|1425115|1425116|1425117|1425118|1425119|1425120|1425121|1425122|1425123|1425124|1425126|1425127|1425128|1425129|1425130|1425131|1425133|1425134|1425135|1425136|1425137|1425138|1425140|1425141|1425142|1425143|1425144|1425145|1425146|1425147|1425148|1425149|1425150|1425151|1425153|1425154|1425155|1425156|1425157|1425158|1425159|1425160|1425161|1425162|1425163|1425164|1425165|1425166|1425167|1425168|1425169|1425170|1425171|1425172|1425173|1425174|1425175|1425176|1425177|1425178|1425179|1425180|1425181|1425182|1425183|1425185|1425186|1425187|1425188|1425189|1425190|1425191|1425192|1425193|1425194|1425195|1425196|1425197|1425198|1425199|1425200|1425201|1425202|1425203|1425204|1425206|1425207|1425208|1425209|1425210|1425211|1425212|1425213|1508586|1508601|1545480|1640020|1645758|1645845|1645846|1645870|1645876|1645877|1671498|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800|1795419|1797252|1797253|1797254|1797255,20071205,"001Chemical|4C Pharma Scientific Inc|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|AOBIOUS INC|ApexBio Technology|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BindingDB|BioChemPartner|BioCrick|BOC Sciences|Boerchem|Broad Institute|CEGChem|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|Cyclic PharmaTech|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|Human Metabolome Database (HMDB)|Hunan Huateng Pharmaceutical Co., Ltd.|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|Matrix Scientific|MedChemexpress MCE|MolCore BioPharmatech|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextMove Software|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|RR Scientific|SCRIPDB|Selleck Chemicals|Sinfoo Biotech|Smolecule|Springer Nature|Starshine Chemical|Sun-shine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|Thieme Chemistry|Thomson Pharma|ToxPlanet|Uchem Meditech|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory|VladaChem|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
121269225,Lazertinib,"Lazertinib|1903008-80-9|YH-25448|GNS-1480|YH25448|GNS1480|JNJ-73841937-AAA|Lazertinib [USAN]|C-18112003-G|N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylamide|N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide|4A2Y23XK11|2-Propenamide, N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)-|Leclaza|Lazertinib  [INN]|LAZERTINIB [INN]|Lazertinib [USAN:INN]|Lazertinib (YH25448)|LAZERTINIB [WHO-DD]|UNII-4A2Y23XK11|CHEMBL4558324|SCHEMBL17670400|GTPL10136|BCP30440|EX-A1912|BDBM50555575|s8724|WHO 10587|AKOS037515597|CCG-270023|Lazertinib (YH25448,GNS-1480)|YH-25448;GNS-1480|AC-36243|BS-15742|Compound 73 [WO2016060443A2]|HY-109061|CS-0032992|A16827|A903188|YH-25448; YH 25448; YH25448; GNS-1480; GNS 1480; GNS1480|N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)acrylamide|N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide",554.600,C30H34N8O3,110.000,837.000,3.400,41,2,9,10,"InChI=1S/C30H34N8O3/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21/h5-12,17-18,20H,1,13-16,19H2,2-4H3,(H,32,39)(H,31,33,34)",CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC,CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC,RRMJMHOQSALEJJ-UHFFFAOYSA-N,N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide,554.275,554.275,0,1,0,0,0,0,0,0,0,48,293,100,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards,9,1640020|1645758|1702613|1702614|1702615|1702616|1702617|1702618|1702619|1702620|1806384,20160806,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|Activate Scientific|Adooq BioScience|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Angel Pharmatech Ltd.|Ark Pharm, Inc.|BenchChem|BindingDB|BioChemPartner|BOC Sciences|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemShuttle|Cooke Chemical Co., Ltd|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|IUPHAR/BPS Guide to PHARMACOLOGY|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|NextMove Software|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Springer Nature|Starshine Chemical|Sun-shine Chemical|SureChEMBL|TargetMol|THE BioTek|University of Kansas High Throughput Screening Laboratory",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
54758501,Olmutinib,"Olmutinib|1353550-13-6|HM61713|1802181-20-9|BI 1482694|Olmutinib [INN]|HM-61713|Olmutinib [WHO-DD]|BI-1482694|HM-61713 (BI-1482694)|olita|N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide|CHL9B67L95|N-(3-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylamide|olmutinib HCl|HM 61713|2-Propenamide, N-(3-((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)-|N-{3-[(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}thieno[3,2-d]pyrimidin-4-yl)oxy]phenyl}prop-2-enamide|2-Propenamide, N-[3-[[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-|N-(3-((2-(4-(4-Methylpiperazin-1-yl)anilino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)prop-2-enamide|N-[3-({2-[4-(4-Methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl}oxy)phenyl]prop-2-enamide|HM71224;Olmutinib|Olmutinib (USAN/INN)|Olmutinib [USAN:INN]|OLMUTINIB [USAN]|Olmutinib(HM-71224)|UNII-CHL9B67L95|GTPL9196|CHEMBL3786343|SCHEMBL14914931|EX-A879|DTXSID001319119|BCP16733|BDBM50160871|MFCD29918158|NSC792848|NSC800980|s8294|AKOS030632791|CCG-269594|CS-5413|DB13164|NSC-792848|NSC-800980|SB19797|Example 1 [US20130116213]|AC-30225|AC-35418|AS-74850|HM 71224|HY-19730|BI1482694|FT-0700176|Olmutinib (HM61713, BI 1482694)|J3.435.413H|D10859|W12116|HM61713, BI 1482694|A900418|J-690142|Q27088175|4-{[4-({[(1R,2S)-2-Phenylcyclopropyl]amino}methyl)-1-piperidinyl]methyl}benzoic acid|BI1482694;BI 1482694;BI-1482694;HM 61713;HM-61713;HM61713|N-(3-(2-(4-(4 methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidine-4-yloxy)phenyl)acrylamide|N-(3-(2-(4-(4-methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidine-4-yloxy)phenyl)acrylamide|N-(3-{2-[4-(4-Methyl-piperazin-1-yl)-phenylamino]-thieno[3,2-d]pyrimidin-4-yloxy}-phenyl)-acrylamide",486.600,C26H26N6O2S,111.000,712.000,4.700,35,2,8,7,"InChI=1S/C26H26N6O2S/c1-3-23(33)27-19-5-4-6-21(17-19)34-25-24-22(11-16-35-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)",CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4,CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4,FDMQDKQUTRLUBU-UHFFFAOYSA-N,"N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide",486.184,486.184,0,1,0,0,0,0,0,0,0,92,1021,405,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Toxicity,9,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1291347|1304230|1345502|1347060|1347064|1347065|1347067|1347068|1347411|1347412|1357746|1357755|1409598|1409605|1622003|1622004|1622005|1622006|1622007|1640020|1645758|1645845|1645846|1645870|1645876|1645877|1703381|1703382|1703383|1703384|1703385|1703386|1703387|1703388|1703389|1703390|1703391|1703392|1703393|1703394|1703395|1703396|1703397|1703398|1703399|1703400|1703402|1703403|1703404|1703405|1724528|1724529|1724530|1724531|1724532|1724533|1724534|1724535|1724536|1724537|1724538|1724539|1724540|1724541|1724542|1724543|1724552|1724553|1724554|1724555|1724563|1724564|1724565|1738670|1738671|1738672|1738677|1738678|1738679|1738680|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794800,20120109,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Adooq BioScience|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Angel Pharmatech Ltd.|Ark Pharm, Inc.|Ark Pharma Scientific Limited|AstaTech, Inc.|BenchChem|BindingDB|BioChemPartner|Biosynth|BLD Pharm|BOC Sciences|Broad Institute|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Clearsynth|Combi-Blocks|Cooke Chemical Co., Ltd|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hangzhou APIChem Technology|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|NextMove Software|NIH/NCATS RNAi|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Selleck Chemicals|Smolecule|Springer Nature|Starshine Chemical|Sun-shine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|Thomson Pharma|Uchem Meditech|University of Kansas High Throughput Screening Laboratory|Wikidata|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
176870,Erlotinib,"Erlotinib|183321-74-6|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine|Tarceva|Erlotinib free base|4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline|Erlotinib [INN]|4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-|OSI-774|erlotinibum|Erlotinib Base|UNII-J4T82NDH7E|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine|J4T82NDH7E|Erlotinib(Tarceva)|DTXSID8046454|Erlotinib, Free Base|HSDB 8082|OSI 744|CHEBI:114785|Erlotinib [INN:BAN]|183321-74-6 (free base)|NSC 718781|CHEMBL553|RG-1415|[6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE|CP358774|CP-358,774|DTXCID6026454|CP-35877401|R 1415|R-1415|MFCD02089651|CP-358774|NCGC00164574-01|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|OSI-744|CAS-183321-74-6|NSC718781|Erlotinib, OS-774|SR-05000001460|Erlotinin|Erotinib|(6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl)-(3-ethynylphenyl)amine|(6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl)-(3-ethynyl-phenyl)-amine|nchembio866-comp3|Kinome_3317|n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride|ERLOTINIB [MI]|ERLOTINIB [VANDF]|D07POC|ERLOTINIB [WHO-DD]|SCHEMBL8413|ERLOTINIB [EMA EPAR]|BDBM5446|cid_176870|GTPL4920|L01XE03|HMS2089F05|HMS3244M19|HMS3244M20|HMS3244N19|HMS3295A19|HMS3713C22|HMS3745M05|Tox21_112202|AC-399|NSC800097|s7786|STK623143|AKOS000282911|Tox21_112202_1|CCG-220420|CS-0620|CS-O-31362|DB00530|NSC-800097|Ro-508231|SB16916|NCGC00164574-03|NCGC00164574-05|NCGC00164574-06|NCGC00164574-14|NCGC00164574-25|AS-35132|BCB03_000783|BE164419|HY-50896|SY028059|LS-184395|AM20090621|CP 358,774|FT-0651539|R1415|EN300-708808|K00241|AB01273955-01|AB01273955-02|AB01273955-03|Q418369|SR-05000001460-1|SR-05000001460-2|SR-05000001460-3|SR-05000001460-6|BRD-K70401845-003-04-7|Z2588038919|n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine|1429636-49-6",393.400,C22H23N3O4,74.700,525.000,3.300,29,1,7,11,"InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,AAKJLRGGTJKAMG-UHFFFAOYSA-N,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",393.169,393.169,0,1,0,0,0,0,0,0,0,15698,64480,18127,2D+3D,Erlotinib Hydrochloride,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,13,514|880|1433|1469|1471|1479|1487|1490|1688|1726|1727|1728|1729|1731|1732|1742|1766|1768|2165|2528|2546|2551|2662|7892|68106|69416|69892|91107|201868|202680|256559|256560|256561|256562|256563|256564|256565|256566|256567|256568|256569|256570|256571|256572|256573|256574|256575|256576|256577|256578|256579|256580|256581|256582|256583|256584|256585|256586|256587|256588|256589|256590|256591|256592|256593|256594|256595|256596|256597|256598|256599|256600|256601|256602|256603|256604|256605|256606|256607|256608|256609|256610|256611|256612|256613|256614|256615|256616|256617|256618|256619|256620|256621|256622|256623|256624|256625|256626|256627|256628|256629|256630|256631|256632|256633|256634|256635|256636|256637|256638|256639|256640|256641|256642|256643|256644|256645|256646|256647|256648|256649|256650|256651|256652|256653|256654|256655|256656|256657|256658|256659|256660|256661|256662|256663|256664|256665|256666|256667|256668|256669|256670|256671|256672|256673|256674|256675|256676|256677|260895|260896|260898|260903|310063|313401|313402|313405|360729|360730|360731|360733|360734|360735|360736|360737|360738|360937|360939|371183|381969|381970|381971|381972|383024|383025|383026|383027|383028|383029|383030|383031|383032|383033|383034|383035|383036|383037|383038|383039|383040|383041|383042|383043|383044|383045|383046|383047|383048|383050|383051|383052|383053|383054|383055|383056|383057|383058|383059|383060|383061|383062|383063|383064|383112|383113|383114|383115|383288|383289|383290|383384|383385|383386|383387|383388|383389|383390|383391|383392|383393|383394|383395|383396|383397|383398|383399|383400|383573|383574|383575|383576|383577|383578|383579|383580|383581|383582|383583|383584|383585|383586|383587|383588|383589|383590|383591|383592|383593|383594|383595|383596|383597|383598|383599|383600|383601|383602|383603|383604|383605|383606|383607|383608|383609|383610|383611|383612|383613|383614|383615|383616|383617|383618|383619|383620|383621|383622|383623|383624|383625|383626|383627|383628|383629|383630|383631|383632|383633|383634|383635|383636|383637|383638|383639|383640|383641|383642|383643|383644|383645|383646|383647|383648|383649|383650|383651|383652|383653|383654|383859|383860|383861|383862|383863|383864|383865|383866|383867|383868|383869|383870|383871|383872|383873|383874|383875|383876|383877|383878|383879|383880|383881|383882|383883|383884|383885|383886|383887|383888|383889|383890|383891|383892|383893|383894|383895|383896|383897|383898|383899|383900|383901|383902|383903|383904|383905|383906|383907|383908|383909|383910|383911|383912|383913|383914|383915|383916|383917|383918|383919|383920|383921|383922|383923|383924|383925|383926|383927|383928|383929|383930|383931|383932|383933|383934|383935|383936|383937|383938|383939|383940|384125|384126|384127|384128|384129|384130|384131|384132|384133|384134|384135|384136|384137|384138|384139|384140|384141|384142|384143|384144|384145|384146|384147|384148|384149|384150|384151|384152|384153|384154|384155|384156|384157|384158|384159|384160|384161|384162|384163|384164|384165|384166|384167|384168|384169|384170|384171|384172|384173|384174|384175|384176|384177|384178|384179|384180|384181|384182|384183|384184|384185|384186|384187|384188|384189|384190|384191|384192|384193|384194|384195|384196|384197|384198|384199|384200|384201|384202|384203|384204|384205|384206|384365|384366|384367|384368|384369|384370|384371|384372|384373|384374|384375|384376|384377|384378|384379|384380|384381|384382|384383|384384|384385|384386|384387|384388|384389|384390|384391|384392|384393|384394|384395|384396|384397|384398|384399|384400|384401|384402|384403|384404|384405|384406|384407|384408|384409|384410|384411|384412|384413|384414|384415|384416|384417|384418|384419|384420|384421|384422|384423|384424|384425|384426|384427|384428|384429|384430|384431|384432|384433|384434|384435|384436|384437|384438|384439|384440|384441|384442|384443|384444|384445|384613|384614|384615|384616|384617|384618|384619|384620|384621|384622|384623|384624|384625|384626|384627|384628|384629|384630|384631|384632|384633|384634|384635|384636|384637|384638|384639|384640|384641|384642|384643|384644|384645|384646|384647|384648|384649|384650|384651|384652|384653|384654|384655|384656|384657|384658|384659|384660|384661|384662|384663|384664|384665|384666|384667|384668|384669|384670|384671|384672|384673|384674|384675|384676|384677|384678|384679|384680|384681|384682|384683|384684|384685|384686|384687|384688|384689|384690|384691|384692|384693|384828|384829|384830|384831|384832|384833|384834|384835|384836|384837|384838|384839|384840|384841|384842|384843|384844|384845|384846|384847|384848|384849|384850|384851|384852|384853|384854|384855|384856|384857|384858|384859|384860|384861|384862|384863|384864|384865|384866|384867|384868|384869|384870|384871|384872|384873|384874|384875|384876|384877|384878|384879|384880|384881|384882|384883|384884|384885|384886|384887|384888|384889|384890|384891|384892|384893|384894|384895|384896|384897|384898|384899|384900|384901|384902|384903|384904|384905|384906|384907|384908|384909|384910|384911|384912|384913|384914|384915|384916|385016|385017|385018|385029|385040|385041|385042|385043|385044|385045|385046|385047|385048|385049|385050|385051|385052|385053|385054|385055|385056|385057|385058|385059|385060|385061|385062|385063|385064|385065|385066|385067|385068|385069|385070|385071|385072|385073|385074|385075|385076|385077|385078|385079|385080|385081|385082|385083|385084|385085|394662|395851|395852|404304|410943|410944|435146|435147|435148|435149|435150|435151|435152|435153|435154|435155|435156|435157|435158|435159|435160|435161|435162|435163|435164|435165|435166|435167|435168|435169|435170|435171|435180|435181|435182|435183|435184|435188|435189|435190|435191|435192|435193|435194|435195|435196|435197|435198|435199|435200|435201|435202|435203|435204|435274|435275|435276|435277|435278|435279|435280|435281|435282|435283|435284|435285|435286|435287|435288|435289|435290|435291|435292|435293|435294|435295|435296|435297|435310|435311|435312|435318|435319|435320|435321|435322|435323|435324|435325|435326|435327|435328|435329|435393|435394|435395|435396|435397|435398|435399|435400|435401|435402|435403|435404|435405|435406|435407|435408|435409|435410|435411|435412|435413|435414|435415|435429|435430|435431|435432|435433|435434|435438|435439|435440|435441|435442|435443|435444|435445|435514|435515|435516|435517|435518|435519|435520|435521|435522|435523|435524|435525|435526|435527|435528|435529|435530|435531|435532|435533|435534|435545|435546|435551|435552|435553|435554|435555|435556|435557|435558|435559|435560|435561|435562|435563|435564|435644|435645|435646|435647|435648|435649|435650|435651|435652|435653|435654|435655|435656|435657|435658|435659|435660|435661|435662|435663|435664|435665|435666|435667|435674|435675|435676|435677|435678|435679|435687|435688|435689|435690|435691|435692|435693|435694|435775|435776|435777|435778|435779|435780|435781|435782|435783|435784|435785|435786|435787|435788|435789|435790|435791|435792|435793|435794|435795|435796|435797|435798|435799|435800|435801|435802|435803|435804|435805|435806|435807|435808|435821|435822|435823|435826|435827|435828|435829|435830|435831|435832|435833|435834|435835|435896|435897|435898|435899|435900|435901|435902|435903|435904|435905|435906|435907|435908|435909|435910|435911|435912|435924|435925|435926|435929|435930|435931|435932|435933|435934|435935|435936|435937|435938|435939|435940|435941|436004|436005|436006|436007|436008|436009|436010|436011|436012|436013|436014|436015|436016|436017|436018|436019|436020|436021|436022|436023|436024|436025|436032|436033|436034|436042|436043|436044|436045|436046|436047|436048|436049|436050|436051|436052|436053|436054|436055|441961|441962|441963|441964|441965|441966|441967|441995|441997|455986|456090|456091|456092|456099|456100|456101|456588|456589|456590|456593|460689|460690|460691|461251|461252|461253|461254|461255|461256|461257|461258|461259|461260|461261|461262|461263|461264|461265|461266|461267|461268|461269|461300|463638|463639|473321|473322|473323|473324|473325|473326|473327|473328|473329|473330|473523|473524|473525|474115|474116|474117|477295|481815|481817|481818|485290|488708|488709|488710|488711|488712|488713|488715|488716|488717|492036|492037|492320|492321|492322|492961|493040|493204|493206|504327|504332|504534|504749|504832|504834|504847|504865|513986|513987|513988|513990|517322|517323|517324|580189|580190|588579|588834|589039|599957|599959|602332|612769|612770|612771|612772|616546|616547|618743|618744|619785|619787|619789|619791|619792|619793|620239|620240|620243|620244|624030|624031|624032|624044|624170|624172|624173|624296|624297|624349|624392|624476|624478|624479|624702|624703|624704|624705|624706|624707|624708|624709|624710|624711|624712|624713|624714|624715|624716|624717|624718|624719|624720|624721|624722|624723|624724|624725|624726|624727|624728|624729|624730|624731|624732|624733|624734|624735|624736|624737|624738|624739|624740|624741|624742|624743|624744|624745|624746|624747|624748|624749|624750|624751|624752|624753|624754|624755|624756|624757|624758|624759|624760|624761|624762|624763|624764|624765|624766|624767|624768|624769|624770|624771|624772|624773|624774|624775|624776|624777|624778|624779|624780|624781|624782|624783|624784|624785|624786|624787|624788|624789|624790|624791|624792|624793|624794|624795|624796|624797|624798|624799|624800|624801|624802|624803|624804|624805|624806|624807|624808|624809|624810|624811|624812|624813|624814|624815|624816|624817|624818|624819|624820|624821|624822|624823|624824|624825|624826|624827|624828|624829|624830|624831|624832|624833|624834|624835|624836|624837|624838|624839|624840|624841|624842|624843|624844|624845|624846|624847|624848|624849|624850|624851|624852|624853|624854|624855|624856|624857|624858|624859|624860|624861|624862|624863|624864|624865|624866|624867|624868|624869|624870|624871|624872|624873|624874|624875|624876|624877|624878|624879|624880|624881|624882|624883|624884|624885|624886|624887|624888|624889|624890|62,20050326,"001Chemical|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abbott Labs|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|Alfa Chemistry|Alsachim|Ambeed|Ambinter|Ambit Biosciences|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Arromax Pharmatech Co., Ltd|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BenchChem|BerrChem|BindingDB|BioChemPartner|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|BroadPharm|CEGChem|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemDB|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemShuttle|ChemSpider|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|Crystallography Open Database|CSNpharm|Cure First|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|Ennopharm|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|Exclusive Chemistry Ltd|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|ForeChem|Founder Pharma|Fragmenta|Glentham Life Sciences Ltd.|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LeadScope|LEAPCHEM|LGC Standards|Life Chemicals|MassBank of North America (MoNA)|Matrix Scientific|Mcule|MedChemexpress MCE|Metabolomics Workbench|MLSMR|MolCore BioPharmatech|Molepedia|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NCBI Structure|NextBio|NextMove Software|NIAID ChemDB|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|Novartis Institutes for BioMedical Research|NovoSeek|Oakwood Products|OChem|Parchem|PATENTSCOPE (WIPO)|Petrascheck Lab, The Scripps Reserach Institute, Department of  Molecular Medicine|Phion Ltd|Pi Chemicals|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Prous Science Drugs of the Future|PubChem Reference Collection|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|Santagata Laboratory - Brigham and Women's Hospital and Harvard Medical School|SCRIPDB|Selleck Chemicals|SGCOxCompounds|Shanghai Mathcon Pharmaceutical Co.,LTD.|Shanghai Send Pharmaceutical Technology Co., Ltd|Sigma-Aldrich|Sinfoo Biotech|SLING Consortium|SMID|Smolecule|Southern Research Institute|Springer Nature|Starshine Chemical|SureChEMBL|Synblock Inc|Syntree|TargetMol|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|The Scripps Research Institute Molecular Screening Center|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Thoreauchem|Tox21|ToxPlanet|Uchem Meditech|University of Kansas High Throughput Screening Laboratory|Vitas-M Laboratory|VladaChem|Wikidata|Wiley|Wubei-Biochem|Wutech|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
71496458,Osimertinib,"osimertinib|1421373-65-0|AZD-9291|AZD9291|Mereletinib|Tagrisso|AZD 9291|Osimertinib [USAN]|UNII-3C06JJ0Z2O|Mereletinib [INN]|N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide|3C06JJ0Z2O|AZD-9291 FREE BASE|N-(2-{[2-(Dimethylamino)ethyl](Methyl)amino}-4-Methoxy-5-{[4-(1-Methyl-1h-Indol-3-Yl)pyrimidin-2-Yl]amino}phenyl)prop-2-Enamide|MereletinibAZD-9291,Osimertinib|N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide|2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-|N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide|N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide|osimertinibum|N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)acrylamide|OSIMERTINIB [MI]|OSIMERTINIB [INN]|D0RT2C|Osimertinib (AZD9291)|Osimertinib; AZD-9291|mereletinib (obsolete INN)|OSIMERTINIB [WHO-DD]|GTPL7719|CHEMBL3353410|SCHEMBL14660911|CHEBI:90943|AMY9161|EX-A314|DTXSID501025961|HMS3653E10|HMS3672M05|BCP08626|BDBM50029668|MFCD27988062|NSC779217|NSC781254|NSC800812|s7297|AKOS025290756|C28-H33-N7-O2|CCG-264683|CS-2018|DB09330|NSC-779217|NSC-781254|NSC-800812|SB22952|NCGC00378622-03|NCGC00378622-04|NCGC00378622-10|AC-29019|AS-16943|HY-15772|4714B|SW219863-1|EN300-7382438|A854509|Q21506464|N(2{[2(diMethylaMino)ethyl](Methyl)aMino}4Methoxy5{[4(1Methyl1Hindol3yl)pyriMidin2yl]aMino}phenyl)prop2enaMide;Osimertinib|N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)acrylamide|N-(2-{2-Dimethylaminoethyl-methylamino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide",499.600,C28H33N7O2,87.600,752.000,3.700,37,2,7,10,"InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)",CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,DUYJMQONPNNFPI-UHFFFAOYSA-N,N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide,499.27,499.27,0,1,0,0,0,0,0,0,0,2194,7910,2316,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing,10,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1167101|1167102|1167103|1167104|1167108|1167109|1167110|1167115|1167116|1167117|1167119|1167120|1167121|1167122|1167123|1167130|1167145|1167146|1167147|1167148|1167149|1167154|1167155|1167156|1167157|1167158|1167159|1167161|1167162|1167164|1167165|1167166|1167167|1167169|1167170|1167171|1167172|1167175|1167176|1239424|1259416|1259421|1270377|1270378|1274037|1274046|1274049|1289545|1289546|1289547|1289550|1289551|1289554|1289555|1289556|1291334|1291335|1291336|1291342|1291343|1291344|1291345|1291346|1291352|1291353|1296008|1296009|1298660|1298661|1298662|1298670|1298671|1298672|1321092|1321093|1321094|1321095|1345084|1345502|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347080|1347159|1347160|1347411|1347412|1359368|1359369|1359370|1359371|1359372|1359373|1359379|1365584|1365586|1365587|1382529|1382530|1382531|1382532|1382533|1382534|1382535|1382539|1382540|1389852|1389853|1389854|1389855|1389856|1389857|1389858|1389859|1390632|1390633|1390634|1390635|1390636|1390638|1390640|1390641|1390643|1390644|1390645|1390646|1390647|1390648|1390649|1390650|1390651|1390652|1390653|1390654|1390655|1390656|1390657|1390658|1390659|1390660|1390661|1390662|1390663|1390664|1391276|1391277|1391278|1391281|1391282|1391283|1391284|1391285|1409579|1409580|1409581|1409598|1409605|1412315|1412316|1412317|1412318|1412319|1412320|1412324|1412325|1412326|1412327|1412328|1423824|1423825|1423827|1423830|1423831|1423832|1423833|1423834|1423835|1424210|1424889|1424890|1424891|1424892|1424894|1424895|1424896|1424898|1424899|1424900|1424901|1424902|1424904|1424905|1424907|1424908|1424909|1424910|1424911|1424912|1424914|1424915|1424917|1424918|1424919|1424920|1424921|1424922|1424923|1424924|1424925|1424926|1424927|1424928|1424929|1424930|1424931|1424932|1424933|1424934|1424935|1424937|1424939|1424940|1424941|1424942|1424944|1424945|1424946|1424947|1424948|1424949|1424950|1424951|1424952|1424953|1424954|1424955|1424956|1424957|1424958|1424959|1424960|1424961|1424962|1424963|1424964|1424965|1424966|1424967|1424968|1424969|1424970|1424971|1424972|1424973|1424974|1424975|1424976|1424977|1424978|1424979|1424980|1424981|1424983|1424984|1424985|1424986|1424987|1424988|1424989|1424990|1424991|1424992|1424993|1424994|1424995|1424996|1424997|1424998|1424999|1425000|1425001|1425002|1425003|1425004|1425006|1425007|1425008|1425009|1425010|1425011|1425012|1425013|1425014|1425015|1425016|1425017|1425018|1425019|1425020|1425021|1425022|1425023|1425024|1425025|1425026|1425027|1425028|1425029|1425030|1425033|1425034|1425035|1425036|1425037|1425038|1425039|1425040|1425042|1425043|1425044|1425045|1425046|1425047|1425048|1425049|1425050|1425051|1425052|1425053|1425054|1425055|1425056|1425057|1425058|1425059|1425060|1425061|1425062|1425063|1425064|1425065|1425066|1425067|1425068|1425069|1425070|1425071|1425072|1425073|1425074|1425077|1425078|1425079|1425080|1425081|1425082|1425083|1425084|1425085|1425086|1425087|1425088|1425089|1425090|1425091|1425092|1425093|1425094|1425095|1425096|1425097|1425098|1425099|1425100|1425104|1425105|1425106|1425107|1425108|1425109|1425110|1425111|1425113|1425115|1425116|1425117|1425118|1425119|1425121|1425122|1425123|1425124|1425125|1425126|1425127|1425128|1425129|1425130|1425131|1425133|1425134|1425136|1425137|1425138|1425140|1425141|1425142|1425143|1425144|1425145|1425146|1425147|1425148|1425149|1425150|1425153|1425154|1425155|1425156|1425157|1425158|1425159|1425160|1425161|1425162|1425163|1425164|1425165|1425166|1425167|1425168|1425169|1425170|1425171|1425172|1425173|1425174|1425175|1425176|1425177|1425178|1425179|1425181|1425182|1425183|1425185|1425186|1425187|1425188|1425189|1425190|1425191|1425192|1425193|1425195|1425196|1425198|1425199|1425200|1425201|1425202|1425203|1425204|1425206|1425207|1425208|1425209|1425210|1425211|1425212|1425213|1434568|1434569|1434570|1434571|1441907|1441910|1441911|1441912|1441913|1441914|1441929|1441930|1441931|1441937|1441938|1441939|1441940|1441941|1441942|1445468|1445469|1445470|1445472|1445473|1445474|1445475|1445476|1445477|1445479|1445480|1445481|1458976|1458977|1458978|1458979|1458980|1458981|1458982|1458983|1458984|1458985|1458986|1458987|1458988|1458989|1458990|1458991|1458992|1458993|1459011|1461706|1461707|1461708|1461709|1461710|1461711|1461712|1461713|1469776|1469777|1479144|1479145|1479146|1479147|1479148|1479149|1479150|1481308|1481309|1481310|1481311|1481312|1481313|1481314|1481315|1481316|1481317|1481318|1481319|1481348|1481349|1481350|1481351|1481353|1481354|1481355|1481356|1481357|1481358|1481359|1481360|1481369|1481370|1481371|1481372|1481437|1481438|1481439|1481440|1481441|1481442|1481443|1481444|1483366|1483367|1483368|1483369|1484430|1484431|1484432|1484433|1484434|1484435|1484436|1484437|1484438|1484439|1484440|1484441|1484442|1484443|1484444|1484445|1484446|1484447|1484448|1484449|1484450|1484451|1484452|1484453|1484454|1484455|1484456|1484457|1484458|1484459|1484460|1484461|1484462|1484463|1484475|1494156|1494157|1494158|1497672|1497673|1497674|1497678|1497679|1497680|1497681|1497685|1497686|1497691|1497692|1497693|1497694|1498607|1498608|1498610|1498611|1508586|1508598|1508601|1508620|1519411|1519412|1519413|1519414|1519415|1519417|1519418|1519419|1519420|1519421|1519430|1519431|1519432|1519440|1519442|1527519|1527520|1527521|1527522|1527525|1527526|1527527|1527528|1527529|1527530|1527532|1527533|1527534|1527541|1565416|1565417|1565418|1565419|1565420|1580125|1580126|1580127|1580128|1580129|1580130|1580131|1580132|1580133|1580134|1580135|1580136|1580137|1580138|1580139|1580140|1580141|1580142|1580143|1580144|1580145|1580148|1583835|1583836|1583837|1583838|1583839|1583840|1583841|1583842|1583843|1583844|1583845|1583851|1583855|1583862|1583863|1583865|1583867|1583869|1583870|1585283|1585284|1585285|1585286|1585287|1585288|1585289|1585290|1585291|1585292|1585293|1585294|1585295|1585296|1585297|1585298|1585299|1585300|1585301|1585302|1585303|1585304|1585308|1585312|1585322|1585323|1585324|1585325|1585919|1585920|1585921|1585922|1585923|1585924|1585925|1585926|1585928|1585929|1585930|1585931|1585932|1585933|1585934|1585935|1585936|1585937|1585979|1589887|1599557|1599832|1599833|1599834|1599835|1599837|1607086|1607089|1607091|1612545|1612546|1612547|1612548|1612549|1612550|1616559|1616560|1616561|1616562|1616563|1617466|1617467|1617468|1617469|1617470|1627104|1627105|1640020|1645758|1645840|1645841|1645842|1645845|1645846|1645851|1645870|1645876|1645877|1656709|1656710|1656711|1656712|1656713|1656714|1656715|1658305|1658306|1658307|1664394|1664395|1664396|1664398|1664399|1664400|1664401|1664402|1664416|1664417|1664418|1671188|1671193|1671498|1671499|1671500|1673934|1676511|1676512|1676513|1676514|1676515|1676528|1676529|1676530|1676531|1688909|1688910|1688911|1688912|1688913|1688919|1688927|1688928|1688929|1688930|1688931|1688932|1688933|1688934|1688935|1688936|1688937|1688938|1688939|1691144|1691145|1702613|1702614|1702615|1702616|1702617|1702618|1702619|1702620|1703386|1703387|1703388|1703389|1703392|1703395|1704923|1704924|1704925|1704926|1708232|1708233|1708234|1708235|1708236|1708237|1708238|1708239|1708240|1708241|1708242|1708243|1708244|1708245|1708246|1708247|1708298|1708299|1709312|1709313|1709314|1709315|1709317|1709318|1709319|1709321|1709322|1709323|1709325|1709326|1709327|1709328|1709329|1709330|1709331|1709332|1709333|1709334|1709335|1709336|1709337|1709341|1715789|1715790|1715791|1717440|1717441|1717442|1717443|1717446|1720096|1724046|1730445|1730446|1730447|1730448|1730449|1730450|1730451|1730452|1730453|1730454|1730455|1730456|1730457|1730460|1730464|1730470|1730472|1730473|1730474|1730475|1730476|1730477|1730478|1730479|1730480|1730481|1730487|1730488|1730489|1730490|1730491|1730527|1730528|1730529|1730530|1730549|1730550|1730551|1730552|1730557|1730858|1738670|1738671|1740135|1740136|1740137|1740138|1740141|1740144|1740145|1740146|1740147|1740148|1745853|1756964|1756965|1756966|1756967|1756968|1756998|1760295|1760296|1760297|1762240|1771671|1771675|1771676|1771693|1771695|1771700|1771702|1771703|1771720|1771721|1771725|1772744|1772745|1772746|1772747|1772778|1772779|1772780|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800|1795741|1798057|1798058|1798059|1798060|1798474|1804171|1805911|1806437|1807691|1807692|1807693|1807694|1807695|1807696|1807697|1807698|1807699|1807700|1807701|1807702|1807703|1807704|1807705|1807706|1807707|1807708|1807709|1807710|1807711|1807712|1807713|1807714|1807715|1807716|1809473|1813865|1815226|1815227|1815228|1815229|1815230|1815231|1815232|1815233|1815248|1815787|1815788|1815789|1815790|1815814|1815815|1815816|1815817|1815818|1815819|1824039|1824040|1824041|1824042|1824043|1824044|1824045|1824046|1824047|1824048|1824058|1824059|1824060|1824070|1824071|1824072|1824085|1824086|1824087|1824088|1824101|1824102|1824103|1824104|1828207|1828208|1828209|1828212|1848536|1848537|1848538|1848539|1848540|1853203|1857184|1857185|1857186|1861552|1861553|1861554|1861555|1861556|1861571|1861572|1861573|1861574|1861575|1861576|1861577|1861578|1861579|1861580|1861581|1861582|1861583|1861584|1861585|1861586|1861606|1865364|1865365|1865379|1865380|1865381|1865382|1865399|1865403|1865404|1865632|1865633|1865634|1865635|1865636|1865637|1865638|1865639|1865640|1865641|1865642|1865643|1865644|1865645|1865646|1865647|1865648|1867479|1867480|1867481|1867482|1867493|1867494|1867495|1867496|1872385|1872386|1872387|1872388|1872409|1876328|1880122|1880123|1,20130610,"001Chemical|4C Pharma Scientific Inc|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|Amadis Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Ansion Pharma|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|AstaTech, Inc.|Aurora Fine Chemicals LLC|AvaChem Scientific|Axon Medchem|BenchChem|BindingDB|BioChemPartner|BioCrick|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|Cangzhou Enke Pharma Tech Co.,Ltd.|CEGChem|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemFaces|ChemFish Tokyo Co., Ltd.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemieTek|ChemShuttle|Clearsynth|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|Cure First|CymitQuimica|DAOGE BIOPHARMA|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hangzhou APIChem Technology|Hefei Hirisun Pharmatech Co., Ltd|Human Metabolome Database (HMDB)|Hunan Chemfish Pharmaceutical Co., Ltd.|Hunan Huateng Pharmaceutical Co., Ltd.|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LGC Standards|Matrix Scientific|MedChemexpress MCE|MolCore BioPharmatech|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|Nature Synthesis|NCBI Structure|NextMove Software|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|Novartis Institutes for BioMedical Research|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Race Chemical|RR Scientific|Selleck Chemicals|Shanghai Send Pharmaceutical Technology Co., Ltd|Smolecule|Springer Nature|Starshine Chemical|Sun-shine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|ToxPlanet|TubePharm|Uchem Meditech|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory|VladaChem|Wikidata|Win-Win Chemical|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
57335384,Rociletinib,"Rociletinib|1374640-70-6|CO-1686|AVL-301|CNX-419|Rociletinib (CO-1686)|N-(3-((2-((4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acrylamide|CO-1686 (AVL-301)|Rociletinib [USAN:INN]|CS-1631|N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)prop-2-enamide|UNII-72AH61702G|72AH61702G|N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide|Rociletinib (CO-1686, AVL-301)|N-(3-{[2-{[4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl]amino}-5-(trifluoromethyl)pyrimidin-4-yl]amino}phenyl)prop-2-enamide|CO1686|Rociletinib [USAN]|CO 1686|ROCILETINIB [INN]|CO-1686(Rociletinib)|Rociletinib (USAN/INN)|Rociletinib; CO-1686|D0M4AV|ROCILETINIB [WHO-DD]|GTPL7966|SCHEMBL4177736|CHEMBL3545308|AMY9218|EX-A228|BDBM149404|DTXSID801025958|HMS3653G08|BCP07085|MFCD26793864|NSC779405|NSC783605|NSC800872|s7284|AKOS025401943|AKOS032949985|CCG-270031|DB11907|NSC-779405|NSC-783605|NSC-800872|SB16488|NCGC00386293-08|AC-27467|AS-17009|HY-15729|US8975249, I-4|FT-0696686|SW219475-1|D10858|Q27088606|2-PROPENAMIDE, N-(3-((2-((4-(4-ACETYL-1-PIPERAZINYL)-2-METHOXYPHENYL)AMINO)-5-(TRIFLUOROMETHYL)-4-PYRIMIDINYL)AMINO)PHENYL)-|N-[3-[[2-[[4-(4-Acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-2-propenamide",555.600,C27H28F3N7O3,112.000,871.000,4.000,40,3,11,8,"InChI=1S/C27H28F3N7O3/c1-4-24(39)32-18-6-5-7-19(14-18)33-25-21(27(28,29)30)16-31-26(35-25)34-22-9-8-20(15-23(22)40-3)37-12-10-36(11-13-37)17(2)38/h4-9,14-16H,1,10-13H2,2-3H3,(H,32,39)(H2,31,33,34,35)",CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC,CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide,555.221,555.221,0,1,0,0,0,0,0,0,0,234,1815,485,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,8,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1241286|1241287|1241288|1241295|1241296|1241297|1241298|1241299|1241300|1241302|1241303|1241305|1259398|1259399|1259416|1259421|1259423|1270377|1270378|1270393|1270394|1289545|1289546|1289547|1289550|1289551|1289554|1289555|1289556|1291323|1291324|1291325|1291326|1291327|1291328|1291329|1291330|1291331|1291332|1291333|1291337|1291338|1291339|1291340|1291341|1296008|1296009|1321092|1321093|1321094|1321095|1321923|1321924|1321925|1321927|1321928|1321929|1321930|1345084|1345502|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347080|1347159|1347160|1347411|1364452|1364453|1364462|1364463|1364464|1364465|1409598|1424192|1424193|1424194|1424195|1424196|1424197|1424198|1424199|1424209|1424255|1424256|1424257|1424258|1424259|1424260|1424889|1424890|1424891|1424892|1424893|1424894|1424895|1424896|1424898|1424899|1424900|1424901|1424902|1424904|1424905|1424906|1424907|1424908|1424909|1424910|1424911|1424912|1424914|1424915|1424916|1424917|1424918|1424919|1424920|1424921|1424922|1424923|1424924|1424925|1424928|1424929|1424930|1424931|1424933|1424934|1424935|1424937|1424939|1424940|1424941|1424942|1424944|1424945|1424946|1424947|1424948|1424949|1424950|1424952|1424953|1424954|1424955|1424956|1424958|1424960|1424961|1424962|1424963|1424964|1424965|1424966|1424967|1424968|1424969|1424970|1424971|1424972|1424973|1424974|1424975|1424976|1424977|1424978|1424980|1424981|1424983|1424984|1424985|1424986|1424988|1424989|1424990|1424991|1424992|1424993|1424994|1424995|1424996|1424997|1424998|1424999|1425000|1425001|1425002|1425003|1425004|1425006|1425007|1425008|1425009|1425010|1425011|1425013|1425014|1425016|1425017|1425018|1425019|1425020|1425021|1425022|1425023|1425025|1425026|1425027|1425028|1425029|1425030|1425033|1425034|1425035|1425036|1425037|1425038|1425039|1425040|1425042|1425043|1425044|1425045|1425046|1425047|1425048|1425049|1425050|1425051|1425052|1425053|1425054|1425055|1425056|1425057|1425059|1425060|1425061|1425062|1425063|1425064|1425065|1425067|1425068|1425069|1425071|1425072|1425073|1425074|1425078|1425079|1425080|1425081|1425082|1425083|1425084|1425085|1425086|1425087|1425089|1425090|1425093|1425094|1425095|1425096|1425097|1425098|1425099|1425100|1425104|1425105|1425106|1425107|1425108|1425110|1425111|1425112|1425115|1425116|1425117|1425118|1425121|1425122|1425123|1425124|1425125|1425126|1425127|1425129|1425130|1425131|1425132|1425133|1425136|1425137|1425138|1425140|1425141|1425142|1425143|1425144|1425145|1425146|1425147|1425148|1425150|1425151|1425153|1425154|1425155|1425156|1425157|1425158|1425159|1425160|1425161|1425162|1425163|1425164|1425165|1425166|1425167|1425168|1425169|1425170|1425171|1425172|1425173|1425174|1425175|1425176|1425177|1425178|1425179|1425181|1425182|1425185|1425186|1425187|1425188|1425189|1425190|1425191|1425192|1425193|1425194|1425196|1425197|1425199|1425200|1425201|1425202|1425203|1425204|1425206|1425207|1425208|1425209|1425210|1425211|1425212|1425213|1434568|1434569|1434570|1434571|1441907|1441910|1441911|1441912|1441913|1441914|1441929|1441930|1441931|1441937|1441938|1441939|1441940|1441941|1441942|1458976|1458977|1458978|1458979|1458980|1458981|1458982|1458984|1458985|1458986|1458987|1458988|1458989|1458990|1458991|1458992|1458993|1459011|1469778|1469779|1470939|1470940|1470941|1470942|1470943|1470944|1470945|1470946|1481311|1481348|1481349|1481369|1481370|1481371|1481372|1481437|1481438|1481439|1481440|1481441|1481442|1481443|1481444|1498599|1498600|1498601|1498602|1498603|1498604|1508586|1508601|1508620|1640020|1645758|1645840|1645841|1645842|1645845|1645846|1645851|1645870|1645876|1645877|1671187|1671188|1671193|1671498|1708231|1708306|1724451|1724452|1724453|1724454|1724455|1724473|1724474|1724475|1745853|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800|1795419|1796430|1797252|1797253|1797254|1797255|1797256|1798869|1800956|1803853|1805847,20120620,"001Chemical|4C Pharma Scientific Inc|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|AstaTech, Inc.|Aurora Fine Chemicals LLC|BenchChem|BindingDB|BioChemPartner|BioCrick|BOC Sciences|Boerchem|Broad Institute|CEGChem|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|ChemFaces|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemieTek|ChemShuttle|Clearsynth|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DrugBank|DTP/NCI|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hangzhou APIChem Technology|Hefei Hirisun Pharmatech Co., Ltd|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|Matrix Scientific|MedChemexpress MCE|MolCore BioPharmatech|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Race Chemical|RR Scientific|Selleck Chemicals|Smolecule|Springer Nature|Starshine Chemical|Sun-shine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|Therapeutic Target Database (TTD)|Thomson Pharma|ToxPlanet|TubePharm|Uchem Meditech|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory|VladaChem|Wikidata|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
118607832,Mobocertinib,"Mobocertinib|1847461-43-1|TAK-788|AP32788|Exkivity|TAK788|Mobocertinib [INN]|AP-32788|Mobocertinib [USAN]|Mobocertinib(TAK-788)|propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop-2-enoylamino)anilino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate|39HBQ4A67L|Isopropyl 2-((5-acrylamido-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenyl)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate|1-Methylethyl 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-4-(1-methyl-1H-indol-3-yl)-5-pyrimidinecarboxylate|5-Pyrimidinecarboxylic acid, 2-((4-((2-(dimethylamino)ethyl)methylamino)-2-methoxy-5-((1-oxo-2-propen-1-yl)amino)phenyl)amino)-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester|Propan-2-yl 2-(5-(acryloylamino)-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyanilino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate|Mobocertinib (TAK788)|Mobocertinib [USAN:INN]|UNII-39HBQ4A67L|MOBOCERTINIB [WHO-DD]|CHEMBL4650319|SCHEMBL17373133|GTPL10468|BDBM368374|DTXSID201336749|BCP31045|EX-A3392|US10227342, Example 10|XYC46143|MFCD32669806|NSC825519|s6813|TAK-788;AP32788|WHO 11183|AKOS040759315|AT30193|NSC-825519|AC-36436|example 94 [WO2015195228A1]|MS-30474|HY-135815|CS-0114256|D81621|A934607|TAK-788;TAK 788; TAK788; AP32788; AP-32788; AP 32788|Isopropyl 2-(5-acrylamido-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenylamino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate|propan-2-yl 2-[(4-{[2-(dimethylamino)ethyl](methyl)amino}-2-methoxy-5-(prop-2-enamido)phenyl)amino]-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate",585.700,C32H39N7O4,114.000,935.000,4.400,43,2,9,13,"InChI=1S/C32H39N7O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26/h9-13,16-20H,1,14-15H2,2-8H3,(H,34,40)(H,33,35,36)",CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,AZSRSNUQCUDCGG-UHFFFAOYSA-N,propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop-2-enoylamino)anilino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate,585.306,585.306,0,1,0,0,0,0,0,0,0,22,25,4,2D+3D,NULL,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing,11,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1798057|1798058|1798059|1798060,20160223,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Ark Pharma Scientific Limited|AstaTech, Inc.|Axon Medchem|BenchChem|BindingDB|BioChemPartner|Biosynth|BOC Sciences|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|ChemShuttle|Cooke Chemical Co., Ltd|CymitQuimica|DC Chemicals|DrugCentral|DTP/NCI|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Google Patents|Hangzhou APIChem Technology|Human Metabolome Database (HMDB)|IUPHAR/BPS Guide to PHARMACOLOGY|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sinfoo Biotech|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
24739943,Allitinib,"AST-1306|Allitinib|897383-62-9|AST1306|AST 1306|N-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)acrylamide|ALS 1306|CX0M5RO7CY|ALL-3|897383-62-9 (free base)|n-(4-((3-chloro-4-((3-fluorophenyl)methoxy)phenyl)amino)-6-quinazolinyl)-2-propenamide|N-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)acrylamide|N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]prop-2-enamide|AST-6|2-Propenamide, N-(4-((3-chloro-4-((3-fluorophenyl)methoxy)phenyl)amino)-6-quinazolinyl)-|N-[4-[[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]amino]quinazolin-6-yl]acrylamide|N-(4-{3-Chloro-4-[(3-fluorophenyl)methoxy]anilino}quinazolin-6-yl)prop-2-enamide|UNII-CX0M5RO7CY|D04OLK|SCHEMBL233985|GTPL9912|CHEMBL1947204|CHEBI:91467|DTXSID30647124|EX-A047|GLXC-15035|BCP05802|XKB38362|AKOS025149073|BCP9000327|CS-0983|SB19364|NCGC00346478-02|NCGC00346478-05|AC-32040|HY-15375|FT-0768662|J-523015|Q27163306|N-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]quinazolin-6-yl]prop-2-enamide|N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-quinazolinyl]-2-propenamide",448.900,C24H18ClFN4O2,76.100,641.000,5.400,32,2,6,7,"InChI=1S/C24H18ClFN4O2/c1-2-23(31)29-17-6-8-21-19(11-17)24(28-14-27-21)30-18-7-9-22(20(25)12-18)32-13-15-4-3-5-16(26)10-15/h2-12,14H,1,13H2,(H,29,31)(H,27,28,30)",C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl,C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl,MVZGYPSXNDCANY-UHFFFAOYSA-N,N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]prop-2-enamide,448.11,448.11,0,1,0,0,0,0,0,0,0,19,1231,287,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,6,642760|642761|642762|642763|642764|743344|743345|743346|743347|1224824|1224825|1224857|1224859|1259252|1259253|1259255|1259256|1259398|1259399|1259416|1259421|1259423|1296008|1296009|1345084|1345502|1345572|1345653|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347109|1347110|1347111|1347112|1347113|1347114|1347115|1347116|1347117|1347118|1347119|1347121|1347122|1347123|1347124|1347125|1347126|1347127|1347128|1347129|1347154|1347159|1347160|1347411|1347412|1409598|1508620|1508623|1508624|1508630|1640020|1645758|1645840|1645841|1645842|1645845|1645846|1645851|1645870|1645876|1645877|1671188|1671190|1671193|1671194|1671498|1745845|1745853,20080303,"001Chemical|4C Pharma Scientific Inc|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|ApexBio Technology|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BenchChem|BioChemPartner|Biocore|BioCrick|Biosynth|BOC Sciences|Broad Institute|CEGChem|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Clearsynth|Cooke Chemical Co., Ltd|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Glixx Labs Inc|Google Patents|Hangzhou APIChem Technology|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Inhibitor 2|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|Matrix Scientific|MedChemexpress MCE|MLSMR|MolCore BioPharmatech|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NIH/NCATS RNAi|Norris Pharm|PATENTSCOPE (WIPO)|Probes & Drugs portal|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|SLING Consortium|Smolecule|Starshine Chemical|Sun-shine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|Therapeutic Target Database (TTD)|Thomson Pharma|Uchem Meditech|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory|Wikidata|Wutech|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
70693519,Dacomitinib monohydrate,"1042385-75-0|Dacomitinib monohydrate|DACOMITINIB HYDRATE|Vizimpro|Dacomitinib [USAN:INN]|pf00299804|(E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide hydrate|PF 00299804|PF-00299804-03|UNII-5092U85G58|Dacomitinib (USAN)|Dacomitinib [USAN]|5092U85G58|Dacomitinib hydrate (JAN)|(2E)-N-(4-(3-Chloro-4-fluorophenyl)amino)7-methoxyquinazolin-6-yl)4-(piperidin-1-yl)but-2-enamide monohydrate|(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide;hydrate|2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)-4-(1- piperidinyl)-, hydrate (1:1), (2E)-|DACOMITINIB HYDRATE [JAN]|Dacomitinib Monhydrate|Vizimpro (TN)|DACOMITINIB [MI]|N-(4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-2-butenamide|CHEMBL2105719|SCHEMBL22498351|DACOMITINIB [ORANGE BOOK]|DTXSID80146359|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide hydrate|EX-A2822|AKOS025401940|AT36716|DACOMITINIB MONOHYDRATE [WHO-DD]|PF-00299804; Dacomitinib monohydrate|AC-27463|BS-45562|PF 299804|D10514|2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-, hydrate (1:1), (2E)-",488.000,C24H27ClFN5O3,80.400,665.000,NULL,34,3,8,7,"InChI=1S/C24H25ClFN5O2.H2O/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31;/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29);1H2/b6-5+;",COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4.O,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4.O,BSPLGGCPNTZPIH-IPZCTEOASA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide;hydrate,487.179,487.179,0,2,0,0,0,0,1,1,0,170,1791,410,2D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing,9,719889|719890|719891|1409605,20130204,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|AstaTech, Inc.|BenchChem|BindingDB|BLD Pharm|BOC Sciences|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Comparative Toxicogenomics Database (CTD)|CymitQuimica|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|J&H Chemical Co.,ltd|KEGG|Key Organics/BIONET|Lan Pharmatech|Molepedia|MolPort|Norris Pharm|PATENTSCOPE (WIPO)|Probes & Drugs portal|Race Chemical|RR Scientific|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|ToxPlanet",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
78357807,Osimertinib mesylate,"Osimertinib mesylate|1421373-66-1|AZD-9291 mesylate|AZD9291 mesylate|Mereletinib mesylate|AZD-9291 (Mesylate)|Tagrisso|osimertinib mesilate|Osimertinib mesylate [USAN]|UNII-RDL94R2A16|Mereletinib mesilate|RDL94R2A16|N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide;methanesulfonic acid|2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-, methanesulfonate (1:1)|N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide methanesulfonate|Osimertinib mesilate (JAN)|Osimertinib mesylate (USAN)|OSIMERTINIB MESILATE [JAN]|Tagrisso (TN)|osimertinib monomesylate|AZD 9291 mesylate|osimertinib methanesulfonate|AMY226|CHEMBL3545063|SCHEMBL14661152|CHEBI:90948|OSIMERTINIB MESYLATE [MI]|DTXSID101027822|BCP09934|EX-A1577|HY-15772A|MFCD28137994|OSIMERTINIB MESILATE [WHO-DD]|AKOS026673944|DS-9913|SB22953|AC-29022|OSIMERTINIB MESYLATE [ORANGE BOOK]|AZD-9291 mesylate (OsimertinibMereletinib)|FT-0699962|S5078|D10766|Q27162942|AZD9291 Ms salt, Osimertinib Ms salt; Mereletinib Ms salt|N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide methanesulfonate|N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide methanesulfonate",595.700,C29H37N7O5S,150.000,845.000,NULL,42,3,10,10,"InChI=1S/C28H33N7O2.CH4O3S/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24;1-5(2,3)4/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32);1H3,(H,2,3,4)",CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC.CS(=O)(=O)O,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC.CS(=O)(=O)O,FUKSNUHSJBTCFJ-UHFFFAOYSA-N,N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide;methanesulfonic acid,595.258,595.258,0,2,0,0,0,0,0,0,0,1164,325,112,2D,NULL,Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,9,NULL,20141010,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AKos Consulting & Solutions|AlchemyPharm|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Apexmol|Ark Pharm, Inc.|AstaTech, Inc.|AvaChem Scientific|BenchChem|BioChemPartner|BioCrick|BOC Sciences|Boerchem|Cangzhou Enke Pharma Tech Co.,Ltd.|ChEBI|Chem-Space.com Database|ChEMBL|ChemFish Tokyo Co., Ltd.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Clearsynth|Combi-Blocks|Cooke Chemical Co., Ltd|CymitQuimica|DAOGE BIOPHARMA|DC Chemicals|Debye Scientific Co., Ltd|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hangzhou APIChem Technology|Hefei Hirisun Pharmatech Co., Ltd|Hunan Chemfish Pharmaceutical Co., Ltd.|Hunan Huateng Pharmaceutical Co., Ltd.|J&H Chemical Co.,ltd|KEGG|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|MedChemexpress MCE|MolCore BioPharmatech|MolPort|MuseChem|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|Race Chemical|RR Scientific|Selleck Chemicals|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|Thomson Pharma|ToxPlanet|University of Kansas High Throughput Screening Laboratory|Wikidata|Win-Win Chemical|Yuhao Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
118912975,Rezivertinib,"Rezivertinib|Rezivertinib [INN]|1835667-12-3|U65F5M6BD5|UNII-U65F5M6BD5|2-Propenamide, N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-|N-(2-(2-(Dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide|2-Propenamide, N-[2-[2-(dimethylamino)ethoxy]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-|REZIVERTINIB [WHO-DD]|SCHEMBL17553564|GTPL10628|BPI7711|BPI-7711|AKOS040755389|example 1 [WO2016094821A2]|MS-29042|HY-109189|CS-0116462|N-[2-[2-(dimethylamino)ethoxy]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide",486.600,C27H30N6O3,93.500,724.000,3.600,36,2,7,10,"InChI=1S/C27H30N6O3/c1-6-26(34)29-22-15-21(24(35-5)16-25(22)36-14-13-32(2)3)31-27-28-12-11-20(30-27)19-17-33(4)23-10-8-7-9-18(19)23/h6-12,15-17H,1,13-14H2,2-5H3,(H,29,34)(H,28,30,31)",CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=CC(=C(C=C4OC)OCCN(C)C)NC(=O)C=C,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=CC(=C(C=C4OC)OCCN(C)C)NC(=O)C=C,BPMZUKYFIDPLEA-UHFFFAOYSA-N,N-[2-[2-(dimethylamino)ethoxy]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide,486.238,486.238,0,1,0,0,0,0,0,0,0,0,32,11,2D+3D,NULL,Classification|Drug and Medication Information|Literature|Patents,5,NULL,20160409,"A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BenchChem|ChemIDplus|DC Chemicals|FDA Global Substance Registration System (GSRS)|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Key Organics/BIONET|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|Shanghai Mathcon Pharmaceutical Co.,LTD.|Starshine Chemical|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
122173919,Olmutinib hydrochloride,"olmutinib hydrochloride|Olmutinib dihydrochloride|XY9T35CX4I|Olmutinib hydrochloride [USAN]|1842366-97-5|Olmutinib hydrochloride (USAN)|2-Propenamide, N-(3-((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)-, hydrochloride (1:2)|N-(3-((2-((4-(4-Methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylamide dihydrochloride|olmutinib 2hcl|N-(3-((2-(4-(4-methylpiperazin-1-yl)anilino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)prop-2-enamide dihydrochloride|N-[3-({2-[4-(4-Methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl}oxy)phenyl]prop-2-enamide dihydrochloride|UNII-XY9T35CX4I|CHEMBL3989930|BI1482694CL2|BI-1482694 DIHYDROCHLORIDE|BI 1482694 CL2|OLMUTINIB HYDROCHLORIDE [WHO-DD]|D11115",559.500,C26H28Cl2N6O2S,111.000,712.000,NULL,37,4,8,7,"InChI=1S/C26H26N6O2S.2ClH/c1-3-23(33)27-19-5-4-6-21(17-19)34-25-24-22(11-16-35-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32;;/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30);2*1H",CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4.Cl.Cl,CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4.Cl.Cl,KIHHNWDWKMJZHH-UHFFFAOYSA-N,"N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;dihydrochloride",558.137,558.137,0,3,0,0,0,0,0,0,0,0,0,0,2D,NULL,Classification|Patents,2,NULL,20161016,BLD Pharm|ChEMBL|ChemIDplus|FDA Global Substance Registration System (GSRS)|KEGG|Lan Pharmatech|PATENTSCOPE (WIPO)|Starshine Chemical,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
154824631,Tuxobertinib,"tuxobertinib|BDTX-189|2414572-47-5|BDTX189|Tuxobertinib [INN]|Tuxobertinib [USAN]|6CE2107J4T|N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-(2-morpholin-4-ylethoxy)quinazolin-6-yl]prop-2-enamide|Tuxobertinib [WHO-DD]|Tuxobertinib [USAN:INN]|UNII-6CE2107J4T|CHEMBL4650279|SCHEMBL23450829|GTPL11676|EX-A4379|example 8 [US11034672B1]|NSC828939|s9786|WHO 11817|AKOS040759649|NSC-828939|AC-36700|MS-30186|HY-136789|CS-0133688|E80424|2-Propenamide, N-[4-[[3-chloro-4-(2-pyridinylmethoxy)phenyl]amino]-7-[2-(4-morpholinyl)ethoxy]-6-quinazolinyl]-|N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-(2-morpholinoethoxy)quinazolin-6-yl)acrylamide",561.000,C29H29ClN6O4,111.000,805.000,3.900,40,2,9,11,"InChI=1S/C29H29ClN6O4/c1-2-28(37)35-25-16-22-24(17-27(25)39-14-11-36-9-12-38-13-10-36)32-19-33-29(22)34-20-6-7-26(23(30)15-20)40-18-21-5-3-4-8-31-21/h2-8,15-17,19H,1,9-14,18H2,(H,35,37)(H,32,33,34)",C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)OCCN5CCOCC5,C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)OCCN5CCOCC5,HIBPKFXWOPYJPZ-UHFFFAOYSA-N,N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-(2-morpholin-4-ylethoxy)quinazolin-6-yl]prop-2-enamide,560.194,560.194,0,1,0,0,0,0,0,0,0,0,5,3,2D,NULL,Biological Test Results|Classification|Drug and Medication Information|Patents,6,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145,20201201,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|AstaTech, Inc.|BenchChem|BOC Sciences|ChEMBL|ChemIDplus|ChemShuttle|Cooke Chemical Co., Ltd|CymitQuimica|DC Chemicals|DTP/NCI|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|IUPHAR/BPS Guide to PHARMACOLOGY|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
162368359,Almonertinib mesylate,Almonertinib mesylate|Aumolertinib mesylate|Almonertinib (mesylate)|HS-10296 Mesylate|2134096-06-1|RZ6I9WX68U|HS-10296 Methanesulfonate|Aumolertinib mesylate [USAN]|N-(5-((4-(1-Cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide methanesulfonate|Aumolertinib mesilate|EQ143 MESYLATE|EQ-143 MESYLATE|UNII-RZ6I9WX68U|Aumolertinib mesilate [WHO-DD]|CHEMBL5095491|EX-A6602|AKOS040759998|HY-112823A|MS-30791|CS-0066156,621.800,C31H39N7O5S,150.000,916.000,NULL,44,3,10,11,"InChI=1S/C30H35N7O2.CH4O3S/c1-6-29(38)32-24-17-25(28(39-5)18-27(24)36(4)16-15-35(2)3)34-30-31-14-13-23(33-30)22-19-37(20-11-12-20)26-10-8-7-9-21(22)26;1-5(2,3)4/h6-10,13-14,17-20H,1,11-12,15-16H2,2-5H3,(H,32,38)(H,31,33,34);1H3,(H,2,3,4)",CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC.CS(=O)(=O)O,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC.CS(=O)(=O)O,WTEXJDGTVUQRQY-UHFFFAOYSA-N,N-[5-[[4-(1-cyclopropylindol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide;methanesulfonic acid,621.273,621.273,0,2,0,0,0,0,0,0,0,0,0,0,2D,NULL,Classification,1,NULL,20211216,AbaChemScene|AKos Consulting & Solutions|ChEMBL|ChemIDplus|CymitQuimica|DC Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Key Organics/BIONET|MedChemexpress MCE|Probes & Drugs portal,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
208908,Lapatinib,"Lapatinib|231277-92-2|Lapatinib Ditosylate|Tykerb|GW572016|GW 572016|Lapatinib [INN]|Lapatinib base|Tyverb|Lapatinib tosilate hydrate|388082-78-8|Lapatinib (INN)|Lapatinib free base|GSK 572016|N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine|N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine|Lapatinib (free base)|Lapatinib [INN:BAN]|231277-92-2 (free base)|GSK572016|FMM|N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE|N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2-yl)quinazolin-4-amine|CHEMBL554|GW 282974X|GW-572016|UNII-0VUA21238F|DTXSID7046675|CHEBI:49603|HSDB 8209|0VUA21238F|NSC745750|GSK-572016|GW 572016X|GW-572016X|1210608-87-9|NCGC00167507-01|Lapatinib Ditosilate|Tykerb (TN)|lapatinib ditosilate hydrate|DTXCID5026675|4-Quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-|4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-|913989-15-8|N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine|N-(3-Chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine|n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine|CAS-231277-92-2|GW-2016|MFCD09264194|C29H26ClFN4O4S|1xkk|Lapatinib, Tykerb, GW572016|C29-H26-Cl-F-N4-O4-S.2C7-H8-O3-S.H2-O|N-[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine|Lapatinib, Free base|nchembio866-comp20|Kinome_3684|Kinome_3685|Lapatinib base- Bio-X|LAPATINIB [MI]|LAPATINIB [VANDF]|D08CDI|LAPATINIB [WHO-DD]|SCHEMBL8100|Lapatinib (GW572016)|LAPATINIB [EMA EPAR]|Lapatinib (ERBB2 inhibitor)|BDBM5445|cid_208908|GTPL5692|EX-A402|BCPP000188|BCPP000189|HMS2089H10|HMS3244N06|HMS3244N10|HMS3244N14|HMS3744K11|Tykerb (TN) (Glaxo Smith Kline)|BCP01874|Tox21_112505|NSC800780|AKOS005145766|C29-H26-Cl-F-N4-O4-S|Tox21_112505_1|AC-1314|BCP9000837|BCP9000838|CCG-270133|CS-O-01724|DB01259|NSC-745750|NSC-800780|SB16918|NCGC00167507-02|NCGC00167507-03|NCGC00167507-04|NCGC00167507-09|AS-14065|BC164610|HY-50898|N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine|LS-187029|LS-187771|AM20090641|FT-0659650|L0360|SW199101-5|A25184|D08108|EN300-117254|AB01273965-01|AB01273965-02|AB01273965-03|AB01273965_04|AB01273965_05|Q420323|Q-101353|SR-05000001472-1|BRD-K19687926-001-01-7|BRD-K19687926-379-02-5|GW572016;GW-572016;GW 572016|1092929-10-6|4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline|GW-2016;N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine;4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline|N-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-[5-({[2-(methanesulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine|N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl] quinazolin-4-amine|N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[1,1,2,2-tetradeuterio-2-(trideuterio(113C)methylsulfonyl)ethyl]amino]methyl]furan-2-yl]quinazolin-4-amine|N-{3-chloro-4-[(3-fluoro-benzyl)oxy]phenyl}-6-[5-({2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methane sulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|N-{3-Chloro-4[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methane sulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|N3-Chloro-4-(3-fluorophenyl)methoxyphenyl-6-5-(2-methylsulfonylethylamino)methyl-2-furylquinazolin-4-amine",581.100,C29H26ClFN4O4S,115.000,898.000,5.100,40,2,9,11,"InChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)",CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,BCFGMOOMADDAQU-UHFFFAOYSA-N,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine,580.135,580.135,0,1,0,0,0,0,0,0,0,7508,40665,11638,2D+3D,Lapatinib,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,14,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1433|1471|1490|1688|1766|1768|1811|2528|2546|2551|2662|68106|69892|256559|256560|256561|256562|256563|256564|256565|256566|256567|256568|256569|256570|256571|256572|256573|256574|256575|256576|256577|256578|256579|256580|256581|256582|256583|256584|256585|256586|256587|256588|256589|256590|256591|256592|256593|256594|256595|256596|256597|256598|256599|256600|256601|256602|256603|256604|256605|256606|256607|256608|256609|256610|256611|256612|256613|256614|256615|256616|256617|256618|256619|256620|256621|256622|256623|256624|256625|256626|256627|256628|256629|256630|256631|256632|256633|256634|256635|256636|256637|256638|256639|256640|256641|256642|256643|256644|256645|256646|256647|256648|256649|256650|256651|256652|256653|256654|256655|256656|256657|256658|256659|256660|256661|256662|256663|256664|256665|256666|256667|256668|256669|256670|256671|256672|256673|256674|256675|256676|256677|263980|263981|263982|263983|270616|270617|270618|270619|270620|270621|270622|314993|345874|345876|361657|404519|410956|410960|435146|435147|435148|435149|435150|435151|435152|435153|435154|435155|435156|435157|435158|435159|435160|435161|435162|435163|435164|435165|435166|435167|435168|435169|435170|435171|435180|435181|435182|435183|435184|435188|435189|435190|435191|435192|435193|435194|435195|435196|435197|435198|435199|435200|435201|435202|435203|435204|435274|435275|435276|435277|435278|435279|435280|435281|435282|435283|435284|435285|435286|435287|435288|435289|435290|435291|435292|435293|435294|435295|435296|435297|435310|435311|435312|435318|435319|435320|435321|435322|435323|435324|435325|435326|435327|435328|435329|435393|435394|435395|435396|435397|435398|435399|435400|435401|435402|435403|435404|435405|435406|435407|435408|435409|435410|435411|435412|435413|435414|435415|435429|435430|435431|435432|435433|435434|435438|435439|435440|435441|435442|435443|435444|435445|435514|435515|435516|435517|435518|435519|435520|435521|435522|435523|435524|435525|435526|435527|435528|435529|435530|435531|435532|435533|435534|435545|435546|435551|435552|435553|435554|435555|435556|435557|435558|435559|435560|435561|435562|435563|435564|435644|435645|435646|435647|435648|435649|435650|435651|435652|435653|435654|435655|435656|435657|435658|435659|435660|435661|435662|435663|435664|435665|435666|435667|435674|435675|435676|435677|435678|435679|435687|435688|435689|435690|435691|435692|435693|435694|435775|435776|435777|435778|435779|435780|435781|435782|435783|435784|435785|435786|435787|435788|435789|435790|435791|435792|435793|435794|435795|435796|435797|435798|435799|435800|435801|435802|435803|435804|435805|435806|435807|435808|435821|435822|435823|435826|435827|435828|435829|435830|435831|435832|435833|435834|435835|435896|435897|435898|435899|435900|435901|435902|435903|435904|435905|435906|435907|435908|435909|435910|435911|435912|435924|435925|435926|435929|435930|435931|435932|435933|435934|435935|435936|435937|435938|435939|435940|435941|436004|436005|436006|436007|436008|436009|436010|436011|436012|436013|436014|436015|436016|436017|436018|436019|436020|436021|436022|436023|436024|436025|436032|436033|436034|436042|436043|436044|436045|436046|436047|436048|436049|436050|436051|436052|436053|436054|436055|441961|441962|441963|441964|441965|441966|441967|441999|461251|461252|461256|461257|461258|461261|461262|461263|461296|463638|463639|474115|474116|474117|492961|493017|493040|493204|493206|504327|504332|504534|504749|504832|504834|504847|504865|509715|517322|517323|517324|546545|546546|546547|546548|546549|546550|546551|546552|546553|546554|546555|546556|546557|546558|546559|546560|546561|546562|546563|546564|546565|546566|588210|588432|588449|588579|588834|598797|598798|598799|599957|599959|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|624349|624392|624476|624478|624479|624702|624703|624704|624705|624706|624707|624708|624709|624710|624711|624712|624713|624714|624715|624716|624717|624718|624719|624720|624721|624722|624723|624724|624725|624726|624727|624728|624729|624730|624731|624732|624733|624734|624735|624736|624737|624738|624739|624740|624741|624742|624743|624744|624745|624746|624747|624748|624749|624750|624751|624752|624753|624754|624755|624756|624757|624758|624759|624760|624761|624762|624763|624764|624765|624766|624767|624768|624769|624770|624771|624772|624773|624774|624775|624776|624777|624778|624779|624780|624781|624782|624783|624784|624785|624786|624787|624788|624789|624790|624791|624792|624793|624794|624795|624796|624797|624798|624799|624800|624801|624802|624803|624804|624805|624806|624807|624808|624809|624810|624811|624812|624813|624814|624815|624816|624817|624818|624819|624820|624821|624822|624823|624824|624825|624826|624827|624828|624829|624830|624831|624832|624833|624834|624835|624836|624837|624838|624839|624840|624841|624842|624843|624844|624845|624846|624847|624848|624849|624850|624851|624852|624853|624854|624855|624856|624857|624858|624859|624860|624861|624862|624863|624864|624865|624866|624867|624868|624869|624870|624871|624872|624873|624874|624875|624876|624877|624878|624879|624880|624881|624882|624883|624884|624885|624886|624887|624888|624889|624890|624891|624892|624893|624894|624895|624896|624897|624898|624899|624900|624901|624902|624903|624904|624905|624906|624907|624908|624909|624910|624911|624912|624913|624914|624915|624916|624917|624918|624919|624920|624921|624922|624923|624924|624925|624926|624927|624928|624929|624930|624931|624932|624933|624934|624935|624936|624937|624938|624939|624940|624941|624942|624943|624944|624945|624946|624947|624948|624949|624950|624951|624952|624953|624954|624955|624956|624957|624958|624959|624960|624961|624962|624963|624964|624965|624966|624967|624968|624969|624970|624971|624972|624973|624974|624975|624976|624977|624978|624979|624980|624981|624982|624983|624984|624985|624986|624987|624988|624989|624990|624991|624992|624993|624994|624995|624996|624997|624998|624999|625000|625001|625002|625003|625004|625005|625006|625007|625008|625009|625010|625011|625012|625013|625014|625015|625016|625017|625018|625019|625020|625021|625022|625023|625024|625025|625026|625027|625028|625029|625030|625031|625032|625033|625034|625035|625036|625037|625038|625039|625040|625041|625042|625043|625044|625045|625046|625047|625048|625049|625050|625051|625052|625053|625054|625055|625056|625057|625058|625059|625060|625061|625062|625063|625064|625065|625066|625067|625068|625069|625070|625071|625072|625073|625074|625075|625076|625077|625078|625079|625080|625081|625082|625083|625084|625085|625086|625087|625088|625089|625090|625091|625092|625093|625094|625095|625096|625097|625098|625099|625100|625101|625102|625103|625104|625105|625106|625107|625108|625109|625110|625111|625112|625113|625114|625115|625116|625117|625118|625119|625120|625121|625122|625123|625124|625125|625126|625127|625128|625129|625130|625131|625132|625133|625134|625135|625136|625137|625138|625139|625140|625141|625142|625143|625276|625293|634136|634138|636160|636161|636162|636164|636165|636166|636167|636168|636169|636170|636171|636172|636173|636174|636175|636176|636177|636178|636179|636180|636181|636182|636183|636184|636185|636186|636187|636188|636189|636190|636191|636192|636193|636194|636195|636196|636197|636198|636199|636200|636201|636202|636203|636204|636205|636384|636385|636386|636387|638067|638068|638069|638070|638082|638910|638911|638912|638913|638914|638915|638916|638917|638918|638919|638920|638921|638922|638923|638924|642760|642761|642762|642763|642764|651631|651632|651633|651634|651635|651645|651646|651696|651712|651713|651784|651789|651828|652048|652051|662802|662803|662804|662805|662806|664618|664620|664631|664632|664633|664634|664740|664741|664742|664743|664744|664745|664746|686947|686950|686978|686979|705604|710534|710535|720516|720532|720533|720552|720634|720635|720637|720641|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720717|720719|720725|728990|729550|729551|729552|739089|739090|741699|741702|741703|741707|741711|741714|741715|741716|741717|741724|741726|741727|741729|741730|741732|741733|741734|741736|741738|741746|741747|741751|741753|741756|741757|741760|741763|741764|741765|741766|741768|741769|741771|741773|741775|741776|741777|741778|741779|741780|741781|741782|741783|741784|741790|741791|741794|741795|741796|741797|741799|741803|741804|741811|741814|741815|741816|741819|741821|741823|741824|741825|741829|741831|741832|741833|741834|741838|741839|741840|741843|741845|741847|741850|741851|741852|741853|741855|741856|741857|741858|741859|741861|741864|741866|741867|741875|741877|741878|741879|741881|741882|741884|741886|741892|741894|741895|741896|741897|741910|741914|741917|741918|741926|741929|741935|741938|741941|741945|741947|741949|741950|741959|741961|741962|741964|741965|741969|741970|741971|741972|741973|741975|741981|741982|741986|741988|741989|741993|741996|741997|742001|742010|742012|742013|742014|742015|742016|742017|742018|742020|742022|742023|742025|742027|742031|742032|742033|742036|742038|742042|742046|742050|742052|742053|742056|742058|742059|742061|742063|742066|742068|742069|742073|742076|742077|742078|742081|742082|742084|742086|742088|742089|742090|742096|742101|742102|742103|742104|742105|742107|742108|742110|742112|742113|742114|742116|742117|742120|742121|742123|742125|742128|742131|742132|742133|742135|742136|742142|742143|742144|742146|742147|742148|742149|742150|742151|742152|742154|742155|742156|742157|742158|742159|742160|742161|742163|742164|742166|742174|742175|742177|742178|742179|742181|742183|742184|742188|742189|742191|742195|742199|742200|742201|742205|742208|742209|742211|742213|742214|742219|742226|742230|742235|742246|742247|742249|742250|742251|742252|742253|742255|742257|742258|742259|742260|742262|742263|74226,20050624,"001Chemical|3WAY PHARM INC|4C Pharma Scientific Inc|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abbott Labs|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|Ambit Biosciences|AN PharmaTech|Angel Pharmatech Ltd.|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Arromax Pharmatech Co., Ltd|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BenchChem|BePharm Ltd.|BerrChem|BindingDB|BioChemPartner|BioCrick|Biopharma PEG Scientific Inc|Biosynth|BLD Pharm|BOC Sciences|Boerchem|Boone Lab, Chemical Genomics, University of Toronto|Boronpharm|Broad Institute|CAPOT|CEGChem|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemFaces|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemShuttle|ChemSpider|ChemTik|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|CoreSyn|CreativePeptides|Crystallography Open Database|CSNpharm|Cure First|CymitQuimica|DAOGE BIOPHARMA|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|Ennopharm|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|Exclusive Chemistry Ltd|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Fluoropharm Co.,Ltd|Founder Pharma|Glentham Life Sciences Ltd.|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|Hangzhou Trylead Chemical Technology|Hefei Hirisun Pharmatech Co., Ltd|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LeadScope|LEAPCHEM|MassBank Europe|MassBank of North America (MoNA)|Matrix Scientific|MedChemexpress MCE|Metabolomics Workbench|MLSMR|MolCore BioPharmatech|Molepedia|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NCBI Structure|NextBio|NextMove Software|NIAID ChemDB|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|Novartis Institutes for BioMedical Research|NovoSeek|Oakwood Products|OChem|OXCHEM CORPORATION|Parchem|PATENTSCOPE (WIPO)|Phion Ltd|Pi Chemicals|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Prous Science Drugs of the Future|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Selleck Chemicals|Shanghai Institute of Organic Chemistry|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sigma-Aldrich|Sinfoo Biotech|SLING Consortium|SMID|Smolecule|Southern Research Institute|Springer Nature|Starshine Chemical|SureChEMBL|Synblock Inc|Syntree|TargetMol|TCI (Tokyo Chemical Industry)|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|The Scripps Research Institute Molecular Screening Center|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Thoreauchem|Tocris Bioscience|Tox21|ToxPlanet|Tractus|U-M Center for Drug Repurposing|Uchem Meditech|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory|VladaChem|Wikidata|WikiPathways|Wiley|Wubei-Biochem|Wutech|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159156 - HER2 Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EH - Human epidermal growth factor receptor 2 (her2) tyrosine kinase inhibitors
6918403,"4-(4-((1-phenylethyl)amino)-7H-pyrrolo(2,3-d)pyrimidin-6-yl)-phenol, R-","PKI-166|187724-61-4|PKI166|PKI 166|9RIE5HW38P|NVP-PKI166|CGP75166|CGP 75166|UNII-9RIE5HW38P|4-(4-((1-phenylethyl)amino)-7H-pyrrolo(2,3-d)pyrimidin-6-yl)-phenol, R-|4-phenethylamino-6-(yderoxyl)phenyl-7H-pyrrolo(2,3-d)pyrimidine|4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenol|4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[4,5-e]pyrimidin-6-yl]phenol|CHEMBL1914653|D07GFF|SCHEMBL177814|GTPL7642|CHEMBL1963502|PKI 166 [WHO-DD]|DTXSID801346629|BDBM50358046|PKI-75166|AKOS037643509|NCGC00387215-02|AS-16676|HY-117155|PKI-166, >=98% (HPLC)|CS-0064017|Q27088404|1350639-79-0",330.400,C20H18N4O,73.800,420.000,4.200,25,3,4,4,"InChI=1S/C20H18N4O/c1-13(14-5-3-2-4-6-14)23-19-17-11-18(24-20(17)22-12-21-19)15-7-9-16(25)10-8-15/h2-13,25H,1H3,(H2,21,22,23,24)/t13-/m1/s1",C[C@H](C1=CC=CC=C1)NC2=NC=NC3=C2C=C(N3)C4=CC=C(C=C4)O,CC(C1=CC=CC=C1)NC2=NC=NC3=C2C=C(N3)C4=CC=C(C=C4)O,XRYJULCDUUATMC-CYBMUJFWSA-N,"4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenol",330.148,330.148,0,1,0,1,1,0,0,0,0,113,5775,994,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards,8,1159388|1296008|1296009|1345084|1345502|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347159|1347160|1347411|1508620|1645840|1645841|1645842|1645845|1645846|1645851|1645870|1645876|1645877|1671188|1671193|1671498|1745853,20060728,"001Chemical|A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|AKos Consulting & Solutions|Ambinter|AOBIOUS INC|Aurora Fine Chemicals LLC|BenchChem|BindingDB|BOC Sciences|Broad Institute|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Comparative Toxicogenomics Database (CTD)|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NIH/NCATS RNAi|Norris Pharm|Novartis Institutes for BioMedical Research|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|RR Scientific|SCRIPDB|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sigma-Aldrich|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Therapeutic Target Database (TTD)|Thomson Pharma|Tocris Bioscience|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159156 - HER2 Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
6918508,Falnidamol,"Falnidamol|196612-93-8|BIBX 1382|BIBX1382|BIBX-1382|Bibx 1382bs|Falnidamol [INN]|N8-(3-Chloro-4-fluorophenyl)-N2-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-2,8-diamine|CHEMBL258940|UNII-0MU316797D|0MU316797D|4-N-(3-chloro-4-fluorophenyl)-6-N-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-4,6-diamine|8-(3-Chloro-4-fluoroanilino)-2-((1-methyl-4-piperidyl)amino)pyrimido(5,4-d)pyrimidine|N4-(3-chloro-4-fluorophenyl)-N6-(1-methyl-4-piperidyl)pyrimido[5,4-d]pyrimidine-4,6-diamine|NCGC00161422-01|BIBX-1382BS|D00RMC|C18H19ClFN7|FALNIDAMOL [WHO-DD]|BIBX-1382BX|SCHEMBL158563|GTPL7646|DTXSID0048399|C18-H19-Cl-F-N7|CHEBI:93243|EX-A570|BCP09515|BDBM50375639|MFCD09838900|CS-0691|DB12966|NCGC00161422-03|NCGC00161422-09|AC-30284|AS-16894|HY-10322|FT-0700465|BRD-K70914287-300-01-0|Q27077274|8-(3-chloro-4-fluorophenylamino)-2-(1-methylpiperidin-4-ylamino)pyrimido[5,4-d]pyrimidine|N-(3-chloro-4-fluorophenyl)-N'-(1-methylpiperidin-4-yl)pyrimido[4,5-e]pyrimidine-4,6-diamine|N4-(3-chloro-4-fluoro-phenyl)-N6-(1-methyl-4-piperidyl)pyrimido[5,4-d]pyrimidine-4,6-diamine|Pyrimido(5,4-d)pyrimidine-2,8-diamine, N8-(3-chloro-4-fluorophenyl)-N2-(1-methyl-4-piperidinyl)-",387.800,C18H19ClFN7,78.900,479.000,3.400,27,2,8,4,"InChI=1S/C18H19ClFN7/c1-27-6-4-11(5-7-27)25-18-21-9-15-16(26-18)17(23-10-22-15)24-12-2-3-14(20)13(19)8-12/h2-3,8-11H,4-7H2,1H3,(H,21,25,26)(H,22,23,24)",CN1CCC(CC1)NC2=NC=C3C(=N2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl,CN1CCC(CC1)NC2=NC=C3C(=N2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl,FTFRZXFNZVCRSK-UHFFFAOYSA-N,"4-N-(3-chloro-4-fluorophenyl)-6-N-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-4,6-diamine",387.137,387.137,0,1,0,0,0,0,0,0,0,32,5701,904,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Toxicity,9,880|881|894|1030|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1688|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2528|2546|2549|2551|2662|325576|325823|325824|325825|325826|325827|325828|485281|485290|492961|504327|504332|504749|504832|504834|504847|504865|588579|602332|624030|624031|624032|624044|624101|624136|624137|624138|624139|624141|624151|624170|624172|624173|624260|624296|624297|625276|625293|651548|686947|686950|1223502|1223503|1223504|1223505|1223506|1223507|1223508|1223518|1224748|1224749|1224750|1224751|1224752|1224753|1224754|1224755|1224756|1224757|1224758|1224759|1224760|1224761|1224762|1224763|1224764|1224765|1224766|1224767|1224768|1224769|1224770|1224771|1224772|1224773|1224774|1224775|1224776|1224777|1224778|1224779|1224780|1224781|1224782|1224783|1224784|1224785|1224786|1224787|1224788|1224789|1224790|1224791|1224792|1224793|1224794|1224795|1224796|1224797|1224798|1224799|1224800|1224801|1224802|1224803|1224804|1224805|1224806|1224807|1259397|1259398|1259416|1259421|1259423|1345502|1345653|1346986|1346987|1347055|1409598|1474166|1474167|1640020|1645758|1645870|1645876|1645877|1745853,20060728,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Adooq BioScience|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|AOBIOUS INC|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BindingDB|BioChemPartner|Biocore|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|Calbiochem|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|CSNpharm|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EMD Millipore|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|Exclusive Chemistry Ltd|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Gulick Lab, Department of Structural Biology, University at Buffalo|Hangzhou APIChem Technology|HDH Pharma|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|Matrix Scientific|MedChemexpress MCE|MolCore BioPharmatech|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NIAID ChemDB|NIST Mass Spectrometry Data Center|NORMAN Suspect List Exchange|Norris Pharm|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|RR Scientific|Santa Cruz Biotechnology, Inc.|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Springer Nature|Starshine Chemical|Sun-shine Chemical|SureChEMBL|TargetMol|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|Therapeutic Target Database (TTD)|Thomson Pharma|Tocris Bioscience|Tox21|ToxPlanet|Tractus|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
44609731,Icotinib Hydrochloride,"Icotinib Hydrochloride|1204313-51-8|Icotinib (Hydrochloride)|Icotinib HCl|BPI-2009H|UNII-JTD32I0J83|JTD32I0J83|N-(3-ethynylphenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.014,19]icosa-1(12),13,15,17,19-pentaen-18-amine;hydrochloride|(1,4,7,10)Tetraoxacyclododecino(2,3-g)quinazolin-4-amine, N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-, hydrochloride (1:1)|CHEMBL4297665|DTXSID80152859|HMS3750O09|BCP06306|EX-A2070|AKOS026750418|CS-0918|ICOTINIB HYDROCHLORIDE [WHO-DD]|AC-29741|AS-78690|HY-15164|FT-0701515|1204313-51-8 (HCl)|A13718|F84862|A925581|Q27281690|N-(3-ethynylphenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.0^{14,19]icosa-1(12),13,15,17,19-pentaen-18-amine;hydrochloride|N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine hydrochloride|N-(3-ETHYNYLPHENYL)-7H,8H,10H,11H,13H,14H-1,4,7,10-TETRAOXACYCLODODECA[2,3-G]QUINAZOLIN-4-AMINE HYDROCHLORIDE",427.900,C22H22ClN3O4,74.700,553.000,NULL,30,2,7,3,"InChI=1S/C22H21N3O4.ClH/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20;/h1,3-5,12-15H,6-11H2,(H,23,24,25);1H",C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4.Cl,C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4.Cl,PNNGXMJMUUJHAV-UHFFFAOYSA-N,"N-(3-ethynylphenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.014,19]icosa-1(12),13,15,17,19-pentaen-18-amine;hydrochloride",427.13,427.13,0,2,0,0,0,0,0,0,0,0,4539,1132,2D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents,7,1508601|1645838,20100215,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|AbovChem LLC|Achemtek|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambinter|Angel Pharmatech Ltd.|AOBIOUS INC|ApexBio Technology|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurum Pharmatech LLC|BenchChem|BioChemPartner|BioCrick|BOC Sciences|Boerchem|CEGChem|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Cooke Chemical Co., Ltd|CymitQuimica|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hangzhou APIChem Technology|ICCB-Longwood Screening Facility, Harvard Medical School|J&H Chemical Co.,ltd|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|MedChemexpress MCE|MolCore BioPharmatech|MolPort|MuseChem|NextMove Software|Norris Pharm|Pi Chemicals|Probes & Drugs portal|RR Scientific|Smolecule|Starshine Chemical|TargetMol|THE BioTek|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
86278355,Denintuzumab mafodotin,"Denintuzumab mafodotin|SGN-CD19A|SGN-CD 19A|UNII-H5324S1M7H|Vorsetzumab Mafodotin|Vorsetuzumab mafodotin|Denintuzumab mafodotin [USAN:INN]|Vorsetzumab Mafodotin [USAN]|UNII-699619YVTQ|SGN 75|H5324S1M7H|1399672-02-6|Immunoglobulin G1-kappa auristatin F conjugate, anti-(homosapiens CD19 (b lymphocyte surface antigen B4, leu-12)), humanized monoclonal antibody|1165741-01-4|Depatux-m|Cys-McMMAF|denintuzumab-mafodotin|CYSTEINYL-MFFA|Depatuxizumab mafodotin|Abbv-221|CYSTEINYL-MAFODOTIN|MAFODOTIN-CYSTEINYL|UNII-F3R7A4P04N|B4S8ET206U|Depatuxizumab mafodotin [USAN]|F3R7A4P04N|SGN-75|ABT-414|699619YVTQ|Vorsetuzumab mafodotin [USAN:INN]|MS-31894|MONOMETHYL AURISTATIN F CYSTEINYL-CONJUGATE|1160590-05-5|1585973-65-4|L-Valinamide, N-(6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl)-N-methyl-L-valyl-N-((1S,2R)-4-((2S)-2-((1S,2R)-3-(((1S)-1-carboxy-2-phenylethyl)amino)-1-methoxy-2-methyl-3-oxopropyl)-1-pyrrolidi nyl)-2-methoxy-1-((1S)-1-methylpropyl)-4-oxobutyl|N-(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl)-N-methyl-L-valyl-N-((3R,4S,5S)-1-((2S)-2-((1S,2R)-3-(((1S)-1-carboxy-2-phenylethyl)amino)-1-methoxy-2-methyl-3-oxopropyl)-1-pyrrolidinyl)-3-methoxy-5-methyl-1-oxo-4-heptanyl)-N-methyl-L-valinamide",1046.300,C52H83N7O13S,301.000,1880.000,1.400,73,5,15,31,"InChI=1S/C52H83N7O13S/c1-12-32(6)45(38(71-10)27-41(61)58-25-19-22-37(58)46(72-11)33(7)47(63)54-36(52(69)70)26-34-20-15-13-16-21-34)57(9)50(66)43(30(2)3)55-48(64)44(31(4)5)56(8)40(60)23-17-14-18-24-59-42(62)28-39(49(59)65)73-29-35(53)51(67)68/h13,15-16,20-21,30-33,35-39,43-46H,12,14,17-19,22-29,53H2,1-11H3,(H,54,63)(H,55,64)(H,67,68)(H,69,70)/t32-,33+,35-,36-,37-,38+,39?,43-,44-,45-,46+/m0/s1",CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN3C(=O)CC(C3=O)SC[C@@H](C(=O)O)N,CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(CC2=CC=CC=C2)C(=O)O)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C(=O)CCCCCN3C(=O)CC(C3=O)SCC(C(=O)O)N,BXTJCSYMGFJEID-XMTADJHZSA-N,"(2S)-2-[[(2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-[6-[3-[(2R)-2-amino-2-carboxyethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]hexanoyl-methylamino]-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methoxy-5-methylheptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methylpropanoyl]amino]-3-phenylpropanoic acid",1045.58,1045.58,0,1,0,11,10,1,0,0,0,21,3352,566,2D,NULL,Classification|Drug and Medication Information|Literature|Patents,5,NULL,20141122,BenchChem|ChemIDplus|FDA Global Substance Registration System (GSRS)|Google Patents|Key Organics/BIONET|PATENTSCOPE (WIPO)|Probes & Drugs portal|Springer Nature|Starshine Chemical|ToxPlanet,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C129821 - Antineoplastic Biological Agent > C129823 - Antineoplastic Antibody-Drug Conjugate|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C198634 - CD19-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C307 - Biological Agent|C308 - Immunotherapeutic Agent > C1512 - Immunoconjugate > C198859 - Anti-CD19 Antibody-drug Conjugate|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D007155 - Immunologic Factors > D000906 - Antibodies|D007155 - Immunologic Factors > D007136 - Immunoglobulins|D007155 - Immunologic Factors > D018796 - Immunoconjugates
92135932,Naquotinib mesylate,"Naquotinib mesylate|1448237-05-5|ASP8273 mesilate|Naquotinib (mesylate)|ASP-8273 mesilate|Naquotinib mesylate [USAN]|ASP-8273 MESYLATE|12T09LV21O|Naquotinib mesilate (JAN)|Naquotinib mesylate (USAN)|6-ethyl-3-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxypyrazine-2-carboxamide;methanesulfonic acid|NAQUOTINIB MESILATE [JAN]|2-Pyrazinecarboxamide, 6-ethyl-3-((4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-(((3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl)oxy)-, methanesulfonate (1:1)|Naquotinib mesilate|UNII-12T09LV21O|CHEMBL3707350|SCHEMBL18687011|YHC23705|1448237-05-5 (mesylate)|CS-5468|HY-19803|MS-31004|D10886|F85364|Q27251440|6-Ethyl-3-((4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-(((3R)-1-(1-oxoprop-2-en-1-yl)pyrrolidin-3-yl)oxy)pyrazine-2-carboxamide monomethanesulfonate|6-Ethyl-3-(4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)anilino)-5-(((3R)-1-(prop-2-enoyl)pyrrolidin-3-yl)oxy)pyrazine-2-carboxamide monomethanesulfonate",658.800,C31H46N8O6S,183.000,976.000,NULL,46,3,12,9,"InChI=1S/C30H42N8O3.CH4O3S/c1-4-25-30(41-24-12-15-38(20-24)26(39)5-2)34-29(27(33-25)28(31)40)32-21-6-8-22(9-7-21)36-13-10-23(11-14-36)37-18-16-35(3)17-19-37;1-5(2,3)4/h5-9,23-24H,2,4,10-20H2,1,3H3,(H2,31,40)(H,32,34);1H3,(H,2,3,4)/t24-;/m1./s1",CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)O[C@@H]5CCN(C5)C(=O)C=C.CS(=O)(=O)O,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC5CCN(C5)C(=O)C=C.CS(=O)(=O)O,ALDUQYYVQWGTMR-GJFSDDNBSA-N,6-ethyl-3-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxypyrazine-2-carboxamide;methanesulfonic acid,658.326,658.326,0,2,0,1,1,0,0,0,0,1,14,4,2D,NULL,Classification|Drug and Medication Information|Literature|Patents,4,NULL,20151207,"A2B Chem|AA BLOCKS|AbaChemScene|AstaTech, Inc.|BenchChem|Biosynth|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemIDplus|CymitQuimica|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA Global Substance Registration System (GSRS)|Google Patents|Hairui Chemical|KEGG|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Smolecule|Springer Nature|SureChEMBL|THE BioTek|Thomson Pharma|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
146026179,Mobocertinib succinate,Mobocertinib succinate|2389149-74-8|TAK-788 succinate|AP32788 succinate|Mobocertinib (succinate)|AP-32788 succinate|53QIA92ZEE|UNII-53QIA92ZEE|Propan-2-yl 2-(5-(acryloylamino)-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyanilino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate succinate|788Succinic acid|CHEMBL4802239|GLXC-25145|BCP33315|EX-A3982|MOBOCERTINIB SUCCINATE [JAN]|AT30194|HY-135815A|MOBOCERTINIB SUCCINATE [WHO-DD]|MS-31177|MOBOCERTINIB SUCCINATE [ORANGE BOOK]|CS-0114257|butanedioic acid;propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop-2-enoylamino)anilino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate|Propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop-2-enoylamino)anilino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate Succinate|TAK-788 succinate; AP32788 succinate;TAK 788 succinate; AP 32788 succinate;TAK788 succinate; AP-32788 succinate,703.800,C36H45N7O8,188.000,1030.000,NULL,51,4,13,16,"InChI=1S/C32H39N7O4.C4H6O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26;5-3(6)1-2-4(7)8/h9-13,16-20H,1,14-15H2,2-8H3,(H,34,40)(H,33,35,36);1-2H2,(H,5,6)(H,7,8)",CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC.C(CC(=O)O)C(=O)O,CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC.C(CC(=O)O)C(=O)O,YXYAEUMTJQGKHS-UHFFFAOYSA-N,butanedioic acid;propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop-2-enoylamino)anilino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate,703.333,703.333,0,2,0,0,0,0,0,0,0,0,0,0,2D,NULL,Classification|Drug and Medication Information|Literature|Patents|Use and Manufacturing,6,NULL,20200430,"A2B Chem|AA BLOCKS|AbaChemScene|AstaTech, Inc.|BenchChem|BioChemPartner|Chem-Space.com Database|ChEMBL|ChemIDplus|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|Probes & Drugs portal|Shanghai Mathcon Pharmaceutical Co.,LTD.|Starshine Chemical|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
54767257,Poziotinib hydrochloride,"Poziotinib hydrochloride|1429757-68-5|HM-781-36B hydrochloride|X4Z7U6JL1C|Poziotinib hydrochloride [USAN]|UNII-X4Z7U6JL1C|HM 781-36B|2-Propen-1-one, 1-(4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)oxy)-1-piperidinyl)-, hydrochloride (1:1)|1-(4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one, hydrochloride (1:1)|1-[4-[4-(3,4-Dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one hydrochloride|Poziotinib HCl|NOV120101 hydrochloride|HM 781-36B hydrochloride|CHEMBL5095402|SCHEMBL14841985|HM781-36B HYDROCHLORIDE|AKOS040759516|BP168498|1-(4-((4-((3,4-Dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one hydrochloride|1-(4-(4-(3,4-DICHLORO-2-FLUOROPHENYLAMINO)-7-METHOXYQUINAZOLIN-6-YLOXY)-PIPERIDIN-1-YL)PROP-2-EN-1-ONE HYDROCHLORIDE|1-[4-[[4-[(3,4-Dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-2-propen-1-one hydrochloride|1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one;hydrochloride",527.800,C23H22Cl3FN4O3,76.600,684.000,NULL,34,2,7,6,"InChI=1S/C23H21Cl2FN4O3.ClH/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26;/h3-5,10-13H,1,6-9H2,2H3,(H,27,28,29);1H",COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C.Cl,COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C.Cl,OMYSOLOMWJFVNK-UHFFFAOYSA-N,"1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one;hydrochloride",526.074,526.074,0,2,0,0,0,0,0,0,0,0,47,2,2D,NULL,Classification|Drug and Medication Information|Literature|Patents,4,NULL,20120123,"001Chemical|A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambeed|BenchChem|Biosynth|BOC Sciences|ChEMBL|ChemIDplus|Cooke Chemical Co., Ltd|CymitQuimica|FDA Global Substance Registration System (GSRS)|Google Patents|Lan Pharmatech|MolPort|PATENTSCOPE (WIPO)|Sinfoo Biotech|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
135379897,Epitinib succinate,Epitinib succinate|Epitinib (succinate)|2252334-12-4|UNII-2138WW3F3R|2138WW3F3R|4-Ethyl-N-(4-((3-ethynylphenyl)amino)-7-methoxy-6-quinazolinyl)-1-piperazinecarboxamide succinate|SCHEMBL20561708|AKOS040754922|HY-139300A|MS-30049|CS-0188812|butanedioic acid;4-ethyl-N-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide,548.600,C28H32N6O6,157.000,765.000,NULL,40,4,10,9,"InChI=1S/C24H26N6O2.C4H6O4/c1-4-17-7-6-8-18(13-17)27-23-19-14-21(22(32-3)15-20(19)25-16-26-23)28-24(31)30-11-9-29(5-2)10-12-30;5-3(6)1-2-4(7)8/h1,6-8,13-16H,5,9-12H2,2-3H3,(H,28,31)(H,25,26,27);1-2H2,(H,5,6)(H,7,8)",CCN1CCN(CC1)C(=O)NC2=C(C=C3C(=C2)C(=NC=N3)NC4=CC=CC(=C4)C#C)OC.C(CC(=O)O)C(=O)O,CCN1CCN(CC1)C(=O)NC2=C(C=C3C(=C2)C(=NC=N3)NC4=CC=CC(=C4)C#C)OC.C(CC(=O)O)C(=O)O,HISXHQFAOANCJX-UHFFFAOYSA-N,butanedioic acid;4-ethyl-N-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide,548.238,548.238,0,2,0,0,0,0,0,0,0,0,6,1,2D,NULL,Classification|Drug and Medication Information|Patents,3,NULL,20181215,"AbaChemScene|AKos Consulting & Solutions|BenchChem|ChemIDplus|DC Chemicals|FDA Global Substance Registration System (GSRS)|Google Patents|Key Organics/BIONET|MedChemexpress MCE|MolPort|Probes & Drugs portal|Shanghai Mathcon Pharmaceutical Co.,LTD.|Starshine Chemical|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
4708,4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline,"194423-15-9|PD168393|PD-168393|4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline|pd 168393|N-(4-((3-bromophenyl)amino)quinazolin-6-yl)acrylamide|N-[4-(3-bromoanilino)quinazolin-6-yl]prop-2-enamide|n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}prop-2-enamide|UNII-3R996Y9T0I|CHEMBL285063|3R996Y9T0I|2-Propenamide, N-(4-((3-bromophenyl)amino)-6-quinazolinyl)-|nchembio866-comp2|N-[4-[(3-bromophenyl)amino]quinazolin-6-yl]acrylamide|D01VFR|D0H6ZP|BMC163482 Compound 1|4-anilinoquinazoline deriv. 2|BDBM4567|SCHEMBL2680536|DTXSID80274444|EX-A808|CHEBI:131504|HMS3652F18|BCP07986|HSCI1_000120|MFCD02179207|s7039|PD 168393 [WHO-DD]|AKOS027337569|CCG-268278|CS-5723|DB07662|SB19366|NCGC00386260-01|NCGC00386260-02|3968-03-4|AC-32813|AS-67687|HY-13896|FT-0700253|SW218184-2|F13662|PD168393, >=98% (HPLC)|J-012594|N-(4-(3-Bromophenylamino)quinazolin-6-yl)acrylamide|Q26998221",369.200,C17H13BrN4O,66.900,433.000,3.900,23,2,4,4,"InChI=1S/C17H13BrN4O/c1-2-16(23)21-13-6-7-15-14(9-13)17(20-10-19-15)22-12-5-3-4-11(18)8-12/h2-10H,1H2,(H,21,23)(H,19,20,22)",C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)Br,C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)Br,HTUBKQUPEREOGA-UHFFFAOYSA-N,N-[4-(3-bromoanilino)quinazolin-6-yl]prop-2-enamide,368.027,368.027,0,1,0,0,0,0,0,0,0,120,170,47,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,5,7878|7911|8077|66614|67281|67282|67283|67284|67285|68096|68098|69422|69432|69562|69714|118099|118101|118108|118109|120554|120557|120560|120561|121287|121288|124668|124672|124785|124786|202224|202681|271838|271839|271840|271844|345876|381969|381970|381971|381972|392129|392130|392131|392132|392133|392134|392135|392136|392137|392138|392139|392140|392405|395850|395851|395852|457029|457030|457031|457032|457033|457035|457044|473321|473322|473323|473324|473325|473326|473327|473328|473329|473330|473523|493017|502957|502958|502959|502960|502961|502962|502963|502964|502965|502966|661561|661562|661565|661566|661567|661568|661569|661570|661571|661577|661578|661579|661580|661581|661582|661586|661587|719884|719906|719907|771338|771339|771340|771341|771342|771346|1077570|1077571|1077572|1077573|1259398|1259399|1259416|1259421|1259423|1296008|1296009|1303328|1303332|1303337|1303341|1303342|1345084|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347080|1347159|1347160|1347411|1347412|1409598|1469826|1469828|1508586|1508601|1508620|1640020|1645758|1645840|1645841|1645842|1645845|1645846|1645851|1645870|1645876|1645877|1671188|1671193|1745852|1745853|1795646|1795681|1799178|1799179|1803310,20050325,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|Abbott Labs|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|ApexBio Technology|Ark Pharm, Inc.|Ark Pharma Scientific Limited|AstaTech, Inc.|Aurora Fine Chemicals LLC|BenchChem|BindingDB|BioChemPartner|Biocore|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Broad Institute|Calbiochem|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|CSNpharm|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EMD Millipore|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hangzhou APIChem Technology|HDH Pharma|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|Matrix Scientific|MedChemexpress MCE|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NextBio|NextMove Software|NIH/NCATS RNAi|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sigma-Aldrich|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|Therapeutic Target Database (TTD)|Thomson Pharma|Thoreauchem|ToxPlanet|Uchem Meditech|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory|Wikidata|WikiPathways|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
6444692,Mubritinib,"Mubritinib|366017-09-6|Mubritinib (TAK 165)|TAK 165|TAK-165|TAK165|Mubritinib [USAN]|Mubritinib (USAN/INN)|Mubritinib [USAN:INN]|(E)-4-((4-(4-(1H-1,2,3-triazol-1-yl)butyl)phenoxy)methyl)-2-(4-(trifluoromethyl)styryl)oxazole|UNII-V734AZP9BR|V734AZP9BR|4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole|1-(4-(4-((2-((1E)-2-(4-(Trifluoromethyl)phenyl)ethenyl)-4-oxazolyl)methoxy)phenyl)butyl)-1H-1,2,3-triazole|1-(4-(4-((2-((E)-2-(4-(Trifluoromethyl)phenyl)ethenyl)oxazol-4-yl)methoxy)phenyl)butyl)-1H-1,2,3-triazole|1H-1,2,3-triazole, 1-(4-(4-((2-((1E)-2-(4-(trifluoromethyl)phenyl)ethenyl)-4-oxazolyl)methoxy)phenyl)butyl)-|(E)-4-[[4-[4-(1H-1,2,3-Triazol-1-yl)butyl]phenoxy]methyl]-2-[4-(trifluoromethyl)styryl]oxazole|1-(4-{4-[(2-{(E)-2-[4-(trifluoromethyl)phenyl]ethenyl}-1,3-oxazol-4-yl)methoxy]phenyl}butyl)-1H-1,2,3-triazole|1-[4-[4-[[2-[(1E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-triazole|1-[4-[4-[[2-[(E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]butyl]-1H-1,2,3-triazole|1-[4-[4-[[2-[(E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]oxazol-4-yl]methoxy]phenyl]butyl]-1H-1,2,3-triazole|Mubritinib;TAK-165|Mubritinib; TAK-165|MUBRITINIB [INN]|Mubritinib - TAK 165|D0A9OV|SCHEMBL94943|MUBRITINIB, FREE BASE|MLS006010161|GTPL6011|CHEMBL1614707|Mubritinib, >=98% (HPLC)|DTXSID501026014|HMS3414A21|HMS3678A21|BCP02837|EX-A2107|MFCD09954135|NSC800802|s2216|AKOS015918001|AC-5248|BCP9000012|C25-H23-F3-N4-O2|CCG-269433|CS-3954|DB12682|NSC-800802|NCGC00346582-08|AS-16256|HY-13501|SMR004458708|M3058|SW219659-1|D04025|A823310|Q6930896|(E)-4-((4-(4-(1H-1,2,3-triazol-1-yl)butyl)phenyl1H-1,2,3-triazol-1-yl)butyl)phenoxy)methyl)-2-(4-(trifluoromethyl)styryl)oxazole|[4-[4-[[2-[(E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]butyl]-1H-1,2,3-triazole|1-[4-[4-[[2-[(E)-2-(4-trifluoromethylphenyl)ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]-butyl]-1H-1,2,3-triazole|1-[4-[4-[[2-[(E)-2-(4-trifluoromethylphenyl)ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]butyl]-1H-1,2,3-triazole|1-[4-[4-[[2-[(E)-2-[-4-(trifiuoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]butyl]-1H-1,2,3-triazole|1-[4-[4-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]butyl]triazole",468.500,C25H23F3N4O2,66.000,620.000,5.400,34,0,8,10,"InChI=1S/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+",C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)/C=C/C4=CC=C(C=C4)C(F)(F)F,C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)C=CC4=CC=C(C=C4)C(F)(F)F,ZTFBIUXIQYRUNT-MDWZMJQESA-N,"4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",468.177,468.177,0,1,0,0,0,0,1,1,0,49,4791,999,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents,7,1259416|1259421|1296008|1296009|1345084|1345085|1345561|1345653|1346986|1346987|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347080|1347159|1347160|1347411|1409598|1424889|1424890|1424891|1424892|1424893|1424894|1424895|1424896|1424898|1424899|1424900|1424901|1424902|1424904|1424905|1424906|1424907|1424908|1424909|1424910|1424911|1424912|1424915|1424916|1424917|1424918|1424919|1424920|1424921|1424922|1424923|1424924|1424925|1424926|1424928|1424929|1424930|1424931|1424932|1424933|1424934|1424935|1424937|1424938|1424939|1424940|1424941|1424942|1424944|1424945|1424947|1424948|1424949|1424950|1424951|1424952|1424953|1424954|1424955|1424956|1424958|1424960|1424961|1424962|1424963|1424964|1424966|1424967|1424968|1424969|1424970|1424971|1424972|1424973|1424974|1424975|1424977|1424978|1424980|1424981|1424983|1424984|1424985|1424987|1424988|1424989|1424990|1424991|1424992|1424993|1424994|1424995|1424996|1424997|1424998|1425000|1425001|1425002|1425003|1425004|1425006|1425007|1425008|1425009|1425010|1425011|1425012|1425013|1425014|1425016|1425017|1425018|1425019|1425021|1425022|1425023|1425024|1425026|1425027|1425028|1425029|1425030|1425033|1425034|1425035|1425036|1425037|1425038|1425039|1425040|1425042|1425043|1425044|1425045|1425046|1425047|1425048|1425049|1425050|1425051|1425052|1425053|1425054|1425055|1425056|1425057|1425058|1425059|1425060|1425061|1425062|1425063|1425064|1425065|1425067|1425068|1425069|1425070|1425072|1425073|1425074|1425075|1425076|1425077|1425078|1425079|1425080|1425081|1425082|1425083|1425084|1425085|1425086|1425087|1425089|1425090|1425091|1425093|1425094|1425095|1425097|1425098|1425099|1425100|1425102|1425104|1425105|1425106|1425107|1425108|1425109|1425110|1425111|1425112|1425115|1425116|1425117|1425118|1425120|1425121|1425122|1425123|1425124|1425125|1425126|1425127|1425128|1425129|1425130|1425131|1425133|1425134|1425136|1425137|1425138|1425140|1425141|1425142|1425143|1425144|1425145|1425146|1425147|1425148|1425149|1425150|1425151|1425153|1425154|1425155|1425156|1425157|1425158|1425159|1425160|1425161|1425162|1425163|1425164|1425165|1425166|1425167|1425168|1425169|1425170|1425171|1425172|1425173|1425174|1425175|1425176|1425177|1425178|1425179|1425180|1425181|1425182|1425184|1425185|1425186|1425187|1425188|1425189|1425190|1425191|1425192|1425193|1425194|1425195|1425196|1425197|1425198|1425199|1425200|1425201|1425202|1425203|1425204|1425205|1425206|1425207|1425208|1425209|1425210|1425211|1425212|1425213|1508620|1640020|1645758|1645840|1645841|1645842|1645843|1645845|1645846|1645851|1645870|1645876|1645877|1671188|1671193|1743694|1745853|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800|1815753|1823171,20060428,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|AOBIOUS INC|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BenchChem|BioChemPartner|BioCrick|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemFaces|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|Collaborative Drug Discovery, Inc.|Combi-Blocks|CSNpharm|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|DTP/NCI|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Glentham Life Sciences Ltd.|Google Patents|Gulick Lab, Department of Structural Biology, University at Buffalo|Hairui Chemical|Hangzhou APIChem Technology|Hefei Hirisun Pharmatech Co., Ltd|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|Inhibitor 2|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|Matrix Scientific|MedChemexpress MCE|MLSMR|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sigma-Aldrich|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|TargetMol|TCI (Tokyo Chemical Industry)|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tocris Bioscience|ToxPlanet|Tractus|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory|Wikidata|Wubei-Biochem|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
11511120,Dacomitinib,"Dacomitinib|1110813-31-4|PF-00299804|PF299804|Dacomitinib (PF299804, PF299)|Vizimpro|Dacomitinib anhydrous|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide|(E)-N-(4-((3-chloro-4-fluorophenyl)aMino)-7-Methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enaMide|PF-299804|Dacomitinib (PF299804)|UNII-2XJX250C20|PF-00299804-03|2XJX250C20|PF 00299804-03|Dacomitinib (INN)|PF-299|(2e)-N-{4-[(3-Chloro-4-Fluorophenyl)amino]-7-Methoxyquinazolin-6-Yl}-4-(Piperidin-1-Yl)but-2-Enamide|DACOMITINIB [INN]|PF-299804 (Dacomitinib PF-00299804)|(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide|PF-804|dacomitinibum|PF299|(E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide|D06XXH|DACOMITINIB [WHO-DD]|MLS006011275|GTPL7422|CHEMBL2110732|CHEBI:91466|DTXSID50149493|EX-A030|CHEBI:132268|BDBM112499|Dacomitinib (PF-00299804)|AMY21292|BCP02530|MFCD19443734|NSC765888|NSC800084|s2727|AKOS025401818|CCG-264987|CS-0500|DB11963|NSC-765888|NSC-800084|US8623883, No. 2|NCGC00263185-09|NCGC00263185-10|AC-25915|AS-57686|HY-13272|SMR004703025|D5450|SW219155-1|D09883|Dacomitinib (PF299804, PF-00299804)|EN300-7406881|J-500784|Q17130597|(2E)-N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-METHOXYQUINAZOLIN-6-YL)-4-PIPERIDIN-1-YLBUT-2-ENAMIDE|(2E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide|(E)-N-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide|(E)-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide|2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-, (2E)-",469.900,C24H25ClFN5O2,79.400,665.000,4.400,33,2,7,7,"InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+",COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,LVXJQMNHJWSHET-AATRIKPKSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide,469.168,469.168,0,1,0,0,0,0,1,1,0,720,5419,1435,2D+3D,NULL,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing,11,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|770073|770078|770079|770080|770081|770082|770083|1159386|1159387|1159388|1159389|1159395|1159396|1159397|1250263|1250264|1259398|1259399|1259416|1259421|1259423|1296008|1296009|1315978|1315979|1315980|1315982|1315986|1315989|1315990|1315991|1315992|1315993|1316000|1316004|1316005|1316006|1316008|1316009|1316010|1316011|1316012|1316013|1316016|1316017|1316018|1316020|1316021|1316022|1316024|1316025|1316026|1316027|1316028|1316029|1316032|1316033|1316034|1316040|1316041|1316042|1316043|1316044|1345084|1345502|1345572|1345653|1346986|1346987|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347159|1347160|1347162|1347411|1347412|1409598|1424366|1424369|1424370|1424374|1424889|1424890|1424891|1424892|1424893|1424894|1424895|1424896|1424897|1424898|1424899|1424900|1424901|1424902|1424904|1424905|1424906|1424907|1424908|1424909|1424910|1424911|1424912|1424915|1424917|1424918|1424919|1424920|1424921|1424922|1424923|1424924|1424925|1424926|1424928|1424929|1424930|1424931|1424932|1424933|1424934|1424935|1424936|1424937|1424939|1424940|1424941|1424942|1424944|1424945|1424946|1424947|1424948|1424949|1424950|1424951|1424952|1424953|1424954|1424955|1424956|1424957|1424959|1424960|1424961|1424962|1424963|1424964|1424965|1424966|1424967|1424968|1424969|1424970|1424971|1424972|1424973|1424974|1424975|1424976|1424977|1424978|1424979|1424980|1424981|1424983|1424984|1424985|1424986|1424988|1424989|1424990|1424991|1424992|1424993|1424994|1424995|1424996|1424997|1424998|1424999|1425000|1425001|1425002|1425003|1425004|1425006|1425007|1425008|1425009|1425010|1425011|1425012|1425013|1425014|1425016|1425017|1425018|1425019|1425021|1425022|1425023|1425024|1425025|1425026|1425027|1425028|1425029|1425030|1425033|1425034|1425035|1425036|1425037|1425038|1425039|1425040|1425041|1425042|1425043|1425044|1425045|1425046|1425047|1425048|1425049|1425050|1425051|1425052|1425053|1425054|1425055|1425056|1425057|1425058|1425059|1425060|1425061|1425062|1425063|1425064|1425065|1425066|1425067|1425068|1425069|1425070|1425071|1425072|1425073|1425074|1425076|1425078|1425080|1425081|1425082|1425083|1425084|1425085|1425086|1425087|1425088|1425089|1425090|1425093|1425094|1425095|1425096|1425097|1425098|1425100|1425104|1425105|1425106|1425107|1425108|1425110|1425111|1425112|1425113|1425115|1425116|1425117|1425118|1425121|1425122|1425123|1425124|1425126|1425127|1425128|1425129|1425130|1425131|1425132|1425133|1425134|1425136|1425137|1425138|1425140|1425141|1425142|1425143|1425144|1425145|1425146|1425147|1425149|1425150|1425151|1425153|1425154|1425155|1425156|1425157|1425158|1425159|1425160|1425161|1425162|1425163|1425164|1425165|1425166|1425167|1425168|1425169|1425170|1425171|1425173|1425174|1425175|1425176|1425177|1425178|1425179|1425181|1425182|1425184|1425185|1425186|1425187|1425188|1425189|1425190|1425191|1425192|1425193|1425195|1425196|1425197|1425198|1425199|1425200|1425201|1425203|1425204|1425206|1425207|1425208|1425209|1425210|1425211|1425212|1425213|1508620|1535438|1535439|1545466|1545479|1545499|1545520|1545521|1595616|1595617|1595620|1640020|1645758|1645840|1645841|1645842|1645845|1645846|1645851|1645870|1645874|1645876|1645877|1645878|1671188|1671193|1671498|1694836|1694837|1694838|1694839|1694840|1694841|1694845|1694846|1694847|1708304|1708305|1724046|1745852|1745853|1762240|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800|1800296|1806437|1836357|1837286|1838215|1839144|1840073|1841002|1841931|1842860|1843789|1844718,20061026,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acadechem|Aceschem Inc|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Alsachim|Ambeed|Ambinter|AOBIOUS INC|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BenchChem|BindingDB|BioChemPartner|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|CEGChem|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemFaces|ChemFish Tokyo Co., Ltd.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemWise|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Cure First|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Glentham Life Sciences Ltd.|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|Human Metabolome Database (HMDB)|Hunan Chemfish Pharmaceutical Co., Ltd.|Inhibitor 2|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|labseeker|Lan Pharmatech|Matrix Scientific|MedChemexpress MCE|MLSMR|Molepedia|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Race Chemical|RR Scientific|Santagata Laboratory - Brigham and Women's Hospital and Harvard Medical School|SCRIPDB|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sinfoo Biotech|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|TargetMol|TCI (Tokyo Chemical Industry)|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Tocris Bioscience|ToxPlanet|Uchem Meditech|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory|VladaChem|Wikidata|Wubei-Biochem|Wutech|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
11557040,Tykerb,"388082-78-8|Lapatinib ditosylate hydrate|Tykerb|LAPATINIB DITOSYLATE MONOHYDRATE|Lapatinib Ditosylate|Tyverb|lapatinib tosilate|Tycerb|GW572016F|Lapatinib Ditosylate [USAN]|Lapatinib tosilate hydrate|GW-572016F|Lapatinib ditoluenesulfonate monohydrate|UNII-G873GX646R|G873GX646R|Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016)|N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine bis(4-methylbenzenesulfonate) hydrate|Tykerb (TN)|Lapatinib ditosylate (USAN)|N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid;hydrate|Lapatinib tosilate hydrate (JAN)|LAPATINIB TOSILATE HYDRATE [JAN]|GW-2016|GW-572016|C29-H26-Cl-F-N4-O4-S.2C7-H8-O3-S.H2-O|N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine bis(4-methylbenzenesulfonate) monohydrate|N-[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]furan-2-yl]quinazolin-4-amine bis(4-methylbenzenesulfonate) monohydrate|Tyverb (TN)|4-Quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl), bis(4-methylbenzenesulfonate), monohydrate|CHEMBL1201179|CHEBI:192581|LAPATINIB TOSILATE [MART.]|EX-A2821|s5241|(non-labelled)Lapatinib-d4 Ditosylate|AKOS015998638|CCG-270586|KS-1300|LAPATINIB DITOSYLATE [ORANGE BOOK]|6-methoxyquinoline-3-carboxylicacidethylester|FT-0658570|Lapatinib Ditosylate Hydrate;  GW-572016;|D04024|LAPATINIB DITOSYLATE MONOHYDRATE [WHO-DD]|LAPATINIB DITOLUENESULFONATE MONOHYDRATE [MI]|Q27278918|4-QUINAZOLINAMINE, N-(3-CHLORO-4-((3-FLUOROPHENYL)METHOXY)PHENYL)-6-(5-(((2-(METHYLSULFONYL)ETHYL)AMINO)METHYL)-2-FURANYL)-, 4-METHYLBENZENESULFONATE, HYDRATE (1:2:1)|4-QUINAZOLINAMINE, N-(3-CHLORO-4-((3-FLUOROPHENYL)METHOXY)PHENYL)-6-(5-(((2-(METHYLSULFONYL)ETHYL)AMINO)METHYL)-2-FURANYL)-, BIS(4-METHYLBENZENESULFONATE), MONOHYDRATE|4-QUINAZOLINAMINE, N-(3-CHLORO-4-((3-FLUOROPHENYL)METHOXY)PHENYL)-6-(5-(((2-(METHYLSULPHONYL)ETHYL)AMINO)METHYL)-2-FURANYL)-, BIS(4-METHYLBENZENESULPHONATE), MONOHYDRATE|N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-aminebis(4-methylbenzenesulfonate)hydrate|N-[3-chloro-4-[(3-luorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulonylethylamino)methyl]uran-2-yl]quinazolin-4-amine;4-methylbenzenesulonic acid;hydrate|N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolin amine ditosylate monohydrate",943.500,C43H44ClFN4O11S3,241.000,1100.000,NULL,63,5,16,13,"InChI=1S/C29H26ClFN4O4S.2C7H8O3S.H2O/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19;2*1-6-2-4-7(5-3-6)11(8,9)10;/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*2-5H,1H3,(H,8,9,10);1H2",CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl.O,CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl.O,XNRVGTHNYCNCFF-UHFFFAOYSA-N,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid;hydrate,942.184,942.184,0,4,0,0,0,0,0,0,0,1813,73245,13096,2D,Lapatinib,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,367173|367174|367178|367179|410943|410944|410945|410946|472048|472049|472050|472051|580189|580190|580191|580192|580193|580194|638068|638084|638085|638086|776716|776718|776720|776722|776724|776726|776728|776729|776730|776743|776744|776745|776746|776747|1219760|1219761|1219762|1219763|1219765|1409598|1640020|1645758,20061026,"001Chemical|3WAY PHARM INC|AbMole Bioscience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Ambinter|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|AvaChem Scientific|BenchChem|BePharm Ltd.|BLD Pharm|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Combi-Blocks|Cooke Chemical Co., Ltd|CSNpharm|CymitQuimica|DAOGE BIOPHARMA|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|J&H Chemical Co.,ltd|KEGG|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|Matrix Scientific|MolCore BioPharmatech|MolPort|NextBio|NextMove Software|NovoSeek|OXCHEM CORPORATION|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|RR Scientific|Selleck Chemicals|Smolecule|Starshine Chemical|Syntree|TargetMol|THE BioTek|Thomson Pharma|ToxPlanet|University of Kansas High Throughput Screening Laboratory|Wikidata|Wutech",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159156 - HER2 Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
16129168,N-(3-Ethynylphenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine,"NRC-2694|936446-61-6|N-(3-Ethynylphenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|UNII-O898S9836V|O898S9836V|N-(3-Ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine|4-Quinazolinamine, N-(3-ethynylphenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-|N-(3-ethynylphenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine|SCHEMBL828788|BCP30237|AKOS040742312|NRC 2694; NRC2694|CS-6754|AC-36681|HY-19909|MS-27321|Q27285472|N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine",418.500,C24H26N4O3,68.700,591.000,3.600,31,1,7,9,"InChI=1S/C24H26N4O3/c1-3-18-6-4-7-19(14-18)27-24-20-15-23(22(29-2)16-21(20)25-17-26-24)31-11-5-8-28-9-12-30-13-10-28/h1,4,6-7,14-17H,5,8-13H2,2H3,(H,25,26,27)",COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCN4CCOCC4,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCN4CCOCC4,WBKHQQZRHCECKK-UHFFFAOYSA-N,N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine,418.2,418.2,0,1,0,0,0,0,0,0,0,0,66,8,2D+3D,NULL,Classification|Patents,4,NULL,20070702,"A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|Ambeed|BenchChem|BioChemPartner|BOC Sciences|Chem-Space.com Database|ChemIDplus|ChemSpider|CymitQuimica|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|IBM|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|NextMove Software|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Thomson Pharma|ToxPlanet|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
44225877,Varlitinib tosylate,"Varlitinib tosylate|1146629-86-8|ARRY-543|Varlitinib tosylate [USAN]|Varlitinib (tosylate)|Varlitinib tosilate|UNII-V4M8FWS152|ARRY 543|V4M8FWS152|Arry-543 ditosilate|Arry-334543 ditosilate|Ar00334543 ditosilate|AR00334543|AR 00334543|Varlitinib tosylate (USAN)|Varlitinib Ditosylate|ARRY-334543 (tosylate); ASLAN001 (tosylate)|ARRY-543 DITOSYLATE|SCHEMBL572691|CHEMBL2105679|ARRY-334543 DITOSYLATE|AR00334543 DITOSYLATE|EX-A4491|HY-10530A|MFCD20275100|VARLITINIB TOSYLATE [WHO-DD]|AKOS040744739|N4-[3-chloro-4-(2-thiazolylmethoxy)phenyl]-N6-[(4R)-4,5-dihydro-4-methyl-2-oxazolyl]-4,6-Quinazolinediamine bis(4-methylbenzenesulfonate)|CS-0091650|D09690|AR00334543 ARRY-334543 ARRY-543|Q27291527|4,6-QUINAZOLINEDIAMINE, N4-(3-CHLORO-4-(2-THIAZOLYLMETHOXY)PHENYL)-N6-((4R)-4,5-DIHYDRO-4-METHYL-2-OXAZOLYL)-, 4-METHYLBENZENESULFONATE (1:2)|4-N-(3-CHLORO-4-(THIAZOL-2-YLMETHOXY)PHENYL)-6-N-((4R)-4-METHYL-4,5-DIHYDROOXAZOL-2- YL)QUINAZOLINE-4,6-DIAMINE BIS(4-METHYLBENZENESULFONATE)",811.400,C36H35ClN6O8S3,247.000,866.000,NULL,54,4,14,9,"InChI=1S/C22H19ClN6O2S.2C7H8O3S/c1-13-10-31-22(27-13)29-14-2-4-18-16(8-14)21(26-12-25-18)28-15-3-5-19(17(23)9-15)30-11-20-24-6-7-32-20;2*1-6-2-4-7(5-3-6)11(8,9)10/h2-9,12-13H,10-11H2,1H3,(H,27,29)(H,25,26,28);2*2-5H,1H3,(H,8,9,10)/t13-;;/m1../s1",C[C@@H]1COC(=N1)NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=NC=CS5)Cl.CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O,CC1COC(=N1)NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=NC=CS5)Cl.CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O,QSUPQMGDXOHVLK-FFXKMJQXSA-N,"4-N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-N-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]quinazoline-4,6-diamine;4-methylbenzenesulfonic acid",810.137,810.137,0,3,0,1,1,0,0,0,0,0,39,9,2D,NULL,Classification|Patents,2,NULL,20091012,"001Chemical|A2Z Chemical|AbaChemScene|abcr GmbH|Achemtek|AKos Consulting & Solutions|AstaTech, Inc.|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|CymitQuimica|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hairui Chemical|J&H Chemical Co.,ltd|KEGG|LabNetwork, a WuXi AppTec Company|MedChemexpress MCE|PATENTSCOPE (WIPO)|RR Scientific|Starshine Chemical|SureChEMBL|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
54759275,Theliatinib,"Theliatinib|1353644-70-8|6ZZ3B7NZ0B|HMPL-309|UNII-6ZZ3B7NZ0B|(3aR,6aR)-N-(4-((3-Ethynylphenyl)amino)-7-methoxy-6-quinazolinyl)hexahydro-1-methylpyrrolo(3,4-b)pyrrole-5(1H)-carboxamide|(3aR,6aR)-N-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole-5-carboxamide|Pyrrolo(3,4-b)pyrrole-5(1H)-carboxamide, N-(4-((3-ethynylphenyl)amino)-7-methoxy-6-quinazolinyl)hexahydro-1-methyl-, (3aR,6aR)-|(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide|XILIERTINIB [INN]|XILIERTINIB [WHO-DD]|SCHEMBL247509|EX-A3179|s8584|ZB1620|AC-35865|MS-27965|HY-104066|CS-0027986",442.500,C25H26N6O2,82.600,754.000,3.100,33,2,6,5,"InChI=1S/C25H26N6O2/c1-4-16-6-5-7-18(10-16)28-24-19-11-21(23(33-3)12-20(19)26-15-27-24)29-25(32)31-13-17-8-9-30(2)22(17)14-31/h1,5-7,10-12,15,17,22H,8-9,13-14H2,2-3H3,(H,29,32)(H,26,27,28)/t17-,22+/m1/s1",CN1CC[C@H]2[C@@H]1CN(C2)C(=O)NC3=C(C=C4C(=C3)C(=NC=N4)NC5=CC=CC(=C5)C#C)OC,CN1CCC2C1CN(C2)C(=O)NC3=C(C=C4C(=C3)C(=NC=N4)NC5=CC=CC(=C5)C#C)OC,FSXCKIBROURMFT-VGSWGCGISA-N,"(3aR,6aR)-N-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole-5-carboxamide",442.212,442.212,0,1,0,2,2,0,0,0,0,0,261,61,2D+3D,NULL,Classification|Drug and Medication Information|Literature|Patents,6,NULL,20120116,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|BenchChem|BOC Sciences|Chem-Space.com Database|ChemIDplus|ChemShuttle|CymitQuimica|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Thomson Pharma|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
71667668,Naquotinib,"Naquotinib|1448232-80-1|ASP8273|Naquotinib [USAN]|ASP-8273|2-Pyrazinecarboxamide, 6-ethyl-3-[[4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[[(3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]oxy]-|47DD4548PB|6-ethyl-3-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxypyrazine-2-carboxamide|(R)-5-((1-acryloylpyrrolidin-3-yl)oxy)-6-ethyl-3-((4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrazine-2-carboxamide|2-Pyrazinecarboxamide, 6-ethyl-3-((4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-(((3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl)oxy)-|e-2-carboxamide|NAQUOTINIB [INN]|Naquotinib (USAN/INN)|ASP8273 (Naquotinib)|Naquotinib; ASP-8273|NAQUOTINIB [WHO-DD]|UNII-47DD4548PB|GTPL9248|CHEMBL3663929|SCHEMBL16196078|BDBM170514|EX-A2669|YHC23280|NSC793322|s8412|CCG-270060|CS-5469|DB12036|NSC-793322|AC-35709|AS-75247|HY-19729|J3.496.214F|A14408|C91356|D10958|US9085540, 54|A857977|Q27074546|5-[[(3R)-1-Acryloylpyrrolidine-3-yl]oxy]-6-ethyl-3-[4-[4-(4-methylpiperazine-1-yl)piperidino]anilino]pyrazine-2-carboxamide|6-Ethyl-3-((4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-(((3R)-1-(1-oxoprop-2-en-1-yl)pyrrolidin-3-yl)oxy)pyrazine-2-carboxamide|6-ethyl-3-({4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-5-{[(3R)-1-(prop-2-enoyl)pyrrolidin-3-yl]oxy}pyrazine-2-carboxamide|6-ETHYL-3-(4-(4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN- 1-YL)ANILINO)-5-(((3R)-1-(PROP-2-ENOYL)PYRROLIDIN- 3-YL)OXY)PYRAZINE-2-CARBOXAMIDE|6-Ethyl-3-(4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)anilino)-5-(((3R)-1-(prop-2-enoyl)pyrrolidin-3-yl)oxy)pyrazine-2-carboxamide|6-Ethyl-3-[[4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[[(3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]oxy]-2-pyrazinecarboxamide",562.700,C30H42N8O3,120.000,883.000,3.400,41,2,9,9,"InChI=1S/C30H42N8O3/c1-4-25-30(41-24-12-15-38(20-24)26(39)5-2)34-29(27(33-25)28(31)40)32-21-6-8-22(9-7-21)36-13-10-23(11-14-36)37-18-16-35(3)17-19-37/h5-9,23-24H,2,4,10-20H2,1,3H3,(H2,31,40)(H,32,34)/t24-/m1/s1",CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)O[C@@H]5CCN(C5)C(=O)C=C,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC5CCN(C5)C(=O)C=C,QKDCLUARMDUUKN-XMMPIXPASA-N,6-ethyl-3-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxypyrazine-2-carboxamide,562.338,562.338,0,1,0,1,1,0,0,0,0,22,421,145,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,8,1|3|5|7|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|133|137|139|141|143|145|1291347|1291349|1291350|1291351|1291354|1345502|1347060|1347064|1347065|1347067|1347068|1347411|1645844|1645845|1645846|1645847|1645870|1645874|1645876|1645877|1801434,20130902,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Adooq BioScience|Amadis Chemical|Ambeed|AstaTech, Inc.|BenchChem|BindingDB|Biosynth|BOC Sciences|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DrugBank|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|NIH/NCATS RNAi|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|RR Scientific|Selleck Chemicals|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Thomson Pharma|Uchem Meditech|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
156413,Canertinib dihydrochloride,"Canertinib dihydrochloride|289499-45-2|Canertinib HCl|Canertinib (dihydrochloride)|CI-1033|Canertinib 2HCl|CI 1033|Canertinib dihydrochloride [USAN]|PD-0183805|PD183805|PD 183805|PD-183805|UNII-ICJ93X8X90|CANERTINIB HYDROCHLORIDE|ICJ93X8X90|N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide dihydrochloride|PD-0183805-002B|289499-45-2 (HCl)|N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide dihydrochloride|CI-1033 dihydrochloride;PD-183805 dihydrochloride|CHEMBL545315|Canertinib dihydrochloride (USAN)|2-Propenamide, N-(4-((3-chloro-4-fluorophenyl) amino)-7-(3-(4-morpholinyl) propoxy)-6-quinazolinyl)-, dihydrochloride|2-Propenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-morpholinyl)propoxy)-6-quinazolinyl)-, dihydrochloride|N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide dihydrochloride|N-(4-(3-chloro-4-fluorophenyl)amino)-7-(3-morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide dihydrochloride|N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;dihydrochloride|N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide dihydrochloride|N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride|SN-26606|C24H25ClFN5O3.2ClH|Canertinib.2HCL|N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-(4-MORPHOLINYL)PROPOXY)-6-QUINAZOLINYL)-2-PROPENAMIDE DIHYDROCHLORIDE|N-[4-(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholin-4-yl)propoxy]quinazolin-6-yl]prop-2-enamide dihydrochloride|MFCD09954112|CI-1033 dihydrochloride|Canertinib(dihydrochloride)|PD-183805 dihydrochloride|Canertinib dihydrochloride salt|SCHEMBL2052123|DTXSID80183143|HMS3295E05|BCP01902|CI-103|HY-10367A|AKOS015924656|289499-45-2 (HCl salt)|AC-2414|CANERTINIB DIHYDROCHLORIDE [MI]|CS-0263|C24-H25-Cl-F-N5-O3.2Cl-H|AS-75065|N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride|CANERTINIB DIHYDROCHLORIDE [WHO-DD]|LS-185636|AM20090674|FT-0724289|S0711|CI-1033, >=98% (HPLC)|A19399|D03350|EN300-19659633|Q-101362|Q-200787|Q27280663|2-PROPENAMIDE, N-(4-((3-CHLORO-4-FLUOROPHENYL) AMINO)-7-(3-(4-MORPHOLINYL)PROPOXY)-6-QUINAZOLINYL)-, DIHYDROCHLORIDE|N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide dihydrochloride",558.900,C24H27Cl3FN5O3,88.600,671.000,NULL,36,4,8,9,"InChI=1S/C24H25ClFN5O3.2ClH/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16;;/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29);2*1H",C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4.Cl.Cl,C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4.Cl.Cl,JZZFDCXSFTVOJY-UHFFFAOYSA-N,N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;dihydrochloride,557.116,557.116,0,3,0,0,0,0,0,0,0,28,1236,213,2D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards,8,8071|8074|8077|8078|27356|66611|66614|69562|69713|260895|260896|260897|260898|260899|260900|260901|260902|260903|599957|599959|1315978|1315979|1315980|1315981|1315982|1315986|1315990|1315991|1315992|1315993|1315998|1316000|1316036|1316037|1316038|1508601|1694836|1694837|1694838|1694839|1694840|1694841|1694845|1694846|1694847|1836244|1837173|1838102|1839031|1839960|1840889|1841818|1842747|1843676|1844605,20050808,"001Chemical|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|AstaTech, Inc.|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BenchChem|BioChemPartner|Biocore|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Boerchem|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|Collaborative Drug Discovery, Inc.|Cooke Chemical Co., Ltd|CSNpharm|CymitQuimica|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|eNovation Chemicals|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Glentham Life Sciences Ltd.|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|KEGG|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LeadScope|Matrix Scientific|MedChemexpress MCE|MolCore BioPharmatech|Molepedia|MolPort|MuseChem|NextBio|Norris Pharm|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sigma-Aldrich|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Thomson Pharma|Tocris Bioscience|ToxPlanet|Wikidata|Wutech|Yuhao Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D002317 - Cardiovascular Agents|D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics|D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents|D020011 - Protective Agents > D002316 - Cardiotonic Agents
44194962,NRC-2694 dihydrochloride,"JRT6MBD7C2|NRC-2694 dihydrochloride|NRC-2694B|UNII-JRT6MBD7C2|N-(3-Ethynylphenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine dihydrochloride|1172627-00-7|4-Quinazolinamine, N-(3-ethynylphenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-, hydrochloride (1:2)|SCHEMBL20534441",491.400,C24H28Cl2N4O3,68.700,591.000,NULL,33,3,7,9,"InChI=1S/C24H26N4O3.2ClH/c1-3-18-6-4-7-19(14-18)27-24-20-15-23(22(29-2)16-21(20)25-17-26-24)31-11-5-8-28-9-12-30-13-10-28;;/h1,4,6-7,14-17H,5,8-13H2,2H3,(H,25,26,27);2*1H",COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCN4CCOCC4.Cl.Cl,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCN4CCOCC4.Cl.Cl,HHXJUNYMDONXMO-UHFFFAOYSA-N,N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;dihydrochloride,490.154,490.154,0,3,0,0,0,0,0,0,0,0,17,3,2D,NULL,Classification|Patents,2,NULL,20090916,ChemIDplus|DiscoveryGate|FDA Global Substance Registration System (GSRS)|Google Patents|PATENTSCOPE (WIPO)|Starshine Chemical|SureChEMBL|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
118861389,Alflutinib,"Alflutinib|1869057-83-9|furmonertinib|AST2818|AST-2818|A49A7A5YN4|Ivesa|N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-6-(2,2,2-trifluoroethoxy)pyridin-3-yl]prop-2-enamide|N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)acrylamide|2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)-6-(2,2,2-trifluoroethoxy)-3-pyridinyl)-|Aflutinib|N-(2-(2-(dimethylamino)ethyl-methylamino)-5-((4-(1-methylindol-3-yl)pyrimidin-2-yl)amino)-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)prop-2-enamide|alflutinib (pseudo INN)|UNII-A49A7A5YN4|FURMONERTINIB [WHO-DD]|CHEMBL4297258|SCHEMBL17490447|GTPL10477|BCP30339|example 3 [US10072002B2]|AKOS040745008|EX-A2868-1|AC-36862|HY-112870|Alflutinib;AST-2818;AST 2818;ASK120067;ASK 120067;ASK-120067",568.600,C28H31F3N8O2,100.000,865.000,4.400,41,2,11,11,"InChI=1S/C28H31F3N8O2/c1-6-24(40)33-21-15-22(26(41-17-28(29,30)31)36-25(21)38(4)14-13-37(2)3)35-27-32-12-11-20(34-27)19-16-39(5)23-10-8-7-9-18(19)23/h6-12,15-16H,1,13-14,17H2,2-5H3,(H,33,40)(H,32,34,35)",CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(N=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OCC(F)(F)F,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(N=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OCC(F)(F)F,GHKOONMJXNWOIW-UHFFFAOYSA-N,"N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-6-(2,2,2-trifluoroethoxy)pyridin-3-yl]prop-2-enamide",568.252,568.252,0,1,0,0,0,0,0,0,0,16,48,9,2D+3D,NULL,Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,6,NULL,20160409,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AKos Consulting & Solutions|Ambeed|AstaTech, Inc.|BenchChem|BioChemPartner|BLD Pharm|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemShuttle|Cooke Chemical Co., Ltd|CymitQuimica|DC Chemicals|ECI Group, LCSB, University of Luxembourg|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Google Patents|Hangzhou APIChem Technology|IUPHAR/BPS Guide to PHARMACOLOGY|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Selleck Chemicals|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Thoreauchem",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
3081361,Vandetanib,"Vandetanib|443913-73-3|Zactima|ZD6474|Caprelsa|N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine|vandetanib (zd6474)|ZD-6474|N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine|ZD 6474|Vandetanib [INN]|C22H24BrFN4O2|338992-00-0|GNF-PF-2188|ZD-64|AZD-6474|NSC-744325|NSC-760766|UNII-YO460OQ37K|CHEMBL24828|N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine|YO460OQ37K|DTXSID1046681|CHEBI:49960|HSDB 8198|Vandetanib [USAN:INN:BAN:JAN]|CH 331|CH-331|MFCD07772346|NCGC00167513-01|4-[(4-Bromo-2-fluorophenyl)amino]-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazoline|N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine|F9995-0087|DTXCID9026681|4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-yl)methoxyquinazoline|4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline|(4-Bromo-2-fluoro-phenyl)-[6-methoxy-7-(1-methyl-piperidin-4-ylmethoxy)-quinazolin-4-yl]-amine|4-Quninazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-|CAS-443913-73-3|Vandetinib|Vandetanib, Zactima, ZD6474|2ivu|Caprelsa (TN)|Vandetanib- Bio-X|Vandetanib (Zactima)|DMPC Cyclic Urea 1|Kinome_3316|Zactima, ZD6474|VANDETANIB [MI]|Vandetanib (JAN/INN)|VANDETANIB [JAN]|Vandetanib [USAN:INN]|VANDETANIB [USAN]|VANDETANIB [VANDF]|BDBM21|D0G6QF|SCHEMBL9044|VANDETANIB [MART.]|4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline|VANDETANIB [WHO-DD]|MLS006011672|Vandetanib (JAN/USAN/INN)|Vandetanib (Pan-TK inhibitor)|AMY599|GTPL5717|SCHEMBL21067679|VANDETANIB [ORANGE BOOK]|cid_3081361|EX-A422|BCPP000023|HMS3244K03|HMS3244K04|HMS3244L03|HMS3654E11|HMS3672C07|BCP01925|C22-H24-Br-F-N4-O2|Tox21_112511|443913-73-3 (free base)|NSC744325|NSC760766|NSC800961|s1046|AKOS015902350|Tox21_112511_1|AC-5251|CCG-269495|CS-0130|DB05294|NSC 744325|NSC 760766|NSC-800961|SB16919|N-(4-bromo-2-fluoro-phenyl)-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazolin-4-amine|NCGC00167513-02|NCGC00167513-03|NCGC00167513-04|NCGC00167513-09|4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE|AS-11067|BV164508|HY-10260|SMR002530472|SY027438|LS-184394|FT-0656736|SW218092-2|EC-000.2359|A25648|D06407|EN300-265835|V-9402|AB01273969-01|AB01273969-02|AB01273969_04|SR-00000000462|Q7914515|SR-00000000462-2|BRD-K77625799-001-01-0|Z2512943095|4-QUINAZOLINAMINE, N-(4-BROMO-2-FLUOROPHENYL)-6-METHOXY-7-((1-METHYL-4- PIPERIDINYL)METHOXY)-|6-[(4R,5S,6S,7R)-4,7-dibenzyl-3-(5-carboxypentyl)-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]hexanoic acid|Quinazolin-4-amine, N-(4-bromo-2-fluorophenyl)-6-mthoxy-7-[(1-methyl-4-piperidinyl)methoxy]-|Vandetanib;7-((4-aminocyclohexyl)methoxy)-N-(4-bromo-2-fluorophenyl)-6-methoxyquinazolin-4-amine|ZD6",475.400,C22H24BrFN4O2,59.500,539.000,4.900,30,1,7,6,"InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)",CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,UHTHHESEBZOYNR-UHFFFAOYSA-N,N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine,474.107,474.107,0,1,0,0,0,0,0,0,0,2551,42535,7649,2D+3D,NULL,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,14,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1433|1471|1490|1688|1766|1768|1811|2528|2546|2551|2662|40729|40730|50766|53175|66624|69879|69880|73308|73451|73452|73628|84822|84823|84824|86729|93094|108256|108335|161407|161408|213567|213568|216619|216631|216632|216648|216649|216652|216653|216922|219188|219509|241758|248240|248370|256559|256560|256561|256562|256563|256564|256565|256566|256567|256568|256569|256570|256571|256572|256573|256574|256575|256576|256577|256578|256579|256580|256581|256582|256583|256584|256585|256586|256587|256588|256589|256590|256591|256592|256593|256594|256595|256596|256597|256598|256599|256600|256601|256602|256603|256604|256605|256606|256607|256608|256609|256610|256611|256612|256613|256614|256615|256616|256617|256618|256619|256620|256621|256622|256623|256624|256625|256626|256627|256628|256629|256630|256631|256632|256633|256634|256635|256636|256637|256638|256639|256640|256641|256642|256643|256644|256645|256646|256647|256648|256649|256650|256651|256652|256653|256654|256655|256656|256657|256658|256659|256660|256661|256662|256663|256664|256665|256666|256667|256668|256669|256670|256671|256672|256673|256674|256675|256676|256677|257072|257073|257074|257075|257076|259702|259703|259704|261930|261931|262070|262071|262072|263455|263456|263457|271127|271137|295762|295765|295766|295768|295769|295771|295773|305869|305870|305871|341898|347657|347658|347672|365969|435146|435147|435148|435149|435150|435151|435152|435153|435154|435155|435156|435157|435158|435159|435160|435161|435162|435163|435164|435165|435166|435167|435168|435169|435170|435171|435180|435181|435182|435183|435184|435188|435189|435190|435191|435192|435193|435194|435195|435196|435197|435198|435199|435200|435201|435202|435203|435204|435274|435275|435276|435277|435278|435279|435280|435281|435282|435283|435284|435285|435286|435287|435288|435289|435290|435291|435292|435293|435294|435295|435296|435297|435310|435311|435312|435318|435319|435320|435321|435322|435323|435324|435325|435326|435327|435328|435329|435393|435394|435395|435396|435397|435398|435399|435400|435401|435402|435403|435404|435405|435406|435407|435408|435409|435410|435411|435412|435413|435414|435415|435429|435430|435431|435432|435433|435434|435438|435439|435440|435441|435442|435443|435444|435445|435514|435515|435516|435517|435518|435519|435520|435521|435522|435523|435524|435525|435526|435527|435528|435529|435530|435531|435532|435533|435534|435545|435546|435551|435552|435553|435554|435555|435556|435557|435558|435559|435560|435561|435562|435563|435564|435644|435645|435646|435647|435648|435649|435650|435651|435652|435653|435654|435655|435656|435657|435658|435659|435660|435661|435662|435663|435664|435665|435666|435667|435674|435675|435676|435677|435678|435679|435687|435688|435689|435690|435691|435692|435693|435694|435775|435776|435777|435778|435779|435780|435781|435782|435783|435784|435785|435786|435787|435788|435789|435790|435791|435792|435793|435794|435795|435796|435797|435798|435799|435800|435801|435802|435803|435804|435805|435806|435807|435808|435821|435822|435823|435826|435827|435828|435829|435830|435831|435832|435833|435834|435896|435897|435898|435899|435900|435901|435902|435903|435904|435905|435906|435907|435908|435909|435910|435911|435912|435924|435925|435926|435929|435930|435931|435932|435933|435934|435935|435936|435937|435938|435939|435940|435941|436004|436005|436006|436007|436008|436009|436010|436011|436012|436013|436014|436015|436016|436017|436018|436019|436020|436021|436022|436023|436024|436025|436032|436033|436034|436042|436043|436044|436045|436046|436047|436048|436049|436050|436051|436052|436053|436054|436055|436060|449703|449704|449705|449706|490454|490455|490456|490459|490460|490461|492961|493040|504327|504332|504749|504832|504834|504847|504865|538338|588211|588212|588213|588579|588834|589575|589576|589577|589578|589580|589582|589583|589662|599957|599959|602156|602332|619785|619787|619789|619791|619792|619793|624030|624031|624032|624044|624170|624172|624173|624296|624297|624392|624476|624478|624479|624702|624703|624704|624705|624706|624707|624708|624709|624710|624711|624712|624713|624714|624715|624716|624717|624718|624719|624720|624721|624722|624723|624724|624725|624726|624727|624728|624729|624730|624731|624732|624733|624734|624735|624736|624737|624738|624739|624740|624741|624742|624743|624744|624745|624746|624747|624748|624749|624750|624751|624752|624753|624754|624755|624756|624757|624758|624759|624760|624761|624762|624763|624764|624765|624766|624767|624768|624769|624770|624771|624772|624773|624774|624775|624776|624777|624778|624779|624780|624781|624782|624783|624784|624785|624786|624787|624788|624789|624790|624791|624792|624793|624794|624795|624796|624797|624798|624799|624800|624801|624802|624803|624804|624805|624806|624807|624808|624809|624810|624811|624812|624813|624814|624815|624816|624817|624818|624819|624820|624821|624822|624823|624824|624825|624826|624827|624828|624829|624830|624831|624832|624833|624834|624835|624836|624837|624838|624839|624840|624841|624842|624843|624844|624845|624846|624847|624848|624849|624850|624851|624852|624853|624854|624855|624856|624857|624858|624859|624860|624861|624862|624863|624864|624865|624866|624867|624868|624869|624870|624871|624872|624873|624874|624875|624876|624877|624878|624879|624880|624881|624882|624883|624884|624885|624886|624887|624888|624889|624890|624891|624892|624893|624894|624895|624896|624897|624898|624899|624900|624901|624902|624903|624904|624905|624906|624907|624908|624909|624910|624911|624912|624913|624914|624915|624916|624917|624918|624919|624920|624921|624922|624923|624924|624925|624926|624927|624928|624929|624930|624931|624932|624933|624934|624935|624936|624937|624938|624939|624940|624941|624942|624943|624944|624945|624946|624947|624948|624949|624950|624951|624952|624953|624954|624955|624956|624957|624958|624959|624960|624961|624962|624963|624964|624965|624966|624967|624968|624969|624970|624971|624972|624973|624974|624975|624976|624977|624978|624979|624980|624981|624982|624983|624984|624985|624986|624987|624988|624989|624990|624991|624992|624993|624994|624995|624996|624997|624998|624999|625000|625001|625002|625003|625004|625005|625006|625007|625008|625009|625010|625011|625012|625013|625014|625015|625016|625017|625018|625019|625020|625021|625022|625023|625024|625025|625026|625027|625028|625029|625030|625031|625032|625033|625034|625035|625036|625037|625038|625039|625040|625041|625042|625043|625044|625045|625046|625047|625048|625049|625050|625051|625052|625053|625054|625055|625056|625057|625058|625059|625060|625061|625062|625063|625064|625065|625066|625067|625068|625069|625070|625071|625072|625073|625074|625075|625076|625077|625078|625079|625080|625081|625082|625083|625084|625085|625086|625087|625088|625089|625090|625091|625092|625093|625094|625095|625096|625097|625098|625099|625100|625101|625102|625103|625104|625105|625106|625107|625108|625109|625110|625111|625112|625113|625114|625115|625116|625117|625118|625119|625120|625121|625122|625123|625124|625125|625126|625127|625128|625129|625130|625131|625132|625133|625134|625135|625136|625137|625138|625139|625140|625141|625142|625143|637249|637250|637269|651631|651632|651633|651634|651635|651645|651646|651696|651712|651713|651784|651789|652048|652051|686947|686950|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|738214|738215|738216|738217|738218|738224|738225|738226|738227|738474|738475|738476|738477|738478|738479|738480|738481|738489|738490|738491|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743244|743322|743323|743324|743344|743345|743346|743347|977610|1053194|1053195|1117298|1117304|1117305|1117310|1117312|1117314|1117326|1117329|1117336|1117340|1117341|1117342|1117343|1117346|1117797|1117799|1117800|1117802|1117804|1117805|1117806|1117807|1157567|1157568|1157569|1157570|1157571|1157579|1159509|1159510|1159511|1159512|1159513|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159525|1159526|1159527|1159528|1159529|1159530|1159531|1159551|1159552|1159553|1159555|1159614|1164732|1204917|1224824|1224825|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224857|1224859|1224863|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|1224883|1224884|1224885|1224886|1224887|1224888|1224889|1224890|1224892|1224893|1224894|1224895|1224896|1256442|1256443|1256444|1259241|1259242|1259243|1259244|1259247|1259248|1259251|1259252|1259253|1259255|1259256|1259318|1259344|1259355|1259356|1259357|1259358|1259359|1259360|1259361|1259362|1259364|1259365|1259366|1259367|1259368|1259369|1259377|1259378|1259379|1259380|1259381|1259382|1259383|1259384|1259385|1259386|1259387|1259388|1259390|1259391|1259392|1259393|1259394|1259395|1259396|1259398|1259399|1259400|1259401|1259402|1259403|1259404|1259416|1259421|1259423|1270933|1272365|1275245|1275246|1275247|1283956|1283957|1283958|1283959|1283960|1283961|1293766|1293767|1293768|1293769|1293770|1293771|1296008|1296009|1309523|1337730|1337731|1337732|1337733|1337734|1345084|1345199|1345502|1345506|1345914|1346378|1346428|1346784|1346795|1346798|1346799|1346824|1346829|1346859|1346877|1346891|1346924|1346977|1346978|1346979|1346980|1346981|1346982|1346983|1346984|1346985|1346986|1346987|1347030|1347031|1347032|1347033|1347034|1347035|1347036|134,20050809,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abbott Labs|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambeed|Ambit Biosciences|AN PharmaTech|Angel Pharmatech Ltd.|Anward|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BenchChem|BePharm Ltd.|BindingDB|BioChemPartner|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|Burnham Center for Chemical Genomics|CAPOT|Carbott PharmTech Inc.|CEGChem|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemFaces|Chemical Probes Portal|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemShuttle|ChemSpider|ChemTik|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|CSNpharm|Cure First|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|DrugCentral|DTP/NCI|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Elsa Biotechnology|Enamine|Ennopharm|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|Exclusive Chemistry Ltd|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Founder Pharma|GlaxoSmithKline (GSK)|Glentham Life Sciences Ltd.|GNF / Scripps  Winzeler lab|Google Patents|Gregory J. Crowther|Hangzhou APIChem Technology|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LeadScope|LEAPCHEM|Life Chemicals|MassBank of North America (MoNA)|Matrix Scientific|Mcule|MedChemexpress MCE|Metabolomics Workbench|MLSMR|Molepedia|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NCBI Structure|NextBio|NextMove Software|NIAID ChemDB|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|NovoSeek|OChem|OXCHEM CORPORATION|Parchem|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Prous Science Drugs of the Future|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|Santagata Laboratory - Brigham and Women's Hospital and Harvard Medical School|SCRIPDB|Selleck Chemicals|Shanghai Institute of Organic Chemistry|Shanghai Mathcon Pharmaceutical Co.,LTD.|Shanghai Send Pharmaceutical Technology Co., Ltd|SLING Consortium|Smolecule|Southern Research Institute|Springer Nature|Starshine Chemical|SureChEMBL|Synblock Inc|Syntree|TargetMol|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|The Scripps Research Institute Molecular Screening Center|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Thoreauchem|Tox21|ToxPlanet|Tractus|Uchem Meditech|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory|UW Madison, Small Molecule Screening Facility|W&J PharmaChem|Wikidata|Wiley|Wubei-Biochem|Wutech|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent|C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors
44194961,NRC-2694 hydrochloride,"NRC-2694 hydrochloride|6RZ8T2FCG6|NRC 2694A|NRC-2694A|UNII-6RZ8T2FCG6|N-(3-Ethynylphenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine monohydrochloride|1172626-99-1|4-Quinazolinamine, N-(3-ethynylphenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-, hydrochloride (1:1)",454.900,C24H27ClN4O3,68.700,591.000,NULL,32,2,7,9,"InChI=1S/C24H26N4O3.ClH/c1-3-18-6-4-7-19(14-18)27-24-20-15-23(22(29-2)16-21(20)25-17-26-24)31-11-5-8-28-9-12-30-13-10-28;/h1,4,6-7,14-17H,5,8-13H2,2H3,(H,25,26,27);1H",COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCN4CCOCC4.Cl,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCN4CCOCC4.Cl,YHFOWANFLQFAKF-UHFFFAOYSA-N,N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;hydrochloride,454.177,454.177,0,2,0,0,0,0,0,0,0,0,22,2,2D,NULL,Classification|Patents,2,NULL,20090916,ChemIDplus|DiscoveryGate|FDA Global Substance Registration System (GSRS)|Google Patents|PATENTSCOPE (WIPO)|Starshine Chemical|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
134828257,AST2818 mesylate,"AST2818 mesylate|2130958-55-1|Alflutinib mesylate|AST-2818 mesylate|Alflutinib (mesylate)|Q09ZKD19V0|Alflutinib mesylate (AST2818|N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)acrylamide methanesulfonate|Ivesa|N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-6-(2,2,2-trifluoroethoxy)pyridin-3-yl]prop-2-enamide;methanesulfonic acid|Furmonertinib mesylate|ALFLUTINIB MESILATE|FURMONERTINIB MESILATE|UNII-Q09ZKD19V0|C29H35F3N8O5S|Alflutinib (AST2818) mesylate|GLXC-25390|BCP30340|EX-A2864|MFCD31746903|s6868|AKOS037648870|FURMONERTINIB MESILATE [WHO-DD]|HY-112870A|AC-35567|BS-15901|CS-0067492|D81030|Alflutinib methanesulfonate;Alflutinib mesylate;AST 2818 mesylate;AST-2818 mesylate;ASK120067 mesylate",664.700,C29H35F3N8O5S,163.000,957.000,NULL,46,3,14,11,"InChI=1S/C28H31F3N8O2.CH4O3S/c1-6-24(40)33-21-15-22(26(41-17-28(29,30)31)36-25(21)38(4)14-13-37(2)3)35-27-32-12-11-20(34-27)19-16-39(5)23-10-8-7-9-18(19)23;1-5(2,3)4/h6-12,15-16H,1,13-14,17H2,2-5H3,(H,33,40)(H,32,34,35);1H3,(H,2,3,4)",CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(N=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OCC(F)(F)F.CS(=O)(=O)O,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(N=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OCC(F)(F)F.CS(=O)(=O)O,WDPGHXINXNBHAS-UHFFFAOYSA-N,"N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-6-(2,2,2-trifluoroethoxy)pyridin-3-yl]prop-2-enamide;methanesulfonic acid",664.24,664.24,0,2,0,0,0,0,0,0,0,16,0,0,2D,NULL,Classification|Drug and Medication Information|Literature|Pharmacology and Biochemistry,4,NULL,20181128,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AKos Consulting & Solutions|Ambeed|AstaTech, Inc.|BenchChem|BioChemPartner|Chem-Space.com Database|ChemIDplus|Cooke Chemical Co., Ltd|CymitQuimica|DC Chemicals|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Hangzhou APIChem Technology|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|Probes & Drugs portal|RR Scientific|Selleck Chemicals|Smolecule|Starshine Chemical|TargetMol|THE BioTek|Thoreauchem",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
139377809,Sunvozertinib,"sunvozertinib|Sunvozertinib [INN]|L1Q2K5JYO8|2370013-12-8|DZD9008|UNII-L1Q2K5JYO8|2-Propenamide, N-(5-((4-((5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl)amino)-2-pyrimidinyl)amino)-2-((3R)-3-(dimethylamino)-1-pyrrolidinyl)-4-methoxyphenyl)-|SUNVOZERTINIB [USAN]|SCHEMBL21232131|GTPL11672|GLXC-25829|ASYM-122507|DZD-9008|EX-A6612|DZ0586|DZ-0586|MS-30456|Example 52 [WO2019149164A1]|HY-132842|CS-0204146|DZ00000586|A-1801|2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1- methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3R)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]-|N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide|N-{5-[(4-{[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino}pyrimidin-2-yl)amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl}prop-2-enamide",584.100,C29H35ClFN7O3,115.000,885.000,5.000,41,4,10,10,"InChI=1S/C29H35ClFN7O3/c1-7-27(39)34-22-14-23(25(41-6)15-24(22)38-11-9-17(16-38)37(4)5)35-28-32-10-8-26(36-28)33-21-13-19(30)20(31)12-18(21)29(2,3)40/h7-8,10,12-15,17,40H,1,9,11,16H2,2-6H3,(H,34,39)(H2,32,33,35,36)/t17-/m1/s1",CC(C)(C1=CC(=C(C=C1NC2=NC(=NC=C2)NC3=C(C=C(C(=C3)NC(=O)C=C)N4CC[C@H](C4)N(C)C)OC)Cl)F)O,CC(C)(C1=CC(=C(C=C1NC2=NC(=NC=C2)NC3=C(C=C(C(=C3)NC(=O)C=C)N4CCC(C4)N(C)C)OC)Cl)F)O,BTMKEDDEMKKSEF-QGZVFWFLSA-N,N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide,583.247,583.247,0,1,0,1,1,0,0,0,0,1,12,1,2D+3D,NULL,Classification|Drug and Medication Information|Literature|Patents|Use and Manufacturing,6,NULL,20191102,AbaChemScene|AbMole Bioscience|BOC Sciences|ChemIDplus|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Key Organics/BIONET|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|Starshine Chemical|Sun-shine Chemical|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159156 - HER2 Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
156414,Canertinib,"Canertinib|267243-28-7|CI-1033|PD-183805|Canertinib free base|Canertinib [INN]|N-(4-(3-chloro-4-fluorophenylamino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide|N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide|Canertinib [INN:BAN]|N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide|CI1033|UNII-C78W1K5ASF|C78W1K5ASF|CHEMBL31965|DTXSID8048943|CHEBI:61399|267243-28-7 (free base)|N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide|NCGC00182713-01|Canertinib (CI-1033)|SN-26606|CI-1033(Canertinib)|CANETINIB|CANERTINIB [MI]|N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride|Caneritinib; CI-1033|D0YB3W|Canertinib - CI-1033|CI-1033 (Canertinib)|CANERTINIB [WHO-DD]|SCHEMBL54837|MLS004774146|PD 183805 dihydrochloride|BDBM4779|cid_156414|GTPL5675|DTXCID1028869|EX-A078|BCPP000301|HMS3244M17|HMS3244M18|HMS3244N17|BCP01790|C24-H25-Cl-F-N5-O3|Tox21_113361|NSC780019|NSC801011|s1019|AKOS005145818|BCP9000481|BCP9000482|BCP9000525|CCG-269588|CS-0121|DB05424|NSC-780019|NSC-801011|SB16594|N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide|N-[4-(3-chloro-4-fluoro-anilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]prop-2-enamide|NCGC00182713-02|NCGC00182713-18|AS-56189|HY-10367|SMR003500789|PD0183805|CAS-267243-28-7|FT-0654215|EC-000.2258|A25038|EN300-6493001|Q5032274|Canertinib, PD-183805, CI1033, PD183805|Z166624030|N-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide|2-PROPENAMIDE, N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-(4-MORPHOLINYL)PROPOXY)-6-QUINAZOLINYL)-|N-(4-(3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-MORPHOLIN-4-YL)PROPOXY)QUINAZOLIN-6-YL)PROP-2-ENAMIDE|N-[4-(3-chloro-4-fluoro-phenyl-amino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide|N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide dihydrochloride|N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide",485.900,C24H25ClFN5O3,88.600,671.000,3.900,34,2,8,9,"InChI=1S/C24H25ClFN5O3/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29)",C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide,485.163,485.163,0,1,0,0,0,0,0,0,0,130,19666,3613,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,8,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1433|7892|45280|45283|45286|45287|67283|67284|67285|68098|69416|91107|201868|202680|222186|222187|223334|223336|225170|225172|256559|256560|256561|256562|256563|256564|256565|256566|256567|256568|256569|256570|256571|256572|256573|256574|256575|256576|256577|256578|256579|256580|256581|256582|256583|256584|256585|256586|256587|256588|256589|256590|256591|256592|256593|256594|256595|256596|256597|256598|256599|256600|256601|256602|256603|256604|256605|256606|256607|256608|256609|256610|256611|256612|256613|256614|256615|256616|256617|256618|256619|256620|256621|256622|256623|256624|256625|256626|256627|256628|256629|256630|256631|256632|256633|256634|256635|256636|256637|256638|256639|256640|256641|256642|256643|256644|256645|256646|256647|256648|256649|256650|256651|256652|256653|256654|256655|256656|256657|256658|256659|256660|256661|256662|256663|256664|256665|256666|256667|256668|256669|256670|256671|256672|256673|256674|256675|256676|256677|392129|392130|392131|392132|392133|392134|392135|392136|392137|392138|392139|392140|395851|395852|410943|410944|410945|410946|435146|435147|435148|435149|435150|435151|435152|435153|435154|435155|435156|435157|435158|435159|435160|435161|435162|435163|435164|435165|435166|435167|435168|435169|435170|435171|435180|435181|435182|435183|435184|435188|435189|435190|435191|435192|435193|435194|435195|435196|435197|435198|435199|435200|435201|435202|435203|435204|435274|435275|435276|435277|435278|435279|435280|435281|435282|435283|435284|435285|435286|435287|435288|435289|435290|435291|435292|435293|435294|435295|435296|435297|435310|435311|435312|435318|435319|435320|435321|435322|435323|435324|435325|435326|435327|435328|435329|435393|435394|435395|435396|435397|435398|435399|435400|435401|435402|435403|435404|435405|435406|435407|435408|435409|435410|435411|435412|435413|435414|435415|435429|435430|435431|435432|435433|435434|435438|435439|435440|435441|435442|435443|435444|435445|435514|435515|435516|435517|435518|435519|435520|435521|435522|435523|435524|435525|435526|435527|435528|435529|435530|435531|435532|435533|435534|435545|435546|435551|435552|435553|435554|435555|435556|435557|435558|435559|435560|435561|435562|435563|435564|435644|435645|435646|435647|435648|435649|435650|435651|435652|435653|435654|435655|435656|435657|435658|435659|435660|435661|435662|435663|435664|435665|435666|435667|435674|435675|435676|435677|435678|435679|435687|435688|435689|435690|435691|435692|435693|435694|435775|435776|435777|435778|435779|435780|435781|435782|435783|435784|435785|435786|435787|435788|435789|435790|435791|435792|435793|435794|435795|435796|435797|435798|435799|435800|435801|435802|435803|435804|435805|435806|435807|435808|435821|435822|435823|435826|435827|435828|435829|435830|435831|435832|435833|435834|435835|435896|435897|435898|435899|435900|435901|435902|435903|435904|435905|435906|435907|435908|435909|435910|435911|435912|435924|435925|435926|435929|435930|435931|435932|435933|435934|435935|435936|435937|435938|435939|435940|435941|436004|436005|436006|436007|436008|436009|436010|436011|436012|436013|436014|436015|436016|436017|436018|436019|436020|436021|436022|436023|436024|436025|436032|436033|436034|436042|436043|436044|436045|436046|436047|436048|436049|436050|436051|436052|436053|436054|436055|624173|624392|624476|624478|624479|624702|624703|624704|624705|624706|624707|624708|624709|624710|624711|624712|624713|624714|624715|624716|624717|624718|624719|624720|624721|624722|624723|624724|624725|624726|624727|624728|624729|624730|624731|624732|624733|624734|624735|624736|624737|624738|624739|624740|624741|624742|624743|624744|624745|624746|624747|624748|624749|624750|624751|624752|624753|624754|624755|624756|624757|624758|624759|624760|624761|624762|624763|624764|624765|624766|624767|624768|624769|624770|624771|624772|624773|624774|624775|624776|624777|624778|624779|624780|624781|624782|624783|624784|624785|624786|624787|624788|624789|624790|624791|624792|624793|624794|624795|624796|624797|624798|624799|624800|624801|624802|624803|624804|624805|624806|624807|624808|624809|624810|624811|624812|624813|624814|624815|624816|624817|624818|624819|624820|624821|624822|624823|624824|624825|624826|624827|624828|624829|624830|624831|624832|624833|624834|624835|624836|624837|624838|624839|624840|624841|624842|624843|624844|624845|624846|624847|624848|624849|624850|624851|624852|624853|624854|624855|624856|624857|624858|624859|624860|624861|624862|624863|624864|624865|624866|624867|624868|624869|624870|624871|624872|624873|624874|624875|624876|624877|624878|624879|624880|624881|624882|624883|624884|624885|624886|624887|624888|624889|624890|624891|624892|624893|624894|624895|624896|624897|624898|624899|624900|624901|624902|624903|624904|624905|624906|624907|624908|624909|624910|624911|624912|624913|624914|624915|624916|624917|624918|624919|624920|624921|624922|624923|624924|624925|624926|624927|624928|624929|624930|624931|624932|624933|624934|624935|624936|624937|624938|624939|624940|624941|624942|624943|624944|624945|624946|624947|624948|624949|624950|624951|624952|624953|624954|624955|624956|624957|624958|624959|624960|624961|624962|624963|624964|624965|624966|624967|624968|624969|624970|624971|624972|624973|624974|624975|624976|624977|624978|624979|624980|624981|624982|624983|624984|624985|624986|624987|624988|624989|624990|624991|624992|624993|624994|624995|624996|624997|624998|624999|625000|625001|625002|625003|625004|625005|625006|625007|625008|625009|625010|625011|625012|625013|625014|625015|625016|625017|625018|625019|625020|625021|625022|625023|625024|625025|625026|625027|625028|625029|625030|625031|625032|625033|625034|625035|625036|625037|625038|625039|625040|625041|625042|625043|625044|625045|625046|625047|625048|625049|625050|625051|625052|625053|625054|625055|625056|625057|625058|625059|625060|625061|625062|625063|625064|625065|625066|625067|625068|625069|625070|625071|625072|625073|625074|625075|625076|625077|625078|625079|625080|625081|625082|625083|625084|625085|625086|625087|625088|625089|625090|625091|625092|625093|625094|625095|625096|625097|625098|625099|625100|625101|625102|625103|625104|625105|625106|625107|625108|625109|625110|625111|625112|625113|625114|625115|625116|625117|625118|625119|625120|625121|625122|625123|625124|625125|625126|625127|625128|625129|625130|625131|625132|625133|625134|625135|625136|625137|625138|625139|625140|625141|625142|625143|651631|651632|651633|651634|651635|651645|651646|651696|651712|651713|651784|651789|652048|652051|662596|662597|662598|662599|662600|686947|686950|686978|686979|719885|719887|719888|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743244|743322|743323|743324|743344|743345|743346|743347|770073|770078|770079|777419|777420|777422|777423|777424|1053194|1053195|1117298|1117304|1117305|1117308|1117309|1117310|1117312|1117314|1117316|1117325|1117326|1117327|1117328|1117329|1117336|1117340|1117341|1117342|1117343|1117346|1117347|1117348|1117349|1117350|1117351|1117353|1117354|1117355|1117356|1159388|1159509|1159510|1159511|1159512|1159513|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159525|1159526|1159527|1159528|1159529|1159530|1159531|1159551|1159552|1159553|1159555|1159614|1171435|1171436|1171437|1171438|1171439|1224824|1224825|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224857|1224859|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|1224883|1224884|1224885|1224886|1224887|1224888|1224889|1224890|1224892|1224893|1224894|1224895|1224896|1244850|1259241|1259242|1259243|1259244|1259247|1259248|1259251|1259252|1259253|1259255|1259256|1259344|1259357|1259358|1259359|1259360|1259361|1259362|1259364|1259365|1259366|1259367|1259368|1259369|1259377|1259378|1259379|1259380|1259381|1259382|1259383|1259384|1259385|1259386|1259387|1259388|1259390|1259391|1259392|1259393|1259394|1259395|1259396|1259398|1259399|1259400|1259401|1259402|1259403|1259404|1259415|1259416|1259421|1259423|1289541|1289545|1289546|1289548|1289552|1289553|1289561|1296008|1296009|1309517|1345052|1345084|1345085|1345199|1345502|1345653|1346378|1346428|1346784|1346795|1346798|1346799|1346824|1346829|1346859|1346877|1346891|1346924|1346977|1346978|1346979|1346980|1346981|1346982|1346986|1346987|1347030|1347031|1347032|1347033|1347034|1347035|1347036|1347037|1347038|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347154|1347395|1347397|1347398|1347399|1347407|1347411|1347412|1347424|1347425|1359917|1364456|1409598|1424366|1424369|1424370|1424371|1424372|1424889|1424890|1424891|1424892|1424893|1424894|1424895|1424896|1424897|1424898|1424899|1424900|1424901|1424902|1424904|1424905|1424907|1424908|1424909|1424910|1424911|1424912|1424913|1424914|1424915|1424917|1424918|1424919|1424920|1424921|1424922|1424923|1424924|1424925|1424926|1424928|1424929|1424930|1424931|1424932|1424933|1424934|1424935|1424937|1424938|1424939|1424940,20050808,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|Ambit Biosciences|AN PharmaTech|Angel Pharmatech Ltd.|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BenchChem|BindingDB|BioChemPartner|Biocore|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|CAPOT|CEGChem|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemFaces|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|CSNpharm|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|Exclusive Chemistry Ltd|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Glentham Life Sciences Ltd.|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LeadScope|LEAPCHEM|Matrix Scientific|MedChemexpress MCE|Metabolomics Workbench|MLSMR|MolCore BioPharmatech|Molepedia|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NIAID ChemDB|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|NovoSeek|OChem|Parchem|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|Prous Science Drugs of the Future|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sigma-Aldrich|SLING Consortium|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|Therapeutic Target Database (TTD)|Thomson Pharma|Thoreauchem|Tocris Bioscience|Tox21|ToxPlanet|Tractus|University of Kansas High Throughput Screening Laboratory|Wikidata|Wubei-Biochem|Wuhan Atomole Chemicals Co., Ltd.|Wutech|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
24756910,Cudc-101,"CUDC-101|1012054-59-9|CUDC 101|7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide|CUDC101|7-[[4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl]oxy]-N-hydroxyheptanamide|UNII-1A7Y9MP123|CHEMBL598797|1A7Y9MP123|7-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide|7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide|7-((4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide|7-({4-[(3-ethynylphenyl)amino]-7-methoxyquinazolin-6-yl}oxy)-N-hydroxyheptanamide|D0Z4RC|CUDC-101, Free Base|SCHEMBL93769|MLS006010163|GTPL8894|CUDC 101 [WHO-DD]|DTXSID00143784|EX-A842|HMS3654C20|BCP01935|BDBM50307768|MFCD15528940|NSC800081|s1194|AKOS022526176|BCP9000556|CCG-264856|compound 8 [PMID: 20143778]|DB12174|NSC-800081|SB19287|NCGC00263177-01|NCGC00263177-05|NCGC00263177-12|1313875-12-5|AC-28428|AS-16955|HY-10223|SMR004701272|FT-0665231|SW219934-1|J-000340|J-519062|Q27076925|Heptanamide, 7-[[4-[(3-ethynylphenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-hydroxy-",434.500,C24H26N4O4,106.000,624.000,4.000,32,3,7,12,"InChI=1S/C24H26N4O4/c1-3-17-9-8-10-18(13-17)27-24-19-14-22(21(31-2)15-20(19)25-16-26-24)32-12-7-5-4-6-11-23(29)28-30/h1,8-10,13-16,30H,4-7,11-12H2,2H3,(H,28,29)(H,25,26,27)",COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO,PLIVFNIUGLLCEK-UHFFFAOYSA-N,7-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide,434.195,434.195,0,1,0,0,0,0,0,0,0,87,4632,916,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents,7,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|461250|461251|461252|461253|461254|461255|461256|461257|461258|461259|461260|461261|461262|461263|461270|461271|461272|461273|461274|461275|461276|461277|461278|461279|461280|461281|461282|461283|461284|461285|461286|461287|461288|461289|461290|461291|461292|461293|461294|461295|461297|461298|461299|461302|463638|463639|463658|624476|624478|624479|651645|651646|651696|651712|651713|686947|686950|743244|743322|743323|743324|743344|743345|743346|743347|743364|743365|743366|1053194|1053195|1159510|1159511|1159512|1159513|1159530|1224824|1224825|1224857|1224859|1259252|1259253|1259255|1259256|1259325|1259357|1259358|1259359|1259360|1259361|1259362|1259416|1259421|1296008|1296009|1330923|1330941|1330942|1341594|1341595|1341596|1341597|1341599|1341600|1341601|1341602|1341603|1341604|1341605|1341606|1341607|1341608|1341609|1341610|1341611|1341612|1341613|1341614|1341615|1341616|1341617|1341618|1341619|1341620|1341621|1341622|1341623|1341624|1341625|1341627|1341649|1341650|1341651|1341652|1341653|1341654|1341657|1341658|1341663|1341664|1341665|1341666|1341667|1341668|1341669|1341670|1341671|1341672|1341673|1341674|1341675|1341676|1341677|1341678|1341685|1341687|1341718|1341719|1341720|1345084|1345502|1345653|1346032|1346048|1346066|1346068|1346077|1346082|1346090|1346104|1346131|1346134|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347080|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347109|1347110|1347111|1347112|1347113|1347114|1347115|1347116|1347117|1347118|1347119|1347121|1347122|1347123|1347124|1347125|1347126|1347127|1347128|1347129|1347154|1347159|1347160|1347162|1347411|1347412|1347414|1347415|1409598|1424889|1424890|1424891|1424892|1424893|1424894|1424895|1424896|1424897|1424898|1424899|1424900|1424901|1424902|1424903|1424904|1424905|1424906|1424907|1424908|1424909|1424910|1424911|1424912|1424914|1424915|1424917|1424918|1424919|1424920|1424921|1424922|1424923|1424924|1424925|1424926|1424928|1424929|1424930|1424931|1424932|1424933|1424934|1424935|1424936|1424937|1424939|1424940|1424941|1424942|1424944|1424945|1424946|1424947|1424948|1424949|1424950|1424951|1424952|1424953|1424954|1424955|1424956|1424957|1424958|1424960|1424961|1424962|1424963|1424964|1424965|1424966|1424967|1424968|1424969|1424970|1424971|1424972|1424973|1424974|1424975|1424976|1424977|1424978|1424979|1424980|1424981|1424983|1424984|1424985|1424987|1424988|1424989|1424990|1424992|1424993|1424994|1424995|1424996|1424997|1424998|1424999|1425000|1425001|1425002|1425003|1425004|1425005|1425006|1425007|1425008|1425009|1425010|1425011|1425012|1425013|1425014|1425016|1425017|1425018|1425019|1425021|1425022|1425023|1425024|1425025|1425026|1425027|1425028|1425029|1425030|1425031|1425033|1425034|1425035|1425036|1425037|1425038|1425039|1425040|1425042|1425043|1425044|1425045|1425046|1425047|1425048|1425049|1425050|1425051|1425052|1425053|1425054|1425055|1425056|1425057|1425058|1425059|1425060|1425061|1425062|1425063|1425064|1425065|1425066|1425067|1425068|1425069|1425070|1425071|1425072|1425073|1425074|1425076|1425077|1425078|1425079|1425080|1425081|1425082|1425083|1425084|1425085|1425086|1425087|1425089|1425090|1425091|1425093|1425094|1425095|1425096|1425097|1425098|1425099|1425100|1425101|1425102|1425103|1425104|1425105|1425106|1425107|1425109|1425110|1425111|1425112|1425113|1425115|1425116|1425117|1425118|1425119|1425120|1425121|1425122|1425123|1425124|1425125|1425126|1425127|1425128|1425129|1425130|1425131|1425132|1425133|1425134|1425135|1425136|1425137|1425138|1425140|1425141|1425142|1425143|1425144|1425145|1425146|1425147|1425148|1425149|1425150|1425151|1425153|1425154|1425155|1425156|1425157|1425158|1425159|1425160|1425161|1425162|1425163|1425164|1425165|1425166|1425167|1425168|1425169|1425170|1425171|1425173|1425174|1425175|1425176|1425177|1425178|1425179|1425181|1425182|1425185|1425186|1425188|1425189|1425190|1425191|1425192|1425193|1425194|1425196|1425197|1425198|1425199|1425200|1425201|1425202|1425203|1425204|1425205|1425206|1425207|1425208|1425209|1425210|1425211|1425212|1425213|1441630|1441631|1441632|1441699|1441700|1508586|1508598|1508601|1508620|1508621|1508622|1508623|1508624|1508630|1508633|1508635|1508636|1508637|1542169|1542170|1542171|1542172|1542173|1542174|1542175|1542176|1542177|1542178|1587859|1587860|1640020|1645758|1645840|1645841|1645842|1645845|1645846|1645851|1645870|1645874|1645875|1645876|1645877|1645878|1671188|1671190|1671193|1671194|1671449|1671450|1671451|1671452|1671453|1671454|1671455|1671456|1671457|1671458|1671459|1671460|1671461|1671462|1671464|1720109|1745845|1745853|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800|1801713,20080331,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|AOBIOUS INC|ApexBio Technology|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BenchChem|BindingDB|BioChemPartner|Biocore|BioCrick|Biosynth|BOC Sciences|Boerchem|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|CAPOT|CEGChem|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemFaces|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Collaborative Drug Discovery, Inc.|Combi-Blocks|Cooke Chemical Co., Ltd|Cure First|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Genome Instability in Tumors (B420) group, DKFZ|Google Patents|Hangzhou APIChem Technology|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Inhibitor 2|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|Matrix Scientific|MedChemexpress MCE|MLSMR|MolCore BioPharmatech|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NIH/NCATS RNAi|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|Probes & Drugs portal|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|Santagata Laboratory - Brigham and Women's Hospital and Harvard Medical School|SCRIPDB|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sinfoo Biotech|Smolecule|Springer Nature|Starshine Chemical|Sun-shine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|Therapeutic Target Database (TTD)|Thomson Pharma|ToxPlanet|Uchem Meditech|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory|Wikidata|Wubei-Biochem|Wutech|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159156 - HER2 Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor
72703790,Nazartinib,"nazartinib|EGF816|1508250-71-2|EGF-816|NVP-EGF816-NX|Nazartinib [USAN]|EGF 816|Nazartinib(EGF816)|UNII-KE7K32EME8|KE7K32EME8|CHEMBL3787344|NVS-816|N-[7-chloro-1-[(3R)-1-[(E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]benzimidazol-2-yl]-2-methylpyridine-4-carboxamide|N-{7-chloro-1-[(3R)-1-[(2E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]-1H-1,3-benzodiazol-2-yl}-2-methylpyridine-4-carboxamide|4-PYRIDINECARBOXAMIDE, N-(7-CHLORO-1-((3R)-1-((2E)-4-(DIMETHYLAMINO)-1-OXO-2-BUTEN-1-YL)HEXAHYDRO-1H-AZEPIN-3-YL)-1H-BENZIMIDAZOL-2-YL)-2-METHYL-|4-Pyridinecarboxamide, N-[7-chloro-1-[(3R)-1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]hexahydro-1H-azepin-3-yl]-1H-benzimidazol-2-yl]-2-methyl-|NAZARTINIB [INN]|Nazartinib (USAN/INN)|NAZARTINIB [WHO-DD]|(R,E)-N-(7-chloro-1-(1-(4-(dimethylamino)but-2-enoyl)azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide|EGF816 [WHO-DD]|GTPL9204|SCHEMBL16767232|SCHEMBL16767240|EGF816; NVS-816;N-[7-chloro-1-[(3R)-1-[(E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]benzimidazol-2-yl]-2-methylpyridine-4-carboxamide|EX-A1640|BDBM50160870|NSC787027|s7824|Nazartinib (EGF816, NVS-816)|CCG-269658|NSC-787027|compound 47 [PMID: 27433829]|AC-29881|AS-75243|HY-12872|J3.535.960E|A14416|C72867|D11430|A884136|Q27087855|N-(7-CHLORO-1-((3R)-1-((2E)-4-(DIMETHYLAMINO) BUT-2-ENOYL)AZEPAN-3-YL)-1HBENZIMIDAZOLOL-2-YL)-2-METHYLPYRIDINE-4-CARBOXAMIDE|N-(7-Chloro-1-{(3R)-1-[(2E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl}-1H-benzimidazol-2-yl)-2-methylpyridine-4-carboxamide|N-[7-chloro-1-[(3r)-1-[(2e)-4-(dimethylamino)-1-oxo-2-buten-1-yl]hexahydro-1h-azepin-3-yl]-1h-benzimidazol-2-yl]-2-methyl-4-pyridinecarboxamide",495.000,C26H31ClN6O2,83.400,764.000,3.200,35,1,5,6,"InChI=1S/C26H31ClN6O2/c1-18-16-19(12-13-28-18)25(35)30-26-29-22-10-6-9-21(27)24(22)33(26)20-8-4-5-15-32(17-20)23(34)11-7-14-31(2)3/h6-7,9-13,16,20H,4-5,8,14-15,17H2,1-3H3,(H,29,30,35)/b11-7+/t20-/m1/s1",CC1=NC=CC(=C1)C(=O)NC2=NC3=C(N2[C@@H]4CCCCN(C4)C(=O)/C=C/CN(C)C)C(=CC=C3)Cl,CC1=NC=CC(=C1)C(=O)NC2=NC3=C(N2C4CCCCN(C4)C(=O)C=CCN(C)C)C(=CC=C3)Cl,IOMMMLWIABWRKL-WUTDNEBXSA-N,N-[7-chloro-1-[(3R)-1-[(E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]benzimidazol-2-yl]-2-methylpyridine-4-carboxamide,494.22,494.22,0,1,0,1,1,0,1,1,0,34,1136,265,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,8,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1291347|1291348|1291349|1321086|1321092|1321093|1321094|1321095|1321099|1321100|1321101|1321102|1321103|1321104|1321105|1321106|1321107|1321108|1321109|1321110|1321117|1321118|1321119|1321121|1321122|1321123|1321125|1321126|1321129|1321130|1321131|1321132|1321133|1321134|1321135|1321136|1321137|1321138|1321139|1321140|1321149|1321150|1321151|1321152|1321153|1321154|1321155|1321156|1345502|1409598|1640020|1645758|1671498|1806437,20140120,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|Amadis Chemical|Ambeed|ApexBio Technology|AstaTech, Inc.|BenchChem|BindingDB|BioCrick|BOC Sciences|Broad Institute|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Combi-Blocks|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|FondChemical Co., Ltd|Google Patents|Hangzhou APIChem Technology|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|Novartis Institutes for BioMedical Research|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Thieme Chemistry|Thomson Pharma|ToxPlanet|Uchem Meditech|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents
89670174,Beigene-283,"lifirafenib|Beigene-283|BGB-283|1446090-77-2|1446090-79-4|BGB283|Lifirafenib [USAN]|5-(((1R,1aS,6bR)-1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one|Bgb 283|8762XZS5ZF|5-(((1R,1aS,6bR)-1-(6-(Trifluoromethyl)-1H-benzimidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa(b)benzofuran-5-yl)oxy)-3,4-dihydro-1H-1,8-naphthyridin-2-one|5-[[(1R,1aS,6bR)-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one|1,8-Naphthyridin-2(1H)-one, 5-(((1R,1aS,6bR)-1a,6b-dihydro-1-(6-(trifluoromethyl)-1H-benzimidazol-2-yl)-1H-cyclopropa(b)benzofuran-5-yl)oxy)-3,4-dihydro-|5-({(1r,1as,6br)-1-[5-(Trifluoromethyl)-1h-Benzimidazol-2-Yl]-1a,6b-Dihydro-1h-Cyclopropa[b][1]benzofuran-5-Yl}oxy)-3,4-Dihydro-1,8-Naphthyridin-2(1h)-One|compound 2.2b|5-{{(1r,1as,6br)-1-[5-(trifluoromethyl)-1h-benzimidazol-2-yl]-1a,6b-dihydro-1h-cyclopropa[b][1]benzofuran-5-yl}oxy}-3,4-dihydro-1,8-naphthyridin-2(1h)-one|LIFIRAFENIB [INN]|Lifirafenib (USAN/INN)|UNII-8762XZS5ZF|BGB-283;Beigene-283|LIFIRAFENIB [WHO-DD]|GTPL8958|CHEMBL4209157|SCHEMBL15085288|BDBM372968|EX-A1473|US9895376, Compound 2.2b|WHC09077|WHC09079|Lifirafenib;BGB-283;Beigene-283|BDBM50453816|WHO 10554|AKOS040745015|CS-6308|DB14773|AC-35880|AC-36373|HY-18957|MS-28874|D11410|A900647|Q27075193|3K3|rel-5-[[(1S,1aS,6bR)-1a,6b-dihydro-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-cyclopropa[b]benzofuran-5-yl]oxy]-3,4-dihydro1,8-Naphthyridin-2(1H)-one",478.400,C25H17F3N4O3,89.100,845.000,3.700,35,2,8,3,"InChI=1S/C25H17F3N4O3/c26-25(27,28)11-1-4-15-16(9-11)31-24(30-15)21-20-14-10-12(2-5-17(14)35-22(20)21)34-18-7-8-29-23-13(18)3-6-19(33)32-23/h1-2,4-5,7-10,20-22H,3,6H2,(H,30,31)(H,29,32,33)/t20-,21-,22-/m0/s1",C1CC(=O)NC2=NC=CC(=C21)OC3=CC4=C(C=C3)O[C@H]5[C@@H]4[C@@H]5C6=NC7=C(N6)C=C(C=C7)C(F)(F)F,C1CC(=O)NC2=NC=CC(=C21)OC3=CC4=C(C=C3)OC5C4C5C6=NC7=C(N6)C=C(C=C7)C(F)(F)F,NGFFVZQXSRKHBM-FKBYEOEOSA-N,"5-[[(1R,1aS,6bR)-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one",478.125,478.125,0,1,0,3,3,0,0,0,0,11,234,88,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents,7,1345502|1345628|1345687|1371341|1640020|1645758|1798191|1804184,20150213,"A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|AbMole Bioscience|AKos Consulting & Solutions|Amadis Chemical|Angel Pharmatech Ltd.|AstaTech, Inc.|Axon Medchem|BenchChem|BindingDB|Biosynth|BOC Sciences|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|ChemShuttle|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DrugBank|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|KEGG|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|NCBI Structure|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|RR Scientific|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
117918742,"(S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl)acrylamide","TAS6417|1661854-97-2|Zipalertinib|TAS-6417|(S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl)acrylamide|CLN-081|Zipalertinib [INN]|CLN081|T4YMU8TW9H|2-Propenamide, N-((8S)-4-amino-8,9-dihydro-6-methyl-5-(3-quinolinyl)pyrimido(5,4-b)indolizin-8-yl)-|N-[(8S)-4-Amino-6-methyl-5-quinolin-3-yl-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide|UNII-T4YMU8TW9H|Cln 081|TPC064|CHEMBL4650281|CLN 081 [WHO-DD]|SCHEMBL16525948|GTPL11889|TPC-064|EX-A3391|NSC812926|s8814|AKOS040742682|NSC-812926|AC-36462|AS-79368|HY-112299|CS-0044757|D93895|A937514",396.400,C23H20N6O,98.700,710.000,2.300,30,2,5,3,"InChI=1S/C23H20N6O/c1-3-18(30)28-16-8-13(2)21-19(15-9-14-6-4-5-7-17(14)25-10-15)20-22(24)26-12-27-23(20)29(21)11-16/h3-10,12,16H,1,11H2,2H3,(H,28,30)(H2,24,26,27)/t16-/m0/s1",CC1=C[C@@H](CN2C1=C(C3=C(N=CN=C32)N)C4=CC5=CC=CC=C5N=C4)NC(=O)C=C,CC1=CC(CN2C1=C(C3=C(N=CN=C32)N)C4=CC5=CC=CC=C5N=C4)NC(=O)C=C,MKCYPWYURWOKST-INIZCTEOSA-N,"N-[(8S)-4-amino-6-methyl-5-quinolin-3-yl-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide",396.17,396.17,0,1,0,1,1,0,0,0,0,3,50,7,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents,6,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145,20160223,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|AKos Consulting & Solutions|Amadis Chemical|AstaTech, Inc.|Axon Medchem|BenchChem|BLD Pharm|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|ChemShuttle|CymitQuimica|DC Chemicals|DTP/NCI|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|NextMove Software|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
131634510,Nazartinib mesylate trihydrate,"Nazartinib mesylate trihydrate|Nazartinib mesylate|NVP-EGF816-AGA|T0ECU9IJ0N|Nazartinib mesylate [USAN]|EGF-816 mesylate trihydrate|UNII-T0ECU9IJ0N|1784778-10-4|Nazartinib mesylate (USAN)|4-Pyridinecarboxamide, N-(7-chloro-1-((3R)-1-((2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl)hexahydro-1H-azepin-3-yl)-1H-benzimidazol-2-yl)-2-methyl-, methanesulfonate, hydrate (1:1:3)|CHEMBL4297222|D11434|N-(7-Chloro-1-{(3R)-1-[(2E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl}-1H-benzimidazol-2-yl)-2-methylpyridine-4-carboxamide methanesulfonate hydrate (1:1:3)",645.200,C27H41ClN6O8S,149.000,857.000,NULL,43,5,11,6,"InChI=1S/C26H31ClN6O2.CH4O3S.3H2O/c1-18-16-19(12-13-28-18)25(35)30-26-29-22-10-6-9-21(27)24(22)33(26)20-8-4-5-15-32(17-20)23(34)11-7-14-31(2)3;1-5(2,3)4;;;/h6-7,9-13,16,20H,4-5,8,14-15,17H2,1-3H3,(H,29,30,35);1H3,(H,2,3,4);3*1H2/b11-7+;;;;/t20-;;;;/m1..../s1",CC1=NC=CC(=C1)C(=O)NC2=NC3=C(N2[C@@H]4CCCCN(C4)C(=O)/C=C/CN(C)C)C(=CC=C3)Cl.CS(=O)(=O)O.O.O.O,CC1=NC=CC(=C1)C(=O)NC2=NC3=C(N2C4CCCCN(C4)C(=O)C=CCN(C)C)C(=CC=C3)Cl.CS(=O)(=O)O.O.O.O,HCKBCMVQGLVGEA-ZBFDXWMPSA-N,N-[7-chloro-1-[(3R)-1-[(E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]benzimidazol-2-yl]-2-methylpyridine-4-carboxamide;methanesulfonic acid;trihydrate,644.24,644.24,0,5,0,1,1,0,1,1,0,5,0,0,2D,NULL,Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,5,NULL,20171017,ChEMBL|ChemIDplus|FDA Global Substance Registration System (GSRS)|KEGG|PATENTSCOPE (WIPO)|Starshine Chemical,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents
155923038,Sutetinib maleate,"Sutetinib maleate|KEV8HMY439|UNII-KEV8HMY439|(2E)-N-(3-Cyano-7-ethoxy-4-((3-ethynylphenyl)amino)-6-quinolinyl)-4-(dimethylamino)-2-butenamide maleate|1701408-75-4|2-Butenamide, N-(3-cyano-7-ethoxy-4-((3-ethynylphenyl)amino)-6-quinolinyl)-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:1)|SCHEMBL23420362",555.600,C30H29N5O6,165.000,897.000,NULL,41,4,10,11,"InChI=1S/C26H25N5O2.C4H4O4/c1-5-18-9-7-10-20(13-18)29-26-19(16-27)17-28-22-15-24(33-6-2)23(14-21(22)26)30-25(32)11-8-12-31(3)4;5-3(6)1-2-4(7)8/h1,7-11,13-15,17H,6,12H2,2-4H3,(H,28,29)(H,30,32);1-2H,(H,5,6)(H,7,8)/b11-8+;2-1-",CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC=CC(=C3)C#C)C#N)NC(=O)/C=C/CN(C)C.C(=C\C(=O)O)\C(=O)O,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC=CC(=C3)C#C)C#N)NC(=O)C=CCN(C)C.C(=CC(=O)O)C(=O)O,AXQMBLZSKCUMJL-CNEOMQSYSA-N,(Z)-but-2-enedioic acid;(E)-N-[3-cyano-7-ethoxy-4-(3-ethynylanilino)quinolin-6-yl]-4-(dimethylamino)but-2-enamide,555.212,555.212,0,2,0,0,0,0,2,2,0,0,1,1,2D,NULL,Classification|Drug and Medication Information|Patents,3,NULL,20210616,ChemIDplus|FDA Global Substance Registration System (GSRS)|Starshine Chemical|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
6445562,Pelitinib,"Pelitinib|257933-82-7|EKB-569|Pelitinib (EKB-569)|WAY-EKB 569|EKB 569|326894-84-2|WAY-EKB-569|(E)-N-(4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide|C24H23ClFN5O2|Pelitinib [USAN]|EKI-569|Pelitinib [USAN:INN]|(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide|UNII-X5DWL380Z6|X5DWL380Z6|(2E)-N-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide|(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl}-4-(dimethylamino)but-2-enamide|CHEBI:38927|(E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide|Pelitinib (EKB-569; WAY-EKB 569)|MFCD09837868|(E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide|(E)-N-[4-[(3-chloranyl-4-fluoranyl-phenyl)amino]-3-cyano-7-ethoxy-quinolin-6-yl]-4-(dimethylamino)but-2-enamide|2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-|2-Butenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-|EKB569|EKI 569|(2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide|(2e)-n-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide|93J|PELITINIB [INN]|Pelitinib (USAN/INN)|Pelitinib - EKB-569|2-Butenamide, (E)-,|D0S3PO|PELITINIB [WHO-DD]|SCHEMBL93756|SCHEMBL93757|MLS006010062|CHEMBL607707|GTPL7644|BDBM31090|cid_6445562|EX-A061|BCPP000118|BCPP000119|BCP02376|C24-H23-Cl-F-N5-O2|NSC729742|NSC800841|s1392|AKOS005146343|CCG-264890|DB05524|NSC-729742|NSC-800841|WAY-172569|NCGC00263103-09|NCGC00263103-10|(E)-N-[4-(3-chloro-4-fluoro-anilino)-3-cyano-7-ethoxy-6-quinolyl]-4-(dimethylamino)but-2-enamide|AC-24700|AC-25029|AS-16280|HY-32718|SMR004701222|P2529|SW219267-1|EC-000.2259|D05399|A818030|Q-101404|BRD-K08799216-001-01-2|Q27088290|(2E)-N-(-((3-CHLORO-4-FLUOROPHENYL)AMINO)3-CYANO-7-ETHOXYQUINOLIN-6-YL)-4-(DIMETHYLAMINO)BUT-2-ENAMIDE|(2e)-n-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide          pelitinib|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-dimethylamino-2-butenamide|(E)-N-[3-Cyano-4-[(4-fluoro-3-chlorophenyl)amino]-7-ethoxyquinoline-6-yl]-4-(dimethylamino)-2-buteneamide|(E)-N-[4-(3-Chloro-4-fluoroanilino)-cyano-7-ethoxyquinolin-6-yl]-4-(dimethlyamino)but-2-enamide, (IUPAC)|(E)-N-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-dimethylaminobut-2-enamide|3-Cyano-4-[(3-chloro-4-fluorophenyl)amino]-6-[[4-(N,N-dimethylamino)-1-oxo-2-buten-1-yl]amino]-7-ethoxyquinoline|4-Dimethylaminobut-2-enoic Acid, [4-(3-Chloro-4-fluoro phenylamino)-3-cyano-7-ethoxyquinoline-6-yl]amide",467.900,C24H23ClFN5O2,90.300,729.000,4.500,33,2,7,8,"InChI=1S/C24H23ClFN5O2/c1-4-33-22-12-20-17(11-21(22)30-23(32)6-5-9-31(2)3)24(15(13-27)14-28-20)29-16-7-8-19(26)18(25)10-16/h5-8,10-12,14H,4,9H2,1-3H3,(H,28,29)(H,30,32)/b6-5+",CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)/C=C/CN(C)C,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)C=CCN(C)C,WVUNYSQLFKLYNI-AATRIKPKSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,467.152,467.152,0,1,0,0,0,0,1,1,0,228,14785,2748,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards,9,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1433|7879|7892|66620|66621|69416|69431|69432|91107|164334|201868|202225|202680|202682|245771|245772|245773|245774|245775|245776|245777|247761|247801|247802|248903|248914|256559|256560|256561|256562|256563|256564|256565|256566|256567|256568|256569|256570|256571|256572|256573|256574|256575|256576|256577|256578|256579|256580|256581|256582|256583|256584|256585|256586|256587|256588|256589|256590|256591|256592|256593|256594|256595|256596|256597|256598|256599|256600|256601|256602|256603|256604|256605|256606|256607|256608|256609|256610|256611|256612|256613|256614|256615|256616|256617|256618|256619|256620|256621|256622|256623|256624|256625|256626|256627|256628|256629|256630|256631|256632|256633|256634|256635|256636|256637|256638|256639|256640|256641|256642|256643|256644|256645|256646|256647|256648|256649|256650|256651|256652|256653|256654|256655|256656|256657|256658|256659|256660|256661|256662|256663|256664|256665|256666|256667|256668|256669|256670|256671|256672|256673|256674|256675|256676|256677|295762|295765|295768|295769|295771|295772|295773|362392|435146|435147|435148|435149|435150|435151|435152|435153|435154|435155|435156|435157|435158|435159|435160|435161|435162|435163|435164|435165|435166|435167|435168|435169|435170|435171|435180|435181|435182|435183|435184|435188|435189|435190|435191|435192|435193|435194|435195|435196|435197|435198|435199|435200|435201|435202|435203|435204|435274|435275|435276|435277|435278|435279|435280|435281|435282|435283|435284|435285|435286|435287|435288|435289|435290|435291|435292|435293|435294|435295|435296|435297|435310|435311|435312|435318|435319|435320|435321|435322|435323|435324|435325|435326|435327|435328|435329|435393|435394|435395|435396|435397|435398|435399|435400|435401|435402|435403|435404|435405|435406|435407|435408|435409|435410|435411|435412|435413|435414|435415|435429|435430|435431|435432|435433|435434|435438|435439|435440|435441|435442|435443|435444|435445|435514|435515|435516|435517|435518|435519|435520|435521|435522|435523|435524|435525|435526|435527|435528|435529|435530|435531|435532|435533|435534|435545|435546|435551|435552|435553|435554|435555|435556|435557|435558|435559|435560|435561|435562|435563|435564|435644|435645|435646|435647|435648|435649|435650|435651|435652|435653|435654|435655|435656|435657|435658|435659|435660|435661|435662|435663|435664|435665|435666|435667|435674|435675|435676|435677|435678|435679|435687|435688|435689|435690|435691|435692|435693|435694|435775|435776|435777|435778|435779|435780|435781|435782|435783|435784|435785|435786|435787|435788|435789|435790|435791|435792|435793|435794|435795|435796|435797|435798|435799|435800|435801|435802|435803|435804|435805|435806|435807|435808|435821|435822|435823|435826|435827|435828|435829|435830|435831|435832|435833|435834|435835|435896|435897|435898|435899|435900|435901|435902|435903|435904|435905|435906|435907|435908|435909|435910|435911|435912|435924|435925|435926|435929|435930|435931|435932|435933|435934|435935|435936|435937|435938|435939|435940|435941|436004|436005|436006|436007|436008|436009|436010|436011|436012|436013|436014|436015|436016|436017|436018|436019|436020|436021|436022|436023|436024|436025|436032|436033|436034|436042|436043|436044|436045|436046|436047|436048|436049|436050|436051|436052|436053|436054|436055|510254|510404|599957|599959|603958|770073|1093388|1159388|1177758|1177759|1205944|1244850|1259398|1259399|1259416|1259421|1259423|1296008|1296009|1316039|1345084|1345085|1345502|1346986|1346987|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347159|1347160|1347162|1347411|1347412|1347414|1409598|1424889|1424890|1424891|1424892|1424893|1424894|1424895|1424896|1424898|1424899|1424900|1424901|1424902|1424904|1424905|1424906|1424907|1424908|1424909|1424910|1424911|1424912|1424914|1424915|1424917|1424918|1424919|1424920|1424921|1424922|1424923|1424924|1424925|1424926|1424928|1424929|1424930|1424931|1424932|1424933|1424934|1424935|1424936|1424937|1424938|1424939|1424940|1424941|1424942|1424944|1424945|1424946|1424947|1424948|1424949|1424950|1424952|1424953|1424954|1424955|1424956|1424958|1424959|1424960|1424961|1424962|1424963|1424964|1424965|1424966|1424967|1424968|1424969|1424970|1424971|1424972|1424973|1424974|1424975|1424976|1424977|1424978|1424979|1424980|1424981|1424983|1424984|1424985|1424987|1424988|1424989|1424990|1424991|1424992|1424993|1424994|1424995|1424996|1424997|1424998|1424999|1425000|1425001|1425002|1425003|1425004|1425006|1425007|1425008|1425009|1425010|1425011|1425013|1425014|1425016|1425017|1425018|1425020|1425021|1425022|1425023|1425024|1425025|1425026|1425027|1425028|1425029|1425030|1425033|1425034|1425035|1425036|1425037|1425038|1425039|1425040|1425041|1425042|1425043|1425044|1425045|1425046|1425047|1425048|1425049|1425050|1425051|1425052|1425053|1425054|1425055|1425056|1425057|1425058|1425059|1425060|1425061|1425062|1425063|1425064|1425065|1425066|1425067|1425068|1425069|1425070|1425071|1425072|1425073|1425074|1425075|1425077|1425078|1425079|1425080|1425081|1425082|1425083|1425084|1425085|1425086|1425087|1425088|1425089|1425090|1425093|1425094|1425095|1425096|1425097|1425098|1425099|1425100|1425101|1425102|1425104|1425105|1425106|1425107|1425108|1425109|1425110|1425111|1425112|1425113|1425115|1425116|1425117|1425118|1425119|1425120|1425121|1425122|1425123|1425124|1425126|1425127|1425128|1425129|1425130|1425131|1425132|1425133|1425134|1425136|1425137|1425138|1425140|1425141|1425142|1425143|1425144|1425145|1425146|1425147|1425148|1425149|1425150|1425151|1425153|1425154|1425155|1425156|1425157|1425158|1425159|1425160|1425161|1425162|1425163|1425164|1425165|1425166|1425167|1425168|1425169|1425170|1425171|1425172|1425173|1425174|1425175|1425177|1425178|1425179|1425181|1425182|1425183|1425184|1425185|1425186|1425187|1425188|1425189|1425190|1425191|1425192|1425193|1425194|1425196|1425197|1425198|1425199|1425200|1425201|1425202|1425203|1425204|1425205|1425206|1425207|1425208|1425209|1425210|1425211|1425212|1425213|1450945|1450946|1450947|1450953|1450954|1450955|1508598|1508620|1535427|1558400|1558401|1595616|1595617|1595620|1619515|1640020|1645758|1645840|1645841|1645842|1645845|1645846|1645851|1645870|1645874|1645876|1645877|1645878|1671188|1671193|1671498|1745852|1745853|1745854|1745855|1752676|1752680|1752700|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800|1801713|1804403,20060429,"001Chemical|3WAY PHARM INC|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Ambit Biosciences|AN PharmaTech|AOBIOUS INC|ApexBio Technology|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BenchChem|BindingDB|BioChemPartner|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|CEGChem|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|ChemWise|Clinivex|Collaborative Drug Discovery, Inc.|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|CSNpharm|Cure First|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Elsa Biotechnology|eNovation Chemicals|Excenen Pharmatech|Exclusive Chemistry Ltd|FDA Global Substance Registration System (GSRS)|Glentham Life Sciences Ltd.|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|Inhibitor 2|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|Matrix Scientific|MedChemexpress MCE|Metabolomics Workbench|MLSMR|Molepedia|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NCBI Structure|NextBio|NextMove Software|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|Novartis Institutes for BioMedical Research|NovoSeek|OChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Prous Science Drugs of the Future|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|Santagata Laboratory - Brigham and Women's Hospital and Harvard Medical School|SCRIPDB|Selleck Chemicals|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|TargetMol|TCI (Tokyo Chemical Industry)|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|Therapeutic Target Database (TTD)|Thomson Pharma|Thoreauchem|Tocris Bioscience|ToxPlanet|Tractus|Uchem Meditech|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory|Wikidata|Wiley|Wubei-Biochem|Wutech|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor"
10437018,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate","BMS-599626|714971-09-2|AC480|AC-480|BMS 599626|(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate|AC480 (BMS-599626)|BMS599626|AC1480 (free base)|CHEMBL1645462|UNII-2252724U5N|BMS-599626 (AC480)|2252724U5N|Carbamic acid, N-(4-((1-((3-fluorophenyl)methyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo(2,1-F)(1,2,4)triazin-6-yl)-, (3S)-3-morpholinylmethyl ester|[(3S)-morpholin-3-yl]methyl N-[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate|D0U4FF|GTPL7647|SCHEMBL12065349|DTXSID60221714|EX-A2296|BDBM50333373|MFCD10565678|NSC764135|NSC799323|s1056|BMS 599626 [WHO-DD]|AKOS015999853|BCP9000428|CCG-269915|CS-0407|DB12318|NSC-764135|NSC-799323|NCGC00346483-01|NCGC00346483-05|NCGC00346483-11|(S)-morpholin-3-ylmethyl 4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-ylcarbamate|AC-32830|AS-16281|HY-10251|B5520|BMS-599626, >=98% (HPLC)|J-502499|J-519990|Q27075357|(3S)-3-Morpholinylmethyl-[4-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]-Carbamic acid|(S)-morpholin-3-ylmethyl 4-(3-(4-fluorobenzyl)-1H-indazol-6-ylamino)pyrrolo[1,2-f][1,2,4]triazin-6-ylcarbamate|(S)-morpholin-3-ylmethyl-4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-ylcarbamate|[(3S)-Morpholin-3-yl]methyl N-[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate|[4-[[1-(3-Fluorobenzyl)-1H-indazole-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-yl]carbamic acid [(3S)-morpholine-3-yl]methyl ester|[4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl]-carbamic acid|Carbamic acid, [4-[[1-[(3-Fluorophenyl)methyl]-1h-indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]-, (3s)-3-morpholiny lmethyl ester",530.600,C27H27FN8O3,120.000,828.000,2.800,39,3,9,8,"InChI=1S/C27H27FN8O3/c1-17-23(34-27(37)39-15-22-14-38-8-7-29-22)13-36-25(17)26(30-16-32-36)33-21-5-6-24-19(10-21)11-31-35(24)12-18-3-2-4-20(28)9-18/h2-6,9-11,13,16,22,29H,7-8,12,14-15H2,1H3,(H,34,37)(H,30,32,33)/t22-/m0/s1",CC1=C2C(=NC=NN2C=C1NC(=O)OC[C@@H]3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F,CC1=C2C(=NC=NN2C=C1NC(=O)OCC3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F,LUJZZYWHBDHDQX-QFIPXVFZSA-N,"[(3S)-morpholin-3-yl]methyl N-[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate",530.219,530.219,0,1,0,1,1,0,0,0,0,37,1706,322,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents,7,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|439896|439897|439898|439899|439900|439901|439902|439903|439904|439905|439906|439907|439908|439909|439910|439911|439912|439913|439914|439915|439916|439917|439918|439919|439920|439921|439922|439923|439924|439925|439926|439927|439928|439929|439930|439931|439932|439933|439934|439935|439936|439937|439938|439939|439940|439941|439942|439943|439944|439945|439946|439947|439948|439949|439950|439951|439952|439953|439954|439955|439956|439957|439958|440179|440180|440181|440182|440183|440184|440185|440186|440187|440188|440189|440190|440191|440192|440193|440194|440195|440196|440197|440198|440199|440200|440201|440202|440203|440204|440205|440206|440207|440208|440209|440210|440211|440212|440213|440214|440215|440216|440217|440218|440219|440220|440221|440222|440223|440224|440225|440226|440227|440228|440229|440230|440231|549931|549932|549933|549935|549936|550091|550098|743344|743345|743346|743347|1159388|1224824|1224825|1224857|1224859|1259252|1259253|1259255|1259256|1259416|1259421|1296008|1296009|1345084|1345502|1345572|1345653|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347109|1347110|1347111|1347112|1347113|1347114|1347115|1347116|1347117|1347118|1347119|1347121|1347122|1347123|1347124|1347125|1347126|1347127|1347128|1347129|1347154|1347159|1347160|1347411|1409598|1424889|1424890|1424891|1424892|1424893|1424894|1424895|1424896|1424897|1424898|1424899|1424900|1424901|1424902|1424903|1424904|1424905|1424907|1424908|1424909|1424910|1424911|1424912|1424914|1424915|1424917|1424918|1424919|1424920|1424921|1424922|1424923|1424924|1424925|1424926|1424927|1424928|1424929|1424930|1424931|1424933|1424934|1424935|1424937|1424939|1424940|1424941|1424944|1424945|1424946|1424947|1424948|1424949|1424950|1424952|1424953|1424954|1424955|1424960|1424961|1424962|1424963|1424964|1424965|1424966|1424967|1424968|1424969|1424970|1424971|1424972|1424973|1424974|1424975|1424976|1424977|1424978|1424980|1424981|1424983|1424984|1424985|1424987|1424988|1424989|1424990|1424991|1424992|1424993|1424994|1424995|1424996|1424997|1424998|1424999|1425000|1425001|1425002|1425003|1425004|1425006|1425007|1425008|1425009|1425010|1425011|1425013|1425014|1425016|1425017|1425018|1425019|1425022|1425023|1425024|1425026|1425027|1425028|1425029|1425030|1425033|1425034|1425035|1425036|1425037|1425038|1425039|1425040|1425042|1425043|1425044|1425045|1425046|1425047|1425048|1425049|1425050|1425051|1425052|1425053|1425054|1425055|1425056|1425057|1425058|1425059|1425060|1425061|1425062|1425063|1425064|1425065|1425067|1425068|1425069|1425070|1425071|1425072|1425073|1425074|1425076|1425078|1425079|1425080|1425081|1425082|1425083|1425085|1425086|1425087|1425089|1425090|1425093|1425094|1425095|1425096|1425097|1425098|1425100|1425101|1425102|1425104|1425105|1425106|1425107|1425108|1425110|1425111|1425112|1425115|1425116|1425117|1425118|1425120|1425121|1425122|1425123|1425124|1425125|1425126|1425127|1425128|1425129|1425130|1425131|1425133|1425134|1425136|1425137|1425138|1425140|1425141|1425142|1425143|1425144|1425145|1425146|1425147|1425148|1425149|1425150|1425153|1425154|1425155|1425156|1425157|1425158|1425159|1425160|1425161|1425162|1425163|1425164|1425165|1425166|1425167|1425168|1425169|1425170|1425171|1425173|1425174|1425175|1425177|1425179|1425180|1425181|1425182|1425185|1425186|1425187|1425188|1425189|1425190|1425191|1425192|1425193|1425194|1425196|1425197|1425198|1425199|1425200|1425201|1425203|1425204|1425205|1425206|1425207|1425208|1425209|1425210|1425211|1425212|1425213|1508605|1508606|1508620|1508623|1508624|1508630|1640020|1645758|1645845|1645846|1645851|1645870|1645876|1645877|1671188|1671190|1671193|1671194|1671498|1745845|1745853|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800,20061025,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Acesobio|Achemtek|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|Ambinter|Anward|AOBIOUS INC|ApexBio Technology|Ark Pharma Scientific Limited|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BenchChem|BePharm Ltd.|BindingDB|BioChemPartner|BioCrick|Biosynth|BOC Sciences|Broad Institute|CAPOT|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Cure First|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|Matrix Scientific|MedChemexpress MCE|MLSMR|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|Novartis Institutes for BioMedical Research|OXCHEM CORPORATION|PATENTSCOPE (WIPO)|Probes & Drugs portal|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sigma-Aldrich|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|TargetMol|TCI (Tokyo Chemical Industry)|THE BioTek|Therapeutic Target Database (TTD)|Thomson Pharma|Tocris Bioscience|ToxPlanet|Tractus|Uchem Meditech|UCSC Chemical Screening Center|Wikidata|Wubei-Biochem|Wutech|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
15606394,Afatinib dimaleate,"AFATINIB DIMALEATE|850140-73-7|Afatinib (diMaleate)|Gilotrif|Afatinib maleate|BIBW 2992MA2|Giotrif|Afatinib (BIBW2992) Dimaleate|Afatinib dimaleate [USAN]|BIBW2992 MA2|Afatinib maleate (JAN)|UNII-V1T5K7RZ0B|V1T5K7RZ0B|BIBW-2992MA2|BIBW2992-MA2|BIBW-2992 MA2|BIBW-2992-MA2|CHEBI:76003|850140-73-7 (dimaleate)|BIBW2992 DiMaleate|Afatinib dimaleate (USAN)|(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide dimaleate|AFATINIB MALEATE [JAN]|(2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin- 6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate)|Gilotrif (TN)|(Z)-but-2-enedioic acid;(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide|Afatinib Impurity F|Giotrif (TN)|BIBW2993 DiMaleate|AMY499|AFATINIB DIMALEATE [MI]|CHEMBL2105712|AFATINIB DIMALEATE [VANDF]|DTXSID701027713|AFATINIB DIMALEATE [WHO-DD]|HY-10261A|s7810|AKOS025401819|CCG-270401|CS-1329|AFATINIB DIMALEATE [ORANGE BOOK]|AC-26080|AS-56967|BA162012|D09733|Q27145677|(2E)-N-(4-[(3-chloro-4-fluorophenyl)amino]-7-{[(3S)-tetrahydrofuran-3-yl]oxy}quinazolin-6-yl)-4-(dimethylamino)but-2-enamide|(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide dimaleate|(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide di[(2Z)-but-2-enedioate]|(E)-4-Dimethylamino-But-2-Enoic Acid-(4-(3-Chloro-4-Fluoro-Phenylamino)-7-((S)-Tetra-Hydrofuran-3-Yloxy)-Quinazolin-6Yl)-Amide Dimaleate|2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)- 6-quinazolinyl)-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:2)|2-butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-, (2e)-, (2Z)-2-butenedioate (1:2)|936631-70-8",718.100,C32H33ClFN5O11,238.000,821.000,NULL,50,6,16,12,"InChI=1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/b4-3+;2*2-1-/t16-;;/m0../s1",CN(C/C=C/C(=O)NC1=C(C=C2N=CN=C(C2=C1)NC3=CC(=C(C=C3)F)Cl)O[C@@H]4COCC4)C.C(=C\C(=O)O)\C(=O)O.C(=C\C(=O)O)\C(=O)O,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,USNRYVNRPYXCSP-JUGPPOIOSA-N,(Z)-but-2-enedioic acid;(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,717.185,717.185,0,3,0,1,1,0,3,3,0,997,4098,999,2D,Afatinib,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,10,1250265|1250266|1250281|1250282|1250292|1250293|1409598|1640020|1645758|1694836|1694837|1694838|1694839|1694840|1694841|1694845|1694846|1694847|1836255|1837184|1838113|1839042|1839971|1840900|1841829|1842758|1843687|1844616|1912865|1912866|1912867|1913054|1913055|1913374|1913375|1913376|1915452|1915453|1915454|1915455|1915456|1915457|1915458|1915459|1915460|1915461|1915462|1915463|1915464|1915465|1915466|1915467|1915468|1915469|1915470|1915471|1915472|1915473|1915474|1915475|1915476|1915477|1915478|1915479,20070212,"A2Z Chemical|AbaChemScene|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AKos Consulting & Solutions|Ambeed|Ambinter|AOBIOUS INC|ApexBio Technology|Apexmol|AstaTech, Inc.|AvaChem Scientific|BenchChem|BioCrick|Biosynth|BOC Sciences|CEGChem|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Combi-Blocks|CymitQuimica|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|J&H Chemical Co.,ltd|KEGG|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LGC Standards|MedChemexpress MCE|MolPort|MuseChem|NextBio|NextMove Software|Norris Pharm|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Springer Nature|TargetMol|THE BioTek|Thomson Pharma|Tocris Bioscience|ToxPlanet|Uchem Meditech|VladaChem|Wikidata|Yuhao Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
71722042,Selatinib ditosilate,"Selatinib ditosilate|6Q2E32HVE7|UNII-6Q2E32HVE7|1452886-38-2|4-Quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfinyl)ethyl)amino)methyl)-2-furanyl)-, 4-methylbenzenesulfonate (1:2)|Q27265313",909.500,C43H42ClFN4O9S3,234.000,993.000,NULL,61,4,15,13,"InChI=1S/C29H26ClFN4O3S.2C7H8O3S/c1-39(36)12-11-32-16-23-7-10-27(38-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)37-17-19-3-2-4-21(31)13-19;2*1-6-2-4-7(5-3-6)11(8,9)10/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*2-5H,1H3,(H,8,9,10)",CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,GUPXYZHIHDNPSW-UHFFFAOYSA-N,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfinylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid,908.179,908.179,0,3,0,1,0,1,0,0,0,0,0,0,2D,NULL,Classification|Drug and Medication Information,2,NULL,20130930,"ChemIDplus|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA Global Substance Registration System (GSRS)|Starshine Chemical|Thomson Pharma|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
130412842,Befotertinib,"Befotertinib|UNII-0XT2CPR891|Befotertinib [INN]|1835667-63-4|0XT2CPR891|D0316|D-0316|2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-|N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)prop-2-enamide|N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-[1-(2,2,2-trifluoroethyl)indol-3-yl]pyrimidin-2-yl]amino]phenyl]prop-2-enamide|CHEMBL5095167|SCHEMBL19337178|D 0316 [WHO-DD]|GLXC-26863|AKOS040757081|MS-30266|HY-137433|CS-0138633|D 0316|F78035",567.600,C29H32F3N7O2,87.600,863.000,4.800,41,2,10,11,"InChI=1S/C29H32F3N7O2/c1-6-27(40)34-22-15-23(26(41-5)16-25(22)38(4)14-13-37(2)3)36-28-33-12-11-21(35-28)20-17-39(18-29(30,31)32)24-10-8-7-9-19(20)24/h6-12,15-17H,1,13-14,18H2,2-5H3,(H,34,40)(H,33,35,36)",CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)CC(F)(F)F)OC,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)CC(F)(F)F)OC,USOCZVZOXKTJTI-UHFFFAOYSA-N,"N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-[1-(2,2,2-trifluoroethyl)indol-3-yl]pyrimidin-2-yl]amino]phenyl]prop-2-enamide",567.257,567.257,0,1,0,0,0,0,0,0,0,0,14,4,2D+3D,NULL,Classification|Drug and Medication Information|Literature|Patents,4,NULL,20171007,"AbaChemScene|AKos Consulting & Solutions|AstaTech, Inc.|BenchChem|ChEMBL|ChemIDplus|ECI Group, LCSB, University of Luxembourg|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Google Patents|Key Organics/BIONET|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|Smolecule|Starshine Chemical|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
11700696,AV-412 Tosylate,"AV-412|451493-31-5|AV-412 Tosylate|MP-412|AV412|UNII-Z541VW0W40|451493-31-5 (tosylate)|AV 412|MP412|Z541VW0W40|MP 412|2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-methyl-3-(4-methyl-1-piperazinyl)-1-butyn-1-yl]-6-quinazolinyl]-, 4-methylbenzenesulfonate (1:2)|2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-methyl-3-(4-methyl-1-piperazinyl)-1-butyn-1-yl]-6-quinazolinyl]-,4-Methylbenzenesulfonate(1:2)|N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-methyl-3-(4-methylpiperazin-1-yl)but-1-yn-1-yl)quinazolin-6-yl)acrylamide bis(4-methylbenzenesulfonate)|2-PROPENAMIDE, N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-METHYL-3-(4-METHYL-1-PIPERAZINYL)-1-BUTYN-1-YL)-6-QUINAZOLINYL)-, 4-METHYLBENZENESULFONATE (1:2)|AV412 cpd|MP412 cpd|MP-412 DITOSYLATE|SCHEMBL4760106|MP 412 [WHO-DD]|EX-A756|MP412MP412|BCP23783|BTA49331|AV-412;MP-412|DB06021|AC-36815|HY-10346|MS-31574|A872417|Q27295006|MP-412; MP 412; MP412; AV-412; AV 412; AV412|2-Propenamide, N-(4-((3-chloro-4-fluorophenyl)amino]-7-(3-methyl-3-(4-methyl-1-piperazinyl)-1-butynyl]-6-quinazolinyl]-, bis(4-methylbenzenesulfonate)|2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-methyl-3-(4-methyl-1-piperazinyl)-1-butyn-1-yl]-6-quinazolinyl]-, 4-methyl benzenesulfonate (1:2)|N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-methyl-3-(4-methyl-1-piperazinyl)-1-butyn-1-yl)-6-quinazolinyl)acrylamide|N-[4-(3-chloro-4-fluoroanilino)-7-[3-methyl-3-(4-methylpiperazin-1-yl)but-1-ynyl]quinazolin-6-yl]prop-2-enamide;4-methylbenzenesulfonic acid",851.400,C41H44ClFN6O7S2,199.000,1060.000,NULL,58,4,13,9,"InChI=1S/C27H28ClFN6O.2C7H8O3S/c1-5-25(36)33-23-16-20-24(30-17-31-26(20)32-19-6-7-22(29)21(28)15-19)14-18(23)8-9-27(2,3)35-12-10-34(4)11-13-35;2*1-6-2-4-7(5-3-6)11(8,9)10/h5-7,14-17H,1,10-13H2,2-4H3,(H,33,36)(H,30,31,32);2*2-5H,1H3,(H,8,9,10)",CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)(C#CC1=CC2=C(C=C1NC(=O)C=C)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)N4CCN(CC4)C,CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)(C#CC1=CC2=C(C=C1NC(=O)C=C)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)N4CCN(CC4)C,GTWJVFFZCKODEV-UHFFFAOYSA-N,N-[4-(3-chloro-4-fluoroanilino)-7-[3-methyl-3-(4-methylpiperazin-1-yl)but-1-ynyl]quinazolin-6-yl]prop-2-enamide;4-methylbenzenesulfonic acid,850.239,850.239,0,3,0,0,0,0,0,0,0,4,10,4,2D,NULL,Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,5,NULL,20061026,"001Chemical|AbaChemScene|abcr GmbH|AbovChem LLC|Achemtek|Adooq BioScience|AK Scientific, Inc. (AKSCI)|Amadis Chemical|Ambinter|ApexBio Technology|AstaTech, Inc.|BenchChem|BioChemPartner|BioCrick|Biosynth|BOC Sciences|Chem-Space.com Database|Chembase.cn|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Combi-Blocks|Cooke Chemical Co., Ltd|CymitQuimica|DC Chemicals|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|Inhibitor 2|J&H Chemical Co.,ltd|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|MedChemexpress MCE|MolCore BioPharmatech|MolPort|MuseChem|NextBio|Norris Pharm|Probes & Drugs portal|RR Scientific|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Starshine Chemical|Sun-shine Chemical|SureChEMBL|TargetMol|THE BioTek|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159156 - HER2 Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
42642648,Varlitinib,"VARLITINIB|845272-21-1|ARRY-334543|ARRY334543|ARRY 334543|ARRY-543|Varlitinib [USAN:INN]|ASLAN-001|Varlitinib [USAN]|UNII-846Y8197W1|ASLAN001|846Y8197W1|N(sup 4)-(3-Chloro-4-(thiazol-2-ylmethoxy)phenyl)-N(sup 6)-((4R)-4-methyl-4,5-dihydrooxazol-2- yl)quinazoline-4,6-diamine|AR-00334543|(R)-N4-(3-chloro-4-(thiazol-2-ylmethoxy)phenyl)-N6-(4-methyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine|4-N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-N-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]quinazoline-4,6-diamine|(R)-N4-(3-chloro-4-(thiazol-2-ylmethoxy)phenyl)-N6-(4-methyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine.|4,6-Quinazolinediamine, N(sup 4)-(3-chloro-4-(2-thiazolylmethoxy)phenyl)-N(sup 6)-((4R)-4,5- dihydro-4-methyl-2-oxazolyl)-|Varlitinib (ARRY334543)|Varlitinib free base|VARLITINIB [INN]|Varlitinib (USAN/INN)|D00NYJ|VARLITINIB [WHO-DD]|MLS006011274|GTPL7645|SCHEMBL1384578|CHEMBL2103842|DTXSID501025597|EX-A1005|VIB27221|BDBM50205268|NSC764823|NSC800962|s2755|AKOS027250815|CCG-269421|CS-5222|DB05944|NSC-764823|NSC-800962|NCGC00346724-01|NCGC00346724-02|AC-35277|HY-10530|MS-28612|SMR004703024|SW219901-1|D09689|A900002|Q27089126|(R)-4-[[3-Chloro-4-[(thiazol-2-yl)methoxy]phenyl]amino]-6-[(4-methyl-4,5-dihydrooxazol-2-yl)amino]quinazoline;Varlitinib|4,6-QUINAZOLINEDIAMINE, N(SUP 4)-(3-CHLORO-4-(2-THIAZOLYLMETHOXY)PHENYL)-N(SUP 6)-((4R)-4,5-DIHYDRO-4-METHYL-2-OXAZOLYL)-|4,6-QUINAZOLINEDIAMINE, N4-(3-CHLORO-4-(2-THIAZOLYLMETHOXY)PHENYL)-N6-((4R)-4,5-DIHYDRO-4-METHYL-2-OXAZOLYL)-|N4-(3-CHLORO-4-(1,3-THIAZOL-2-YLMETHOXY)PHENYL)-N6-((4R)-4-METHYL-4,5-DIHYDRO-1,3-OXAZOL-2-YL)QUINAZOLINE-4,6-DIAMINE",466.900,C22H19ClN6O2S,122.000,660.000,4.200,32,2,8,7,"InChI=1S/C22H19ClN6O2S/c1-13-10-31-22(27-13)29-14-2-4-18-16(8-14)21(26-12-25-18)28-15-3-5-19(17(23)9-15)30-11-20-24-6-7-32-20/h2-9,12-13H,10-11H2,1H3,(H,27,29)(H,25,26,28)/t13-/m1/s1",C[C@@H]1COC(=N1)NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=NC=CS5)Cl,CC1COC(=N1)NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=NC=CS5)Cl,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,"4-N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-N-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]quinazoline-4,6-diamine",466.098,466.098,0,1,0,1,1,0,0,0,0,39,2367,513,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards,9,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|743344|743345|743346|743347|1224824|1224825|1224857|1224859|1259252|1259253|1259255|1259256|1259398|1259399|1259416|1259421|1259423|1296008|1296009|1330937|1330938|1345084|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347154|1347159|1347160|1347411|1347412|1409598|1424889|1424890|1424891|1424893|1424894|1424895|1424896|1424897|1424898|1424899|1424900|1424901|1424902|1424904|1424905|1424907|1424908|1424909|1424910|1424911|1424912|1424913|1424914|1424915|1424916|1424917|1424918|1424919|1424920|1424921|1424922|1424923|1424924|1424925|1424926|1424928|1424929|1424930|1424931|1424932|1424933|1424934|1424935|1424936|1424937|1424939|1424940|1424941|1424942|1424944|1424945|1424946|1424947|1424948|1424949|1424950|1424951|1424952|1424953|1424954|1424955|1424956|1424958|1424960|1424961|1424962|1424963|1424964|1424965|1424966|1424967|1424968|1424969|1424970|1424971|1424972|1424973|1424974|1424975|1424976|1424977|1424978|1424979|1424980|1424981|1424983|1424984|1424985|1424987|1424988|1424989|1424990|1424991|1424992|1424993|1424994|1424995|1424996|1424997|1424998|1425000|1425001|1425002|1425003|1425004|1425006|1425007|1425008|1425009|1425010|1425012|1425013|1425014|1425016|1425017|1425018|1425019|1425021|1425022|1425023|1425024|1425025|1425026|1425027|1425028|1425029|1425030|1425033|1425034|1425035|1425036|1425037|1425038|1425039|1425040|1425041|1425042|1425043|1425044|1425045|1425046|1425047|1425048|1425049|1425050|1425051|1425052|1425053|1425054|1425055|1425056|1425057|1425058|1425059|1425060|1425061|1425062|1425063|1425064|1425065|1425066|1425067|1425068|1425069|1425070|1425071|1425072|1425073|1425074|1425075|1425076|1425077|1425078|1425080|1425081|1425082|1425083|1425084|1425085|1425086|1425087|1425088|1425089|1425090|1425093|1425094|1425095|1425096|1425097|1425098|1425099|1425100|1425101|1425102|1425104|1425105|1425106|1425108|1425109|1425110|1425111|1425112|1425113|1425115|1425116|1425117|1425118|1425119|1425121|1425122|1425123|1425124|1425125|1425126|1425127|1425128|1425129|1425130|1425131|1425133|1425134|1425136|1425137|1425138|1425140|1425141|1425142|1425143|1425144|1425145|1425146|1425147|1425148|1425149|1425150|1425151|1425153|1425154|1425155|1425156|1425157|1425158|1425159|1425160|1425161|1425162|1425163|1425164|1425165|1425166|1425167|1425168|1425169|1425170|1425171|1425172|1425173|1425174|1425175|1425176|1425177|1425178|1425179|1425180|1425181|1425182|1425183|1425184|1425185|1425186|1425187|1425188|1425189|1425190|1425191|1425192|1425193|1425194|1425195|1425196|1425197|1425198|1425199|1425200|1425201|1425202|1425203|1425204|1425205|1425206|1425207|1425208|1425209|1425210|1425211|1425212|1425213|1508620|1508623|1508624|1508630|1545486|1545487|1545488|1640020|1645758|1645845|1645846|1645851|1645852|1645870|1645876|1645877|1671188|1671190|1671193|1671194|1671498|1745845|1745853|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800,20090720,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambinter|Angene Chemical|ApexBio Technology|Ark Pharma Scientific Limited|AstaTech, Inc.|BenchChem|BindingDB|BioCrick|Biosynth|BOC Sciences|Boerchem|Broad Institute|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DiscoveryGate|DrugBank|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|Matrix Scientific|MedChemexpress MCE|MLSMR|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Norris Pharm|PATENTSCOPE (WIPO)|Probes & Drugs portal|Race Chemical|RR Scientific|SCRIPDB|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|Therapeutic Target Database (TTD)|Thomson Pharma|ToxPlanet|Uchem Meditech|UCSC Chemical Screening Center|Wikidata|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
68165256,Brigatinib,"Brigatinib|1197953-54-0|ALUNBRIG|AP-26113|Brigatinib [USAN]|Brigatinib (AP-26113)|UNII-HYW8DB273J|HYW8DB273J|AP 26113|(2-((5-chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide|5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine|2,4-Pyrimidinediamine, 5-chloro-N4-(2-(dimethylphosphinyl)phenyl)-N2-(2-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)-|5-Chloro-N4-(2-(dimethylphosphoryl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1- yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine|(2-((5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethyl-,delta5-phosphanone|2,4-Pyrimidinediamine, 5-chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-|5-Chloro-N~4~-[2-(Dimethylphosphoryl)phenyl]-N~2~-{2-Methoxy-4-[4-(4-Methylpiperazin-1-Yl)piperidin-1-Yl]phenyl}pyrimidine-2,4-Diamine|5-chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine|Brigatiib|Alunbrig (TN)|5-Chloro-N4-(2-(dimethylphosphoryl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine|6GY|BRIGATINIB [MI]|BRIGATINIB [INN]|BRIGATINIB [JAN]|Brigatinib (JAN/USAN)|Brigatinib [USAN:INN]|Brigatinib; AP26113|Brigatinib (AP26113)|BRIGATINIB [WHO-DD]|GTPL7741|BRIGATINIB [ORANGE BOOK]|CHEMBL3545311|SCHEMBL11916361|EX-A775|DTXSID501027929|AMY10294|BCP17214|BDBM50185140|MFCD29472221|NSC784728|NSC787457|AKOS030257612|CS-4278|DB12267|NSC-784728|NSC-787457|SB40412|NCGC00483924-01|5-chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-2,4-Pyrimidinediamine|AC-29958|AS-75176|HY-12857|FT-0700112|S8229|J3.535.964H|D10866|EN300-6477855|Q27456393|Z2512157852|(2-((5-CHLORO-2-((2-METHOXY-4-(4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL)PHENYL)AMINO)PYRIMIDIN-4-YL)AMINO)PHENYL)DIMETHYL-,.DELTA.5-PHOSPHANONE|1350848-43-9",584.100,C29H39ClN7O2P,85.900,835.000,4.600,40,2,9,8,"InChI=1S/C29H39ClN7O2P/c1-35-15-17-37(18-16-35)21-11-13-36(14-12-21)22-9-10-24(26(19-22)39-2)33-29-31-20-23(30)28(34-29)32-25-7-5-6-8-27(25)40(3,4)38/h5-10,19-21H,11-18H2,1-4H3,(H2,31,32,33,34)",CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,AILRADAXUVEEIR-UHFFFAOYSA-N,"5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine",583.259,583.259,0,1,0,0,0,0,0,0,0,628,4302,1264,2D+3D,NULL,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,12,1|3|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1296008|1296009|1310801|1310802|1310803|1310804|1310805|1310806|1310807|1310808|1310809|1310810|1310811|1310812|1310813|1310814|1310815|1310816|1310817|1310818|1310819|1310820|1310822|1310823|1310824|1310825|1310827|1310828|1310829|1310831|1310832|1310833|1310836|1310837|1310838|1310839|1310840|1310841|1310842|1310843|1310844|1310846|1345084|1345502|1345542|1345544|1345550|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347159|1347160|1347411|1347412|1372112|1409598|1409605|1423824|1423825|1423832|1423833|1423834|1479145|1479147|1479149|1479150|1508591|1508612|1508620|1576796|1576797|1599832|1599833|1599834|1599835|1617466|1617467|1617468|1617469|1617470|1640020|1645758|1645844|1645845|1645846|1645847|1645848|1645851|1645870|1645876|1645877|1664394|1664395|1664396|1664397|1671188|1671193|1673939|1673940|1673941|1673946|1691146|1691147|1691151|1691163|1691164|1691166|1691169|1691170|1694845|1694846|1694847|1745853|1758571|1765709|1765710|1765726|1765727|1765728|1765729|1765738|1765739|1765740|1765741|1771671|1771672|1806351|1809460|1809461|1809462|1809463|1809464|1809465|1809466|1809467|1809468|1809469|1809470|1809471|1809473|1809477|1809478|1811961|1811968|1811972|1811973|1811976|1811978|1811979|1811980|1811981|1811982|1811983|1811984|1811985|1811988|1811989|1815787|1815788|1815789|1815790|1815814|1815815|1815816|1815817|1815818|1815819|1836378|1837307|1838236|1839165|1840094|1841023|1841952|1842881|1843810|1844739,20121130,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Adooq BioScience|AKos Consulting & Solutions|Ambeed|Angel Pharmatech Ltd.|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|AstaTech, Inc.|AvaChem Scientific|Axon Medchem|BenchChem|BindingDB|BioChemPartner|BOC Sciences|Broad Institute|Cangzhou Enke Pharma Tech Co.,Ltd.|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Chemodex Ltd.|ChemShuttle|Clearsynth|Combi-Blocks|CSNpharm|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hangzhou APIChem Technology|Human Metabolome Database (HMDB)|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|King Scientific|Lan Pharmatech|MedChemexpress MCE|MolCore BioPharmatech|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NCBI Structure|NIH/NCATS RNAi|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|RR Scientific|Selleck Chemicals|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|Thieme Chemistry|Thomson Pharma|ToxPlanet|University of Kansas High Throughput Screening Laboratory|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01ED - Anaplastic lymphoma kinase (alk) inhibitors
72734520,Abivertinib,"Avitinib|Abivertinib|1557267-42-1|AC0010|Avitinib free base|N-(3-((2-((3-Fluoro-4-(4-methylpiperazin-1-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylamide|EX-ACEA0010|Abivertinib [USAN]|ACEA100610|CER0OPG92L|AC-0010|A610|Abivertinib (USAN)|1557267-42-1 (free base)|N-[3-[[2-[3-fluoro-4-(4-methylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide|2-Propenamide, N-(3-((2-((3-fluoro-4-(4-methyl-1-piperazinyl)phenyl)amino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)-|2-Propenamide, N-[3-[[2-[[3-fluoro-4-(4-methyl-1-piperazinyl)phenyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]-|N-(3-{2-[3-Fluoro-4-(4-methyl-piperazin-1-yl)-phenylamino]-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy-phenyl)-acrylamide|N-(3-((2-((3-Fluoro-4-(4-methylpiperazin-1-yl)phenyl)amino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)prop-2-enamide|N-{3-[(2-{[3-Fluoro-4-(4-methylpiperazin-1-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy]phenyl}prop-2-enamide|FUJOVEE|Avitinib (AC0010)|UNII-CER0OPG92L|ABIVERTINIB [INN]|avitinib (superceded INN)|AVITINIB [WHO-DD]|ABIVERTINIB [WHO-DD]|CHEMBL4297865|SCHEMBL15453394|GTPL10044|EX-A783|BDBM294480|Avitinib(AC0010/AC0010MA)|BCP16381|US9586965, Cpd 3|MFCD29089376|s8741|AC 0010|CS-W008904|DB15327|AC-35320|DS-19269|HY-19816|N-(3-{2-[3-Fluoro-4-(4-methyl-piperazin-1-yl)-phenylamino]-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy}-phenyl)-acrylamide|CS-0016789|A16826|D11308|F17427|A927386|N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1- yl)phenyl)amino)-7H-pyrrolo[2,3-d]- pyrimidin-4-yl)oxy)phenyl)acrylamide|N-(3-(2-(3-Fluoro-4-(4-methylpiperazin-1-yl)phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl)acrylamide|N-[3-[[2-[[3-fluoro-4-(4-methyl-1-piperazinyl)phenyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]-2-propenamide",487.500,C26H26FN7O2,98.400,752.000,4.200,36,3,8,7,"InChI=1S/C26H26FN7O2/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32)",CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F,CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F,UOFYSRZSLXWIQB-UHFFFAOYSA-N,"N-[3-[[2-[3-fluoro-4-(4-methylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide",487.213,487.213,0,1,0,0,0,0,0,0,0,22,147,38,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,8,1347060|1347064|1347065|1347067|1347068|1347411|1347412|1551642|1640020|1645758|1645845|1645846|1645870|1645876|1645877|1671498|1770166|1770167|1770168|1770169|1770170|1770171|1770172|1770173|1770174|1770178|1770179|1770180|1770181|1770182|1770183|1770184|1770185|1770186|1770187|1770188|1770189|1770190|1770191|1770192|1770193|1770194|1770195|1770196|1770197|1770198|1770199|1770200|1770201|1770202|1770203|1770204|1770205|1770206|1770207|1770208|1770209|1770210|1770211|1770212|1770213|1770214|1770215|1770216|1770217|1770218|1770219|1770220|1770221|1770222|1770223|1770224|1770225|1770226|1770227|1770228|1770229|1770230|1770231|1770232|1770233|1770234|1770235|1770236|1770237|1770238|1770239|1770240|1770241|1770242|1770243|1770244|1770245|1770246|1770247|1770248|1770249|1770250|1770251|1770252|1795944,20140218,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|Amadis Chemical|Ambeed|Angel Pharmatech Ltd.|Ark Pharm, Inc.|AstaTech, Inc.|Axon Medchem|BenchChem|BePharm Ltd.|BindingDB|BioChemPartner|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Combi-Blocks|Cooke Chemical Co., Ltd|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DrugBank|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|KEGG|Key Organics/BIONET|King Scientific|Lan Pharmatech|MedChemexpress MCE|MolCore BioPharmatech|MolPort|MuseChem|NIH/NCATS RNAi|OXCHEM CORPORATION|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Selleck Chemicals|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Thomson Pharma|University of Kansas High Throughput Screening Laboratory|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank]|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor"
78209992,"(R)-4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl 2,4-dimethylpiperazine-1-carboxylate","AZD3759|1626387-80-1|AZD-3759|zorifertinib|(R)-4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl 2,4-dimethylpiperazine-1-carboxylate|67SX9H68W2|AZD 3759|UNII-67SX9H68W2|CHEMBL3623290|4-[(3-CHLORO-2-FLUOROPHENYL)AMINO]-7-METHOXYQUINAZOLIN-6-YL (2R)-2,4-DIMETHYLPIPERAZINE-1-CARBOXYLATE|4-((3-Chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl (2R)-2,4-dimethylpiperazine-1-carboxylate|(2R)-2,4-dimethyl-1-piperazinecarboxylic acid, 4-[(3-chloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl ester|[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl] (2R)-2,4-dimethylpiperazine-1-carboxylate|ZORIFERTINIB [INN]|ZORIFERTINIB [WHO-DD]|SCHEMBL16010006|GTPL10456|EX-A720|AMY10302|BDBM50123453|MFCD29058564|NSC788121|NSC800978|s7971|AKOS027327321|CCG-269329|CS-5029|DB14795|NSC-788121|NSC-800978|compound 1m [PMID: 26313252]|NCGC00483922-01|NCGC00483922-02|AC-29957|AS-74755|HY-18750|A882818|Z2471604138|(2R)-2,4-Dimethyl-1-piperazinecarboxylic acid 4-[(3-chloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl ester|(2R)-2,4-Dimethylpiperazine-1-carboxylic acid (4-(2-fluoro-3-chloroanilino)-7-methoxyquinazoline-6-yl) ester|(R)-4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl 2,4-dimethylpiperazine-1-carboxylate|1-PIPERAZINECARBOXYLIC ACID, 2,4-DIMETHYL-, 4-((3-CHLORO-2-FLUOROPHENYL)AMINO)-7-METHOXY-6-QUINAZOLINYL ESTER, (2R)-",459.900,C22H23ClFN5O3,79.800,649.000,4.100,32,1,8,5,"InChI=1S/C22H23ClFN5O3/c1-13-11-28(2)7-8-29(13)22(30)32-19-9-14-17(10-18(19)31-3)25-12-26-21(14)27-16-6-4-5-15(23)20(16)24/h4-6,9-10,12-13H,7-8,11H2,1-3H3,(H,25,26,27)/t13-/m1/s1",C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C,CC1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C,MXDSJQHFFDGFDK-CYBMUJFWSA-N,"[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl] (2R)-2,4-dimethylpiperazine-1-carboxylate",459.147,459.147,0,1,0,1,1,0,0,0,0,21,85,36,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents,6,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1250365|1250366|1250367|1250370|1250371|1250374|1250375|1250380|1250382|1250384|1250386|1250387|1250388|1250397|1250398|1250399|1250401|1250403|1250404|1250405|1250406|1250407|1250408|1250409|1250410|1250411|1250412|1250413|1250414|1250415|1250416|1250417|1250418|1250419|1250420|1250421|1250422|1250423|1250424|1250425|1250426|1250427|1250428|1250429|1250430|1250431|1250432|1250433|1250434|1250435|1250436|1250437|1250438|1250439|1250440|1250441|1250442|1250443|1250444|1250445|1250446|1250447|1250448|1250449|1250450|1250451|1250452|1250453|1250454|1250455|1250456|1250457|1250458|1296008|1296009|1345084|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347159|1347160|1347411|1409598|1420665|1420666|1420667|1420668|1420669|1420670|1420691|1420692|1420693|1420694|1420703|1420704|1420705|1420706|1420715|1420716|1420717|1420718|1420727|1420728|1420729|1420730|1420737|1508620|1586911|1586912|1586913|1586914|1586915|1640020|1645758|1645845|1645846|1645851|1645870|1645874|1645875|1645876|1645877|1645878|1671188|1671193|1745853|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794800|1821424|1821425|1821518,20140929,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Angene Chemical|Apexmol|AstaTech, Inc.|AvaChem Scientific|Axon Medchem|BenchChem|BindingDB|BioCrick|BLD Pharm|BOC Sciences|Broad Institute|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Combi-Blocks|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DrugBank|DTP/NCI|Enamine|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|Matrix Scientific|MedChemexpress MCE|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NIH/NCATS RNAi|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Selleck Chemicals|Smolecule|Starshine Chemical|Sun-shine Chemical|SureChEMBL|TargetMol|THE BioTek|Thomson Pharma|Uchem Meditech|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
137321960,Abivertinib maleate,"Abivertinib maleate|EX-ACEA0010MA|Abivertinib maleate dihydrate|EX-ACEA-0010MA|A610MA|AC0010MA|ACEA100610MA|ACEA-100610MA|AC-0010MA|A-610MA|STI-5656|Ac0010 maleate dihydrate|Abivertinib maleate [USAN]|Y50131AMFJ|Abivertinib maleate (USAN)|1822357-78-7|2-Propenamide, N-(3-((2-((3-fluoro-4-(4-methyl-1-piperazinyl)phenyl)amino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)-, (2Z)-2-butenedioate, hydrate (1:1:2)|N-(3-(2-(3-Fluoro-4-(4-methyl-piperazin-1-yl)-phenylamino)-7H-pyrrolo(2,3-d)pyrimidin-4-yloxy)-phenyl)-acrylamide maleate di-hydrate|UNII-Y50131AMFJ|CHEMBL4297866|ABIVERTINIB MALEATE [WHO-DD]|D11362",639.600,C30H34FN7O8,175.000,871.000,NULL,46,7,14,9,"InChI=1S/C26H26FN7O2.C4H4O4.2H2O/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34;5-3(6)1-2-4(7)8;;/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32);1-2H,(H,5,6)(H,7,8);2*1H2/b;2-1-;;",CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F.C(=C\C(=O)O)\C(=O)O.O.O,CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F.C(=CC(=O)O)C(=O)O.O.O,QITOONQVTOGMOJ-IUJXYRIYSA-N,"(Z)-but-2-enedioic acid;N-[3-[[2-[3-fluoro-4-(4-methylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide;dihydrate",639.245,639.245,0,4,0,0,0,0,1,1,0,17,14,2,2D,NULL,Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,6,NULL,20190205,ChEMBL|ChemIDplus|FDA Global Substance Registration System (GSRS)|Google Patents|KEGG|PATENTSCOPE (WIPO),Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor"
9549299,EGFR Inhibitor,"EGFR Inhibitor|879127-07-8|EGFR-IN-12|N-(3-((6-((3-(Trifluoromethyl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)cyclopropanecarboxamide|EGFR Inhibitor 324674|CHEMBL387187|N-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide|CyclopropanecarboxaMide, N-[3-[[6-[[3-(trifluoroMethyl)phenyl]aMino]-4-pyriMidinyl]aMino]phenyl]-|N-[3-[[6-[[3-(trifluoromethyl)phenyl]amino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide|EGFR?Inhibitor|K00598a|N-{3-[(6-{[3-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}cyclopropanecarboxamide|YUN27078|EGFR|D03BJB|Cyclopropanecarboxylic acid-(3-(6-(3-trifluoromethyl-phenylamino)-pyrimidin-4-ylamino)-phenyl)-amide|SCHEMBL242230|EGFR inhibitor(YUN27078)|GTPL5963|DTXSID40429554|HMS3229E03|BCP32602|EX-A4013|BDBM50200394|MFCD13191284|AKOS037515644|CCG-206749|EGFR Inhibitor [879127-07-8]|NCGC00167954-01|NCGC00167954-03|HY-17499|MS-27145|EGFR Inhibitor - CAS 879127-07-8|CS-0009241|D81537|Q27077159|4-[3-(Trifluoromethyl)anilino]-6-[3-(cyclopropylcarbonylamino)anilino]pyrimidine|N-(3-(6-(3-(trifluoromethyl)phenylamino)pyrimidin-4-ylamino)phenyl)cyclopropanecarboxamide|N-3-6-3-trifluoromethyl)phenylamino)pyrimidin-4-ylamino)phenyl)cyclopropanecarboxamide|7PL|CyclopropanecarboxaMide,N-[3-[[6-[[3-(trifluoroMethyl)phenyl]aMino]-4-pyriMidinyl]aMino]phenyl]-|Cyclopropanecarboxylic acid (3-(6-(3-trifluoromethyl-phenylamino)-pyrimidin-4-ylamino)-phenyl)-amide",413.400,C21H18F3N5O,78.900,586.000,4.500,30,3,8,6,"InChI=1S/C21H18F3N5O/c22-21(23,24)14-3-1-4-15(9-14)27-18-11-19(26-12-25-18)28-16-5-2-6-17(10-16)29-20(30)13-7-8-13/h1-6,9-13H,7-8H2,(H,29,30)(H2,25,26,27,28)",C1CC1C(=O)NC2=CC=CC(=C2)NC3=NC=NC(=C3)NC4=CC=CC(=C4)C(F)(F)F,C1CC1C(=O)NC2=CC=CC(=C2)NC3=NC=NC(=C3)NC4=CC=CC(=C4)C(F)(F)F,YOHYSYJDKVYCJI-UHFFFAOYSA-N,N-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide,413.146,413.146,0,1,0,0,0,0,0,0,0,9,119,17,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents,6,503|514|2390|273821|273822|325546|325547|325548|325549|624349|651828|720017|720018|720019|720020|720021|720022|720023|720024|720025|720026|720027|720028|720029|720030|720031|720032|720033|720034|720035|720036|720037|720038|720039|720040|720041|720042|720043|720044|720045|720046|720047|720048|720049|720050|720051|720052|720053|720054|720055|720056|720057|720058|720059|720060|720061|720062|720063|720064|720065|720066|720067|720068|720069|720070|720071|720072|720073|720074|720075|720076|720077|720078|720079|720080|720081|720082|720083|720084|720085|720086|720087|720088|720089|720090|720091|720092|720093|720094|720095|720096|720097|720098|720099|720100|720101|720102|720103|720104|720105|720106|720107|720108|720109|720110|720111|720112|720113|720114|720115|720116|720117|720118|720119|720120|720121|720122|720123|720124|720125|720126|720127|720128|720129|720130|720131|720132|720133|720134|720135|720136|720137|720138|720139|720140|720141|720142|720143|720144|720145|720146|720147|720148|720149|720150|720151|720152|720153|720154|720155|720156|720157|720158|720159|720160|720161|720162|720163|720164|720165|720166|720167|720168|720169|720170|720171|720172|720173|720174|720175|720176|720177|720178|720179|720180|720181|720182|720183|720184|720185|720186|720187|720188|720189|720190|720191|720192|720193|720194|720195|720196|720197|720198|720199|720200|720201|720202|720203|720204|720205|720206|720207|720208|720209|720210|720211|720212|720213|720214|720215|720216|720217|720218|720219|720220|720221|720222|720223|720224|720225|720226|720227|720228|720229|720230|720231|720232|720233|720234|720235|720236|720237|720238|720239|720240|720241|720242|720243|720244|720245|720246|720247|720248|720249|720250|720251|720252|720253|720254|720255|720256|720257|720258|720259|720260|720261|720262|720263|720264|720265|720266|720267|720268|720269|720270|720271|720272|720273|720274|720275|720276|720277|720278|720279|720280|720281|720282|720283|720284|720285|720286|720287|720288|720289|720290|720291|720292|720293|720294|720295|720296|720297|720298|720299|720300|720301|720302|720303|720304|720305|720306|720307|720308|720309|720310|720311|720312|720313|720314|720315|720316|720317|720318|720319|720320|720321|720322|720323|720324|720325|720326|720327|720328|720329|720330|720331|720332|720333|720334|720335|720336|720337|720338|720339|720340|720341|720342|720343|720344|720345|720346|720347|720348|720349|720350|720351|720352|720353|720354|720355|720356|720357|720358|720359|720360|720361|720362|720363|720364|720365|720366|720367|720368|720369|720370|720371|720372|720373|720374|720375|720376|720377|720378|720379|720380|720381|720382|720383|720384|720385|720386|720387|720388|720389|720390|720391|720392|720393|720394|720395|720396|720397|720398|720399|720400|720401|720402|720403|720404|720405|720406|720407|720408|720409|720410|720411|720412|720413|720414|720415|720416|720417|720418|720419|720420|720421|720422|720423|720424|720425|720426|720427|720428|720429|720430|720431|720432|720433|720434|720435|720436|720437|720438|720439|720440|720441|720442|720443|720444|720445|720446|720447|720448|720449|720450|720451|720452|720453|720454|720455|720456|720457|720458|720459|720460|720461|720462|720463|720464|720465|720466|720467|720468|720469|720470|720471|720472|720473|720474|720475|720476|720477|720478|720479|720480|720481|720482|720483|720484|1224748|1224749|1224750|1224751|1224752|1224753|1224754|1224755|1224756|1224757|1224758|1224759|1224760|1224761|1224762|1224763|1224764|1224765|1224766|1224767|1224768|1224769|1224770|1224771|1224772|1224773|1224774|1224775|1224776|1224777|1224778|1224779|1224780|1224781|1224782|1224783|1224784|1224785|1224786|1224787|1224788|1224789|1224790|1224791|1224792|1224793|1224794|1224795|1224796|1224797|1224798|1224799|1224800|1224801|1224802|1224803|1224804|1224805|1224806|1224807|1345502|1346986|1346987|1347055|1617963|1617964|1617965|1617966|1617967|1645870|1645876|1645877|1745852|1745853,20061020,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|Adooq BioScience|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Ambinter|AstaTech, Inc.|Axon Medchem|BenchChem|BindingDB|BioChemPartner|Biocore|BOC Sciences|Calbiochem|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Cooke Chemical Co., Ltd|CymitQuimica|DC Chemicals|DiscoveryGate|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EMD Millipore|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|Google Patents|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolCore BioPharmatech|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NCBI Structure|NextBio|Norris Pharm|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Selleck Chemicals|SGCOxCompounds|Smolecule|Springer Nature|SureChEMBL|TargetMol|THE BioTek|Therapeutic Target Database (TTD)|Thomson Pharma|Thoreauchem|Tractus|Wikidata|Wubei-Biochem|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,NULL
9843206,EGFR/ErbB-2 Inhibitor,"EGFR/ErbB-2 Inhibitor|179248-61-4|4557W|EGFR/ErbB-2/ErbB-4 inhibitor-2|6,7-dimethoxy-N-(4-phenylmethoxyphenyl)quinazolin-4-amine|4-(4-Benzyloxyanilino)-6,7-dimethoxyquinazoline|N-(4-(benzyloxy)phenyl)-6,7-dimethoxyquinazolin-4-amine|6,7-Dimethoxy-N-[4-(phenylmethoxy)phenyl]-4-quinazolinamine|EGFR/ErbB2 Inhibitor|N-[4-(benzyloxy)phenyl]-6,7-dimethoxyquinazolin-4-amine|EGFR/ErbB-2|D0X4OU|SCHEMBL242224|CHEMBL563845|GTPL5964|DTXSID40431718|BDBM429418|HMS3229C21|4-Quinazolinamine, 6,7-dimethoxy-N-[4-(phenylmethoxy)phenyl]-|APS-2-12|US10548897, Compound 10|HSCI1_000238|CCG-206748|MS-26408|HY-112420|CS-0046027|J-011438|BRD-K76819286-001-01-0|Q27077157|N-[4-(Benzyloxy)phenyl]-6,7-dimethoxyquinazoline-4-amine",387.400,C23H21N3O3,65.500,480.000,4.800,29,1,6,7,"InChI=1S/C23H21N3O3/c1-27-21-12-19-20(13-22(21)28-2)24-15-25-23(19)26-17-8-10-18(11-9-17)29-14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,24,25,26)",COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)OCC4=CC=CC=C4)OC,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)OCC4=CC=CC=C4)OC,DNOKYISWMVFYFA-UHFFFAOYSA-N,"6,7-dimethoxy-N-(4-phenylmethoxyphenyl)quinazolin-4-amine",387.158,387.158,0,1,0,0,0,0,0,0,0,6,115,23,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,5,2240|2241|2275|2313|2316|2322|2330|420261|434959|624101|624136|624138|624139|624141|624151|624156|624349|651828|720017|720018|720019|720020|720021|720022|720023|720024|720025|720026|720027|720028|720029|720030|720031|720032|720033|720034|720035|720036|720037|720038|720039|720040|720041|720042|720043|720044|720045|720046|720047|720048|720049|720050|720051|720052|720053|720054|720055|720056|720057|720058|720059|720060|720061|720062|720063|720064|720065|720066|720067|720068|720069|720070|720071|720072|720073|720074|720075|720076|720077|720078|720079|720080|720081|720082|720083|720084|720085|720086|720087|720088|720089|720090|720091|720092|720093|720094|720095|720096|720097|720098|720099|720100|720101|720102|720103|720104|720105|720106|720107|720108|720109|720110|720111|720112|720113|720114|720115|720116|720117|720118|720119|720120|720121|720122|720123|720124|720125|720126|720127|720128|720129|720130|720131|720132|720133|720134|720135|720136|720137|720138|720139|720140|720141|720142|720143|720144|720145|720146|720147|720148|720149|720150|720151|720152|720153|720154|720155|720156|720157|720158|720159|720160|720161|720162|720163|720164|720165|720166|720167|720168|720169|720170|720171|720172|720173|720174|720175|720176|720177|720178|720179|720180|720181|720182|720183|720184|720185|720186|720187|720188|720189|720190|720191|720192|720193|720194|720195|720196|720197|720198|720199|720200|720201|720202|720203|720204|720205|720206|720207|720208|720209|720210|720211|720212|720213|720214|720215|720216|720217|720218|720219|720220|720221|720222|720223|720224|720225|720226|720227|720228|720229|720230|720231|720232|720233|720234|720235|720236|720237|720238|720239|720240|720241|720242|720243|720244|720245|720246|720247|720248|720249|720250|720251|720252|720253|720254|720255|720256|720257|720258|720259|720260|720261|720262|720263|720264|720265|720266|720267|720268|720269|720270|720271|720272|720273|720274|720275|720276|720277|720278|720279|720280|720281|720282|720283|720284|720285|720286|720287|720288|720289|720290|720291|720292|720293|720294|720295|720296|720297|720298|720299|720300|720301|720302|720303|720304|720305|720306|720307|720308|720309|720310|720311|720312|720313|720314|720315|720316|720317|720318|720319|720320|720321|720322|720323|720324|720325|720326|720327|720328|720329|720330|720331|720332|720333|720334|720335|720336|720337|720338|720339|720340|720341|720342|720343|720344|720345|720346|720347|720348|720349|720350|720351|720352|720353|720354|720355|720356|720357|720358|720359|720360|720361|720362|720363|720364|720365|720366|720367|720368|720369|720370|720371|720372|720373|720374|720375|720376|720377|720378|720379|720380|720381|720382|720383|720384|720385|720386|720387|720388|720389|720390|720391|720392|720393|720394|720395|720396|720397|720398|720399|720400|720401|720402|720403|720404|720405|720406|720407|720408|720409|720410|720411|720412|720413|720414|720415|720416|720417|720418|720419|720420|720421|720422|720423|720424|720425|720426|720427|720428|720429|720430|720431|720432|720433|720434|720435|720436|720437|720438|720439|720440|720441|720442|720443|720444|720445|720446|720447|720448|720449|720450|720451|720452|720453|720454|720455|720456|720457|720458|720459|720460|720461|720462|720463|720464|720465|720466|720467|720468|720469|720470|720471|720472|720473|720474|720475|720476|720477|720478|720479|720480|720481|720482|720483|720484|1345502|1345653|1589075|1589076|1589077|1589078|1589079|1589080|1589081|1804130,20061025,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Ambinter|BenchChem|BindingDB|Biocore|Biosynth|BLD Pharm|BOC Sciences|Broad Institute|Calbiochem|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChemBank|ChEMBL|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Clearsynth|Collaborative Drug Discovery, Inc.|CymitQuimica|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EMD Millipore|EPA DSSTox|Google Patents|HDH Pharma|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|NextBio|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Springer Nature|SureChEMBL|TargetMol|THE BioTek|Therapeutic Target Database (TTD)|Thomson Pharma|Tractus|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,NULL
138911391,Egfr-IN-7,"EGFR-IN-7|2267329-76-8|5-bromo-N4-[5-(dimethylphosphinyl)-6-quinoxalinyl]-N2-[2-methoxy-5-methyl-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-2,4-pyrimidinediamine|(6-((5-Bromo-2-((2-methoxy-5-methyl-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)quinoxalin-5-yl)dimethylphosphine oxide|5-bromo-4-N-(5-dimethylphosphorylquinoxalin-6-yl)-2-N-[2-methoxy-5-methyl-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine|tqb-3804|SCHEMBL22025688|Egfr-IN-7(TQB3804 )|TBQ3804|TQB3804|BDBM561454|BCP34208|EX-A4322|TQB3804 (EGFR-IN-7)|US11390625, Compound 34|US11390625, Example 34|s6698|AKOS040733074|AT31337|HY-128862|CS-0101441|A935219",694.600,C32H41BrN9O2P,112.000,994.000,4.400,45,2,11,8,"InChI=1S/C32H41BrN9O2P/c1-21-18-26(28(44-3)19-27(21)42-12-8-22(9-13-42)41-16-14-40(2)15-17-41)38-32-36-20-23(33)31(39-32)37-25-7-6-24-29(35-11-10-34-24)30(25)45(4,5)43/h6-7,10-11,18-20,22H,8-9,12-17H2,1-5H3,(H2,36,37,38,39)",CC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)C)OC)NC4=NC=C(C(=N4)NC5=C(C6=NC=CN=C6C=C5)P(=O)(C)C)Br,CC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)C)OC)NC4=NC=C(C(=N4)NC5=C(C6=NC=CN=C6C=C5)P(=O)(C)C)Br,ZYSKXRAGBGLELB-UHFFFAOYSA-N,"5-bromo-4-N-(5-dimethylphosphorylquinoxalin-6-yl)-2-N-[2-methoxy-5-methyl-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine",693.23,693.23,0,1,0,0,0,0,0,0,0,0,13,5,2D+3D,NULL,Biological Test Results|Drug and Medication Information|Patents,3,1806667|1806668,20190902,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AKos Consulting & Solutions|Amadis Chemical|Ambeed|AstaTech, Inc.|BenchChem|BindingDB|BioChemPartner|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemShuttle|Cooke Chemical Co., Ltd|CSNpharm|CymitQuimica|DC Chemicals|Excenen Pharmatech|Google Patents|Lan Pharmatech|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|Selleck Chemicals|Smolecule|Starshine Chemical|SureChEMBL|TargetMol",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
78357783,Mutant EGFR inhibitor,Mutant EGFR inhibitor|1421373-62-7|CHEMBL3353408|MDK3627|N-[5-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide|utant EGFR inhibitor|SCHEMBL14663463|ABM-3627|BCP23941|EX-A2254|WGC37362|BDBM50029664|AKOS026750607|NCGC00378578-01|HY-13984|MS-29643|MDK3627; MDK 3627; MDK-3627|N-(5-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide|N-(5-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxyphenyl)prop-2-enamide|N-(5-{[5-Chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-2-{2-dimethylaminoethyl-methylamino}-4-methoxyphenyl)prop-2-enamide,520.000,C27H30ClN7O2,98.400,758.000,4.400,37,3,7,10,"InChI=1S/C27H30ClN7O2/c1-6-25(36)31-21-13-22(24(37-5)14-23(21)35(4)12-11-34(2)3)32-27-30-16-19(28)26(33-27)18-15-29-20-10-8-7-9-17(18)20/h6-10,13-16,29H,1,11-12H2,2-5H3,(H,31,36)(H,30,32,33)",CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=C(C(=N2)C3=CNC4=CC=CC=C43)Cl)OC,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=C(C(=N2)C3=CNC4=CC=CC=C43)Cl)OC,SUPQPCQJBYPRPC-UHFFFAOYSA-N,N-[5-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide,519.215,519.215,0,1,0,0,0,0,0,0,0,5,31,3,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,4,1167101|1167102|1167103|1167104|1167108|1167109|1167110|1167115|1167116|1167117|1167119|1167121|1167122|1167123|1167130|1167148|1167149|1167154|1167155|1296008|1296009|1345084|1346986|1346987|1347055|1347159|1347160|1508620|1645840|1645841|1645842|1645851|1645852|1645870|1645876|1645877|1671188|1671193|1745852|1745853|1798057|1798058|1798059|1798060,20141010,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|AbovChem LLC|AKos Consulting & Solutions|Ambinter|AstaTech, Inc.|BenchChem|BindingDB|BioChemPartner|BioCrick|Biosynth|BOC Sciences|Boerchem|Chem-Space.com Database|ChEMBL|Chemieliva Pharmaceutical Co., Ltd|CSNpharm|CymitQuimica|DC Chemicals|Excenen Pharmatech|Google Patents|IBM|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextMove Software|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development,NULL
11566580,EGFR/ErbB-2/ErbB-4 Inhibitor,"HDS 029|881001-19-0|EGFR/ErbB-2/ErbB-4 Inhibitor|HDS-029|TKI-39|ZN0X0Q76F1|TKI39|UNII-ZN0X0Q76F1|CHEMBL203644|HDS029|N-[4-(3-chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]but-2-ynamide|2-Butynamide, N-(4-((3-chloro-4-fluorophenyl)amino)pyrido(3,4-d)pyrimidin-6-yl)-|N-(4-((3-Chloro-4-fluorophenyl)amino)pyrido(3,4-d)pyrimidin-6-yl)-2-butynamide|N-(4-((3-Chloro-4-fluorophenyl)amino)pyrido(3,4-d)pyrimidin-6-yl)but-2-ynamide|N-(4-((3-Chloro-4-fluorophenyl)amino)pyrido[3,4-d]pyrimidin-6-yl)but-2-ynamide|N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-2-butynamide|N-{4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl}but-2-ynamide|D05FFT|SCHEMBL238877|GTPL5965|DTXSID50468712|HMS3229E05|EGFR/ErbB-2/ErbB-4 inhibitor-3|BDBM50182693|AKOS024457218|CCG-206750|NCGC00167809-01|HY-103440|Q27077156|N-(4-[(-3-Chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl-2-butynamide",355.800,C17H11ClFN5O,79.800,550.000,3.600,25,2,6,3,"InChI=1S/C17H11ClFN5O/c1-2-3-16(25)24-15-7-11-14(8-20-15)21-9-22-17(11)23-10-4-5-13(19)12(18)6-10/h4-9H,1H3,(H,20,24,25)(H,21,22,23)",CC#CC(=O)NC1=NC=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl,CC#CC(=O)NC1=NC=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl,DLPSDPPZXRJQOY-UHFFFAOYSA-N,"N-[4-(3-chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]but-2-ynamide",355.064,355.064,0,1,0,0,0,0,0,0,0,8,86,21,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,5,1469|1477|1479|1490|1766|1768|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|260895|260896|260897|260898|260899|485281|485290|504327|504847|588579|602332|624349|651828|720017|720018|720019|720020|720021|720022|720023|720024|720025|720026|720027|720028|720029|720030|720031|720032|720033|720034|720035|720036|720037|720038|720039|720040|720041|720042|720043|720044|720045|720046|720047|720048|720049|720050|720051|720052|720053|720054|720055|720056|720057|720058|720059|720060|720061|720062|720063|720064|720065|720066|720067|720068|720069|720070|720071|720072|720073|720074|720075|720076|720077|720078|720079|720080|720081|720082|720083|720084|720085|720086|720087|720088|720089|720090|720091|720092|720093|720094|720095|720096|720097|720098|720099|720100|720101|720102|720103|720104|720105|720106|720107|720108|720109|720110|720111|720112|720113|720114|720115|720116|720117|720118|720119|720120|720121|720122|720123|720124|720125|720126|720127|720128|720129|720130|720131|720132|720133|720134|720135|720136|720137|720138|720139|720140|720141|720142|720143|720144|720145|720146|720147|720148|720149|720150|720151|720152|720153|720154|720155|720156|720157|720158|720159|720160|720161|720162|720163|720164|720165|720166|720167|720168|720169|720170|720171|720172|720173|720174|720175|720176|720177|720178|720179|720180|720181|720182|720183|720184|720185|720186|720187|720188|720189|720190|720191|720192|720193|720194|720195|720196|720197|720198|720199|720200|720201|720202|720203|720204|720205|720206|720207|720208|720209|720210|720211|720212|720213|720214|720215|720216|720217|720218|720219|720220|720221|720222|720223|720224|720225|720226|720227|720228|720229|720230|720231|720232|720233|720234|720235|720236|720237|720238|720239|720240|720241|720242|720243|720244|720245|720246|720247|720248|720249|720250|720251|720252|720253|720254|720255|720256|720257|720258|720259|720260|720261|720262|720263|720264|720265|720266|720267|720268|720269|720270|720271|720272|720273|720274|720275|720276|720277|720278|720279|720280|720281|720282|720283|720284|720285|720286|720287|720288|720289|720290|720291|720292|720293|720294|720295|720296|720297|720298|720299|720300|720301|720302|720303|720304|720305|720306|720307|720308|720309|720310|720311|720312|720313|720314|720315|720316|720317|720318|720319|720320|720321|720322|720323|720324|720325|720326|720327|720328|720329|720330|720331|720332|720333|720334|720335|720336|720337|720338|720339|720340|720341|720342|720343|720344|720345|720346|720347|720348|720349|720350|720351|720352|720353|720354|720355|720356|720357|720358|720359|720360|720361|720362|720363|720364|720365|720366|720367|720368|720369|720370|720371|720372|720373|720374|720375|720376|720377|720378|720379|720380|720381|720382|720383|720384|720385|720386|720387|720388|720389|720390|720391|720392|720393|720394|720395|720396|720397|720398|720399|720400|720401|720402|720403|720404|720405|720406|720407|720408|720409|720410|720411|720412|720413|720414|720415|720416|720417|720418|720419|720420|720421|720422|720423|720424|720425|720426|720427|720428|720429|720430|720431|720432|720433|720434|720435|720436|720437|720438|720439|720440|720441|720442|720443|720444|720445|720446|720447|720448|720449|720450|720451|720452|720453|720454|720455|720456|720457|720458|720459|720460|720461|720462|720463|720464|720465|720466|720467|720468|720469|720470|720471|720472|720473|720474|720475|720476|720477|720478|720479|720480|720481|720482|720483|720484|720532|720533|1159524|1345502|1345572|1345653|1347131|1347154|1508630|1671190,20061026,"001Chemical|A2B Chem|AA BLOCKS|AKos Consulting & Solutions|ApexBio Technology|Aurora Fine Chemicals LLC|BenchChem|BindingDB|Biocore|BioCrick|BOC Sciences|Calbiochem|Center for Chemical Genomics, University of Michigan|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|CymitQuimica|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EMD Millipore|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Google Patents|HDH Pharma|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|IUPHAR/BPS Guide to PHARMACOLOGY|MedChemexpress MCE|MolCore BioPharmatech|MuseChem|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NextBio|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Santa Cruz Biotechnology, Inc.|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thomson Pharma|Tocris Bioscience|Tractus|Wikidata|Wubei-Biochem|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,NULL
154573746,Egfr-IN-1 (tfa),EGFR-IN-1 (TFA)|EGFR-IN-1 TFA|HY-19617B|MS-30837|CS-0131618,628.600,C30H31F3N6O6,146.000,950.000,NULL,45,3,13,10,"InChI=1S/C28H30N6O4.C2HF3O2/c1-6-25(35)30-19-8-7-9-20(15-19)34-26(36)14-18(2)22-17-29-28(32-27(22)34)31-23-11-10-21(16-24(23)37-5)38-13-12-33(3)4;3-2(4,5)1(6)7/h6-11,14-17H,1,12-13H2,2-5H3,(H,30,35)(H,29,31,32);(H,6,7)",CC1=CC(=O)N(C2=NC(=NC=C12)NC3=C(C=C(C=C3)OCCN(C)C)OC)C4=CC=CC(=C4)NC(=O)C=C.C(=O)(C(F)(F)F)O,CC1=CC(=O)N(C2=NC(=NC=C12)NC3=C(C=C(C=C3)OCCN(C)C)OC)C4=CC=CC(=C4)NC(=O)C=C.C(=O)(C(F)(F)F)O,YXUXRIRLHPSVTF-UHFFFAOYSA-N,"N-[3-[2-[4-[2-(dimethylamino)ethoxy]-2-methoxyanilino]-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]phenyl]prop-2-enamide;2,2,2-trifluoroacetic acid",628.226,628.226,0,2,0,0,0,0,0,0,0,0,0,0,2D,NULL,Classification,1,NULL,20200901,AbaChemScene|DC Chemicals|Key Organics/BIONET|MedChemexpress MCE|MolPort|Probes & Drugs portal,Chemical Vendors|Research and Development,NULL
134817166,mutant EGFR inhibitor B30,"EGFR-IN-5|mutant EGFR inhibitor B30|2225887-26-1|CHEMBL4209019|(1-(6-((5-(4-(Dimethylamino)piperidin-1-yl)pyridin-2-yl)amino)-2-((4-fluorophenyl)amino)pyrido[3,4-d]pyrimidin-4-yl)piperidin-4-yl)methanol|[1-[6-[[5-[4-(dimethylamino)piperidin-1-yl]pyridin-2-yl]amino]-2-(4-fluoroanilino)pyrido[3,4-d]pyrimidin-4-yl]piperidin-4-yl]methanol|BDBM50458062|AKOS040733073|BS-46313|HY-111415|CS-0040561|E85233",571.700,C31H38FN9O,106.000,816.000,4.800,42,3,11,8,"InChI=1S/C31H38FN9O/c1-39(2)24-11-15-40(16-12-24)25-7-8-28(33-18-25)37-29-17-26-27(19-34-29)36-31(35-23-5-3-22(32)4-6-23)38-30(26)41-13-9-21(20-42)10-14-41/h3-8,17-19,21,24,42H,9-16,20H2,1-2H3,(H,33,34,37)(H,35,36,38)",CN(C)C1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C(=C3)C(=NC(=N4)NC5=CC=C(C=C5)F)N6CCC(CC6)CO,CN(C)C1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C(=C3)C(=NC(=N4)NC5=CC=C(C=C5)F)N6CCC(CC6)CO,DXOUQSZKEPSXBC-UHFFFAOYSA-N,"[1-[6-[[5-[4-(dimethylamino)piperidin-1-yl]pyridin-2-yl]amino]-2-(4-fluoroanilino)pyrido[3,4-d]pyrimidin-4-yl]piperidin-4-yl]methanol",571.318,571.318,0,1,0,0,0,0,0,0,0,2,0,0,2D+3D,NULL,Biological Test Results|Classification|Literature,3,1382529|1382530|1382531|1382532|1382533|1382534|1382535|1382536|1382537|1382538|1382539|1382540|1688909|1688913|1688918|1688919|1688927|1688928|1688929|1688930|1688931|1688932|1688933|1688934|1688935|1688936|1688937|1688938|1688939,20181002,"A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|Ambeed|AstaTech, Inc.|BenchChem|BindingDB|ChEMBL|CSNpharm|CymitQuimica|DC Chemicals|Key Organics/BIONET|MedChemexpress MCE|MolPort|RR Scientific|Starshine Chemical|THE BioTek",Chemical Vendors|Curation Efforts|Research and Development,NULL
146026038,EGFR-IN-1 (hydrochloride),EGFR-IN-1 (hydrochloride)|EGFR-IN-1 hydrochloride|HY-19617A|AKOS040733070|CS-0114965|2227455-78-7,551.000,C28H31ClN6O4,109.000,866.000,NULL,39,3,8,10,"InChI=1S/C28H30N6O4.ClH/c1-6-25(35)30-19-8-7-9-20(15-19)34-26(36)14-18(2)22-17-29-28(32-27(22)34)31-23-11-10-21(16-24(23)37-5)38-13-12-33(3)4;/h6-11,14-17H,1,12-13H2,2-5H3,(H,30,35)(H,29,31,32);1H",CC1=CC(=O)N(C2=NC(=NC=C12)NC3=C(C=C(C=C3)OCCN(C)C)OC)C4=CC=CC(=C4)NC(=O)C=C.Cl,CC1=CC(=O)N(C2=NC(=NC=C12)NC3=C(C=C(C=C3)OCCN(C)C)OC)C4=CC=CC(=C4)NC(=O)C=C.Cl,SDTFYMHVYLJYFV-UHFFFAOYSA-N,"N-[3-[2-[4-[2-(dimethylamino)ethoxy]-2-methoxyanilino]-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]phenyl]prop-2-enamide;hydrochloride",550.21,550.21,0,2,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20200430,AbaChemScene|AKos Consulting & Solutions|MedChemexpress MCE,Chemical Vendors,NULL
156853935,Egfr-IN-31,EGFR-IN-31|HY-144048|CS-0374991,569.700,C32H36FN7O2,94.600,834.000,5.900,42,3,9,12,"InChI=1S/C32H36FN7O2/c1-7-30(41)36-26-18-27(29(42-6)19-28(26)40(5)17-16-39(3)4)37-32-34-20-25(22-10-12-23(33)13-11-22)31(38-32)35-24-14-8-21(2)9-15-24/h7-15,18-20H,1,16-17H2,2-6H3,(H,36,41)(H2,34,35,37,38)",CC1=CC=C(C=C1)NC2=NC(=NC=C2C3=CC=C(C=C3)F)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,CC1=CC=C(C=C1)NC2=NC(=NC=C2C3=CC=C(C=C3)F)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,LTHVDNXRWSAVNX-UHFFFAOYSA-N,N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[5-(4-fluorophenyl)-4-(4-methylanilino)pyrimidin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide,569.291,569.291,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,Classification|Patents,2,NULL,20211110,AbaChemScene|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,NULL
164517079,Egfr/brafv600E-IN-1,EGFR/BRAFV600E-IN-1|HY-147825,437.900,C24H24ClN3O3,54.800,677.000,4.200,31,0,4,4,"InChI=1S/C24H24ClN3O3/c1-16-20-14-18(25)4-7-21(20)28-22(29)15-27(24(30)23(16)28)9-8-17-2-5-19(6-3-17)26-10-12-31-13-11-26/h2-7,14H,8-13,15H2,1H3",CC1=C2C(=O)N(CC(=O)N2C3=C1C=C(C=C3)Cl)CCC4=CC=C(C=C4)N5CCOCC5,CC1=C2C(=O)N(CC(=O)N2C3=C1C=C(C=C3)Cl)CCC4=CC=C(C=C4)N5CCOCC5,OOIHXWXWHGUVBG-UHFFFAOYSA-N,"8-chloro-10-methyl-2-[2-(4-morpholin-4-ylphenyl)ethyl]-3H-pyrazino[1,2-a]indole-1,4-dione",437.151,437.151,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220727,MedChemexpress MCE,Chemical Vendors,NULL
46354956,Egfr/her2-IN-3,"EGFR/HER2-IN-3|HY-115952|CS-0434398|N-(2,4-dimethoxybenzyl)-N-{2-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-4-quinazolinyl}amine",453.500,C26H23N5O3,95.200,634.000,4.800,34,1,8,7,"InChI=1S/C26H23N5O3/c1-16-8-10-17(11-9-16)25-30-31-26(34-25)24-28-21-7-5-4-6-20(21)23(29-24)27-15-18-12-13-19(32-2)14-22(18)33-3/h4-14H,15H2,1-3H3,(H,27,28,29)",CC1=CC=C(C=C1)C2=NN=C(O2)C3=NC4=CC=CC=C4C(=N3)NCC5=C(C=C(C=C5)OC)OC,CC1=CC=C(C=C1)C2=NN=C(O2)C3=NC4=CC=CC=C4C(=N3)NCC5=C(C=C(C=C5)OC)OC,DKJFXPDCLVAOGB-UHFFFAOYSA-N,"N-[(2,4-dimethoxyphenyl)methyl]-2-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinazolin-4-amine",453.18,453.18,0,1,0,0,0,0,0,0,0,0,0,0,2D+3D,NULL,NULL,0,NULL,20100721,AbaChemScene|Ambinter|ChemDiv|DiscoveryGate|Mcule|MedChemexpress MCE|ZINC,Chemical Vendors|Legacy Depositors|Subscription Services,NULL
129627020,"HER2/EGFR dual kinase inhibitor, 5e","BDBM246608|HER2/EGFR dual kinase inhibitor, 5e|4-{4-[6-(4-(4-Bromophenyl)-3-cyano-2-imino)-1,2-dihydropyridyl]phenylamino}6,7-dimethoxyquinazoline",557.400,C28H25BrN6O2,118.000,834.000,5.200,37,2,7,6,"InChI=1S/C28H25BrN6O2/c1-36-25-12-21-24(13-26(25)37-2)32-15-33-28(21)34-19-9-5-17(6-10-19)23-11-20(22(14-30)27(31)35-23)16-3-7-18(29)8-4-16/h3-10,12-13,15,20,22-23H,11H2,1-2H3,(H2,31,35)(H,32,33,34)",COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)C4CC(C(C(=N4)N)C#N)C5=CC=C(C=C5)Br)OC,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)C4CC(C(C(=N4)N)C#N)C5=CC=C(C=C5)Br)OC,XBXWGSAUERHHJO-UHFFFAOYSA-N,"6-amino-4-(4-bromophenyl)-2-[4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenyl]-2,3,4,5-tetrahydropyridine-5-carbonitrile",556.122,556.122,0,1,0,3,0,3,0,0,0,1,0,0,2D,NULL,Biological Test Results|Literature,3,1803399,20170904,BindingDB,Curation Efforts|Research and Development,NULL
134826780,[pTyr5] EGFR (988-993),[pTyr5] EGFR (988-993)|Asp-Ala-Asp-Glu-pTyr-Leu|HY-P1799|CS-0095796,804.700,C31H45N6O17P,388.000,1460.000,-5.300,55,12,18,24,"InChI=1S/C31H45N6O17P/c1-14(2)10-22(31(49)50)37-29(47)20(11-16-4-6-17(7-5-16)54-55(51,52)53)36-28(46)19(8-9-23(38)39)34-30(48)21(13-25(42)43)35-26(44)15(3)33-27(45)18(32)12-24(40)41/h4-7,14-15,18-22H,8-13,32H2,1-3H3,(H,33,45)(H,34,48)(H,35,44)(H,36,46)(H,37,47)(H,38,39)(H,40,41)(H,42,43)(H,49,50)(H2,51,52,53)/t15-,18-,19-,20-,21-,22-/m0/s1",C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N,CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CC(=O)O)N,KVTXKWFVCLLHQU-TVVJCWKZSA-N,(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]propanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-methylpentanoic acid,804.258,804.258,0,1,0,6,6,0,0,0,0,1,0,0,2D,NULL,Literature,1,NULL,20181116,AbaChemScene|MedChemexpress MCE|NextMove Biologics,Chemical Vendors|Research and Development,NULL
146673164,[pTyr5] EGFR (988-993) (TFA),[pTyr5] EGFR (988-993) (TFA)|HY-P1799A|CS-0128935,918.700,C33H46F3N6O19P,425.000,1550.000,NULL,62,13,23,24,"InChI=1S/C31H45N6O17P.C2HF3O2/c1-14(2)10-22(31(49)50)37-29(47)20(11-16-4-6-17(7-5-16)54-55(51,52)53)36-28(46)19(8-9-23(38)39)34-30(48)21(13-25(42)43)35-26(44)15(3)33-27(45)18(32)12-24(40)41;3-2(4,5)1(6)7/h4-7,14-15,18-22H,8-13,32H2,1-3H3,(H,33,45)(H,34,48)(H,35,44)(H,36,46)(H,37,47)(H,38,39)(H,40,41)(H,42,43)(H,49,50)(H2,51,52,53);(H,6,7)/t15-,18-,19-,20-,21-,22-;/m0./s1",C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N.C(=O)(C(F)(F)F)O,CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CC(=O)O)N.C(=O)(C(F)(F)F)O,PCQWDGGWAHUXTQ-OUSXHNLLSA-N,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]propanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-methylpentanoic acid;2,2,2-trifluoroacetic acid",918.251,918.251,0,2,0,6,6,0,0,0,0,0,0,0,2D,NULL,Classification,1,NULL,20200702,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
162663491,Egfr-IN-56,EGFR-IN-56|CHEMBL4780534|BDBM50561282|HY-146136|CS-0514462,434.500,C23H22N4O3S,111.000,601.000,4.200,31,2,7,7,"InChI=1S/C23H22N4O3S/c1-3-21(28)24-16-5-4-6-18(13-16)30-22-19-14-31-12-11-20(19)26-23(27-22)25-15-7-9-17(29-2)10-8-15/h3-10,13H,1,11-12,14H2,2H3,(H,24,28)(H,25,26,27)",COC1=CC=C(C=C1)NC2=NC3=C(CSCC3)C(=N2)OC4=CC=CC(=C4)NC(=O)C=C,COC1=CC=C(C=C1)NC2=NC3=C(CSCC3)C(=N2)OC4=CC=CC(=C4)NC(=O)C=C,MXQIWUCOUMEFAW-UHFFFAOYSA-N,"N-[3-[[2-(4-methoxyanilino)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide",434.141,434.141,0,1,0,0,0,0,0,0,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature,3,1724528|1724529|1724530|1724531|1724532|1724533|1724534|1724535|1724536|1724537|1724538|1724539|1724540|1724541|1724542|1724543|1724544|1724545|1724546|1724547|1724548|1724549|1724550|1724551|1724552|1724553|1724554|1724555|1724556|1724557|1724558|1724559|1724560|1724561|1724562|1724563|1724564|1724565|1724566|1724567|1724568|1724569,20220315,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
162679548,Egfr-IN-42,EGFR-IN-42|GTPL11941|compound 17b [PMID: 35286086]|HY-145823|CS-0434074|(Z)-N-(3-((4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)-6-((2-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenoxy)ethyl)(methyl)amino)hexanamide,846.400,C49H53ClFN5O5,118.000,1290.000,11.300,61,3,10,22,"InChI=1S/C49H53ClFN5O5/c1-4-40(34-12-7-5-8-13-34)48(35-15-20-38(57)21-16-35)36-17-22-39(23-18-36)60-29-27-56(2)26-10-6-9-14-47(58)52-25-11-28-61-46-31-41-44(32-45(46)59-3)53-33-54-49(41)55-37-19-24-43(51)42(50)30-37/h5,7-8,12-13,15-24,30-33,57H,4,6,9-11,14,25-29H2,1-3H3,(H,52,58)(H,53,54,55)/b48-40-",CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)CCCCCC(=O)NCCCOC3=C(C=C4C(=C3)C(=NC=N4)NC5=CC(=C(C=C5)F)Cl)OC)/C6=CC=CC=C6,CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCN(C)CCCCCC(=O)NCCCOC3=C(C=C4C(=C3)C(=NC=N4)NC5=CC(=C(C=C5)F)Cl)OC)C6=CC=CC=C6,RMOTTYOBLRRJDT-XXBDBSAUSA-N,N-[3-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypropyl]-6-[2-[4-[(Z)-1-(4-hydroxyphenyl)-2-phenylbut-1-enyl]phenoxy]ethyl-methylamino]hexanamide,845.372,845.372,0,1,0,0,0,0,1,1,0,1,0,0,2D,NULL,Classification|Literature,3,NULL,20220331,AbaChemScene|IUPHAR/BPS Guide to PHARMACOLOGY|MedChemexpress MCE|Probes & Drugs portal,Chemical Vendors|Curation Efforts|Research and Development,NULL
163196259,Egfr-IN-27,EGFR-IN-27|SCHEMBL24107903|HY-142519|CS-0372620,655.800,C35H46N9O2P,112.000,1050.000,4.900,47,2,11,10,"InChI=1S/C35H46N9O2P/c1-7-24-21-29(31(46-4)22-30(24)44-15-11-26(12-16-44)43-19-17-42(3)18-20-43)40-35-38-23-25(8-2)34(41-35)39-28-10-9-27-32(37-14-13-36-27)33(28)47(5,6)45/h8-10,13-14,21-23,26H,2,7,11-12,15-20H2,1,3-6H3,(H2,38,39,40,41)",CCC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)C)OC)NC4=NC=C(C(=N4)NC5=C(C6=NC=CN=C6C=C5)P(=O)(C)C)C=C,CCC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)C)OC)NC4=NC=C(C(=N4)NC5=C(C6=NC=CN=C6C=C5)P(=O)(C)C)C=C,LUKWWQICCRFYBL-UHFFFAOYSA-N,"4-N-(5-dimethylphosphorylquinoxalin-6-yl)-5-ethenyl-2-N-[5-ethyl-2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine",655.351,655.351,0,1,0,0,0,0,0,0,0,0,1,1,2D,NULL,Patents,1,NULL,20220428,AbaChemScene|MedChemexpress MCE|SureChEMBL,Chemical Vendors|Curation Efforts|Research and Development,NULL
164517196,Egfr-IN-68,EGFR-IN-68|HY-147997|CS-0530617,354.400,C24H22N2O,24.800,509.000,5.600,27,0,3,5,"InChI=1S/C24H22N2O/c1-27-23-16-14-21(15-17-23)26-22(13-12-19-8-4-2-5-9-19)18-24(25-26)20-10-6-3-7-11-20/h2-17,22H,18H2,1H3/b13-12+",COC1=CC=C(C=C1)N2C(CC(=N2)C3=CC=CC=C3)/C=C/C4=CC=CC=C4,COC1=CC=C(C=C1)N2C(CC(=N2)C3=CC=CC=C3)C=CC4=CC=CC=C4,QGXAWMHVNOXVHQ-OUKQBFOZSA-N,"2-(4-methoxyphenyl)-5-phenyl-3-[(E)-2-phenylethenyl]-3,4-dihydropyrazole",354.173,354.173,0,1,0,1,0,1,1,1,0,0,0,0,2D,NULL,NULL,0,NULL,20220727,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
164887603,Egfr/her2-IN-8,EGFR/HER2-IN-8|CS-0572440,328.400,C16H16N4O2S,104.000,453.000,3.500,23,2,4,3,"InChI=1S/C16H16N4O2S/c1-3-14(21)18-19-15(22)13-9-23-16-17-8-12(20(13)16)11-6-4-10(2)5-7-11/h4-9H,3H2,1-2H3,(H,18,21)(H,19,22)",CCC(=O)NNC(=O)C1=CSC2=NC=C(N12)C3=CC=C(C=C3)C,CCC(=O)NNC(=O)C1=CSC2=NC=C(N12)C3=CC=C(C=C3)C,VNEUERRAUAGHGO-UHFFFAOYSA-N,"5-(4-methylphenyl)-N'-propanoylimidazo[2,1-b][1,3]thiazole-3-carbohydrazide",328.099,328.099,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220905,AbaChemScene|ChEMBL,Chemical Vendors|Curation Efforts|Research and Development,NULL
76900441,"HER2/EGFR dual kinase inhibitor, 7e","BDBM246609|HER2/EGFR dual kinase inhibitor, 7e|(E)-3-(4-Chlorophenyl)-1-{4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenyl}prop-2-en-1-one",445.900,C25H20ClN3O3,73.300,632.000,5.800,32,1,6,7,"InChI=1S/C25H20ClN3O3/c1-31-23-13-20-21(14-24(23)32-2)27-15-28-25(20)29-19-10-6-17(7-11-19)22(30)12-5-16-3-8-18(26)9-4-16/h3-15H,1-2H3,(H,27,28,29)/b12-5+",COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)C(=O)/C=C/C4=CC=C(C=C4)Cl)OC,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)C(=O)C=CC4=CC=C(C=C4)Cl)OC,MIFKLWONDMFKNY-LFYBBSHMSA-N,"(E)-3-(4-chlorophenyl)-1-[4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenyl]prop-2-en-1-one",445.119,445.119,0,1,0,0,0,0,1,1,0,1,0,0,2D+3D,NULL,Biological Test Results|Literature,3,1803399,20140818,BindingDB|Thomson Pharma,Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
78358313,Mutated EGFR-IN-1,"Mutated EGFR-IN-1|1421372-66-8|N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine|AZD9291DA HCl salt|N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine|1-N-[2-(dimethylamino)ethyl]-5-methoxy-1-N-methyl-4-N-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine|N1-[2-(dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine|MutatedEGFR-IN-1|CHEMBL5028834|SCHEMBL14660679|AMY5307|BCP28639|MFCD28167800|AKOS027327325|CS-3259|SB18655|NCGC00390638-01|AC-30103|AS-75022|HY-78869|FT-0757730|A885232|N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine hydrochloride|N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine; N1-(2-dimethylaminoethyl)-5-methoxy-N1-methyl-N4-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine|N1-(2-dimethylaminoethyl)-5-methoxy-N1-methyl-N4-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine",445.600,C25H31N7O,84.500,607.000,3.300,33,2,7,8,"InChI=1S/C25H31N7O/c1-30(2)12-13-31(3)23-15-24(33-5)21(14-19(23)26)29-25-27-11-10-20(28-25)18-16-32(4)22-9-7-6-8-17(18)22/h6-11,14-16H,12-13,26H2,1-5H3,(H,27,28,29)",CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)N)N(C)CCN(C)C)OC,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)N)N(C)CCN(C)C)OC,HTNTZPBKKCORTP-UHFFFAOYSA-N,"1-N-[2-(dimethylamino)ethyl]-5-methoxy-1-N-methyl-4-N-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine",445.259,445.259,0,1,0,0,0,0,0,0,0,4,51,10,2D+3D,NULL,Biological Test Results|Literature|Patents,3,1296008|1296009|1345084|1346986|1346987|1347055|1347159|1347160|1508605|1508606|1508620|1645840|1645841|1645842|1645851|1645870|1645876|1645877|1671188|1671193|1745853,20141010,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbovChem LLC|Aceschem Inc|Acorn PharmaTech Product List|Activate Scientific|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Angel Pharmatech Ltd.|Angene Chemical|Apexmol|Ark Pharm, Inc.|AstaTech, Inc.|BenchChem|BioChemPartner|BioCrick|BOC Sciences|Cangzhou Enke Pharma Tech Co.,Ltd.|Chem-Space.com Database|ChEMBL|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Clearsynth|Combi-Blocks|Cooke Chemical Co., Ltd|CSNpharm|CymitQuimica|DC Chemicals|Debye Scientific Co., Ltd|eNovation Chemicals|Finetech Industry Limited|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|Hefei Hirisun Pharmatech Co., Ltd|Hunan Huateng Pharmaceutical Co., Ltd.|IBM|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|Matrix Scientific|MedChemexpress MCE|MolCore BioPharmatech|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextMove Software|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|RR Scientific|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Starshine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|Thieme Chemistry|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,NULL
156431353,Egfr-IN-21,EGFR-IN-21|SCHEMBL23442001|HY-142678|CS-0372532,759.700,C36H44BrN10O2P,117.000,1140.000,4.900,50,2,11,9,"InChI=1S/C36H44BrN10O2P/c1-44-14-16-46(17-15-44)25-10-12-47(13-11-25)32-19-33(49-3)30(18-27(32)24-20-40-45(2)23-24)42-36-39-21-28(37)35(43-36)41-31-22-38-29-9-7-6-8-26(29)34(31)50(4,5)48/h6-9,18-23,25H,10-17H2,1-5H3,(H2,39,41,42,43)",CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3C4=CN(N=C4)C)NC5=NC=C(C(=N5)NC6=C(C7=CC=CC=C7N=C6)P(=O)(C)C)Br)OC,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3C4=CN(N=C4)C)NC5=NC=C(C(=N5)NC6=C(C7=CC=CC=C7N=C6)P(=O)(C)C)Br)OC,LSEIPGIXLLFPNX-UHFFFAOYSA-N,"5-bromo-4-N-(4-dimethylphosphorylquinolin-3-yl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-5-(1-methylpyrazol-4-yl)phenyl]pyrimidine-2,4-diamine",758.257,758.257,0,1,0,0,0,0,0,0,0,0,1,1,2D,NULL,Patents,1,NULL,20210821,AbaChemScene|MedChemexpress MCE|SureChEMBL,Chemical Vendors|Curation Efforts|Research and Development,NULL
156853993,Egfr-IN-36,EGFR-IN-36|HY-144053|CS-0375010,489.000,C26H25ClN6O2,98.600,743.000,3.400,35,1,6,6,"InChI=1S/C26H25ClN6O2/c1-2-24(34)32-11-5-6-18(14-32)22-13-20(25-26(28)30-16-31-33(22)25)17-8-9-23(21(27)12-17)35-15-19-7-3-4-10-29-19/h2-4,7-10,12-13,16,18H,1,5-6,11,14-15H2,(H2,28,30,31)",C=CC(=O)N1CCCC(C1)C2=CC(=C3N2N=CN=C3N)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl,C=CC(=O)N1CCCC(C1)C2=CC(=C3N2N=CN=C3N)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl,QZSUQMZPWHXHOE-UHFFFAOYSA-N,"1-[3-[4-amino-5-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]piperidin-1-yl]prop-2-en-1-one",488.173,488.173,0,1,0,1,0,1,0,0,0,0,0,0,2D,NULL,Patents,1,NULL,20211110,AbaChemScene|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,NULL
162640905,Egfr/csc-IN-1,EGFR/CSC-IN-1|CHEMBL5094282|BDBM50580159|HY-132883|CS-0254166,1067.100,C54H54Cl2FN7O7S2,184.000,1860.000,9.200,73,1,15,22,"InChI=1S/C54H54Cl2FN7O7S2/c1-73(67,68)29-27-63(52(65)18-19-53(66)69-28-26-62-24-22-61(23-25-62)20-5-21-64-46-8-2-3-9-50(46)72-51-17-11-39(55)32-47(51)64)34-42-13-16-48(71-42)38-10-14-45-43(31-38)54(59-36-58-45)60-41-12-15-49(44(56)33-41)70-35-37-6-4-7-40(57)30-37/h2-4,6-17,30-33,36H,5,18-29,34-35H2,1H3,(H,58,59,60)",CS(=O)(=O)CCN(CC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl)C(=O)CCC(=O)OCCN6CCN(CC6)CCCN7C8=CC=CC=C8SC9=C7C=C(C=C9)Cl,CS(=O)(=O)CCN(CC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl)C(=O)CCC(=O)OCCN6CCN(CC6)CCCN7C8=CC=CC=C8SC9=C7C=C(C=C9)Cl,OVNXJZUYPUTQOA-UHFFFAOYSA-N,2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethyl 4-[[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methyl-(2-methylsulfonylethyl)amino]-4-oxobutanoate,1065.29,1065.29,0,1,0,0,0,0,0,0,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature,3,1809331|1809332|1809333|1809334|1809335|1809336|1809337|1809338|1809339|1809342|1809343|1809344|1809345|1809346|1809347|1809348|1809349|1809350|1809351|1809352|1809353|1809354|1809355|1809356|1809357|1809359|1809360|1809361|1809362|1809363|1809364|1809365|1809366|1809367|1809368|1809369|1809370|1809371|1809372|1809373,20220315,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
163322009,Egfr-IN-47,EGFR-IN-47|HY-143337|CS-0437223,481.600,C29H35N7,75.200,685.000,4.100,36,2,6,6,"InChI=1S/C29H35N7/c1-34-13-15-35(16-14-34)27-12-11-23(18-26(27)21-7-3-2-4-8-21)32-29-31-20-22-17-25(19-30)36(28(22)33-29)24-9-5-6-10-24/h2-4,7-8,11-12,17-18,20,24H,5-6,9-10,13-16,19,30H2,1H3,(H,31,32,33)",CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC=C4C=C(N(C4=N3)C5CCCC5)CN)C6=CC=CC=C6,CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC=C4C=C(N(C4=N3)C5CCCC5)CN)C6=CC=CC=C6,CJZBVEFQWNNGOR-UHFFFAOYSA-N,"6-(aminomethyl)-7-cyclopentyl-N-[4-(4-methylpiperazin-1-yl)-3-phenylphenyl]pyrrolo[2,3-d]pyrimidin-2-amine",481.295,481.295,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220602,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
6199344,Egfr/cdk2-IN-1,EGFR/CDK2-IN-1|AKOS002737994|HY-151573|CS-0617165,387.700,C19H12BrClO2,30.200,431.000,5.800,23,0,2,4,InChI=1S/C19H12BrClO2/c20-14-7-5-13(6-8-14)18(22)11-9-15-10-12-19(23-15)16-3-1-2-4-17(16)21/h1-12H/b11-9+,C1=CC=C(C(=C1)C2=CC=C(O2)/C=C/C(=O)C3=CC=C(C=C3)Br)Cl,C1=CC=C(C(=C1)C2=CC=C(O2)C=CC(=O)C3=CC=C(C=C3)Br)Cl,YIOGDNXXYFSGJY-PKNBQFBNSA-N,(E)-1-(4-bromophenyl)-3-[5-(2-chlorophenyl)furan-2-yl]prop-2-en-1-one,385.971,385.971,0,1,0,0,0,0,1,1,0,0,0,0,2D+3D,NULL,NULL,0,NULL,20050916,AbaChemScene|ABI Chem|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|ChemSpider|DiscoveryGate|Excenen Pharmatech|MedChemexpress MCE|NextBio,Chemical Vendors|Legacy Depositors|Research and Development|Subscription Services,NULL
22122640,Egfr-IN-451,EGFR-IN-451|220576-72-7|N-[4-(1H-Indol-5-ylamino)-quinazolin-6-yl]-acrylamide|SCHEMBL7127185|N-[4-(1H-indol-5-ylamino)quinazolin-6-yl]prop-2-enamide,329.400,C19H15N5O,82.700,498.000,3.300,25,3,4,4,"InChI=1S/C19H15N5O/c1-2-18(25)23-14-4-6-17-15(10-14)19(22-11-21-17)24-13-3-5-16-12(9-13)7-8-20-16/h2-11,20H,1H2,(H,23,25)(H,21,22,24)",C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC4=C(C=C3)NC=C4,C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC4=C(C=C3)NC=C4,ZEPDLDKXAUOXBS-UHFFFAOYSA-N,N-[4-(1H-indol-5-ylamino)quinazolin-6-yl]prop-2-enamide,329.128,329.128,0,1,0,0,0,0,0,0,0,0,3,1,2D+3D,NULL,Patents,1,NULL,20071205,BenchChem|ChEMBL|ChemSpider|Google Patents|IBM|PATENTSCOPE (WIPO)|Smolecule|SureChEMBL|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,NULL
24231093,Egfr/her2/cdk9-IN-1,EGFR/HER2/CDK9-IN-1|NSC798942|AKOS033716319|NSC-798942|HY-147796|Z19846859,451.600,C23H21N3O3S2,127.000,751.000,3.800,31,1,6,7,"InChI=1S/C23H21N3O3S2/c24-31(28,29)19-12-10-17(11-13-19)14-15-26-22(27)20-8-4-5-9-21(20)25-23(26)30-16-18-6-2-1-3-7-18/h1-13H,14-16H2,(H2,24,28,29)",C1=CC=C(C=C1)CSC2=NC3=CC=CC=C3C(=O)N2CCC4=CC=C(C=C4)S(=O)(=O)N,C1=CC=C(C=C1)CSC2=NC3=CC=CC=C3C(=O)N2CCC4=CC=C(C=C4)S(=O)(=O)N,BBMUYWDZIIQJMA-UHFFFAOYSA-N,4-[2-(2-benzylsulfanyl-4-oxoquinazolin-3-yl)ethyl]benzenesulfonamide,451.102,451.102,0,1,0,0,0,0,0,0,0,0,0,0,2D+3D,NULL,Biological Test Results,1,1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794763|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794788|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800,20080229,"AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|ChEMBL|Collaborative Drug Discovery, Inc.|DiscoveryGate|DTP/NCI|Enamine|Mcule|MedChemexpress MCE|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,NULL
53012917,Egfr/her2-IN-2,"EGFR/HER2-IN-2|HY-115951|CS-0434396|BRD-K25352577-001-01-2|N-(2-ethoxybenzyl)-2-[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]quinazolin-4-amine",453.500,C26H23N5O3,95.200,619.000,4.800,34,1,8,8,"InChI=1S/C26H23N5O3/c1-3-33-22-11-7-4-8-18(22)16-27-23-20-9-5-6-10-21(20)28-24(29-23)26-31-30-25(34-26)17-12-14-19(32-2)15-13-17/h4-15H,3,16H2,1-2H3,(H,27,28,29)",CCOC1=CC=CC=C1CNC2=NC(=NC3=CC=CC=C32)C4=NN=C(O4)C5=CC=C(C=C5)OC,CCOC1=CC=CC=C1CNC2=NC(=NC3=CC=CC=C32)C4=NN=C(O4)C5=CC=C(C=C5)OC,CYUOSMVCLLYSOZ-UHFFFAOYSA-N,"N-[(2-ethoxyphenyl)methyl]-2-[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]quinazolin-4-amine",453.18,453.18,0,1,0,0,0,0,0,0,0,0,0,0,2D+3D,NULL,Biological Test Results,1,1259416,20110621,AbaChemScene|Ambinter|Broad Institute|ChemDiv|Mcule|MedChemexpress MCE|MolPort|ZINC,Chemical Vendors|Legacy Depositors|NIH Initiatives,NULL
72713387,Egfr-IN-40,"EGFR-IN-40|CHEMBL2437471|SCHEMBL16680652|BDBM195881|HY-143901|CS-0376719|US9670213, Compound 026 N-(3-(2-(4-methoxyphenylamino)-6-methyl-7-oxo-8(7H)-pteridin-yl)phenyl) acrylamide",428.400,C23H20N6O3,109.000,735.000,2.700,32,2,7,6,"InChI=1S/C23H20N6O3/c1-4-20(30)26-16-6-5-7-17(12-16)29-21-19(25-14(2)22(29)31)13-24-23(28-21)27-15-8-10-18(32-3)11-9-15/h4-13H,1H2,2-3H3,(H,26,30)(H,24,27,28)",CC1=NC2=CN=C(N=C2N(C1=O)C3=CC=CC(=C3)NC(=O)C=C)NC4=CC=C(C=C4)OC,CC1=NC2=CN=C(N=C2N(C1=O)C3=CC=CC(=C3)NC(=O)C=C)NC4=CC=C(C=C4)OC,FGPPXNCHKYRZCI-UHFFFAOYSA-N,N-[3-[2-(4-methoxyanilino)-6-methyl-7-oxopteridin-8-yl]phenyl]prop-2-enamide,428.16,428.16,0,1,0,0,0,0,0,0,0,2,8,1,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,4,775613|775614|775622|775623|775624|1795051|1822762|1822763|1822764|1822765|1822766,20140203,AbaChemScene|BindingDB|ChEMBL|Google Patents|IBM|MedChemexpress MCE|PATENTSCOPE (WIPO)|Probes & Drugs portal|SureChEMBL|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
117685125,Egfr/her2-IN-9,"EGFR/HER2-IN-9|US9556191, example 1|SCHEMBL16219901|US9556191, example 20|BDBM228107|BDBM228113|HY-153111|CS-0651111|(e)-n-(4-((3-chloro-4-fluorophenyl)amino)-7-(methoxy-d3)quinazolin-6-yl)-4-((4ar,7as)-tetrahydro 2h-[1,4]dioxino[2,3-c]pyrrol-6(3h)-yl)but-2-enamide|(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-((4aR,7aS)-tetrahydro-2H-[1,4]dioxin[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",513.900,C25H25ClFN5O4,97.800,767.000,3.000,36,2,9,7,"InChI=1S/C25H25ClFN5O4/c1-34-21-11-19-16(25(29-14-28-19)30-15-4-5-18(27)17(26)9-15)10-20(21)31-24(33)3-2-6-32-12-22-23(13-32)36-8-7-35-22/h2-5,9-11,14,22-23H,6-8,12-13H2,1H3,(H,31,33)(H,28,29,30)/b3-2+/t22-,23+",COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4C[C@@H]5[C@H](C4)OCCO5,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CC5C(C4)OCCO5,REGOTSLWVKSZRG-GYQWKJCYSA-N,"(E)-4-[(4aR,7aS)-2,3,4a,5,7,7a-hexahydro-[1,4]dioxino[2,3-c]pyrrol-6-yl]-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]but-2-enamide",513.158,513.158,0,1,0,2,2,0,1,1,0,0,3,1,2D+3D,NULL,Biological Test Results|Classification|Patents,3,1795123,20160223,AbaChemScene|BindingDB|MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
129627019,"HER2/EGFR dual kinase inhibitor, 5d","BDBM246607|HER2/EGFR dual kinase inhibitor, 5d",436.500,C26H21FN6,100.000,732.000,4.700,33,2,6,4,"InChI=1S/C26H21FN6/c27-18-9-5-16(6-10-18)21-13-24(33-25(29)22(21)14-28)17-7-11-19(12-8-17)32-26-20-3-1-2-4-23(20)30-15-31-26/h1-12,15,21-22,24H,13H2,(H2,29,33)(H,30,31,32)",C1C(C(C(=NC1C2=CC=C(C=C2)NC3=NC=NC4=CC=CC=C43)N)C#N)C5=CC=C(C=C5)F,C1C(C(C(=NC1C2=CC=C(C=C2)NC3=NC=NC4=CC=CC=C43)N)C#N)C5=CC=C(C=C5)F,COYAHVNLGLGKNM-UHFFFAOYSA-N,"6-amino-4-(4-fluorophenyl)-2-[4-(quinazolin-4-ylamino)phenyl]-2,3,4,5-tetrahydropyridine-5-carbonitrile",436.181,436.181,0,1,0,3,0,3,0,0,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature,4,1803399,20170904,BindingDB,Curation Efforts|Research and Development,NULL
146180757,Egfr/C797S-IN-1,EGFR/C797S-IN-1|SCHEMBL21473613|HY-152019|CS-0627114,470.600,C28H30N4O3,68.700,617.000,5.700,35,1,7,8,"InChI=1S/C28H30N4O3/c1-32-14-12-20(13-15-32)18-34-27-17-25-24(16-26(27)33-2)28(30-19-29-25)31-21-8-10-23(11-9-21)35-22-6-4-3-5-7-22/h3-11,16-17,19-20H,12-15,18H2,1-2H3,(H,29,30,31)",CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=CC=C(C=C4)OC5=CC=CC=C5)OC,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=CC=C(C=C4)OC5=CC=CC=C5)OC,OGARAQZJFVUHBN-UHFFFAOYSA-N,6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]-N-(4-phenoxyphenyl)quinazolin-4-amine,470.232,470.232,0,1,0,0,0,0,0,0,0,0,3,1,2D+3D,NULL,Patents,1,NULL,20200627,AbaChemScene|Google Patents|MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
155813973,Egfr-IN-59,EGFR-IN-59|NSC798832|NSC-798832|HY-147802|CS-0529083,513.600,C27H23N5O4S,128.000,851.000,5.400,37,2,9,8,"InChI=1S/C27H23N5O4S/c1-18-17-26(31-36-18)32-37(33,34)22-14-10-20(11-15-22)28-27-23-5-3-4-6-24(23)29-25(30-27)16-9-19-7-12-21(35-2)13-8-19/h3-17H,1-2H3,(H,31,32)(H,28,29,30)/b16-9+",CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)NC3=NC(=NC4=CC=CC=C43)/C=C/C5=CC=C(C=C5)OC,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)NC3=NC(=NC4=CC=CC=C43)C=CC5=CC=C(C=C5)OC,BHPUGVPSLDRNDT-CXUHLZMHSA-N,"4-[[2-[(E)-2-(4-methoxyphenyl)ethenyl]quinazolin-4-yl]amino]-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide",513.147,513.147,0,1,0,0,0,0,1,1,0,0,0,0,2D,NULL,Biological Test Results,1,1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794763|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794788|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800,20210319,AbaChemScene|DTP/NCI|MedChemexpress MCE,Chemical Vendors|Governmental Organizations,NULL
156853872,Egfr-IN-32,EGFR-IN-32|HY-144049|CS-0374993,538.600,C31H34N6O3,91.800,778.000,5.200,40,2,8,12,"InChI=1S/C31H34N6O3/c1-6-30(38)33-25-20-26(29(39-5)21-27(25)37(4)19-18-36(2)3)35-31-32-17-16-24(34-31)23-14-10-11-15-28(23)40-22-12-8-7-9-13-22/h6-17,20-21H,1,18-19H2,2-5H3,(H,33,38)(H,32,34,35)",CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CC=CC=C3OC4=CC=CC=C4)OC,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CC=CC=C3OC4=CC=CC=C4)OC,BVPMIKLQWLLAPT-UHFFFAOYSA-N,N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(2-phenoxyphenyl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide,538.269,538.269,0,1,0,0,0,0,0,0,0,0,1,1,2D,NULL,Patents,1,NULL,20211110,AbaChemScene|Google Patents|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations|Research and Development,NULL
156854004,Egfr-IN-35,EGFR-IN-35|HY-144052|CS-0375003,490.000,C25H24ClN7O2,112.000,745.000,2.800,35,1,7,6,"InChI=1S/C25H24ClN7O2/c1-2-21(34)32-11-5-6-17(13-32)25-31-22(23-24(27)29-15-30-33(23)25)16-8-9-20(19(26)12-16)35-14-18-7-3-4-10-28-18/h2-4,7-10,12,15,17H,1,5-6,11,13-14H2,(H2,27,29,30)/t17-/m1/s1",C=CC(=O)N1CCC[C@H](C1)C2=NC(=C3N2N=CN=C3N)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl,C=CC(=O)N1CCCC(C1)C2=NC(=C3N2N=CN=C3N)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl,IGGCKIOWUQAPKJ-QGZVFWFLSA-N,"1-[(3R)-3-[4-amino-5-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]imidazo[5,1-f][1,2,4]triazin-7-yl]piperidin-1-yl]prop-2-en-1-one",489.168,489.168,0,1,0,1,1,0,0,0,0,0,0,0,2D,NULL,Patents,1,NULL,20211110,AbaChemScene|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,NULL
156854016,Egfr-IN-37,EGFR-IN-37|HY-144054|CS-0375014,489.000,C26H25ClN6O2,98.600,743.000,3.800,35,1,6,6,"InChI=1S/C26H25ClN6O2/c1-2-22(34)32-12-5-6-18(15-32)26-31-23(24-25(28)30-11-13-33(24)26)17-8-9-21(20(27)14-17)35-16-19-7-3-4-10-29-19/h2-4,7-11,13-14,18H,1,5-6,12,15-16H2,(H2,28,30)/t18-/m1/s1",C=CC(=O)N1CCC[C@H](C1)C2=NC(=C3N2C=CN=C3N)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl,C=CC(=O)N1CCCC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl,KGPUEOFIYJJWCW-GOSISDBHSA-N,"1-[(3R)-3-[8-amino-1-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]prop-2-en-1-one",488.173,488.173,0,1,0,1,1,0,0,0,0,0,0,0,2D,NULL,Patents,1,NULL,20211110,AbaChemScene|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,NULL
162513220,PROTAC EGFR degrader 3,"PROTAC EGFR degrader 3|HY-144605|CS-0433000|EN300-44826021|(2S,4R)-1-[(2S)-3,3-dimethyl-2-{8-[4-(4-{[8-(phenylamino)-9-[(3S)-1-(prop-2-enoyl)piperidin-3-yl]-9H-purin-2-yl]amino}phenyl)piperazin-1-yl]octanamido}butanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide",1092.400,C60H77N13O5S,234.000,1970.000,8.900,79,5,14,22,"InChI=1S/C60H77N13O5S/c1-7-52(76)71-30-16-19-47(37-71)73-55-49(66-59(73)65-44-17-12-11-13-18-44)36-61-58(68-55)64-45-25-27-46(28-26-45)70-33-31-69(32-34-70)29-15-10-8-9-14-20-51(75)67-54(60(4,5)6)57(78)72-38-48(74)35-50(72)56(77)63-40(2)42-21-23-43(24-22-42)53-41(3)62-39-79-53/h7,11-13,17-18,21-28,36,39-40,47-48,50,54,74H,1,8-10,14-16,19-20,29-35,37-38H2,2-6H3,(H,63,77)(H,65,66)(H,67,75)(H,61,64,68)/t40-,47-,48+,50-,54+/m0/s1",CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCN4CCN(CC4)C5=CC=C(C=C5)NC6=NC=C7C(=N6)N(C(=N7)NC8=CC=CC=C8)[C@H]9CCCN(C9)C(=O)C=C)O,CC1=C(SC=N1)C2=CC=C(C=C2)C(C)NC(=O)C3CC(CN3C(=O)C(C(C)(C)C)NC(=O)CCCCCCCN4CCN(CC4)C5=CC=C(C=C5)NC6=NC=C7C(=N6)N(C(=N7)NC8=CC=CC=C8)C9CCCN(C9)C(=O)C=C)O,RYXQXEGTLNBKEC-DKQRTKIFSA-N,"(2S,4R)-1-[(2S)-2-[8-[4-[4-[[8-anilino-9-[(3S)-1-prop-2-enoylpiperidin-3-yl]purin-2-yl]amino]phenyl]piperazin-1-yl]octanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide",1091.59,1091.59,0,1,0,5,5,0,0,0,0,0,0,0,2D,NULL,Patents,1,NULL,20220206,AbaChemScene|ChEMBL|Enamine|MedChemexpress MCE|PATENTSCOPE (WIPO)|Probes & Drugs portal,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
162647755,PROTAC EGFR degrader 4,"PROTAC EGFR degrader 4|CHEMBL4746600|HY-146349|EN300-44832719|(2S,4R)-1-[(2S)-2-{7-[4-(4-{[9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl]amino}phenyl)piperazin-1-yl]heptanamido}-3,3-dimethylbutanoyl]-4-hydroxy-N-{[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl}pyrrolidine-2-carboxamide",995.300,C55H70N12O4S,214.000,1710.000,8.500,72,5,13,20,"InChI=1S/C55H70N12O4S/c1-37-48(72-36-58-37)39-21-19-38(20-22-39)33-56-51(70)46-32-44(68)35-66(46)52(71)49(55(2,3)4)62-47(69)18-10-5-6-13-27-64-28-30-65(31-29-64)42-25-23-41(24-26-42)59-53-57-34-45-50(63-53)67(43-16-11-12-17-43)54(61-45)60-40-14-8-7-9-15-40/h7-9,14-15,19-26,34,36,43-44,46,49,68H,5-6,10-13,16-18,27-33,35H2,1-4H3,(H,56,70)(H,60,61)(H,62,69)(H,57,59,63)/t44-,46+,49-/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCN4CCN(CC4)C5=CC=C(C=C5)NC6=NC=C7C(=N6)N(C(=N7)NC8=CC=CC=C8)C9CCCC9)O,CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)C3CC(CN3C(=O)C(C(C)(C)C)NC(=O)CCCCCCN4CCN(CC4)C5=CC=C(C=C5)NC6=NC=C7C(=N6)N(C(=N7)NC8=CC=CC=C8)C9CCCC9)O,MCPFQJKJCFMAIH-CRHSMECVSA-N,"(2S,4R)-1-[(2S)-2-[7-[4-[4-[(8-anilino-9-cyclopentylpurin-2-yl)amino]phenyl]piperazin-1-yl]heptanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",994.536,994.536,0,1,0,3,3,0,0,0,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature,3,1704923|1704924|1704925|1704926|1704928|1704930|1704931|1704932|1704933|1704934|1704935|1704936|1704937|1704938|1704939|1704940|1704943|1704945|1704947|1704950|1704951|1704952|1704954|1704955|1704956|1704957|1704958|1704959|1704960|1704961|1704962|1704964|1704967|1704968|1704969|1704971|1704973|1704974|1704975|1704976,20220315,ChEMBL|Enamine|MedChemexpress MCE|Probes & Drugs portal,Chemical Vendors|Curation Efforts|Research and Development,NULL
162678811,EGFR Protein Tyrosine Kinase Substrate,EGFR Protein Tyrosine Kinase Substrate|945830-38-6|HY-P2503|AKOS040758482|MS-31933|CS-0135047,1076.200,C48H73N11O17,468.000,2100.000,-4.500,76,14,18,33,"InChI=1S/C48H73N11O17/c1-6-24(4)39(47(74)59-19-7-8-34(59)46(73)53-28(13-16-35(50)61)41(68)54-30(48(75)76)14-17-36(51)62)58-45(72)31(20-23(2)3)56-43(70)32(21-26-9-11-27(60)12-10-26)57-42(69)29(15-18-37(63)64)52-44(71)33(22-38(65)66)55-40(67)25(5)49/h9-12,23-25,28-34,39,60H,6-8,13-22,49H2,1-5H3,(H2,50,61)(H2,51,62)(H,52,71)(H,53,73)(H,54,68)(H,55,67)(H,56,70)(H,57,69)(H,58,72)(H,63,64)(H,65,66)(H,75,76)/t24-,25-,28-,29-,30-,31-,32-,33-,34-,39-/m0/s1",CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N,CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(C)N,LQRUFPWSECMCHG-YBFBXAKBSA-N,"(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoic acid",1075.52,1075.52,0,1,0,10,10,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220324,AbaChemScene|AKos Consulting & Solutions|Key Organics/BIONET|MedChemexpress MCE|Probes & Drugs portal,Chemical Vendors|Research and Development,NULL
163196340,Egfr-IN-34,EGFR-IN-34|HY-144051|CS-0375000,491.000,C26H27ClN6O2,96.100,904.000,2.100,35,2,6,6,"InChI=1S/C26H27ClN6O2/c1-2-23(34)32-11-5-7-19(13-32)33-14-20(24-25(28)30-16-31-26(24)33)17-8-9-22(21(27)12-17)35-15-18-6-3-4-10-29-18/h2-4,6,8-10,12,14,16,19,26H,1,5,7,11,13,15,28H2,(H,30,31)/t19-,26?/m1/s1",C=CC(=O)N1CCC[C@H](C1)N2C=C(C3=C(NC=NC32)N)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl,C=CC(=O)N1CCCC(C1)N2C=C(C3=C(NC=NC32)N)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl,YFQVIDHPRPGTRQ-ICCFGIFFSA-N,"1-[(3R)-3-[4-amino-5-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3,7a-dihydropyrrolo[2,3-d]pyrimidin-7-yl]piperidin-1-yl]prop-2-en-1-one",490.188,490.188,0,1,0,2,1,1,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220428,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
163322288,Egfr-IN-46,EGFR-IN-46|HY-144794|CS-0434614,503.600,C27H32F3N3O3,55.800,654.000,5.200,36,1,9,9,"InChI=1S/C27H32F3N3O3/c1-33-12-9-20(10-13-33)31-11-4-14-36-24-16-22(18-5-7-19(8-6-18)27(28,29)30)32-23-17-26(35-3)25(34-2)15-21(23)24/h5-8,15-17,20,31H,4,9-14H2,1-3H3",CN1CCC(CC1)NCCCOC2=CC(=NC3=CC(=C(C=C32)OC)OC)C4=CC=C(C=C4)C(F)(F)F,CN1CCC(CC1)NCCCOC2=CC(=NC3=CC(=C(C=C32)OC)OC)C4=CC=C(C=C4)C(F)(F)F,GTFSJMZEXMPUJA-UHFFFAOYSA-N,"N-[3-[6,7-dimethoxy-2-[4-(trifluoromethyl)phenyl]quinolin-4-yl]oxypropyl]-1-methylpiperidin-4-amine",503.24,503.24,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,Classification,1,NULL,20220602,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
163388532,EGFR inhibitor 57,"EGFR inhibitor 57|SCHEMBL24499766|GTPL12278|GLXC-26334|2-(4-(Difluoromethyl)-6-((4-((4-(hydroxymethyl)piperidin-1-yl)methyl)phenyl)ethynyl)-7-methyl-2H-indazol-2-yl)-2-(6',7'-dihydrospiro[cyclopropane-1,5'-pyrrolo[1,2-c]imidazol]-1'-yl)-N-(thiazol-2-yl)acetamide|2-[4-(difluoromethyl)-6-[2-[4-[[4-(hydroxymethyl)piperidin-1-yl]methyl]phenyl]ethynyl]-7-methylindazol-2-yl]-2-spiro[6,7-dihydropyrrolo[1,2-c]imidazole-5,1'-cyclopropane]-1-yl-N-(1,3-thiazol-2-yl)acetamide",681.800,C37H37F2N7O2S,129.000,1250.000,5.400,49,2,9,10,"InChI=1S/C37H37F2N7O2S/c1-23-27(7-6-24-2-4-25(5-3-24)19-44-15-9-26(21-47)10-16-44)18-28(34(38)39)29-20-46(43-31(23)29)33(35(48)42-36-40-14-17-49-36)32-30-8-11-37(12-13-37)45(30)22-41-32/h2-5,14,17-18,20,22,26,33-34,47H,8-13,15-16,19,21H2,1H3,(H,40,42,48)",CC1=C(C=C(C2=CN(N=C12)C(C3=C4CCC5(N4C=N3)CC5)C(=O)NC6=NC=CS6)C(F)F)C#CC7=CC=C(C=C7)CN8CCC(CC8)CO,CC1=C(C=C(C2=CN(N=C12)C(C3=C4CCC5(N4C=N3)CC5)C(=O)NC6=NC=CS6)C(F)F)C#CC7=CC=C(C=C7)CN8CCC(CC8)CO,XGCQKFFIRIFVIZ-UHFFFAOYSA-N,"2-[4-(difluoromethyl)-6-[2-[4-[[4-(hydroxymethyl)piperidin-1-yl]methyl]phenyl]ethynyl]-7-methylindazol-2-yl]-2-spiro[6,7-dihydropyrrolo[1,2-c]imidazole-5,1'-cyclopropane]-1-yl-N-(1,3-thiazol-2-yl)acetamide",681.27,681.27,0,1,0,1,0,1,0,0,0,1,1,1,2D,NULL,Classification|Literature|Patents,4,NULL,20220623,ChEMBL|Glixx Labs Inc|IUPHAR/BPS Guide to PHARMACOLOGY|PATENTSCOPE (WIPO)|Probes & Drugs portal|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
164517099,Egfr-IN-61,EGFR-IN-61|HY-147860|CS-0529691,629.100,C33H37ClN8O3,121.000,919.000,4.300,45,3,9,13,"InChI=1S/C33H37ClN8O3/c1-40(2)15-16-41(3)29-20-30(45-4)27(19-26(29)37-32(44)22-10-12-35-31(34)18-22)39-33-36-13-11-25(38-33)24-21-42(14-7-17-43)28-9-6-5-8-23(24)28/h5-6,8-13,18-21,43H,7,14-17H2,1-4H3,(H,37,44)(H,36,38,39)",CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C2=CC(=NC=C2)Cl)NC3=NC=CC(=N3)C4=CN(C5=CC=CC=C54)CCCO)OC,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C2=CC(=NC=C2)Cl)NC3=NC=CC(=N3)C4=CN(C5=CC=CC=C54)CCCO)OC,XELFLRFPUQAHBD-UHFFFAOYSA-N,2-chloro-N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-[1-(3-hydroxypropyl)indol-3-yl]pyrimidin-2-yl]amino]-4-methoxyphenyl]pyridine-4-carboxamide,628.268,628.268,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220727,AbaChemScene|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
164517195,Egfr-IN-67,EGFR-IN-67|HY-147996|CS-0530616,307.400,C18H17N3S,73.700,445.000,3.400,22,1,2,3,"InChI=1S/C18H17N3S/c19-18(22)21-16(12-11-14-7-3-1-4-8-14)13-17(20-21)15-9-5-2-6-10-15/h1-12,16H,13H2,(H2,19,22)/b12-11+",C1C(N(N=C1C2=CC=CC=C2)C(=S)N)/C=C/C3=CC=CC=C3,C1C(N(N=C1C2=CC=CC=C2)C(=S)N)C=CC3=CC=CC=C3,DVEFZLZUDQXPCI-VAWYXSNFSA-N,"5-phenyl-3-[(E)-2-phenylethenyl]-3,4-dihydropyrazole-2-carbothioamide",307.114,307.114,0,1,0,1,0,1,1,1,0,0,0,0,2D,NULL,NULL,0,NULL,20220727,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
164886603,Egfr/her2/TS-IN-2,EGFR/HER2/TS-IN-2|NSC818054|NSC-818054|HY-146239|CS-0530325,511.600,C26H21N7OS2,163.000,817.000,5.600,36,1,8,6,"InChI=1S/C26H21N7OS2/c1-15-9-10-20-21(11-15)36-26(28-20)29-22(34)14-35-25-30-23(18-7-5-4-6-8-18)19(13-27)24(31-25)33-17(3)12-16(2)32-33/h4-12H,14H2,1-3H3,(H,28,29,34)",CC1=CC2=C(C=C1)N=C(S2)NC(=O)CSC3=NC(=C(C(=N3)N4C(=CC(=N4)C)C)C#N)C5=CC=CC=C5,CC1=CC2=C(C=C1)N=C(S2)NC(=O)CSC3=NC(=C(C(=N3)N4C(=CC(=N4)C)C)C#N)C5=CC=CC=C5,BXTQVBISDVMYCS-UHFFFAOYSA-N,"2-[5-cyano-4-(3,5-dimethylpyrazol-1-yl)-6-phenylpyrimidin-2-yl]sulfanyl-N-(6-methyl-1,3-benzothiazol-2-yl)acetamide",511.125,511.125,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,Biological Test Results,1,1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794763|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794788|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800,20220905,AbaChemScene|DTP/NCI|MedChemexpress MCE,Chemical Vendors|Governmental Organizations,NULL
164886619,Egfr-IN-63,EGFR-IN-63|HY-147967|CS-0530499,434.300,C20H12BrN5S,91.800,511.000,5.500,27,1,6,3,"InChI=1S/C20H12BrN5S/c21-13-7-8-15-14(10-13)19(25-18(23-15)12-4-3-9-22-11-12)26-20-24-16-5-1-2-6-17(16)27-20/h1-11H,(H,23,24,25,26)",C1=CC=C2C(=C1)N=C(S2)NC3=NC(=NC4=C3C=C(C=C4)Br)C5=CN=CC=C5,C1=CC=C2C(=C1)N=C(S2)NC3=NC(=NC4=C3C=C(C=C4)Br)C5=CN=CC=C5,PVDVDPIAKYSVQR-UHFFFAOYSA-N,"N-(6-bromo-2-pyridin-3-ylquinazolin-4-yl)-1,3-benzothiazol-2-amine",433,433,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220905,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
165412576,EGFR kinase inhibitor 1,EGFR kinase inhibitor 1|HY-143246|CS-0433145,521.600,C30H31N7O2,89.200,827.000,3.800,39,2,6,9,"InChI=1S/C30H31N7O2/c1-6-29(38)32-24-16-25(28(39-5)17-27(24)37-15-9-10-20(37)18-35(2)3)34-30-31-14-13-23(33-30)22-19-36(4)26-12-8-7-11-21(22)26/h6-17,19H,1,18H2,2-5H3,(H,32,38)(H,31,33,34)",CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5C=CC=C5CN(C)C)OC,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5C=CC=C5CN(C)C)OC,YIYTWDRDNVPEHZ-UHFFFAOYSA-N,N-[2-[2-[(dimethylamino)methyl]pyrrol-1-yl]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide,521.254,521.254,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20221102,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
165412708,Egfr/her2-IN-6,EGFR/HER2-IN-6|HY-151156|CS-0572406,387.500,C18H21N5O3S,122.000,513.000,1.900,27,2,7,5,"InChI=1S/C18H21N5O3S/c1-25-13-4-2-12(3-5-13)16-14(10-22-6-8-26-9-7-22)20-18-23(16)15(11-27-18)17(24)21-19/h2-5,11H,6-10,19H2,1H3,(H,21,24)",COC1=CC=C(C=C1)C2=C(N=C3N2C(=CS3)C(=O)NN)CN4CCOCC4,COC1=CC=C(C=C1)C2=C(N=C3N2C(=CS3)C(=O)NN)CN4CCOCC4,ADWBIWIWVFJDMV-UHFFFAOYSA-N,"5-(4-methoxyphenyl)-6-(morpholin-4-ylmethyl)imidazo[2,1-b][1,3]thiazole-3-carbohydrazide",387.137,387.137,0,1,0,0,0,0,0,0,0,0,0,0,NULL,NULL,NULL,0,NULL,20221102,AbaChemScene|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
165412709,Egfr/her2-IN-7,EGFR/HER2-IN-7|HY-151158|CS-0572413,355.500,C19H21N3O2S,86.100,477.000,2.200,25,1,5,4,"InChI=1S/C19H21N3O2S/c1-13-5-7-14(8-6-13)17-15(11-21-9-3-2-4-10-21)20-19-22(17)16(12-25-19)18(23)24/h5-8,12H,2-4,9-11H2,1H3,(H,23,24)",CC1=CC=C(C=C1)C2=C(N=C3N2C(=CS3)C(=O)O)CN4CCCCC4,CC1=CC=C(C=C1)C2=C(N=C3N2C(=CS3)C(=O)O)CN4CCCCC4,PGZHYLDDJOVDMW-UHFFFAOYSA-N,"5-(4-methylphenyl)-6-(piperidin-1-ylmethyl)imidazo[2,1-b][1,3]thiazole-3-carboxylic acid",355.135,355.135,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20221102,AbaChemScene|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
165413013,PROTAC PARP/EGFR ligand 1,PROTAC PARP/EGFR ligand 1|HY-141486A|CS-0613804,1020.500,C53H56ClF2N9O8,206.000,1910.000,6.000,73,4,14,24,"InChI=1S/C53H56ClF2N9O8/c1-3-25-72-32-45(61-48(66)14-6-5-11-26-73-47-30-39-43(31-46(47)71-2)58-33-59-50(39)60-35-17-19-42(56)40(54)29-35)52(69)57-20-10-4-7-15-49(67)64-21-23-65(24-22-64)53(70)38-27-34(16-18-41(38)55)28-44-36-12-8-9-13-37(36)51(68)63-62-44/h1,8-9,12-13,16-19,27,29-31,33,45H,4-7,10-11,14-15,20-26,28,32H2,2H3,(H,57,69)(H,61,66)(H,63,68)(H,58,59,60)/t45-/m0/s1",COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCCCC(=O)N[C@@H](COCC#C)C(=O)NCCCCCC(=O)N4CCN(CC4)C(=O)C5=C(C=CC(=C5)CC6=NNC(=O)C7=CC=CC=C76)F,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCCCC(=O)NC(COCC#C)C(=O)NCCCCCC(=O)N4CCN(CC4)C(=O)C5=C(C=CC(=C5)CC6=NNC(=O)C7=CC=CC=C76)F,BNDSNLWRYZUWNY-GWHBCOKCSA-N,6-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxy-N-[(2S)-1-[[6-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-6-oxohexyl]amino]-1-oxo-3-prop-2-ynoxypropan-2-yl]hexanamide,1019.39,1019.39,0,1,0,1,1,0,0,0,0,0,0,0,2D,NULL,Classification,1,NULL,20221102,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
166176964,Egfr-IN-73,EGFR-IN-73|HY-151882,405.800,C19H17ClFN3O4,74.700,508.000,3.700,28,1,8,1,"InChI=1S/C19H17ClFN3O4/c1-25-17-9-14-11-6-18(17)28-5-3-26-2-4-27-16-8-13(21)12(20)7-15(16)24-19(11)23-10-22-14/h6-10H,2-5H2,1H3,(H,22,23,24)",COC1=C2C=C3C(=C1)N=CN=C3NC4=CC(=C(C=C4OCCOCCO2)F)Cl,COC1=C2C=C3C(=C1)N=CN=C3NC4=CC(=C(C=C4OCCOCCO2)F)Cl,AUQWYJACINWNEL-UHFFFAOYSA-N,"5-chloro-6-fluoro-17-methoxy-9,12,15-trioxa-2,20,22-triazatetracyclo[14.6.2.03,8.019,23]tetracosa-1(22),3,5,7,16,18,20,23-octaene",405.089,405.089,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,Classification,1,NULL,20230103,ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
166177024,Egfr-IN-74,EGFR-IN-74|HY-151981,729.600,C32H28BrF3N6O4S,118.000,1160.000,6.300,47,1,12,9,"InChI=1S/C32H28BrF3N6O4S/c1-2-46-31(43)28-29(24-19-22(33)9-12-25(24)38-30(28)42-14-13-37-20-42)41-17-15-40(16-18-41)27-6-4-3-5-26(27)39-47(44,45)23-10-7-21(8-11-23)32(34,35)36/h3-14,19-20,39H,2,15-18H2,1H3",CCOC(=O)C1=C(C2=C(C=CC(=C2)Br)N=C1N3C=CN=C3)N4CCN(CC4)C5=CC=CC=C5NS(=O)(=O)C6=CC=C(C=C6)C(F)(F)F,CCOC(=O)C1=C(C2=C(C=CC(=C2)Br)N=C1N3C=CN=C3)N4CCN(CC4)C5=CC=CC=C5NS(=O)(=O)C6=CC=C(C=C6)C(F)(F)F,NTWIRWVNYBTFDJ-UHFFFAOYSA-N,ethyl 6-bromo-2-imidazol-1-yl-4-[4-[2-[[4-(trifluoromethyl)phenyl]sulfonylamino]phenyl]piperazin-1-yl]quinoline-3-carboxylate,728.103,728.103,0,1,0,0,0,0,0,0,0,0,0,0,NULL,NULL,Classification,1,NULL,20230103,MedChemexpress MCE,Chemical Vendors,NULL
166642395,Egfr-IN-75,EGFR-IN-75|HY-152144|CS-0635194,274.300,C10H6N6S2,160.000,314.000,1.700,18,2,8,0,"InChI=1S/C10H6N6S2/c11-8-6-4(13-1-15-8)3-5-7(18-10(3)17-6)9(12)16-2-14-5/h1-2H,(H2,11,13,15)(H2,12,14,16)",C1=NC2=C(C(=N1)N)SC3=C2C4=C(S3)C(=NC=N4)N,C1=NC2=C(C(=N1)N)SC3=C2C4=C(S3)C(=NC=N4)N,NPLLCTPDYCQUES-UHFFFAOYSA-N,"8,10-dithia-3,5,13,15-tetrazatetracyclo[7.7.0.02,7.011,16]hexadeca-1(9),2(7),3,5,11(16),12,14-heptaene-6,12-diamine",274.01,274.01,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20230316,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
86303858,Egfr-IN-1,EGFR-IN-1|CHEMBL3633152|SCHEMBL15994254|BDBM50131843|AKOS040733069|HY-19617|CS-0015974|1625677-63-5,514.600,C28H30N6O4,109.000,866.000,3.200,38,2,8,10,"InChI=1S/C28H30N6O4/c1-6-25(35)30-19-8-7-9-20(15-19)34-26(36)14-18(2)22-17-29-28(32-27(22)34)31-23-11-10-21(16-24(23)37-5)38-13-12-33(3)4/h6-11,14-17H,1,12-13H2,2-5H3,(H,30,35)(H,29,31,32)",CC1=CC(=O)N(C2=NC(=NC=C12)NC3=C(C=C(C=C3)OCCN(C)C)OC)C4=CC=CC(=C4)NC(=O)C=C,CC1=CC(=O)N(C2=NC(=NC=C12)NC3=C(C=C(C=C3)OCCN(C)C)OC)C4=CC=CC(=C4)NC(=O)C=C,RGZXAQQHXALOBL-UHFFFAOYSA-N,"N-[3-[2-[4-[2-(dimethylamino)ethoxy]-2-methoxyanilino]-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]phenyl]prop-2-enamide",514.233,514.233,0,1,0,0,0,0,0,0,0,1,5,1,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,4,1255205|1255206|1255207|1255208|1255209|1255210|1255211|1255212|1255213|1255216|1255217|1255218|1255219|1255220|1255221|1255222|1255223|1255224|1255225|1255226|1255227|1255228|1255229|1255230|1255231|1255232|1255233|1255234|1255235|1255236|1255237|1255238|1255239|1255240|1255241|1255242|1255243|1255244|1255245|1255246|1255247|1255248|1255249,20141231,AbaChemScene|AKos Consulting & Solutions|BindingDB|ChEMBL|DC Chemicals|Google Patents|IBM|Key Organics/BIONET|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|SureChEMBL|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
126649709,Mutated EGFR-IN-2,Mutated EGFR-IN-2|SCHEMBL18586074|AKOS040733792|HY-128860|CS-0101439|2050906-97-1,562.600,C29H35FN8O3,106.000,909.000,3.800,41,2,9,11,"InChI=1S/C29H35FN8O3/c1-8-27(39)32-20-16-21(25(41-7)17-23(20)36(6)14-13-35(4)5)33-28-31-12-11-26(34-28)38-22-10-9-19(30)15-24(22)37(18(2)3)29(38)40/h8-12,15-18H,1,13-14H2,2-7H3,(H,32,39)(H,31,33,34)",CC(C)N1C2=C(C=CC(=C2)F)N(C1=O)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,CC(C)N1C2=C(C=CC(=C2)F)N(C1=O)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,ZISPMWTYPDYENI-UHFFFAOYSA-N,N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-(5-fluoro-2-oxo-3-propan-2-ylbenzimidazol-1-yl)pyrimidin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide,562.282,562.282,0,1,0,0,0,0,0,0,0,0,7,1,2D+3D,NULL,Classification|Patents,2,NULL,20170422,AbaChemScene|AKos Consulting & Solutions|Google Patents|MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
138911325,EGFR mutant-IN-1,EGFR mutant-IN-1|CHEMBL4474196|BDBM50518964|AKOS040733077|HY-125841|CS-0101138,632.200,C34H39ClFN7O2,84.900,1100.000,5.100,45,1,8,6,"InChI=1S/C34H39ClFN7O2/c1-5-29(44)42-13-7-8-24(20-42)43-32-26(22(3)30(33(43)45)25-9-6-10-27(36)31(25)35)19-37-34(39-32)38-23-11-12-28(21(2)18-23)41-16-14-40(4)15-17-41/h6,9-12,18-19,24H,5,7-8,13-17,20H2,1-4H3,(H,37,38,39)/t24-/m1/s1",CCC(=O)N1CCC[C@H](C1)N2C3=NC(=NC=C3C(=C(C2=O)C4=C(C(=CC=C4)F)Cl)C)NC5=CC(=C(C=C5)N6CCN(CC6)C)C,CCC(=O)N1CCCC(C1)N2C3=NC(=NC=C3C(=C(C2=O)C4=C(C(=CC=C4)F)Cl)C)NC5=CC(=C(C=C5)N6CCN(CC6)C)C,REZLHNFSSBBSFC-XMMPIXPASA-N,"6-(2-chloro-3-fluorophenyl)-5-methyl-2-[3-methyl-4-(4-methylpiperazin-1-yl)anilino]-8-[(3R)-1-propanoylpiperidin-3-yl]pyrido[2,3-d]pyrimidin-7-one",631.284,631.284,0,1,0,1,1,0,0,0,0,1,0,0,2D+3D,NULL,Biological Test Results|Classification|Literature,3,1576795|1576796|1576797|1576798|1576799|1576800|1576801|1576802,20190902,AbaChemScene|AKos Consulting & Solutions|BindingDB|ChEMBL|DC Chemicals|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
145712397,Egfr-IN-11,EGFR-IN-11|CHEMBL4786787|2463200-44-2|BDBM50559060|AKOS040733071|MS-30336|HY-130616|CS-0109498,573.700,C29H35N9O2S,120.000,971.000,3.700,41,2,10,8,"InChI=1S/C29H35N9O2S/c1-35-15-17-36(18-16-35)23-9-7-22(8-10-23)31-28-30-19-26-27(34-28)38(29(33-26)32-21-5-3-2-4-6-21)24-13-14-37(20-24)41(39,40)25-11-12-25/h2-10,19,24-25H,11-18,20H2,1H3,(H,32,33)(H,30,31,34)/t24-/m1/s1",CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C4C(=N3)N(C(=N4)NC5=CC=CC=C5)[C@@H]6CCN(C6)S(=O)(=O)C7CC7,CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C4C(=N3)N(C(=N4)NC5=CC=CC=C5)C6CCN(C6)S(=O)(=O)C7CC7,RNEHWYIFHKBZAW-XMMPIXPASA-N,"9-[(3R)-1-cyclopropylsulfonylpyrrolidin-3-yl]-2-N-[4-(4-methylpiperazin-1-yl)phenyl]-8-N-phenylpurine-2,8-diamine",573.263,573.263,0,1,0,1,1,0,0,0,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature,3,1717440|1717441|1717442|1717443|1717444|1717445|1717446|1717447|1717448|1717449|1717450|1717451|1717452|1717453|1717454|1717455,20191231,AbaChemScene|AKos Consulting & Solutions|BindingDB|ChEMBL|Key Organics/BIONET|MedChemexpress MCE|MolPort|Probes & Drugs portal,Chemical Vendors|Curation Efforts|Research and Development,NULL
151183629,Egfr-IN-69,EGFR-IN-69|5-chloranyl-N-[5-chloranyl-2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-(1-ethylsulfonylindol-3-yl)pyrimidin-2-amine|SCHEMBL22089965|MS-31002|HY-150610|CS-0534862|2433837-65-9|7VH,658.600,C31H37Cl2N7O3S,104.000,1040.000,5.600,44,1,9,8,"InChI=1S/C31H37Cl2N7O3S/c1-4-44(41,42)40-20-23(22-7-5-6-8-27(22)40)30-25(33)19-34-31(36-30)35-26-17-24(32)28(18-29(26)43-3)39-11-9-21(10-12-39)38-15-13-37(2)14-16-38/h5-8,17-21H,4,9-16H2,1-3H3,(H,34,35,36)",CCS(=O)(=O)N1C=C(C2=CC=CC=C21)C3=NC(=NC=C3Cl)NC4=CC(=C(C=C4OC)N5CCC(CC5)N6CCN(CC6)C)Cl,CCS(=O)(=O)N1C=C(C2=CC=CC=C21)C3=NC(=NC=C3Cl)NC4=CC(=C(C=C4OC)N5CCC(CC5)N6CCN(CC6)C)Cl,NEVDBLDTOAJSBN-UHFFFAOYSA-N,5-chloro-N-[5-chloro-2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-(1-ethylsulfonylindol-3-yl)pyrimidin-2-amine,657.206,657.206,0,1,0,0,0,0,0,0,0,1,1,1,2D+3D,NULL,Literature|Patents,3,NULL,20200813,AbaChemScene|ChEMBL|Key Organics/BIONET|MedChemexpress MCE|NCBI Structure|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
156695922,Egfr-IN-22,EGFR-IN-22|HY-142679|CS-0372561,805.700,C38H47BrFN10O2P,126.000,1250.000,5.600,53,2,12,10,"InChI=1S/C38H47BrFN10O2P/c1-37(2,24-40)50-17-11-38(12-18-50)9-15-49(16-10-38)31-20-32(52-4)30(19-26(31)25-21-44-48(3)23-25)46-36-43-22-27(39)35(47-36)45-29-8-7-28-33(42-14-13-41-28)34(29)53(5,6)51/h7-8,13-14,19-23H,9-12,15-18,24H2,1-6H3,(H2,43,45,46,47)",CC(C)(CF)N1CCC2(CCN(CC2)C3=CC(=C(C=C3C4=CN(N=C4)C)NC5=NC=C(C(=N5)NC6=C(C7=NC=CN=C7C=C6)P(=O)(C)C)Br)OC)CC1,CC(C)(CF)N1CCC2(CCN(CC2)C3=CC(=C(C=C3C4=CN(N=C4)C)NC5=NC=C(C(=N5)NC6=C(C7=NC=CN=C7C=C6)P(=O)(C)C)Br)OC)CC1,FRZRMIPAYIRAHD-UHFFFAOYSA-N,"5-bromo-4-N-(5-dimethylphosphorylquinoxalin-6-yl)-2-N-[4-[3-(1-fluoro-2-methylpropan-2-yl)-3,9-diazaspiro[5.5]undecan-9-yl]-2-methoxy-5-(1-methylpyrazol-4-yl)phenyl]pyrimidine-2,4-diamine",804.279,804.279,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,Classification|Patents,2,NULL,20211110,AbaChemScene|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,NULL
156825437,Egfr-IN-29,EGFR-IN-29|SCHEMBL23759587|HY-143729,733.700,C36H46BrN8O2P,98.800,1100.000,5.900,48,2,10,9,"InChI=1S/C36H46BrN8O2P/c1-23-20-31(33(47-3)21-32(23)45-14-12-25(13-15-45)44-18-16-43(2)17-19-44)41-36-38-22-27(37)35(42-36)40-30-11-10-29-26(34(30)48(4,5)46)8-9-28(39-29)24-6-7-24/h8-11,20-22,24-25H,6-7,12-19H2,1-5H3,(H2,38,40,41,42)",CC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)C)OC)NC4=NC=C(C(=N4)NC5=C(C6=C(C=C5)N=C(C=C6)C7CC7)P(=O)(C)C)Br,CC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)C)OC)NC4=NC=C(C(=N4)NC5=C(C6=C(C=C5)N=C(C=C6)C7CC7)P(=O)(C)C)Br,DKMXEBIKMPYHST-UHFFFAOYSA-N,"5-bromo-4-N-(2-cyclopropyl-5-dimethylphosphorylquinolin-6-yl)-2-N-[2-methoxy-5-methyl-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine",732.266,732.266,0,1,0,0,0,0,0,0,0,0,1,1,2D,NULL,Patents,1,NULL,20211110,MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
162664546,Egfr-IN-51,EGFR-IN-51|CHEMBL4782320|BDBM50564478|HY-146471|CS-0499067,373.400,C21H15N3O2S,87.500,526.000,4.500,27,2,4,2,"InChI=1S/C21H15N3O2S/c27-21(22-13-9-10-18-19(11-13)26-12-25-18)24-20-14-5-1-3-7-16(14)23-17-8-4-2-6-15(17)20/h1-11H,12H2,(H2,22,23,24,27)",C1OC2=C(O1)C=C(C=C2)NC(=S)NC3=C4C=CC=CC4=NC5=CC=CC=C53,C1OC2=C(O1)C=C(C=C2)NC(=S)NC3=C4C=CC=CC4=NC5=CC=CC=C53,UXZDJRJJDCBSLW-UHFFFAOYSA-N,"1-acridin-9-yl-3-(1,3-benzodioxol-5-yl)thiourea",373.088,373.088,0,1,0,0,0,0,0,0,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature,3,1738027|1738028|1738029|1738030|1738031|1738032|1738033|1738034|1738035|1738036|1738037|1738038|1738039|1738040|1738041|1738042|1738043,20220315,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
162669709,PROTAC EGFR degrader 5,PROTAC EGFR degrader 5|CHEMBL4789790|HY-146422,1070.300,C57H72FN13O5S,245.000,1850.000,7.700,77,6,17,21,"InChI=1S/C57H72FN13O5S/c1-37-51(77-36-62-37)40-12-10-38(11-13-40)31-61-54(75)47-29-44(73)34-71(47)55(76)52(57(2,3)4)66-50(74)9-7-5-6-8-22-68-25-27-69(28-26-68)43-18-19-48(59-32-43)65-49-30-45-46(33-60-49)64-56(63-42-16-14-41(58)15-17-42)67-53(45)70-23-20-39(35-72)21-24-70/h10-19,30,32-33,36,39,44,47,52,72-73H,5-9,20-29,31,34-35H2,1-4H3,(H,61,75)(H,66,74)(H,59,60,65)(H,63,64,67)/t44-,47+,52-/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCN4CCN(CC4)C5=CN=C(C=C5)NC6=NC=C7C(=C6)C(=NC(=N7)NC8=CC=C(C=C8)F)N9CCC(CC9)CO)O,CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)C3CC(CN3C(=O)C(C(C)(C)C)NC(=O)CCCCCCN4CCN(CC4)C5=CN=C(C=C5)NC6=NC=C7C(=C6)C(=NC(=N7)NC8=CC=C(C=C8)F)N9CCC(CC9)CO)O,LCTCXOPSLJEXKE-FEDPBZRBSA-N,"(2S,4R)-1-[(2S)-2-[7-[4-[6-[[2-(4-fluoroanilino)-4-[4-(hydroxymethyl)piperidin-1-yl]pyrido[3,4-d]pyrimidin-6-yl]amino]pyridin-3-yl]piperazin-1-yl]heptanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",1069.55,1069.55,0,1,0,3,3,0,0,0,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature,3,1688909|1688910|1688911|1688912|1688913|1688914|1688915|1688917|1688918|1688919|1688920|1688922|1688923|1688924|1688925|1688926|1688927|1688928|1688929|1688930|1688931|1688932|1688933|1688934|1688935|1688936|1688937|1688938|1688939,20220315,ChEMBL|MedChemexpress MCE|Probes & Drugs portal,Chemical Vendors|Curation Efforts|Research and Development,NULL
163196258,Egfr-IN-25,EGFR-IN-25|HY-142517|CS-0372598,609.800,C34H43N9O2,128.000,944.000,4.500,45,4,9,8,"InChI=1S/C34H43N9O2/c1-41-17-19-43(20-18-41)26-10-15-42(16-11-26)25-7-5-23(6-8-25)37-34-31(32(35)44)39-30(28-3-2-4-29-27(28)9-14-36-29)33(40-34)38-24-12-21-45-22-13-24/h2-9,14,24,26,36H,10-13,15-22H2,1H3,(H2,35,44)(H2,37,38,40)",CN1CCN(CC1)C2CCN(CC2)C3=CC=C(C=C3)NC4=NC(=C(N=C4C(=O)N)C5=C6C=CNC6=CC=C5)NC7CCOCC7,CN1CCN(CC1)C2CCN(CC2)C3=CC=C(C=C3)NC4=NC(=C(N=C4C(=O)N)C5=C6C=CNC6=CC=C5)NC7CCOCC7,ZNERTSDRRJRWIJ-UHFFFAOYSA-N,6-(1H-indol-4-yl)-3-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide,609.354,609.354,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,Patents,1,NULL,20220428,AbaChemScene|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,NULL
163196269,Egfr-IN-23,EGFR-IN-23|HY-142680|CS-0372579,775.700,C36H44BrN10O3P,135.000,1150.000,4.300,51,2,12,10,"InChI=1S/C36H44BrN10O3P/c1-45-23-25(20-41-45)26-18-30(32(49-2)19-31(26)47-13-8-24(9-14-47)22-46-12-5-16-50-17-15-46)43-36-40-21-27(37)35(44-36)42-29-7-6-28-33(39-11-10-38-28)34(29)51(3,4)48/h6-7,10-11,18-21,23-24H,5,8-9,12-17,22H2,1-4H3,(H2,40,42,43,44)",CN1C=C(C=N1)C2=CC(=C(C=C2N3CCC(CC3)CN4CCCOCC4)OC)NC5=NC=C(C(=N5)NC6=C(C7=NC=CN=C7C=C6)P(=O)(C)C)Br,CN1C=C(C=N1)C2=CC(=C(C=C2N3CCC(CC3)CN4CCCOCC4)OC)NC5=NC=C(C(=N5)NC6=C(C7=NC=CN=C7C=C6)P(=O)(C)C)Br,JKILGRCOKYPKGD-UHFFFAOYSA-N,"5-bromo-4-N-(5-dimethylphosphorylquinoxalin-6-yl)-2-N-[2-methoxy-5-(1-methylpyrazol-4-yl)-4-[4-(1,4-oxazepan-4-ylmethyl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine",774.252,774.252,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220428,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
163196338,Egfr-IN-30,EGFR-IN-30|HY-144044|CS-0374978,610.500,C28H33BrN7O2P,97.200,864.000,5.100,39,2,8,7,"InChI=1S/C28H33BrN7O2P/c1-17(2)36-12-11-23-19(15-31-35(23)3)18-13-22(25(38-4)14-24(18)36)33-28-30-16-20(29)27(34-28)32-21-9-7-8-10-26(21)39(5,6)37/h7-10,13-17H,11-12H2,1-6H3,(H2,30,32,33,34)",CC(C)N1CCC2=C(C=NN2C)C3=CC(=C(C=C31)OC)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Br,CC(C)N1CCC2=C(C=NN2C)C3=CC(=C(C=C31)OC)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Br,GPRZWEDMKSTCPZ-UHFFFAOYSA-N,"5-bromo-4-N-(2-dimethylphosphorylphenyl)-2-N-(8-methoxy-3-methyl-6-propan-2-yl-4,5-dihydropyrazolo[3,4-d][1]benzazepin-9-yl)pyrimidine-2,4-diamine",609.162,609.162,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220428,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
163322317,Egfr-IN-45,EGFR-IN-45|HY-145867|CS-0434293,473.500,C28H23N7O,100.000,836.000,5.300,36,2,7,4,"InChI=1S/C28H23N7O/c1-17-23(28(36)35(34(17)2)19-13-7-4-8-14-19)31-27-22-24(20-15-9-10-16-21(20)30-27)32-26(33-25(22)29)18-11-5-3-6-12-18/h3-16H,1-2H3,(H,30,31)(H2,29,32,33)",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC3=NC4=CC=CC=C4C5=C3C(=NC(=N5)C6=CC=CC=C6)N,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC3=NC4=CC=CC=C4C5=C3C(=NC(=N5)C6=CC=CC=C6)N,MDSMFLZNYFGNHZ-UHFFFAOYSA-N,"4-[(4-amino-2-phenylpyrimido[5,4-c]quinolin-5-yl)amino]-1,5-dimethyl-2-phenylpyrazol-3-one",473.196,473.196,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220602,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
164886642,Egfr-IN-71,EGFR-IN-71|HY-150781|CS-0564171,405.620,C16H9ClIN3,37.800,410.000,4.900,21,1,3,3,"InChI=1S/C16H9ClIN3/c1-2-10-7-12(4-6-14(10)17)21-16-13-5-3-11(18)8-15(13)19-9-20-16/h1,3-9H,(H,19,20,21)",C#CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=CC(=C3)I)Cl,C#CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=CC(=C3)I)Cl,NLIGPBIDARIYKE-UHFFFAOYSA-N,N-(4-chloro-3-ethynylphenyl)-7-iodoquinazolin-4-amine,404.953,404.953,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220905,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
165412706,Egfr/her2/dhfr-IN-1,EGFR/HER2/DHFR-IN-1|HY-151154|CS-0572395,379.230,C14H11BrN4O2S,104.000,445.000,3.300,22,2,4,2,"InChI=1S/C14H11BrN4O2S/c1-8(20)17-18-13(21)12-7-22-14-16-6-11(19(12)14)9-2-4-10(15)5-3-9/h2-7H,1H3,(H,17,20)(H,18,21)",CC(=O)NNC(=O)C1=CSC2=NC=C(N12)C3=CC=C(C=C3)Br,CC(=O)NNC(=O)C1=CSC2=NC=C(N12)C3=CC=C(C=C3)Br,OJCVSCAUEKBQAE-UHFFFAOYSA-N,"N'-acetyl-5-(4-bromophenyl)imidazo[2,1-b][1,3]thiazole-3-carbohydrazide",377.979,377.979,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20221102,AbaChemScene|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
71433873,EGFR/ErbB-2/ErbB-4 Inhibitor II,"EGFR/ErbB-2/ErbB-4 Inhibitor II|944341-54-2|4-N-(3-chloro-4-phenylmethoxyphenyl)-5-(2-morpholin-4-ylethoxyiminomethyl)pyrimidine-4,6-diamine;hydrochloride|DTXSID70849569|N~4~-[4-(Benzyloxy)-3-chlorophenyl]-5-({[2-(morpholin-4-yl)ethoxy]imino}methyl)pyrimidine-4,6-diamine--hydrogen chloride (1/1)",519.400,C24H28Cl2N6O3,107.000,605.000,NULL,35,3,9,10,"InChI=1S/C24H27ClN6O3.ClH/c25-21-14-19(6-7-22(21)33-16-18-4-2-1-3-5-18)30-24-20(23(26)27-17-28-24)15-29-34-13-10-31-8-11-32-12-9-31;/h1-7,14-15,17H,8-13,16H2,(H3,26,27,28,30);1H",C1COCCN1CCON=CC2=C(N=CN=C2NC3=CC(=C(C=C3)OCC4=CC=CC=C4)Cl)N.Cl,C1COCCN1CCON=CC2=C(N=CN=C2NC3=CC(=C(C=C3)OCC4=CC=CC=C4)Cl)N.Cl,ZXKZRKQMKNRZNN-UHFFFAOYSA-N,"4-N-(3-chloro-4-phenylmethoxyphenyl)-5-(2-morpholin-4-ylethoxyiminomethyl)pyrimidine-4,6-diamine;hydrochloride",518.16,518.16,0,2,0,0,0,0,1,0,1,0,0,0,2D,NULL,NULL,0,NULL,20130522,BenchChem|Biocore|ChemTik|CymitQuimica|EPA DSSTox|MolCore BioPharmatech|RR Scientific|Smolecule|THE BioTek|Wubei-Biochem,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,NULL
118900273,Egfr/her2-IN-5,"EGFR/HER2-IN-5|SCHEMBL17538506|BDBM332544|US10196365, Compound 12|HY-147994|CS-0530614|Synthesis of (E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-7-(2-ethoxyethoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide",577.100,C30H33ClN6O4,111.000,807.000,4.100,41,2,9,14,"InChI=1S/C30H33ClN6O4/c1-4-39-14-15-40-28-18-25-23(17-26(28)36-29(38)9-7-13-37(2)3)30(34-20-33-25)35-21-10-11-27(24(31)16-21)41-19-22-8-5-6-12-32-22/h5-12,16-18,20H,4,13-15,19H2,1-3H3,(H,36,38)(H,33,34,35)/b9-7+",CCOCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)NC(=O)/C=C/CN(C)C,CCOCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)NC(=O)C=CCN(C)C,XPZGTHUXSPUGHN-VQHVLOKHSA-N,(E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-(2-ethoxyethoxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide,576.225,576.225,0,1,0,0,0,0,1,1,0,0,5,1,2D+3D,NULL,Biological Test Results|Patents,2,1796911,20160409,AbaChemScene|BindingDB|Google Patents|MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
139035057,Egfr-IN-8,"EGFR-IN-8|2407957-87-1|N-(3-Chloro-4-(5-(3-(3-(4-(cyclopropanecarboxamido)-3-(trifluoromethyl)phenyl)ureido)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)nicotinamide|N-[3-chloro-4-[5-[3-[[4-(cyclopropanecarbonylamino)-3-(trifluoromethyl)phenyl]carbamoylamino]phenyl]-1,2,4-oxadiazol-3-yl]phenyl]pyridine-3-carboxamide|starbld0000884|CHEMBL4443455|EX-A7176|AKOS040733075|AC-36780|MS-31022|HY-126320|CS-0102598",662.000,C32H23ClF3N7O4,151.000,1120.000,4.900,47,4,10,8,"InChI=1S/C32H23ClF3N7O4/c33-25-15-22(38-29(45)19-4-2-12-37-16-19)8-10-23(25)27-42-30(47-43-27)18-3-1-5-20(13-18)39-31(46)40-21-9-11-26(24(14-21)32(34,35)36)41-28(44)17-6-7-17/h1-5,8-17H,6-7H2,(H,38,45)(H,41,44)(H2,39,40,46)",C1CC1C(=O)NC2=C(C=C(C=C2)NC(=O)NC3=CC=CC(=C3)C4=NC(=NO4)C5=C(C=C(C=C5)NC(=O)C6=CN=CC=C6)Cl)C(F)(F)F,C1CC1C(=O)NC2=C(C=C(C=C2)NC(=O)NC3=CC=CC(=C3)C4=NC(=NO4)C5=C(C=C(C=C5)NC(=O)C6=CN=CC=C6)Cl)C(F)(F)F,IIUNSVLRVWGJRM-UHFFFAOYSA-N,"N-[3-chloro-4-[5-[3-[[4-(cyclopropanecarbonylamino)-3-(trifluoromethyl)phenyl]carbamoylamino]phenyl]-1,2,4-oxadiazol-3-yl]phenyl]pyridine-3-carboxamide",661.145,661.145,0,1,0,0,0,0,0,0,0,2,0,0,2D+3D,NULL,Biological Test Results|Classification|Literature,3,1548404|1548405|1565408|1565409|1565410|1565411|1565412|1565413|1565414|1565415|1565416|1565417|1565418|1565419|1565420|1565421|1565422|1565423|1565424|1565425|1565426|1565427|1565428|1565429|1565430|1565431|1565432|1565433|1565434|1565435|1565436|1565437|1565438|1565439|1565440|1565441|1565442|1565443|1565444|1565445|1565446|1565447|1565448|1565449|1565450|1565451,20190930,"A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|Ambeed|BenchChem|BLD Pharm|ChEMBL|Chemenu Inc.|CymitQuimica|DC Chemicals|Excenen Pharmatech|Hangzhou APIChem Technology|Key Organics/BIONET|MedChemexpress MCE|MolPort|Probes & Drugs portal|Shanghai Mathcon Pharmaceutical Co.,LTD.|Smolecule|Starshine Chemical",Chemical Vendors|Curation Efforts|Research and Development,NULL
146014465,Mutated EGFR-IN-3,Mutated EGFR-IN-3|CHEMBL4558528|SCHEMBL22713096|BDBM50529377|AKOS040733793|HY-130608|CS-0109436|2375107-27-8,508.600,C31H29FN4O2,48.000,778.000,5.600,38,1,6,5,"InChI=1S/C31H29FN4O2/c1-34-15-17-35(18-16-34)24-8-10-25(11-9-24)38-26-12-14-28-27(20-26)31(37)36(21-22-5-3-2-4-6-22)30-19-23(32)7-13-29(30)33-28/h2-14,19-20,33H,15-18,21H2,1H3",CN1CCN(CC1)C2=CC=C(C=C2)OC3=CC4=C(C=C3)NC5=C(C=C(C=C5)F)N(C4=O)CC6=CC=CC=C6,CN1CCN(CC1)C2=CC=C(C=C2)OC3=CC4=C(C=C3)NC5=C(C=C(C=C5)F)N(C4=O)CC6=CC=CC=C6,ZPNTXOKOIHPCLI-UHFFFAOYSA-N,"5-benzyl-3-fluoro-8-[4-(4-methylpiperazin-1-yl)phenoxy]-11H-benzo[b][1,4]benzodiazepin-6-one",508.227,508.227,0,1,0,0,0,0,0,0,0,1,3,3,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,5,1611559|1611560|1611561|1611562|1611563|1611564|1611565|1611566|1611567|1611568|1611569|1611570,20200331,AbaChemScene|AKos Consulting & Solutions|BindingDB|ChEMBL|Google Patents|MedChemexpress MCE|PATENTSCOPE (WIPO)|Probes & Drugs portal|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
163196257,Egfr-IN-24,EGFR-IN-24|SCHEMBL24171719|HY-142512|CS-0372562,546.600,C30H35FN6O3,105.000,857.000,3.000,40,2,8,7,"InChI=1S/C30H35FN6O3/c1-18-14-21(26(31)27(33-18)22-16-32-11-8-25(22)40-5)28(38)35-29-34-23-15-20(19-9-12-36(4)13-10-19)6-7-24(23)37(29)17-30(2,3)39/h6-8,11,14-16,19,39H,9-10,12-13,17H2,1-5H3,(H,34,35,38)",CC1=CC(=C(C(=N1)C2=C(C=CN=C2)OC)F)C(=O)NC3=NC4=C(N3CC(C)(C)O)C=CC(=C4)C5CCN(CC5)C,CC1=CC(=C(C(=N1)C2=C(C=CN=C2)OC)F)C(=O)NC3=NC4=C(N3CC(C)(C)O)C=CC(=C4)C5CCN(CC5)C,RBKVODXBOOCADL-UHFFFAOYSA-N,3-fluoro-N-[1-(2-hydroxy-2-methylpropyl)-5-(1-methylpiperidin-4-yl)benzimidazol-2-yl]-2-(4-methoxypyridin-3-yl)-6-methylpyridine-4-carboxamide,546.275,546.275,0,1,0,0,0,0,0,0,0,0,1,1,2D,NULL,Classification|Patents,2,NULL,20220428,AbaChemScene|MedChemexpress MCE|SureChEMBL,Chemical Vendors|Curation Efforts|Research and Development,NULL
163322305,Egfr-IN-43,EGFR-IN-43|HY-145824|CS-0434077,860.400,C50H55ClFN5O5,118.000,1310.000,11.900,62,3,10,23,"InChI=1S/C50H55ClFN5O5/c1-4-41(35-13-8-7-9-14-35)49(36-16-21-39(58)22-17-36)37-18-23-40(24-19-37)61-30-28-57(2)27-11-6-5-10-15-48(59)53-26-12-29-62-47-32-42-45(33-46(47)60-3)54-34-55-50(42)56-38-20-25-44(52)43(51)31-38/h7-9,13-14,16-25,31-34,58H,4-6,10-12,15,26-30H2,1-3H3,(H,53,59)(H,54,55,56)/b49-41-",CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)CCCCCCC(=O)NCCCOC3=C(C=C4C(=C3)C(=NC=N4)NC5=CC(=C(C=C5)F)Cl)OC)/C6=CC=CC=C6,CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCN(C)CCCCCCC(=O)NCCCOC3=C(C=C4C(=C3)C(=NC=N4)NC5=CC(=C(C=C5)F)Cl)OC)C6=CC=CC=C6,GTBNNKSMXPTINB-RJNVDUOCSA-N,N-[3-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypropyl]-7-[2-[4-[(Z)-1-(4-hydroxyphenyl)-2-phenylbut-1-enyl]phenoxy]ethyl-methylamino]heptanamide,859.388,859.388,0,1,0,0,0,0,1,1,0,0,0,0,2D,NULL,Classification,1,NULL,20220602,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
126496758,EGFR-HER2 Ex20Ins inhibitor 1a,2068806-31-3|EGFR-HER2 Ex20Ins inhibitor 1a|JBJ-03-142-02|SCHEMBL18411387|EX-A7265|AKOS040754910|(4-fluorophenyl)methyl N-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-N-[3-(prop-2-enoylamino)phenyl]carbamate,487.500,C25H22FN7O3,114.000,751.000,3.400,36,2,8,9,"InChI=1S/C25H22FN7O3/c1-3-23(34)29-19-5-4-6-21(13-19)33(25(35)36-16-17-7-9-18(26)10-8-17)22-11-12-27-24(31-22)30-20-14-28-32(2)15-20/h3-15H,1,16H2,2H3,(H,29,34)(H,27,30,31)",CN1C=C(C=N1)NC2=NC=CC(=N2)N(C3=CC=CC(=C3)NC(=O)C=C)C(=O)OCC4=CC=C(C=C4)F,CN1C=C(C=N1)NC2=NC=CC(=N2)N(C3=CC=CC(=C3)NC(=O)C=C)C(=O)OCC4=CC=C(C=C4)F,IFRXGTCPIGRGHP-UHFFFAOYSA-N,(4-fluorophenyl)methyl N-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-N-[3-(prop-2-enoylamino)phenyl]carbamate,487.177,487.177,0,1,0,0,0,0,0,0,0,0,5,1,2D+3D,NULL,Classification|Patents,2,NULL,20170422,A2B Chem|AKos Consulting & Solutions|BenchChem|CymitQuimica|DC Chemicals|Excenen Pharmatech|Google Patents|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|Starshine Chemical|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
135157094,Egfr protac,"2230821-40-4|EGFR PROTAC|SCHEMBL20305672|AKOS040755146|BP-27854|(2S,4R)-1-[(2S)-2-[[2-[2-[2-[2-[4-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",1074.700,C57H61ClFN7O9S,224.000,1780.000,8.900,76,4,15,25,"InChI=1S/C57H61ClFN7O9S/c1-36-52(76-35-63-36)40-10-8-37(9-11-40)30-60-55(69)49-29-44(67)31-66(49)56(70)53(57(2,3)4)65-51(68)33-73-23-22-71-20-21-72-24-25-74-45-16-12-39(13-17-45)41-14-18-48-46(27-41)54(62-34-61-48)64-43-15-19-50(47(58)28-43)75-32-38-6-5-7-42(59)26-38/h5-19,26-28,34-35,44,49,53,67H,20-25,29-33H2,1-4H3,(H,60,69)(H,65,68)(H,61,62,64)/t44-,49+,53-/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)COCCOCCOCCOC4=CC=C(C=C4)C5=CC6=C(C=C5)N=CN=C6NC7=CC(=C(C=C7)OCC8=CC(=CC=C8)F)Cl)O,CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)C3CC(CN3C(=O)C(C(C)(C)C)NC(=O)COCCOCCOCCOC4=CC=C(C=C4)C5=CC6=C(C=C5)N=CN=C6NC7=CC(=C(C=C7)OCC8=CC(=CC=C8)F)Cl)O,XZNORRXEBCTXPB-KHBXAZQSSA-N,"(2S,4R)-1-[(2S)-2-[[2-[2-[2-[2-[4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",1073.39,1073.39,0,1,0,3,3,0,0,0,0,0,6,1,2D,NULL,Classification|Patents,2,NULL,20181215,AKos Consulting & Solutions|BenchChem|BroadPharm|CymitQuimica|Google Patents|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
141464430,Egfr-IN-55,EGFR-IN-55|CHEMBL4793105|BDBM50561269|HY-146132|CS-0514225,526.400,C25H25Cl2N7O2,103.000,772.000,4.600,36,3,7,7,"InChI=1S/C25H25Cl2N7O2/c1-16(26)24(36)30-20-5-3-4-19(14-20)29-23-22(27)15-28-25(32-23)31-18-6-8-21(9-7-18)34-12-10-33(11-13-34)17(2)35/h3-9,14-15H,1,10-13H2,2H3,(H,30,36)(H2,28,29,31,32)",CC(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C(=C)Cl)Cl,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C(=C)Cl)Cl,IKFWHIAKKGOESN-UHFFFAOYSA-N,N-[3-[[2-[4-(4-acetylpiperazin-1-yl)anilino]-5-chloropyrimidin-4-yl]amino]phenyl]-2-chloroprop-2-enamide,525.145,525.145,0,1,0,0,0,0,0,0,0,1,0,0,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,4,1724451|1724452|1724453|1724454|1724455|1724456|1724457|1724458|1724459|1724460|1724461|1724462|1724463|1724464|1724465|1724466|1724467|1724468|1724469|1724470|1724471|1724472|1724473|1724474|1724475,20191206,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
156854006,Egfr-IN-38,EGFR-IN-38|HY-144055|CS-0375018,490.000,C25H24ClN7O2,112.000,745.000,3.000,35,1,7,6,"InChI=1S/C25H24ClN7O2/c1-2-21(34)32-11-5-6-16(13-32)22-23-24(25(27)30-15-29-23)33(31-22)18-8-9-20(19(26)12-18)35-14-17-7-3-4-10-28-17/h2-4,7-10,12,15-16H,1,5-6,11,13-14H2,(H2,27,29,30)",C=CC(=O)N1CCCC(C1)C2=NN(C3=C2N=CN=C3N)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl,C=CC(=O)N1CCCC(C1)C2=NN(C3=C2N=CN=C3N)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl,HQOCCHVXFDMXOK-UHFFFAOYSA-N,"1-[3-[7-amino-1-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]pyrazolo[4,3-d]pyrimidin-3-yl]piperidin-1-yl]prop-2-en-1-one",489.168,489.168,0,1,0,1,0,1,0,0,0,0,0,0,2D,NULL,Patents,1,NULL,20211110,AbaChemScene|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,NULL
162394926,Egfr-IN-58,EGFR-IN-58|NSC809640|NSC-809640|HY-146154,535.600,C31H30FN7O,78.300,818.000,5.200,40,2,7,7,"InChI=1S/C31H30FN7O/c1-37-13-15-38(16-14-37)27-8-5-25(6-9-27)36-31(40)28-19-33-21-34-30(28)35-26-7-10-29-23(18-26)11-12-39(29)20-22-3-2-4-24(32)17-22/h2-12,17-19,21H,13-16,20H2,1H3,(H,36,40)(H,33,34,35)",CN1CCN(CC1)C2=CC=C(C=C2)NC(=O)C3=CN=CN=C3NC4=CC5=C(C=C4)N(C=C5)CC6=CC(=CC=C6)F,CN1CCN(CC1)C2=CC=C(C=C2)NC(=O)C3=CN=CN=C3NC4=CC5=C(C=C4)N(C=C5)CC6=CC(=CC=C6)F,GOIQVBPLPBGDMO-UHFFFAOYSA-N,4-[[1-[(3-fluorophenyl)methyl]indol-5-yl]amino]-N-[4-(4-methylpiperazin-1-yl)phenyl]pyrimidine-5-carboxamide,535.25,535.25,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,Biological Test Results|Classification,2,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794763|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794788|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800,20220118,DTP/NCI|MedChemexpress MCE,Chemical Vendors|Governmental Organizations,NULL
162641006,Dual PARP EGFR ligand for PROTAC,Dual PARP EGFR ligand for PROTAC|HY-141486|CS-0173301,1020.500,C53H56ClF2N9O8,206.000,1910.000,6.000,73,4,14,24,"InChI=1S/C53H56ClF2N9O8/c1-3-25-72-32-45(61-48(66)14-6-5-11-26-73-47-30-39-43(31-46(47)71-2)58-33-59-50(39)60-35-17-19-42(56)40(54)29-35)52(69)57-20-10-4-7-15-49(67)64-21-23-65(24-22-64)53(70)38-27-34(16-18-41(38)55)28-44-36-12-8-9-13-37(36)51(68)63-62-44/h1,8-9,12-13,16-19,27,29-31,33,45H,4-7,10-11,14-15,20-26,28,32H2,2H3,(H,57,69)(H,61,66)(H,63,68)(H,58,59,60)",COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCCCC(=O)NC(COCC#C)C(=O)NCCCCCC(=O)N4CCN(CC4)C(=O)C5=C(C=CC(=C5)CC6=NNC(=O)C7=CC=CC=C76)F,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCCCC(=O)NC(COCC#C)C(=O)NCCCCCC(=O)N4CCN(CC4)C(=O)C5=C(C=CC(=C5)CC6=NNC(=O)C7=CC=CC=C76)F,BNDSNLWRYZUWNY-UHFFFAOYSA-N,6-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxy-N-[1-[[6-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-6-oxohexyl]amino]-1-oxo-3-prop-2-ynoxypropan-2-yl]hexanamide,1019.39,1019.39,0,1,0,1,0,1,0,0,0,0,0,0,2D,NULL,Classification,1,NULL,20220315,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
162642614,Egfr-IN-15,EGFR-IN-15|2573869-16-4|AKOS040757870|HY-138746|CS-0167761|F89541,509.400,C24H25BrN6O2,86.900,700.000,4.100,33,1,5,0,"InChI=1S/C24H25BrN6O2/c1-14-5-4-8-33-23-18(12-26-30(23)3)20-10-16(9-15(2)27-20)22(32)29-24-28-19-7-6-17(25)11-21(19)31(24)13-14/h6-7,9-12,14H,4-5,8,13H2,1-3H3,(H,28,29,32)/t14-/m1/s1",C[C@@H]1CCCOC2=C(C=NN2C)C3=NC(=CC(=C3)C(=O)NC4=NC5=C(N4C1)C=C(C=C5)Br)C,CC1CCCOC2=C(C=NN2C)C3=NC(=CC(=C3)C(=O)NC4=NC5=C(N4C1)C=C(C=C5)Br)C,UPMBIKXABDDVHH-CQSZACIVSA-N,"(11R)-16-bromo-5,11,26-trimethyl-7-oxa-4,5,13,20,22,27-hexazapentacyclo[22.3.1.02,6.013,21.014,19]octacosa-1(27),2(6),3,14(19),15,17,20,24(28),25-nonaen-23-one",508.122,508.122,0,1,0,1,1,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220315,"AbaChemScene|AKos Consulting & Solutions|AstaTech, Inc.|MedChemexpress MCE",Chemical Vendors,NULL
162643526,Egfr-IN-53,EGFR-IN-53|CHEMBL4776925|BDBM50564479|HY-146473|CS-0499069,287.340,C14H13N3O2S,86.600,336.000,3.200,20,3,4,3,"InChI=1S/C14H13N3O2S/c20-14(17-16-10-4-2-1-3-5-10)15-11-6-7-12-13(8-11)19-9-18-12/h1-8,16H,9H2,(H2,15,17,20)",C1OC2=C(O1)C=C(C=C2)NC(=S)NNC3=CC=CC=C3,C1OC2=C(O1)C=C(C=C2)NC(=S)NNC3=CC=CC=C3,QAPZEXCQOSDZQS-UHFFFAOYSA-N,"1-anilino-3-(1,3-benzodioxol-5-yl)thiourea",287.073,287.073,0,1,0,0,0,0,0,0,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature,3,1738027|1738028|1738029|1738030|1738031,20220315,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
162663118,Egfr-IN-50,EGFR-IN-50|CHEMBL4779194|BDBM50565141|HY-146210|CS-0459617,564.500,C24H26BrN3O4S2,133.000,621.000,5.600,34,1,9,15,"InChI=1S/C24H26BrN3O4S2/c1-3-11-33-34-12-8-23(29)32-10-5-9-31-22-15-20-19(14-21(22)30-2)24(27-16-26-20)28-18-7-4-6-17(25)13-18/h3-4,6-7,13-16H,1,5,8-12H2,2H3,(H,26,27,28)",COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br)OCCCOC(=O)CCSSCC=C,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br)OCCCOC(=O)CCSSCC=C,WISOXVRWVHHVTF-UHFFFAOYSA-N,3-[4-(3-bromoanilino)-6-methoxyquinazolin-7-yl]oxypropyl 3-(prop-2-enyldisulfanyl)propanoate,563.055,563.055,0,1,0,0,0,0,0,0,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature,3,1740135|1740136|1740137|1740138|1740139|1740140|1740141|1740143|1740144|1740145|1740146|1740147|1740148|1740149|1740150|1740151|1740152|1740153|1740154|1740155|1740156|1740157|1740158|1740159|1740160,20220315,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
162667990,PROTAC EGFR degrader 6,PROTAC EGFR degrader 6|CHEMBL4786098|HY-146423,913.100,C49H57FN12O5,201.000,1640.000,5.300,67,5,15,17,"InChI=1S/C49H57FN12O5/c50-33-10-12-34(13-11-33)53-49-55-40-29-52-43(27-37(40)46(58-49)61-21-18-32(31-63)19-22-61)56-42-16-14-35(28-51-42)60-25-23-59(24-26-60)20-5-3-1-2-4-9-44(64)54-39-8-6-7-36-38(39)30-62(48(36)67)41-15-17-45(65)57-47(41)66/h6-8,10-14,16,27-29,32,41,63H,1-5,9,15,17-26,30-31H2,(H,54,64)(H,51,52,56)(H,53,55,58)(H,57,65,66)",C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3NC(=O)CCCCCCCN4CCN(CC4)C5=CN=C(C=C5)NC6=NC=C7C(=C6)C(=NC(=N7)NC8=CC=C(C=C8)F)N9CCC(CC9)CO,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3NC(=O)CCCCCCCN4CCN(CC4)C5=CN=C(C=C5)NC6=NC=C7C(=C6)C(=NC(=N7)NC8=CC=C(C=C8)F)N9CCC(CC9)CO,ZWLPWTDAYPOQGR-UHFFFAOYSA-N,"N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]-8-[4-[6-[[2-(4-fluoroanilino)-4-[4-(hydroxymethyl)piperidin-1-yl]pyrido[3,4-d]pyrimidin-6-yl]amino]pyridin-3-yl]piperazin-1-yl]octanamide",912.456,912.456,0,1,0,1,0,1,0,0,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature|Patents,4,1688909|1688910|1688911|1688912|1688913|1688914|1688915|1688916|1688918|1688919|1688920|1688921|1688923|1688924|1688925|1688926|1688927|1688928|1688929|1688930|1688931|1688932|1688933|1688934|1688935|1688936|1688937|1688938|1688939,20220315,ChEMBL|MedChemexpress MCE|PATENTSCOPE (WIPO)|Probes & Drugs portal,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
162669174,Egfr-IN-49,EGFR-IN-49|CHEMBL4789286|BDBM50555791|HY-146782|CS-0438703,413.500,C22H15N5O2S,128.000,667.000,4.500,30,2,7,6,"InChI=1S/C22H15N5O2S/c1-2-19(28)24-16-7-4-8-17(12-16)29-21-20-18(9-10-30-20)26-22(27-21)25-15-6-3-5-14(11-15)13-23/h2-12H,1H2,(H,24,28)(H,25,26,27)",C=CC(=O)NC1=CC(=CC=C1)OC2=NC(=NC3=C2SC=C3)NC4=CC=CC(=C4)C#N,C=CC(=O)NC1=CC(=CC=C1)OC2=NC(=NC3=C2SC=C3)NC4=CC=CC(=C4)C#N,DUPFAGNYEYZTGC-UHFFFAOYSA-N,"N-[3-[2-(3-cyanoanilino)thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide",413.095,413.095,0,1,0,0,0,0,0,0,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature,3,1703381|1703382|1703383|1703384|1703385|1703386|1703387|1703388|1703389|1703390|1703391|1703392|1703393|1703394|1703395|1703396|1703397|1703398|1703399|1703400|1703401|1703406|1703407|1703408|1703409|1703410|1703411|1703412|1703413|1703414|1703415|1703416|1703417|1703418,20220315,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
163322022,Egfr-IN-48,EGFR-IN-48|SCHEMBL24780460|HY-143445|CS-0437776,800.800,C35H47BrN9O4PS,154.000,1260.000,4.200,51,2,13,12,"InChI=1S/C35H47BrN9O4PS/c1-6-24-21-29(31(49-2)22-30(24)45-13-9-25(10-14-45)44-17-15-43(16-18-44)19-20-51(5,47)48)41-35-39-23-26(36)34(42-35)40-28-8-7-27-32(38-12-11-37-27)33(28)50(3,4)46/h7-8,11-12,21-23,25H,6,9-10,13-20H2,1-5H3,(H2,39,40,41,42)",CCC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)CCS(=O)(=O)C)OC)NC4=NC=C(C(=N4)NC5=C(C6=NC=CN=C6C=C5)P(=O)(C)C)Br,CCC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)CCS(=O)(=O)C)OC)NC4=NC=C(C(=N4)NC5=C(C6=NC=CN=C6C=C5)P(=O)(C)C)Br,VFCRMLIPZXPGDA-UHFFFAOYSA-N,"5-bromo-4-N-(5-dimethylphosphorylquinoxalin-6-yl)-2-N-[5-ethyl-2-methoxy-4-[4-[4-(2-methylsulfonylethyl)piperazin-1-yl]piperidin-1-yl]phenyl]pyrimidine-2,4-diamine",799.239,799.239,0,1,0,0,0,0,0,0,0,0,1,1,2D,NULL,Patents,1,NULL,20220602,AbaChemScene|ChEMBL|MedChemexpress MCE|SureChEMBL,Chemical Vendors|Curation Efforts|Research and Development,NULL
163408862,Egfr-IN-57,EGFR-IN-57|HY-146138|CS-0514466,385.400,C22H15N3O2S,92.800,657.000,5.700,28,1,5,2,"InChI=1S/C22H15N3O2S/c1-13-10-20(25-27-13)23-22-24-21(26)19(28-22)12-18-16-8-4-2-6-14(16)11-15-7-3-5-9-17(15)18/h2-12H,1H3,(H,23,24,25,26)/b19-12-",CC1=CC(=NO1)N=C2NC(=O)/C(=C/C3=C4C=CC=CC4=CC5=CC=CC=C53)/S2,CC1=CC(=NO1)N=C2NC(=O)C(=CC3=C4C=CC=CC4=CC5=CC=CC=C53)S2,BEJMCFWWVSSWOF-UNOMPAQXSA-N,"(5Z)-5-(anthracen-9-ylmethylidene)-2-[(5-methyl-1,2-oxazol-3-yl)imino]-1,3-thiazolidin-4-one",385.088,385.088,0,1,0,0,0,0,1,1,0,0,0,0,2D,NULL,NULL,0,NULL,20220630,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
163409086,Egfr-IN-44,EGFR-IN-44|HY-145844|CS-0434192,537.100,C27H29ClN6O2S,111.000,762.000,5.300,37,2,8,10,"InChI=1S/C27H29ClN6O2S/c1-6-25(35)30-20-13-21(23(36-5)14-22(20)34(4)12-11-33(2)3)31-27-29-15-19(28)26(32-27)18-16-37-24-10-8-7-9-17(18)24/h6-10,13-16H,1,11-12H2,2-5H3,(H,30,35)(H,29,31,32)",CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=C(C(=N2)C3=CSC4=CC=CC=C43)Cl)OC,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=C(C(=N2)C3=CSC4=CC=CC=C43)Cl)OC,NQHAPTCMWDMAIX-UHFFFAOYSA-N,N-[5-[[4-(1-benzothiophen-3-yl)-5-chloropyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide,536.176,536.176,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220630,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
164517102,Egfr-IN-62,EGFR-IN-62|HY-147862|CS-0529702,551.600,C30H33N9O2,113.000,834.000,3.400,41,2,9,10,"InChI=1S/C30H33N9O2/c1-37(2)14-15-38(3)27-17-28(41-5)25(16-24(27)34-29(40)23-10-12-31-19-33-23)36-30-32-13-11-22(35-30)21-18-39(4)26-9-7-6-8-20(21)26/h6-13,16-19H,14-15H2,1-5H3,(H,34,40)(H,32,35,36)",CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C5=NC=NC=C5)N(C)CCN(C)C)OC,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C5=NC=NC=C5)N(C)CCN(C)C)OC,YISSGLCFSAVMBW-UHFFFAOYSA-N,N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]pyrimidine-4-carboxamide,551.276,551.276,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220727,AbaChemScene|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
36982442,Egfr/her2/cdk9-IN-2,EGFR/HER2/CDK9-IN-2|NSC798947|NSC-798947|HY-147797,496.600,C23H20N4O5S2,172.000,869.000,3.700,34,1,8,7,"InChI=1S/C23H20N4O5S2/c24-34(31,32)19-11-7-16(8-12-19)13-14-26-22(28)20-3-1-2-4-21(20)25-23(26)33-15-17-5-9-18(10-6-17)27(29)30/h1-12H,13-15H2,(H2,24,31,32)",C1=CC=C2C(=C1)C(=O)N(C(=N2)SCC3=CC=C(C=C3)[N+](=O)[O-])CCC4=CC=C(C=C4)S(=O)(=O)N,C1=CC=C2C(=C1)C(=O)N(C(=N2)SCC3=CC=C(C=C3)[N+](=O)[O-])CCC4=CC=C(C=C4)S(=O)(=O)N,WQEFYEUNVFDIII-UHFFFAOYSA-N,4-[2-[2-[(4-nitrophenyl)methylsulfanyl]-4-oxoquinazolin-3-yl]ethyl]benzenesulfonamide,496.088,496.088,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,Biological Test Results,1,1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794763|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794788|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800,20090529,ChEMBL|DTP/NCI|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
46212970,Egfr-IN-9,"EGFR-IN-9|CHEMBL1172843|1226549-39-8|SCHEMBL3318183|BDBM50322822|AKOS040733076|HY-18213|MS-28840|CS-0007283|(S)-N-(3-(4-(2-hydroxy-1-phenylethylamino)-6-phenylfuro[2,3-d]pyrimidin-5-yl)phenyl)acrylamide",476.500,C29H24N4O3,100.000,723.000,5.200,36,3,6,8,"InChI=1S/C29H24N4O3/c1-2-24(35)32-22-15-9-14-21(16-22)25-26-28(33-23(17-34)19-10-5-3-6-11-19)30-18-31-29(26)36-27(25)20-12-7-4-8-13-20/h2-16,18,23,34H,1,17H2,(H,32,35)(H,30,31,33)/t23-/m1/s1",C=CC(=O)NC1=CC=CC(=C1)C2=C(OC3=NC=NC(=C23)N[C@H](CO)C4=CC=CC=C4)C5=CC=CC=C5,C=CC(=O)NC1=CC=CC(=C1)C2=C(OC3=NC=NC(=C23)NC(CO)C4=CC=CC=C4)C5=CC=CC=C5,GFTOODFOXIDLNF-HSZRJFAPSA-N,"N-[3-[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]-6-phenylfuro[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",476.185,476.185,0,1,0,1,1,0,0,0,0,2,5,2,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,4,492109|492110|492111|1616555|1616556|1616557|1616558|1616605|1616606|1616607|1616608|1616609|1616611|1616613|1616615|1616617,20100706,"AbaChemScene|AKos Consulting & Solutions|BindingDB|ChEMBL|Collaborative Drug Discovery, Inc.|DiscoveryGate|Google Patents|IBM|Key Organics/BIONET|MedChemexpress MCE|PATENTSCOPE (WIPO)|Probes & Drugs portal|SCRIPDB|SureChEMBL|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
118900298,Egfr/her2-IN-4,"EGFR/HER2-IN-4|CHEMBL4473875|SCHEMBL17538538|US10196365, Compound 4|BDBM332539|HY-147992|CS-0530613|Synthesis of (E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-ethoxyethoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide",488.000,C24H27ClFN5O3,88.600,658.000,3.800,34,2,8,11,"InChI=1S/C24H27ClFN5O3/c1-4-33-10-11-34-22-14-20-17(13-21(22)30-23(32)6-5-9-31(2)3)24(28-15-27-20)29-16-7-8-19(26)18(25)12-16/h5-8,12-15H,4,9-11H2,1-3H3,(H,30,32)(H,27,28,29)/b6-5+",CCOCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN(C)C,CCOCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN(C)C,DBDXRFYGZAEXEW-AATRIKPKSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(2-ethoxyethoxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide,487.179,487.179,0,1,0,0,0,0,1,1,0,1,5,1,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,4,1535500|1535501|1535502|1535503|1535504|1535505|1535506|1535507|1535508|1535509|1535510|1535512|1535513|1535514|1535516|1535517|1535518|1796911,20160409,AbaChemScene|BindingDB|ChEMBL|Google Patents|MedChemexpress MCE|PATENTSCOPE (WIPO)|Probes & Drugs portal|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
127264586,Chmfl-egfr-202,CHMFL-EGFR-202|CHEMBL4068839|SCHEMBL19095672|HY-101522|CS-0021625,490.000,C25H24ClN7O2,112.000,745.000,3.100,35,1,7,6,"InChI=1S/C25H24ClN7O2/c1-2-21(34)32-11-5-7-18(13-32)33-25-22(24(27)29-15-30-25)23(31-33)16-8-9-20(19(26)12-16)35-14-17-6-3-4-10-28-17/h2-4,6,8-10,12,15,18H,1,5,7,11,13-14H2,(H2,27,29,30)/t18-/m1/s1",C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl)N,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl)N,RVCKMZIQUFKZFD-GOSISDBHSA-N,"1-[(3R)-3-[4-amino-3-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one",489.168,489.168,0,1,0,1,1,0,0,0,0,1,42,10,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,4,1481308|1481309|1481310|1481311|1481312|1481313|1481314|1481315|1481316|1481317|1481318|1481319|1481320|1481321|1481322|1481323|1481324|1481325|1481326|1481327|1481328|1481329|1481330|1481331|1481332|1481333|1481334|1481335|1481336|1481337|1481338|1481339|1481340|1481341|1481342|1481343|1481344|1481345|1481346|1481347|1481348|1481349|1481350|1481351|1481352|1481353|1481354|1481355|1481356|1481357|1481358|1481359|1481360|1481361|1481362|1481363|1481364|1481365|1481366|1481367|1481368|1481373|1481374|1481375|1481376|1481377|1481378|1481379|1481380|1481381|1481382|1481383|1481384|1481385|1481386|1481387|1481388|1481389|1481390|1481391|1481392|1481393|1481394|1481395|1481396|1481397|1481398|1481399|1481400|1481401|1481402|1481403|1481404|1481405|1481406|1481407|1481408|1481409|1481410|1481411|1481412|1481413|1481414|1481415|1481416|1481417|1481418|1481419|1481420|1481421|1481422|1481423|1481424|1481425|1481426|1481427|1481428|1481429|1481430|1481431|1481432|1481433|1481434|1481435|1481436,20170618,AbaChemScene|ChEMBL|Google Patents|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
163321914,Egfr/braf-IN-1,EGFR/BRAF-IN-1|HY-115933|CS-0433857,482.000,C26H28ClN3O4,64.000,725.000,3.800,34,0,5,7,"InChI=1S/C26H28ClN3O4/c1-2-33-17-22-21-15-19(27)5-8-23(21)30-24(31)16-29(26(32)25(22)30)10-9-18-3-6-20(7-4-18)28-11-13-34-14-12-28/h3-8,15H,2,9-14,16-17H2,1H3",CCOCC1=C2C(=O)N(CC(=O)N2C3=C1C=C(C=C3)Cl)CCC4=CC=C(C=C4)N5CCOCC5,CCOCC1=C2C(=O)N(CC(=O)N2C3=C1C=C(C=C3)Cl)CCC4=CC=C(C=C4)N5CCOCC5,UFZGYOVIIUOGHF-UHFFFAOYSA-N,"8-chloro-10-(ethoxymethyl)-2-[2-(4-morpholin-4-ylphenyl)ethyl]-3H-pyrazino[1,2-a]indole-1,4-dione",481.177,481.177,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220602,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
164517098,PROTAC EGFR degrader 7,PROTAC EGFR degrader 7|HY-147858|CS-0529684,836.900,C46H48N10O6,183.000,1670.000,3.300,62,4,11,17,"InChI=1S/C46H48N10O6/c1-6-21-55(22-11-16-42(58)48-33-14-10-13-30-32(33)28-56(45(30)61)38-17-18-43(59)52-44(38)60)24-23-53(3)39-26-40(62-5)36(25-35(39)49-41(57)7-2)51-46-47-20-19-34(50-46)31-27-54(4)37-15-9-8-12-29(31)37/h1,7-10,12-15,19-20,25-27,38H,2,11,16-18,21-24,28H2,3-5H3,(H,48,58)(H,49,57)(H,47,50,51)(H,52,59,60)",CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(CCCC(=O)NC5=CC=CC6=C5CN(C6=O)C7CCC(=O)NC7=O)CC#C)OC,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(CCCC(=O)NC5=CC=CC6=C5CN(C6=O)C7CCC(=O)NC7=O)CC#C)OC,MTMBWVDGSVDKJC-UHFFFAOYSA-N,"N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]-4-[2-[5-methoxy-N-methyl-4-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-2-(prop-2-enoylamino)anilino]ethyl-prop-2-ynylamino]butanamide",836.376,836.376,0,1,0,1,0,1,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220727,AbaChemScene|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
164517194,Egfr-IN-64,EGFR-IN-64|HY-147995|CS-0530615,351.400,C20H21N3O3,77.200,532.000,2.500,26,1,4,5,"InChI=1S/C20H21N3O3/c1-25-17-9-4-14(5-10-17)3-8-16-13-19(23(22-16)20(21)24)15-6-11-18(26-2)12-7-15/h3-12,19H,13H2,1-2H3,(H2,21,24)/b8-3+",COC1=CC=C(C=C1)/C=C/C2=NN(C(C2)C3=CC=C(C=C3)OC)C(=O)N,COC1=CC=C(C=C1)C=CC2=NN(C(C2)C3=CC=C(C=C3)OC)C(=O)N,SFPKMOYGYUJLBH-FPYGCLRLSA-N,"3-(4-methoxyphenyl)-5-[(E)-2-(4-methoxyphenyl)ethenyl]-3,4-dihydropyrazole-2-carboxamide",351.158,351.158,0,1,0,1,0,1,1,1,0,0,0,0,2D,NULL,NULL,0,NULL,20220727,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
164886602,Egfr/her2/TS-IN-1,EGFR/HER2/TS-IN-1|NSC818063|NSC-818063|HY-146238|CS-0530323,501.500,C24H15N5O4S2,187.000,1080.000,3.500,35,2,9,5,"InChI=1S/C24H15N5O4S2/c1-12-6-7-16-18(8-12)35-24(26-16)27-19(30)11-34-23-28-20(14(9-25)22(32)29-23)15-10-33-17-5-3-2-4-13(17)21(15)31/h2-8,10H,11H2,1H3,(H,26,27,30)(H,28,29,32)",CC1=CC2=C(C=C1)N=C(S2)NC(=O)CSC3=NC(=C(C(=O)N3)C#N)C4=COC5=CC=CC=C5C4=O,CC1=CC2=C(C=C1)N=C(S2)NC(=O)CSC3=NC(=C(C(=O)N3)C#N)C4=COC5=CC=CC=C5C4=O,KVHGAEBTDZLAAL-UHFFFAOYSA-N,"2-[[5-cyano-6-oxo-4-(4-oxochromen-3-yl)-1H-pyrimidin-2-yl]sulfanyl]-N-(6-methyl-1,3-benzothiazol-2-yl)acetamide",501.057,501.057,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,Biological Test Results,1,1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794763|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794777|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794788|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800,20220905,AbaChemScene|DTP/NCI|MedChemexpress MCE,Chemical Vendors|Governmental Organizations,NULL
164887498,Egfr-IN-70,EGFR-IN-70|CS-0534865,626.200,C31H36ClN5O5S,116.000,1000.000,5.700,43,1,9,3,"InChI=1S/C31H36ClN5O5S/c1-3-43(38,39)37-20-24-23-9-8-22(17-27(23)37)41-12-6-4-5-7-13-42-29-18-26(34-31-33-19-25(32)30(24)35-31)21(2)16-28(29)36-10-14-40-15-11-36/h8-9,16-20H,3-7,10-15H2,1-2H3,(H,33,34,35)",CCS(=O)(=O)N1C=C2C3=C1C=C(C=C3)OCCCCCCOC4=C(C=C(C(=C4)NC5=NC=C(C2=N5)Cl)C)N6CCOCC6,CCS(=O)(=O)N1C=C2C3=C1C=C(C=C3)OCCCCCCOC4=C(C=C(C(=C4)NC5=NC=C(C2=N5)Cl)C)N6CCOCC6,SOZJLUNPQMFFFL-UHFFFAOYSA-N,"27-chloro-4-ethylsulfonyl-21-methyl-19-morpholin-4-yl-10,17-dioxa-4,23,25,28-tetrazapentacyclo[22.3.1.15,9.118,22.02,6]triaconta-1(28),2,5,7,9(30),18,20,22(29),24,26-decaene",625.213,625.213,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20220905,AbaChemScene|ChEMBL|Probes & Drugs portal,Chemical Vendors|Curation Efforts|Research and Development,NULL
139448024,Egfr-IN-26,"EGFR-IN-26|SCHEMBL21311299|BDBM525443|HY-142518|CS-0372605|US11174245, # I-028",514.600,C29H34N6O3,105.000,790.000,2.500,38,2,7,7,"InChI=1S/C29H34N6O3/c1-29(2,37)18-35-25-6-5-20(19-9-13-34(3)14-10-19)15-24(25)32-28(35)33-27(36)21-7-12-31-23(16-21)22-17-30-11-8-26(22)38-4/h5-8,11-12,15-17,19,37H,9-10,13-14,18H2,1-4H3,(H,32,33,36)",CC(C)(CN1C2=C(C=C(C=C2)C3CCN(CC3)C)N=C1NC(=O)C4=CC(=NC=C4)C5=C(C=CN=C5)OC)O,CC(C)(CN1C2=C(C=C(C=C2)C3CCN(CC3)C)N=C1NC(=O)C4=CC(=NC=C4)C5=C(C=CN=C5)OC)O,CZLZIJCQAQKFQQ-UHFFFAOYSA-N,N-[1-(2-hydroxy-2-methylpropyl)-5-(1-methylpiperidin-4-yl)benzimidazol-2-yl]-2-(4-methoxypyridin-3-yl)pyridine-4-carboxamide,514.269,514.269,0,1,0,0,0,0,0,0,0,0,3,1,2D+3D,NULL,Biological Test Results|Patents,2,1806100,20191102,AbaChemScene|BindingDB|Google Patents|MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
156853992,Egfr-IN-33,EGFR-IN-33|HY-144050|CS-0374995,489.000,C26H25ClN6O2,99.200,743.000,3.400,35,1,6,6,"InChI=1S/C26H25ClN6O2/c1-2-23(34)32-11-5-6-17(13-32)20-14-33(25-24(20)30-16-31-26(25)28)19-8-9-22(21(27)12-19)35-15-18-7-3-4-10-29-18/h2-4,7-10,12,14,16-17H,1,5-6,11,13,15H2,(H2,28,30,31)",C=CC(=O)N1CCCC(C1)C2=CN(C3=C2N=CN=C3N)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl,C=CC(=O)N1CCCC(C1)C2=CN(C3=C2N=CN=C3N)C4=CC(=C(C=C4)OCC5=CC=CC=N5)Cl,STUXODUGAYCQRS-UHFFFAOYSA-N,"1-[3-[4-amino-5-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]pyrrolo[3,2-d]pyrimidin-7-yl]piperidin-1-yl]prop-2-en-1-one",488.173,488.173,0,1,0,1,0,1,0,0,0,0,0,0,2D,NULL,Patents,1,NULL,20211110,AbaChemScene|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,NULL
156854008,Egfr-IN-39,EGFR-IN-39|HY-144056|CS-0375019,480.900,C24H25ClN6O3,129.000,742.000,2.700,34,2,6,7,"InChI=1S/C24H25ClN6O3/c1-2-20(32)30-11-5-6-15(13-30)22-21(26)23(24(27)33)31(29-22)17-8-9-19(18(25)12-17)34-14-16-7-3-4-10-28-16/h2-4,7-10,12,15H,1,5-6,11,13-14,26H2,(H2,27,33)",C=CC(=O)N1CCCC(C1)C2=NN(C(=C2N)C(=O)N)C3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl,C=CC(=O)N1CCCC(C1)C2=NN(C(=C2N)C(=O)N)C3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl,KYCDFGPPAQMRQO-UHFFFAOYSA-N,4-amino-2-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-5-(1-prop-2-enoylpiperidin-3-yl)pyrazole-3-carboxamide,480.168,480.168,0,1,0,1,0,1,0,0,0,0,0,0,2D,NULL,Patents,1,NULL,20211110,AbaChemScene|MedChemexpress MCE|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,NULL
162640600,Egfr-IN-17,EGFR-IN-17|CHEMBL5087264|BDBM50580190|HY-115716|CS-0254060,568.000,C27H31ClN7O3P,106.000,833.000,3.800,39,2,9,8,"InChI=1S/C27H31ClN7O3P/c1-34-17-18(15-30-34)19-13-22(24(37-2)14-23(19)35-9-11-38-12-10-35)32-27-29-16-20(28)26(33-27)31-21-7-5-6-8-25(21)39(3,4)36/h5-8,13-17H,9-12H2,1-4H3,(H2,29,31,32,33)",CN1C=C(C=N1)C2=CC(=C(C=C2N3CCOCC3)OC)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl,CN1C=C(C=N1)C2=CC(=C(C=C2N3CCOCC3)OC)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl,LLUHSVVGRQBIMO-UHFFFAOYSA-N,"5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-5-(1-methylpyrazol-4-yl)-4-morpholin-4-ylphenyl]pyrimidine-2,4-diamine",567.191,567.191,0,1,0,0,0,0,0,0,0,1,0,0,2D,NULL,Biological Test Results|Literature,2,1809460|1809461|1809462|1809463|1809464|1809465|1809466|1809467|1809468|1809469|1809470|1809471|1809474|1809475|1809476|1809477|1809478|1809479|1809480|1809481|1809482|1809483,20220314,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE|Probes & Drugs portal,Chemical Vendors|Curation Efforts|Research and Development,NULL
162677080,Egfr-IN-54,EGFR-IN-54|CHEMBL4799700|BDBM50564475|HY-146474|CS-0499070,434.500,C17H14N4O4S3,170.000,651.000,1.700,28,3,8,5,"InChI=1S/C17H14N4O4S3/c22-28(23,21-17-18-7-8-27-17)13-4-1-11(2-5-13)19-16(26)20-12-3-6-14-15(9-12)25-10-24-14/h1-9H,10H2,(H,18,21)(H2,19,20,26)",C1OC2=C(O1)C=C(C=C2)NC(=S)NC3=CC=C(C=C3)S(=O)(=O)NC4=NC=CS4,C1OC2=C(O1)C=C(C=C2)NC(=S)NC3=CC=C(C=C3)S(=O)(=O)NC4=NC=CS4,AKJZGCUHFBZJNV-UHFFFAOYSA-N,"1-(1,3-benzodioxol-5-yl)-3-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]thiourea",434.018,434.018,0,1,0,0,0,0,0,0,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature,3,1738027|1738028|1738029|1738030|1738031,20220315,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
163196376,PROTAC EGFR degrader 2,PROTAC EGFR degrader 2|CHEMBL5085885|HY-144304|CS-0379269,1151.800,C58H72ClFN12O8S,268.000,1990.000,7.000,81,5,17,28,"InChI=1S/C58H72ClFN12O8S/c1-38-53(81-37-64-38)40-16-14-39(15-17-40)32-61-56(76)49-29-43(73)34-72(49)57(77)54(58(2,3)4)67-52(75)35-79-27-26-78-25-23-71-33-42(68-69-71)12-7-5-10-24-80-50-31-47-44(55(63-36-62-47)65-41-18-19-46(60)45(59)28-41)30-48(50)66-51(74)13-11-22-70-20-8-6-9-21-70/h11,13-19,28,30-31,33,36-37,43,49,54,73H,5-10,12,20-27,29,32,34-35H2,1-4H3,(H,61,76)(H,66,74)(H,67,75)(H,62,63,65)/b13-11+/t43-,49+,54-/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)COCCOCCN4C=C(N=N4)CCCCCOC5=C(C=C6C(=C5)N=CN=C6NC7=CC(=C(C=C7)F)Cl)NC(=O)/C=C/CN8CCCCC8)O,CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)C3CC(CN3C(=O)C(C(C)(C)C)NC(=O)COCCOCCN4C=C(N=N4)CCCCCOC5=C(C=C6C(=C5)N=CN=C6NC7=CC(=C(C=C7)F)Cl)NC(=O)C=CCN8CCCCC8)O,PXQHEFZTJMGFAP-QLJGRUAOSA-N,"(2S,4R)-1-[(2S)-2-[[2-[2-[2-[4-[5-[4-(3-chloro-4-fluoroanilino)-6-[[(E)-4-piperidin-1-ylbut-2-enoyl]amino]quinazolin-7-yl]oxypentyl]triazol-1-yl]ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide",1150.5,1150.5,0,1,0,3,3,0,1,1,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature,3,1825946|1825947|1825948|1825949|1825969,20220428,AbaChemScene|ChEMBL|MedChemexpress MCE|Probes & Drugs portal,Chemical Vendors|Curation Efforts|Research and Development,NULL
164517080,Egfr-IN-60,EGFR-IN-60|HY-147826,535.500,C28H28Cl2N6O,84.200,1070.000,5.300,37,2,6,4,"InChI=1S/C28H28Cl2N6O/c1-28(2)12-20-23(21(37)13-28)22(18-6-5-7-19(29)25(18)30)24-26(31)36(15-32-27(24)34-20)33-14-16-8-10-17(11-9-16)35(3)4/h5-11,14-15,22,31,34H,12-13H2,1-4H3/b31-26?,33-14+",CC1(CC2=C(C(C3=C(N2)N=CN(C3=N)/N=C/C4=CC=C(C=C4)N(C)C)C5=C(C(=CC=C5)Cl)Cl)C(=O)C1)C,CC1(CC2=C(C(C3=C(N2)N=CN(C3=N)N=CC4=CC=C(C=C4)N(C)C)C5=C(C(=CC=C5)Cl)Cl)C(=O)C1)C,HFGBVNJPTHYXRL-ZSBAPAOWSA-N,"5-(2,3-dichlorophenyl)-3-[(E)-[4-(dimethylamino)phenyl]methylideneamino]-4-imino-8,8-dimethyl-5,7,9,10-tetrahydropyrimido[4,5-b]quinolin-6-one",534.17,534.17,0,1,0,1,0,1,1,1,0,0,0,0,NULL,NULL,NULL,0,NULL,20220727,MedChemexpress MCE,Chemical Vendors,NULL
6711154,"5,6-Bis[(4-fluorophenyl)amino]-1H-isoindole-1,3(2H)-dione","145915-60-2|CGP-53353|CGP 53353|DAPH-7|CGP53353|5,6-BIS[(4-FLUOROPHENYL)AMINO]-1H-ISOINDOLE-1,3(2H)-DIONE|DAPH 7|CHEMBL7939|5,6-Bis((4-fluorophenyl)amino)isoindoline-1,3-dione|5,6-bis(4-fluoroanilino)isoindole-1,3-dione|1H-Isoindole-1,3(2H)-dione, 5,6-bis[(4-fluorophenyl)amino]-|4,5-Bis(4-fluoroanilino)phthalimide|4,5-Bis[4-fluoroanilino]phthalimide|1H-Isoindole-1,3(2H)-dione, 5,6-bis((4-fluorophenyl)amino)-|PKCbII/EGFR Inhibitor|CGP-53353, solid|D0HO1S|DAPH-2|MolMap_000016|SCHEMBL230492|GTPL5163|CHEBI:92560|HMS3229K07|HMS3269E05|HMS3413M18|HMS3677M18|BDBM50040930|AKOS015911570|CCG-206784|SB65936|NCGC00159569-01|NCGC00159569-02|NCGC00159569-04|MS-25827|HY-108600|CS-0029281|FT-0643387|5,6-bis(4-fluorophenylamino)isoindoline-1,3-dione|J-008169|PKCbetaII/EGFR Inhibitor - CAS 145915-60-2|5,6-Bis-(4-fluoro-phenylamino)-isoindole-1,3-dione|BRD-K32292990-001-01-0|Q27075911|1H-Isoindole-1,3(2H)-dione,5,6-bis[(4-fluorophenyl)amino]-|5,6-Bis[(4-fluorophenyl)amino]-2H-isoindole-1,3-dione;DAPH 2|5,6-bis[(4-fluorophenyl)amino]-2,3-dihydro-1H-isoindole-1,3-dione",365.300,C20H13F2N3O2,70.200,511.000,4.000,27,3,6,4,"InChI=1S/C20H13F2N3O2/c21-11-1-5-13(6-2-11)23-17-9-15-16(20(27)25-19(15)26)10-18(17)24-14-7-3-12(22)4-8-14/h1-10,23-24H,(H,25,26,27)",C1=CC(=CC=C1NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=C(C=C4)F)F,C1=CC(=CC=C1NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=C(C=C4)F)F,RONQPWQYDRPRGG-UHFFFAOYSA-N,"5,6-bis(4-fluoroanilino)isoindole-1,3-dione",365.098,365.098,0,1,0,0,0,0,0,0,0,55,2079,335,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents|Pharmacology and Biochemistry,6,880|881|894|1030|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|3353|7901|69403|70056|155691|155709|219660|228852|485281|485290|504327|504332|504847|588579|602332|624101|624136|624137|624138|624139|624141|624151|624260|624349|651548|651828|683924|683929|720017|720018|720019|720020|720021|720022|720023|720024|720025|720026|720027|720028|720029|720030|720031|720032|720033|720034|720035|720036|720037|720038|720039|720040|720041|720042|720043|720044|720045|720046|720047|720048|720049|720050|720051|720052|720053|720054|720055|720056|720057|720058|720059|720060|720061|720062|720063|720064|720065|720066|720067|720068|720069|720070|720071|720072|720073|720074|720075|720076|720077|720078|720079|720080|720081|720082|720083|720084|720085|720086|720087|720088|720089|720090|720091|720092|720093|720094|720095|720096|720097|720098|720099|720100|720101|720102|720103|720104|720105|720106|720107|720108|720109|720110|720111|720112|720113|720114|720115|720116|720117|720118|720119|720120|720121|720122|720123|720124|720125|720126|720127|720128|720129|720130|720131|720132|720133|720134|720135|720136|720137|720138|720139|720140|720141|720142|720143|720144|720145|720146|720147|720148|720149|720150|720151|720152|720153|720154|720155|720156|720157|720158|720159|720160|720161|720162|720163|720164|720165|720166|720167|720168|720169|720170|720171|720172|720173|720174|720175|720176|720177|720178|720179|720180|720181|720182|720183|720184|720185|720186|720187|720188|720189|720190|720191|720192|720193|720194|720195|720196|720197|720198|720199|720200|720201|720202|720203|720204|720205|720206|720207|720208|720209|720210|720211|720212|720213|720214|720215|720216|720217|720218|720219|720220|720221|720222|720223|720224|720225|720226|720227|720228|720229|720230|720231|720232|720233|720234|720235|720236|720237|720238|720239|720240|720241|720242|720243|720244|720245|720246|720247|720248|720249|720250|720251|720252|720253|720254|720255|720256|720257|720258|720259|720260|720261|720262|720263|720264|720265|720266|720267|720268|720269|720270|720271|720272|720273|720274|720275|720276|720277|720278|720279|720280|720281|720282|720283|720284|720285|720286|720287|720288|720289|720290|720291|720292|720293|720294|720295|720296|720297|720298|720299|720300|720301|720302|720303|720304|720305|720306|720307|720308|720309|720310|720311|720312|720313|720314|720315|720316|720317|720318|720319|720320|720321|720322|720323|720324|720325|720326|720327|720328|720329|720330|720331|720332|720333|720334|720335|720336|720337|720338|720339|720340|720341|720342|720343|720344|720345|720346|720347|720348|720349|720350|720351|720352|720353|720354|720355|720356|720357|720358|720359|720360|720361|720362|720363|720364|720365|720366|720367|720368|720369|720370|720371|720372|720373|720374|720375|720376|720377|720378|720379|720380|720381|720382|720383|720384|720385|720386|720387|720388|720389|720390|720391|720392|720393|720394|720395|720396|720397|720398|720399|720400|720401|720402|720403|720404|720405|720406|720407|720408|720409|720410|720411|720412|720413|720414|720415|720416|720417|720418|720419|720420|720421|720422|720423|720424|720425|720426|720427|720428|720429|720430|720431|720432|720433|720434|720435|720436|720437|720438|720439|720440|720441|720442|720443|720444|720445|720446|720447|720448|720449|720450|720451|720452|720453|720454|720455|720456|720457|720458|720459|720460|720461|720462|720463|720464|720465|720466|720467|720468|720469|720470|720471|720472|720473|720474|720475|720476|720477|720478|720479|720480|720481|720482|720483|720484|720532|720533|1053188|1159524|1259397|1259398|1259416|1259421|1259423|1345308|1345561|1346986|1346987|1347055|1347080|1347131|1347154|1409598|1508605|1508606|1508630|1640020|1645758|1645843|1645870|1645876|1645877|1671190|1745853,20060605,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|ApexBio Technology|Aurora Fine Chemicals LLC|BenchChem|BindingDB|Biocore|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Broad Institute|Calbiochem|Center for Chemical Genomics, University of Michigan|ChEBI|ChemBank|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EMD Millipore|Finetech Industry Limited|Glentham Life Sciences Ltd.|Google Patents|Gulick Lab, Department of Structural Biology, University at Buffalo|HDH Pharma|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|MedChemexpress MCE|MolCore BioPharmatech|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|Probes & Drugs portal|Prous Science Drugs of the Future|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Sigma-Aldrich|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|Therapeutic Target Database (TTD)|Thomson Pharma|Tocris Bioscience|ToxPlanet|Tractus|Wikidata|Wubei-Biochem|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
44607530,N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide,"WZ4002|1213269-23-8|WZ-4002|N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide|WZ 4002|CHEBI:61400|UNII-6BQ432Z61M|N-(3-((5-chloro-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)oxy)phenyl)acrylamide|N-{3-[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)oxy]phenyl}prop-2-enamide|CHEMBL1229592|6BQ432Z61M|N-[3-[5-chloro-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide|N-[3-[[5-Chloro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]oxy]phenyl]-2-propenamide|SMR001913510|N-(3-((5-CHLORO-2-((2-METHOXY-4-(4-METHYL-1-PIPERAZINYL)PHENYL)AMINO)-4-PYRIMIDINYL)OXY)PHENYL)-2-PROPENAMIDE|D0NJ3Q|SCHEMBL93699|MLS003230945|MLS006011213|AMY370|GTPL9176|DTXSID30153230|EX-A416|HMS3265O15|HMS3265O16|HMS3265P15|HMS3265P16|HMS3654C16|BCP02515|BDBM50383274|NSC755927|s1173|AKOS025401946|CCG-264847|CS-0167|NSC-755927|SB19360|NCGC00263144-01|NCGC00263144-02|NCGC00263144-11|AC-27472|AS-19387|HY-12026|N-(3-((5-chloro-2-((2-methoxy-4-(4-methyl-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)oxy)phenyl)acrylamide|WZ4002, >=98% (HPLC)|EGFR-T790M kinase inhibitors (lung cancer)|FT-0730384|SW219315-1|EC-000.2280|A25634|J-004480|J-523322|Q27089236|EGFR-T790M kinase inhibitors (lung cancer), Gatekeeper Pharmaceuticals|2-PROPENAMIDE, N-(3-((5-CHLORO-2-((2-METHOXY-4-(4-METHYL-1-PIPERAZINYL)PHENYL)AMINO)-4-PYRIMIDINYL)OXY)PHENYL)-|N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazine-1-yl)phenylamino)pyrimidin-4yloxy)phenyl)acrylam|N-[3-[[5-Chloro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]oxy]phenyl]-2-propenamide HBr",495.000,C25H27ClN6O3,91.800,694.000,4.200,35,2,8,8,"InChI=1S/C25H27ClN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h4-9,14-16H,1,10-13H2,2-3H3,(H,28,33)(H,27,29,30)",CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)OC4=CC=CC(=C4)NC(=O)C=C)Cl)OC,CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)OC4=CC=CC(=C4)NC(=O)C=C)Cl)OC,ITTRLTNMFYIYPA-UHFFFAOYSA-N,N-[3-[5-chloro-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide,494.183,494.183,0,1,0,0,0,0,0,0,0,56,631,157,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents|Pharmacology and Biochemistry,6,1|3|5|7|9|13|15|19|21|23|25|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|85|89|91|93|95|97|99|101|103|105|107|109|113|119|123|129|131|133|137|139|141|143|145|552132|552133|552134|552135|552136|552137|552138|552139|552140|552141|552142|624377|624392|624416|624466|624467|624476|624478|624479|651572|651602|651610|651640|651645|651646|651658|651661|651696|651704|651710|651711|651712|651713|651718|651719|651800|651821|651957|651958|652010|652017|652039|652067|652115|652116|652126|652128|652154|652162|652163|652257|662478|662479|662480|662481|662482|662483|662485|662508|662509|662510|662512|662578|662580|662582|662584|662586|662588|662590|662592|662596|662597|662598|662599|662600|662601|686940|686947|686950|686964|686992|686996|687014|687016|719892|720508|720509|720511|720543|720582|720596|720647|720648|720700|720702|720704|720706|743126|743238|743244|743247|743269|743287|743322|743323|743324|743344|743345|743346|743347|743397|743398|748060|748063|748064|748065|748066|748070|748071|748072|748075|748076|748086|748087|748088|748089|748090|748091|748092|748093|748094|761587|761588|761589|761596|761597|761598|761599|761600|761601|761602|761603|770080|770081|770082|770083|775613|775614|775622|775623|775624|1053194|1053195|1053197|1117263|1120256|1120257|1120258|1120259|1120260|1120263|1120264|1120265|1129567|1129568|1129569|1129570|1129571|1129572|1129573|1129574|1129575|1129577|1129578|1129579|1129581|1129582|1129583|1159387|1159388|1159395|1159396|1159510|1159511|1159512|1159513|1159530|1204628|1204629|1204630|1224824|1224825|1224857|1224859|1239424|1239472|1239473|1239474|1241286|1241287|1241288|1259252|1259253|1259255|1259256|1259318|1259357|1259358|1259359|1259360|1259361|1259362|1259398|1259399|1259415|1259416|1259421|1259423|1264283|1264284|1264285|1264286|1264287|1264288|1264289|1264290|1270377|1270378|1270380|1270393|1270398|1270399|1270405|1296008|1296009|1298660|1298661|1298662|1298670|1298671|1298672|1345084|1345502|1345572|1345617|1345682|1345705|1345741|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347080|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347109|1347110|1347111|1347112|1347113|1347114|1347115|1347116|1347117|1347118|1347119|1347121|1347122|1347123|1347124|1347125|1347126|1347127|1347128|1347129|1347154|1347159|1347160|1347162|1347411|1347412|1350813|1350814|1350815|1350816|1350817|1350820|1350821|1350822|1350829|1350830|1350831|1350832|1350833|1350834|1350835|1350838|1350839|1365564|1365565|1365566|1365567|1365568|1365569|1365570|1365571|1365572|1365573|1365574|1365575|1365576|1365577|1365578|1365579|1365580|1372109|1390633|1390635|1390636|1390638|1390640|1390641|1409598|1445468|1445469|1445470|1445475|1445476|1445477|1458976|1458977|1458978|1458979|1458980|1458981|1458982|1458983|1458984|1470859|1470860|1470861|1470862|1481311|1481348|1481349|1483366|1483367|1483368|1483369|1508586|1508598|1508601|1508620|1508623|1508624|1508630|1583835|1583836|1583837|1583838|1583839|1583840|1583841|1583842|1583843|1583844|1583845|1599510|1599511|1599557|1625319|1625320|1625321|1625322|1625323|1625324|1625328|1625329|1625330|1625331|1625332|1625333|1625334|1625335|1640020|1645758|1645838|1645840|1645841|1645842|1645845|1645846|1645851|1645870|1645876|1645877|1671188|1671190|1671193|1671194|1671463|1673937|1673938|1694836|1694837|1694838|1694839|1694840|1694841|1694845|1694846|1694847|1708231|1708306|1715789|1715790|1715791|1745845|1745853|1760611|1760612|1760613|1760614|1760615|1795051|1796430|1836277|1837206|1838135|1839064|1839993|1840922|1841851|1842780|1843709|1844638,20100208,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurum Pharmatech LLC|Axon Medchem|BenchChem|BindingDB|BioChemPartner|Biocore|BioCrick|Biosynth|BOC Sciences|Boerchem|Broad Institute|CEGChem|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemFaces|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemieTek|ChemShuttle|ChemTik|Clearsynth|Collaborative Drug Discovery, Inc.|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|Cure First|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|Exclusive Chemistry Ltd|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Inhibitor 2|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LEAPCHEM|Matrix Scientific|MedChemexpress MCE|Metabolomics Workbench|MLSMR|MolCore BioPharmatech|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NCBI Structure|NIH/NCATS RNAi|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|Santagata Laboratory - Brigham and Women's Hospital and Harvard Medical School|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sigma-Aldrich|Smolecule|Starshine Chemical|SureChEMBL|Synblock Inc|TargetMol|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|Therapeutic Target Database (TTD)|Thomson Pharma|ToxPlanet|Uchem Meditech|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory|Wikidata|Wutech|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
73774623,"4-N-[1-[(3-fluorophenyl)methyl]indol-5-yl]quinazoline-4,6-diamine",EGFR-IN-542|AKOS040748309|1639040-81-5,383.400,C23H18FN5,68.800,547.000,4.500,29,2,5,4,"InChI=1S/C23H18FN5/c24-17-3-1-2-15(10-17)13-29-9-8-16-11-19(5-7-22(16)29)28-23-20-12-18(25)4-6-21(20)26-14-27-23/h1-12,14H,13,25H2,(H,26,27,28)",C1=CC(=CC(=C1)F)CN2C=CC3=C2C=CC(=C3)NC4=NC=NC5=C4C=C(C=C5)N,C1=CC(=CC(=C1)F)CN2C=CC3=C2C=CC(=C3)NC4=NC=NC5=C4C=C(C=C5)N,WYXMKTQSYLOAAG-UHFFFAOYSA-N,"4-N-[1-[(3-fluorophenyl)methyl]indol-5-yl]quinazoline-4,6-diamine",383.155,383.155,0,1,0,0,0,0,0,0,0,0,0,0,2D+3D,NULL,Classification,1,NULL,20140526,AKos Consulting & Solutions|ChEMBL|Thomson Pharma,Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
121595975,"2-[1-[1-[(2~{s})-Butan-2-Yl]-6-[[2-(1-Cyclopropylsulfonylpyrazol-4-Yl)pyrimidin-4-Yl]amino]pyrazolo[4,3-C]pyridin-3-Yl]azetidin-3-Yl]propan-2-Ol","EGFR-IN-2|2-[1-[1-[(2~{s})-Butan-2-Yl]-6-[[2-(1-Cyclopropylsulfonylpyrazol-4-Yl)pyrimidin-4-Yl]amino]pyrazolo[4,3-C]pyridin-3-Yl]azetidin-3-Yl]propan-2-Ol|SCHEMBL20078168|AKOS040733072|1643497-70-4|HY-100520|CS-0019658|Q27456139|60E",551.700,C26H33N9O3S,152.000,970.000,2.800,39,2,10,9,"InChI=1S/C26H33N9O3S/c1-5-16(2)35-21-10-23(28-12-20(21)25(32-35)33-14-18(15-33)26(3,4)36)30-22-8-9-27-24(31-22)17-11-29-34(13-17)39(37,38)19-6-7-19/h8-13,16,18-19,36H,5-7,14-15H2,1-4H3,(H,27,28,30,31)/t16-/m0/s1",CC[C@H](C)N1C2=CC(=NC=C2C(=N1)N3CC(C3)C(C)(C)O)NC4=NC(=NC=C4)C5=CN(N=C5)S(=O)(=O)C6CC6,CCC(C)N1C2=CC(=NC=C2C(=N1)N3CC(C3)C(C)(C)O)NC4=NC(=NC=C4)C5=CN(N=C5)S(=O)(=O)C6CC6,RDWYRIOEHIKPRE-INIZCTEOSA-N,"2-[1-[1-[(2S)-butan-2-yl]-6-[[2-(1-cyclopropylsulfonylpyrazol-4-yl)pyrimidin-4-yl]amino]pyrazolo[4,3-c]pyridin-3-yl]azetidin-3-yl]propan-2-ol",551.243,551.243,0,1,0,1,1,0,0,0,0,1,1,1,2D+3D,NULL,Literature|Patents,3,NULL,20160908,"AbaChemScene|AKos Consulting & Solutions|BOC Sciences|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|MedChemexpress MCE|NCBI Structure|Protein Data Bank in Europe (PDBe)|SureChEMBL|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
4346688,4-{2-[4-oxo-2-[(2-oxo-2-phenylethyl)thio]quinazolin-3(4H)-yl]ethyl}benzenesulfonamide,Oprea1_426638|EGFR/HER2/CDK9-IN-3|NSC798949|NSC-798949|HY-147798|SR-01000557237|SR-01000557237-1|4-{2-[4-oxo-2-[(2-oxo-2-phenylethyl)thio]quinazolin-3(4H)-yl]ethyl}benzenesulfonamide,479.600,C24H21N3O4S2,144.000,840.000,3.800,33,1,7,8,"InChI=1S/C24H21N3O4S2/c25-33(30,31)19-12-10-17(11-13-19)14-15-27-23(29)20-8-4-5-9-21(20)26-24(27)32-16-22(28)18-6-2-1-3-7-18/h1-13H,14-16H2,(H2,25,30,31)",C1=CC=C(C=C1)C(=O)CSC2=NC3=CC=CC=C3C(=O)N2CCC4=CC=C(C=C4)S(=O)(=O)N,C1=CC=C(C=C1)C(=O)CSC2=NC3=CC=CC=C3C(=O)N2CCC4=CC=C(C=C4)S(=O)(=O)N,ZTSOUXIIJZKOEJ-UHFFFAOYSA-N,4-[2-(4-oxo-2-phenacylsulfanylquinazolin-3-yl)ethyl]benzenesulfonamide,479.097,479.097,0,1,0,0,0,0,0,0,0,0,0,0,2D+3D,NULL,Biological Test Results,1,1259310|1259374|1259422|1508602|1794731|1794732|1794733|1794735|1794736|1794738|1794739|1794740|1794742|1794745|1794746|1794748|1794750|1794751|1794752|1794753|1794754|1794755|1794756|1794757|1794758|1794759|1794760|1794761|1794763|1794764|1794765|1794766|1794767|1794768|1794769|1794771|1794772|1794773|1794774|1794775|1794776|1794778|1794779|1794780|1794781|1794782|1794783|1794784|1794785|1794786|1794787|1794788|1794789|1794790|1794792|1794793|1794794|1794795|1794796|1794798|1794799|1794800,20050914,ABI Chem|Ambinter|ChemBank|ChEMBL|ChemDB|ChemDiv|ChemSpider|DiscoveryGate|DTP/NCI|Mcule|MedChemexpress MCE|NextBio|The Scripps Research Institute Molecular Screening Center|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,NULL
5328763,"(E)-2-benzoyl-3-(3,4-dihydroxyphenyl)prop-2-enenitrile","Tyrphostin deriv. 29|EGFR-IN-16|133550-22-8|(E)-2-benzoyl-3-(3,4-dihydroxyphenyl)prop-2-enenitrile|AG473|(E)-2-Benzoyl-3-(3,4-dihydroxyphenyl)acrylonitrile|D00VZA|CHEMBL56132|BDBM4296|AKOS040759442|HY-137786|CS-0141938|2-benzoyl-3-(3,4-dihydroxyphenyl)acrylonitrile|2-(Benzoyl)-3-(3,4-dihydroxyphenyl)acrylonitrile|(2E)-2-benzoyl-3-(3,4-dihydroxyphenyl)prop-2-enenitrile",265.260,C16H11NO3,81.300,428.000,2.900,20,2,4,3,"InChI=1S/C16H11NO3/c17-10-13(16(20)12-4-2-1-3-5-12)8-11-6-7-14(18)15(19)9-11/h1-9,18-19H/b13-8+",C1=CC=C(C=C1)C(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N,C1=CC=C(C=C1)C(=O)C(=CC2=CC(=C(C=C2)O)O)C#N,QBKFKKGORMOFFU-MDWZMJQESA-N,"(E)-2-benzoyl-3-(3,4-dihydroxyphenyl)prop-2-enenitrile",265.074,265.074,0,1,0,0,0,0,1,1,0,3,0,0,2D+3D,NULL,Biological Test Results|Classification|Literature,4,54308|66448|68095|69711|89324|162571|164335|358171|1795628,20060130,"A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|AKos Consulting & Solutions|BenchChem|BindingDB|BLD Pharm|ChEMBL|ChemSpider|Collaborative Drug Discovery, Inc.|CymitQuimica|DC Chemicals|DiscoveryGate|Japan Chemical Substance Dictionary (Nikkaji)|MedChemexpress MCE|NextBio|Probes & Drugs portal|Smolecule|Starshine Chemical|THE BioTek|Therapeutic Target Database (TTD)|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,NULL
17747413,Jnj 28871063 hydrochloride,"JNJ 28871063 HYDROCHLORIDE|944342-90-9|JNJ28871063Hydrochloride|JNJ28871063 (hydrochloride)|944341-54-2|4-N-(3-chloro-4-phenylmethoxyphenyl)-5-[(E)-2-morpholin-4-ylethoxyiminomethyl]pyrimidine-4,6-diamine;hydrochloride|(E)-4-Amino-6-((4-(benzyloxy)-3-chlorophenyl)amino)pyrimidine-5-carbaldehyde O-(2-morpholinoethyl) oxime|SCHEMBL5007769|SCHEMBL20214611|5E-4-Amino-6-(4-benzyloxy-3-chlorophenylamino)pyrimidine-5-carboxaldehyde N-(2-morpholin-4-ylethyl) oxime hydrochloride|AKOS024457573|HY-103441|CS-0027890|EGFR/ErbB-2/ErbB-4 Inhibitor II - CAS 944341-54-2",519.400,C24H28Cl2N6O3,107.000,605.000,NULL,35,3,9,10,"InChI=1S/C24H27ClN6O3.ClH/c25-21-14-19(6-7-22(21)33-16-18-4-2-1-3-5-18)30-24-20(23(26)27-17-28-24)15-29-34-13-10-31-8-11-32-12-9-31;/h1-7,14-15,17H,8-13,16H2,(H3,26,27,28,30);1H/b29-15+;",C1COCCN1CCO/N=C/C2=C(N=CN=C2NC3=CC(=C(C=C3)OCC4=CC=CC=C4)Cl)N.Cl,C1COCCN1CCON=CC2=C(N=CN=C2NC3=CC(=C(C=C3)OCC4=CC=CC=C4)Cl)N.Cl,ZXKZRKQMKNRZNN-GZPZNDDGSA-N,"4-N-(3-chloro-4-phenylmethoxyphenyl)-5-[(E)-2-morpholin-4-ylethoxyiminomethyl]pyrimidine-4,6-diamine;hydrochloride",518.16,518.16,0,2,0,0,0,0,1,1,0,0,17,9,2D,NULL,Patents,1,NULL,20071114,"001Chemical|A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|Alfa Chemistry|Aurora Fine Chemicals LLC|BenchChem|BioCrick|BOC Sciences|Chemieliva Pharmaceutical Co., Ltd|ChemMol|CymitQuimica|DiscoveryGate|EMD Biosciences|EMD Millipore|MedChemexpress MCE|MolPort|MuseChem|PATENTSCOPE (WIPO)|Santa Cruz Biotechnology, Inc.|SureChEMBL|THE BioTek|Thomson Pharma|Tractus",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
24768165,"4-[(2S)-2-{[(1S,2R)-1-{[(1S)-2-carbamoyl-1-{[(1S)-3-carbamoyl-1-{[(1S)-1-{[(1S)-1-carbamoyl-2-methylpropyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propyl]carbamoyl}ethyl]carbamoyl}-2-methylbutyl]carbamoyl}-2-acetamidoethyl]phenoxyphosphonic acid","Y(p)INQSV|BDBM20255|EGFR (1068) derived peptide, 11|4-[(2S)-2-{[(1S,2R)-1-{[(1S)-2-carbamoyl-1-{[(1S)-3-carbamoyl-1-{[(1S)-1-{[(1S)-1-carbamoyl-2-methylpropyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propyl]carbamoyl}ethyl]carbamoyl}-2-methylbutyl]carbamoyl}-2-acetamidoethyl]phenoxyphosphonic acid",843.800,C34H54N9O14P,391.000,1540.000,-3.900,58,12,14,25,"InChI=1S/C34H54N9O14P/c1-6-17(4)28(43-32(51)22(38-18(5)45)13-19-7-9-20(10-8-19)57-58(54,55)56)34(53)40-23(14-26(36)47)31(50)39-21(11-12-25(35)46)30(49)41-24(15-44)33(52)42-27(16(2)3)29(37)48/h7-10,16-17,21-24,27-28,44H,6,11-15H2,1-5H3,(H2,35,46)(H2,36,47)(H2,37,48)(H,38,45)(H,39,50)(H,40,53)(H,41,49)(H,42,52)(H,43,51)(H2,54,55,56)/t17?,21-,22-,23-,24-,27-,28-/m0/s1",CCC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)C,CCC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(C(C)C)C(=O)N)NC(=O)C(CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)C,JRBFXEOBSAAIFI-SOMDNTCNSA-N,"[4-[(2S)-2-acetamido-3-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-oxopropyl]phenyl] dihydrogen phosphate",843.353,843.353,0,1,0,7,6,1,0,0,0,1,0,0,2D,NULL,Biological Test Results|Literature,3,1797963,20080423,BindingDB,Curation Efforts|Research and Development,NULL
46861540,Bibx 1382 dihydrochloride,"BIBX 1382 DIHYDROCHLORIDE|1216920-18-1|Falnidamol dihydrochloride|BIBX1382Dihydrochloride|N8-(3-Chloro-4-fluorophenyl)-N2-(1-methyl-4-piperidinyl)-pyrimido[5,4-d]pyrimidine-2,8-diamine dihydrochloride|DTXSID0046307|DTXCID8026307|CAS-1216920-18-1|NCGC00161422-01|CHEMBL2136050|Tox21_111996|AKOS015950779|Tox21_111996_1|NCGC00161422-04|EC-000.2387|EGFR Inhibitor II, BIBX1382 - CAS 196612-93-8|4-N-(3-chloro-4-fluorophenyl)-6-N-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-4,6-diamine;dihydrochloride|N8-(3-Chloro-4-fluorophenyl)-N2-(1-methyl-4-piperidinyl)-pyrimido[5,4-d]pyrimidine-2,8-diaminedihydrochloride|N8-(3-chloro-4-fluorophenyl)-N2-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-2,8-diamine dihydrochloride",460.800,C18H21Cl3FN7,78.900,479.000,NULL,29,4,8,4,"InChI=1S/C18H19ClFN7.2ClH/c1-27-6-4-11(5-7-27)25-18-21-9-15-16(26-18)17(23-10-22-15)24-12-2-3-14(20)13(19)8-12;;/h2-3,8-11H,4-7H2,1H3,(H,21,25,26)(H,22,23,24);2*1H",CN1CCC(CC1)NC2=NC=C3C(=N2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl.Cl.Cl,CN1CCC(CC1)NC2=NC=C3C(=N2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl.Cl.Cl,RFXGEKWBTCMDAW-UHFFFAOYSA-N,"4-N-(3-chloro-4-fluorophenyl)-6-N-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-4,6-diamine;dihydrochloride",459.091,459.091,0,3,0,0,0,0,0,0,0,9,5,3,2D,NULL,Biological Test Results|Classification|Literature|Patents,4,2517|588834|651631|651632|651633|651634|651635|651784|651789|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743244|1117298|1117304|1117305|1117310|1117312|1117314|1117322|1117323|1117326|1117329|1117330|1117332|1117334|1117336|1117338|1117339|1117340|1117341|1117342|1117343|1117346|1117347|1117349|1117350|1117351|1117352|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159524|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159553|1159555|1159614|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224857|1224859|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|1224883|1224884|1224885|1224886|1224887|1224888|1224889|1224890|1224892|1224893|1224894|1224895|1224896|1259241|1259242|1259243|1259244|1259247|1259248|1259344|1259355|1259356|1259364|1259365|1259366|1259367|1259368|1259369|1259377|1259378|1259379|1259380|1259381|1259382|1259383|1259384|1259385|1259386|1259387|1259388|1259390|1259391|1259392|1259393|1259394|1259395|1259396|1259400|1259401|1259402|1259403|1259404|1296008|1296009|1345084|1345199|1345561|1346378|1346428|1346784|1346795|1346798|1346799|1346824|1346829|1346859|1346877|1346891|1346924|1346977|1346978|1346979|1346980|1346981|1346982|1346983|1346984|1346985|1346986|1346987|1347030|1347031|1347032|1347033|1347034|1347035|1347036|1347037|1347038|1347053|1347055|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347131|1347154|1347395|1347397|1347398|1347399|1347407|1347416|1347424|1347425|1508616|1508620|1508623|1508624|1508627|1508628|1508629|1508630|1645839|1645840|1645841|1645842|1645851|1645870|1645876|1645877|1645882|1645883|1645886|1645887|1671188|1671190|1671193|1671194|1671196|1671197|1671198|1671199|1671200|1671201|1745845|1745856|1745857,20100902,"001Chemical|A2B Chem|AA BLOCKS|ABBLIS Chemicals|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|BenchChem|Biocore|BOC Sciences|Boerchem|ChEMBL|ChemMol|CymitQuimica|DiscoveryGate|EPA DSSTox|Exclusive Chemistry Ltd|Google Patents|Gulick Lab, Department of Structural Biology, University at Buffalo|Matrix Scientific|MolCore BioPharmatech|MolPort|MuseChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|Santa Cruz Biotechnology, Inc.|Smolecule|THE BioTek|Thomson Pharma|Tocris Bioscience|Tox21",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
2140690,"1-(1,3-Benzodioxol-5-yl)-3-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)thiourea","EGFR-IN-52|454436-75-0|CHEMBL4779958|1-(2H-1,3-benzodioxol-5-yl)-3-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)thiourea|1-(benzo[d][1,3]dioxol-5-yl)-3-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)thiourea|Oprea1_300853|BDBM50564477|AKOS002276803|1-(1,3-benzodioxol-5-yl)-3-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)thiourea|HY-146472|CS-0499068|SR-01000013084|SR-01000013084-1|F1533-0323",382.400,C19H18N4O3S,98.200,634.000,3.200,27,2,5,3,"InChI=1S/C19H18N4O3S/c1-12-17(18(24)23(22(12)2)14-6-4-3-5-7-14)21-19(27)20-13-8-9-15-16(10-13)26-11-25-15/h3-10H,11H2,1-2H3,(H2,20,21,27)",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=S)NC3=CC4=C(C=C3)OCO4,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=S)NC3=CC4=C(C=C3)OCO4,ZNMSKFVKBVCPAJ-UHFFFAOYSA-N,"1-(1,3-benzodioxol-5-yl)-3-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)thiourea",382.11,382.11,0,1,0,0,0,0,0,0,0,2,0,0,2D+3D,NULL,Biological Test Results|Classification|Literature,3,1159607|1259310|1259374|1259422|1272365|1508602|1738027|1738028|1738029|1738030|1738031|1738032|1738033|1738034|1738035|1738036|1738037|1738038|1738039|1738040|1738041|1738042|1738043,20050714,"A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|AKos Consulting & Solutions|Ambinter|BenchChem|BindingDB|ChemBank|ChEMBL|ChemSpider|DiscoveryGate|Innovapharm|Life Chemicals|Mcule|MedChemexpress MCE|MolPort|NextBio|The Scripps Research Institute Molecular Screening Center|TimTec|UW Madison, Small Molecule Screening Facility|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,NULL
155818893,"N-(3-{5-[2-(acetylamino)pyridin-4-yl]-2-(methylsulfanyl)-1H-imidazol-4-yl}phenyl)-2-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)methyl]benzamide","N-(3-{5-[2-(acetylamino)pyridin-4-yl]-2-(methylsulfanyl)-1H-imidazol-4-yl}phenyl)-2-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)methyl]benzamide|EGFR-IN-18|CS-0256203|TQA",588.700,C33H28N6O3S,145.000,1000.000,4.000,43,3,6,8,"InChI=1S/C33H28N6O3S/c1-20(40)35-28-17-22(14-15-34-28)30-29(37-33(38-30)43-2)21-10-7-11-25(16-21)36-31(41)26-12-5-3-8-23(26)18-39-19-24-9-4-6-13-27(24)32(39)42/h3-17H,18-19H2,1-2H3,(H,36,41)(H,37,38)(H,34,35,40)",CC(=O)NC1=NC=CC(=C1)C2=C(N=C(N2)SC)C3=CC(=CC=C3)NC(=O)C4=CC=CC=C4CN5CC6=CC=CC=C6C5=O,CC(=O)NC1=NC=CC(=C1)C2=C(N=C(N2)SC)C3=CC(=CC=C3)NC(=O)C4=CC=CC=C4CN5CC6=CC=CC=C6C5=O,MYCFQBCOJLOXJZ-UHFFFAOYSA-N,N-[3-[5-(2-acetamidopyridin-4-yl)-2-methylsulfanyl-1H-imidazol-4-yl]phenyl]-2-[(3-oxo-1H-isoindol-2-yl)methyl]benzamide,588.194,588.194,0,1,0,0,0,0,0,0,0,0,0,0,2D+3D,NULL,Patents,2,NULL,20210401,AbaChemScene|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,NULL
6603857,"N6,N6-dimethyl-N4-[1-(phenylmethyl)-5-indazolyl]pyrido[3,4-d]pyrimidine-4,6-diamine","GW2974|202272-68-2|EGFR/HER2 Inhibitor|GW 2974|GW-2974|CHEMBL30432|GW 974|GW282974X|4-N-(1-benzylindazol-5-yl)-6-N,6-N-dimethylpyrido[3,4-d]pyrimidine-4,6-diamine|N4-(1-Benzyl-1H-indazol-5-yl)-N6,N6-dimethyl-pyrido [3,4-d]pyrimidine-4,6-diamine|N6,N6-dimethyl-N4-[1-(phenylmethyl)-5-indazolyl]pyrido[3,4-d]pyrimidine-4,6-diamine|Lopac-G-0668|Lopac0_000509|SCHEMBL1737530|CHEBI:95273|DTXSID40424963|HMS3261F19|HMS3303J07|HMS3305C14|Tox21_500509|BDBM50099963|GW-974|NSC756204|AKOS040745835|CCG-204600|LP00509|NSC-756204|SDCCGSBI-0050493.P002|SMP2_000268|SMP2_000301|NCGC00015468-01|NCGC00015468-02|NCGC00015468-03|NCGC00015468-04|NCGC00015468-05|NCGC00015468-06|NCGC00015468-07|NCGC00093907-01|NCGC00093907-02|NCGC00261194-01|GW2974, >=98% (HPLC), solid|EU-0100509|G 0668|AB01092265-01|SR-01000075892|J-013131|SR-01000075892-1|Q27167122|N*4*-(1-Benzyl-1H-indazol-5-yl)-N*6*,N*6*-dimethyl-pyrido[3,4-d]pyrimidine-4,6-diamine|N4-(1-Benzyl-1H-indazol-5-yl)-N6,N6-dimethyl-pyrido[3,4-d]pyrimidine-4,6-diamine|N4-(1-Benzyl-1H-indazol-5-yl)-N6,N6-dimethyl-pyrido[3,4-d]pyrimidine4-4,6-diamine|N4-(1-benzylindazol-5-yl)-N6,N6-dimethyl-pyrido[3,4-d]pyrimidine-4,6-diamine",395.500,C23H21N7,71.800,552.000,4.000,30,1,6,5,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)C1=NC=C2C(=C1)C(=NC=N2)NC3=CC4=C(C=C3)N(N=C4)CC5=CC=CC=C5,CN(C)C1=NC=C2C(=C1)C(=NC=N2)NC3=CC4=C(C=C3)N(N=C4)CC5=CC=CC=C5,DYYZXRCFCVDSKD-UHFFFAOYSA-N,"4-N-(1-benzylindazol-5-yl)-6-N,6-N-dimethylpyrido[3,4-d]pyrimidine-4,6-diamine",395.186,395.186,0,1,0,0,0,0,0,0,0,54,102,24,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,6,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|357|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|940|943|944|945|954|957|958|959|992|995|997|998|1030|1379|1422|1452|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1519|1705|1707|1708|1724|1725|1728|1730|1732|1766|1768|1815|1816|1828|1851|1865|1876|1877|1882|1883|1886|1948|1967|2101|2107|2112|2147|2323|2326|2353|2364|2451|2517|2528|2549|2660|2662|2666|2667|2668|2675|2732|2774|7657|7860|8560|9140|9568|9716|9904|9942|10628|10995|11115|13169|42142|45095|53184|53521|66431|79616|79617|81335|106357|108466|164358|197676|197677|205319|463096|463097|463106|463189|485290|485295|485297|485298|485313|485314|485342|485345|485366|485368|488745|488752|488772|488773|488816|488837|488949|488953|488978|488979|488980|488981|488982|488983|493106|493107|493127|493153|493164|493189|504327|504332|504364|504536|504547|504548|504810|504812|504821|504836|504845|504847|504865|521220|540256|540276|588349|588378|588453|588456|588579|588590|588591|588795|588834|602332|624146|624147|624148|624149|624392|624455|624486|651018|651019|651020|651021|651022|651023|651024|651025|651026|651027|651028|651029|651030|651031|651032|651033|651034|651035|651036|651037|651038|651039|651040|651041|651042|651043|651044|651045|651046|651047|651048|651049|651050|651051|651052|651053|651054|651055|651056|651057|651058|651059|651060|651061|651062|651063|651064|651065|651066|651067|651068|651069|651070|651071|651072|651073|651074|651075|651076|651077|651078|651079|651080|651081|651082|651083|651084|651085|651086|651087|651088|651089|651090|651091|651092|651093|651094|651095|651096|651097|651098|651099|651100|651101|651102|651103|651104|651105|651106|651107|651108|651109|651110|651111|651112|651113|651114|651115|651116|651117|651118|651119|651120|651121|651122|651123|651124|651125|651126|651127|651128|651129|651130|651131|651132|651133|651134|651135|651136|651137|651138|651139|651140|651141|651142|651143|651144|651145|651146|651147|651148|651149|651150|651151|651152|651153|651154|651155|651156|651157|651158|651159|651160|651161|651162|651163|651164|651165|651166|651167|651168|651169|651170|651171|651172|651173|651174|651175|651176|651177|651178|651179|651180|651181|651182|651183|651184|651185|651186|651187|651188|651189|651190|651191|651192|651193|651194|651195|651196|651197|651198|651199|651200|651201|651202|651203|651204|651205|651206|651207|651208|651209|651210|651211|651212|651213|651214|651215|651216|651217|651218|651219|651220|651221|651222|651223|651224|651225|651226|651227|651228|651229|651230|651231|651232|651233|651234|651235|651236|651237|651238|651239|651240|651241|651242|651243|651244|651245|651246|651247|651248|651249|651250|651251|651252|651253|651254|651255|651256|651257|651258|651259|651260|651261|651262|651263|651264|651265|651266|651267|651268|651269|651270|651271|651272|651273|651274|651275|651276|651277|651278|651279|651280|651281|651282|651283|651284|651285|651286|651287|651288|651289|651290|651291|651292|651293|651294|651295|651296|651297|651298|651299|651300|651301|651302|651303|651304|651305|651306|651307|651308|651309|651310|651311|651312|651313|651314|651315|651316|651317|651318|651319|651320|651321|651322|651323|651324|651325|651326|651327|651328|651329|651330|651331|651332|651333|651334|651335|651336|651337|651338|651339|651340|651341|651342|651343|651344|651345|651346|651347|651348|651349|651350|651351|651352|651353|651354|651355|651356|651357|651358|651359|651360|651361|651362|651363|651364|651365|651366|651367|651368|651369|651370|651371|651372|651373|651374|651375|651376|651377|651378|651379|651380|651381|651382|651383|651384|651385|651386|651387|651388|651389|651390|651391|651392|651393|651394|651395|651396|651397|651398|651399|651400|651401|651402|651403|651404|651405|651406|651407|651408|651409|651410|651411|651412|651413|651414|651415|651416|651417|651418|651419|651420|651421|651422|651423|651424|651425|651426|651427|651428|651429|651430|651431|651432|651433|651434|651435|651436|651437|651438|651439|651440|651441|651442|651443|651444|651445|651446|651447|651448|651449|651450|651451|651452|651453|651454|651455|651456|651457|651458|651459|651460|651461|651462|651463|651464|651465|651541|651542|651543|651544|651545|651546|651566|651828|652015|652016|652106|652131|686947|686950|687035|687037|720532|720533|720538|720559|720572|720573|720834|720835|743205|743206|743207|743244|1053116|1053176|1159580|1159607|1159619|1198817|1198818|1224818|1224819|1224820|1224821|1224822|1224823|1224857|1224859|1224905|1259310|1259325|1259354|1259370|1259374|1259398|1259399|1259422|1259423|1296008|1296009|1345084|1346212|1346378|1346428|1346986|1346987|1347045|1347049|1347050|1347053|1347055|1347057|1347058|1347059|1347074|1347079|1347080|1347082|1347083|1347085|1347086|1347143|1347151|1347159|1347160|1347166|1347384|1347405|1347410|1347418|1347420|1347427|1347428|1347429|1347430|1508586|1508602|1508616|1508618|1508620|1508630|1525558|1619185|1619186|1645843|1645851|1645870|1645873|1645876|1645877|1645882|1645883|1645886|1645887|1671188|1671193|1671194|1745852|1745853,20060530,"001Chemical|A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|BenchChem|BindingDB|Biocore|Biosynth|Burnham Center for Chemical Genomics|C. David Weaver Laboratory, Vanderbilt University|Center for Chemical Genomics, University of Michigan|ChEBI|ChemBank|Chembase.cn|ChEMBL|chemical genetic matrix|ChemIDplus|ChemSpider|ChemTik|Circadian Research, Kay Laboratory, University of California at San Diego (UCSD)|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CymitQuimica|DC Chemicals|DiscoveryGate|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Emory University Molecular Libraries Screening Center|EPA DSSTox|Glentham Life Sciences Ltd.|Google Patents|Gulick Lab, Department of Structural Biology, University at Buffalo|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Japan Chemical Substance Dictionary (Nikkaji)|King Scientific|McMaster CMCB|Milwaukee Institute for Drug Discovery|MolCore BioPharmatech|National Center for Advancing Translational Sciences (NCATS)|NextBio|NextMove Software|NIAID ChemDB|NovoSeek|Paczesny and Yang Labs, IUPUI and University of Michigan|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Sigma-Aldrich|Smolecule|Southern Research Institute|Springer Nature|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|The Scripps Research Institute Molecular Screening Center|Thomson Pharma|Tox21|ToxPlanet|Tractus|University of Kansas High Throughput Screening Laboratory|University of Pittsburgh Molecular Library Screening Center|UW Madison, Small Molecule Screening Facility|Wikidata|ZINC|Zoeller Lab, School of Medicine, Boston University",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,NULL
156071569,"(E)-N-[4-(3-chloro-2-fluoroanilino)-7-[2-[(1R,5S)-3-methyl-3-azabicyclo[3.1.0]hexan-1-yl]ethynyl]quinazolin-6-yl]-4-morpholin-4-ylbut-2-enamide",EGFR-IN-76|SCHEMBL22983932|HY-153268|CS-0675480,561.000,C30H30ClFN6O2,82.600,1010.000,3.900,40,2,8,8,"InChI=1S/C30H30ClFN6O2/c1-37-17-21-16-30(21,18-37)8-7-20-14-26-22(29(34-19-33-26)36-24-5-2-4-23(31)28(24)32)15-25(20)35-27(39)6-3-9-38-10-12-40-13-11-38/h2-6,14-15,19,21H,9-13,16-18H2,1H3,(H,35,39)(H,33,34,36)/b6-3+/t21-,30+/m1/s1",CN1C[C@H]2C[C@]2(C1)C#CC3=CC4=C(C=C3NC(=O)/C=C/CN5CCOCC5)C(=NC=N4)NC6=C(C(=CC=C6)Cl)F,CN1CC2CC2(C1)C#CC3=CC4=C(C=C3NC(=O)C=CCN5CCOCC5)C(=NC=N4)NC6=C(C(=CC=C6)Cl)F,LMOVDLRMIRLIJF-TUVXKDNKSA-N,"(E)-N-[4-(3-chloro-2-fluoroanilino)-7-[2-[(1R,5S)-3-methyl-3-azabicyclo[3.1.0]hexan-1-yl]ethynyl]quinazolin-6-yl]-4-morpholin-4-ylbut-2-enamide",560.21,560.21,0,1,0,2,2,0,1,1,0,0,3,2,2D,NULL,Classification|Patents,2,NULL,20210821,AbaChemScene|Excenen Pharmatech|MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
118870,"2H-1-Benzopyran-2-one, 3-(2-benzoxazolyl)-7-(diethylamino)-","35773-42-3|2H-1-Benzopyran-2-one, 3-(2-benzoxazolyl)-7-(diethylamino)-|3-(Benzoxazol-2-yl)-7-(diethylamino)-2-benzopyrone|EMI1|3-(1,3-benzoxazol-2-yl)-7-(diethylamino)-2H-chromen-2-one|EMI1 (EGFR MaMTH Inhibitor 1)|EINECS 252-721-7|3-(Benzoxazolyl-2')-7-diethylaminocoumarin|3-(1,3-benzoxazol-2-yl)-7-(diethylamino)chromen-2-one|Probes1_000034|Probes2_000170|Oprea1_339712|Oprea1_741108|CBDivE_006515|SCHEMBL869636|CHEMBL210065|DTXSID3067940|3-(2-benzoxazolyl)-7-(diethylamino)-2h-1-benzopyran-2-one|HMS1578O17|STK386372|AKOS001028797|SDCCGSBI-0087014.P001|HY-138072|7-Diethylamino-3-(benzoxazole-2-yl)coumarin|CS-0144250|7-(diethylamino)-3-(benzoxazol-2-yl)coumarin|SR-01000395140|SR-01000395140-1|2H-1-Benzopyran-2-one, 2-(benzoxazolyl)-7-(diethylamino)-",334.400,C20H18N2O3,55.600,531.000,4.300,25,0,5,4,"InChI=1S/C20H18N2O3/c1-3-22(4-2)14-10-9-13-11-15(20(23)25-18(13)12-14)19-21-16-7-5-6-8-17(16)24-19/h5-12H,3-4H2,1-2H3",CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C3=NC4=CC=CC=C4O3,CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C3=NC4=CC=CC=C4O3,UJOQSHCJYVRZKJ-UHFFFAOYSA-N,"3-(1,3-benzoxazol-2-yl)-7-(diethylamino)chromen-2-one",334.132,334.132,0,1,0,0,0,0,0,0,0,12,91,31,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents|Use and Manufacturing,6,270397|270398|270399|270400|270401|270402|270403|485350|485395|492967|493033|504770|540299|588519|602314|720641|720717|1224905|1259310|1259374|1259422|1347422|1508602|1635967|1635968|1635969|1635970,20050708,"A2B Chem|AA BLOCKS|AAA Chemistry|AbaChemScene|ABI Chem|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|ASINEX|Aurora Fine Chemicals LLC|BenchChem|Burnham Center for Chemical Genomics|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemBridge|ChemDB|ChemDiv|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|CymitQuimica|DC Chemicals|DiscoveryGate|EPA DSSTox|EPA Substance Registry Services|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|LabNetwork, a WuXi AppTec Company|Mcule|MedChemexpress MCE|MolPort|Nature Chemical Biology|NextBio|NORMAN Suspect List Exchange|Norris Pharm|PATENTSCOPE (WIPO)|RR Scientific|SCRIPDB|Springer Nature|Starshine Chemical|SureChEMBL|The Scripps Research Institute Molecular Screening Center|Thomson Pharma|TimTec|ToxPlanet|Vitas-M Laboratory|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,NULL
24768166,4-[(2S)-2-{[(1S)-1-{[(1S)-2-carbamoyl-1-{[(2S)-4-carbamoyl-1-[(2S)-2-{[(1S)-1-carbamoyl-3-methylbutyl]carbamoyl}pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamoyl}ethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-acetamidoethyl]phenoxyphosphonic acid,"Y(p)HNQPL|BDBM20256|EGFR (1086) derived peptide, 12|4-[(2S)-2-{[(1S)-1-{[(1S)-2-carbamoyl-1-{[(2S)-4-carbamoyl-1-[(2S)-2-{[(1S)-1-carbamoyl-3-methylbutyl]carbamoyl}pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamoyl}ethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-acetamidoethyl]phenoxyphosphonic acid",891.900,C37H54N11O13P,391.000,1690.000,-3.700,62,11,14,24,"InChI=1S/C37H54N11O13P/c1-19(2)13-25(32(40)52)45-36(56)29-5-4-12-48(29)37(57)24(10-11-30(38)50)44-35(55)28(16-31(39)51)47-34(54)27(15-22-17-41-18-42-22)46-33(53)26(43-20(3)49)14-21-6-8-23(9-7-21)61-62(58,59)60/h6-9,17-19,24-29H,4-5,10-16H2,1-3H3,(H2,38,50)(H2,39,51)(H2,40,52)(H,41,42)(H,43,49)(H,44,55)(H,45,56)(H,46,53)(H,47,54)(H2,58,59,60)/t24-,25-,26-,27-,28-,29-/m0/s1",CC(C)C[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C,CC(C)CC(C(=O)N)NC(=O)C1CCCN1C(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C,MXOPXVIXJHXWJD-AQRCPPRCSA-N,"[4-[(2S)-2-acetamido-3-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-5-amino-1-[(2S)-2-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1,5-dioxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-oxopropyl]phenyl] dihydrogen phosphate",891.364,891.364,0,1,0,6,6,0,0,0,0,1,0,0,2D,NULL,Biological Test Results|Literature,3,1797963,20080423,BindingDB,Curation Efforts|Research and Development,NULL
118797290,EGFRInhibitorIII,"EGFRInhibitorIII|733009-42-2|EGFR Inhibitor III|N-(4-((3,4-Dichloro-6-fluorophenyl)amino)-quinazolin-6-yl)-2-chloroacetamide",397.600,C16H8Cl3FN4O,66.900,475.000,4.600,25,2,5,3,"InChI=1S/C16H8Cl3FN4O/c17-6-15(25)23-8-1-2-13-9(3-8)16(22-7-21-13)24-14-5-11(19)10(18)4-12(14)20/h1-5,7H,(H,23,25)(H,21,22,24)",C1=CC2=C(C=C1NC(=O)[C]Cl)C(=NC=N2)NC3=CC(=C(C=C3F)Cl)Cl,C1=CC2=C(C=C1NC(=O)[C]Cl)C(=NC=N2)NC3=CC(=C(C=C3F)Cl)Cl,TUYZBSNOXFHLKL-UHFFFAOYSA-N,NULL,395.975,395.975,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,Classification,1,NULL,20160325,"A2B Chem|AA BLOCKS|Biocore|Santa Cruz Biotechnology, Inc.",Chemical Vendors|Legacy Depositors,NULL
92044040,Protein Kinase C Substrate,Protein Kinase C Substrate|HY-P3764|EGFR(650-658)|CS-0620603,1197.500,C51H100N22O11,600.000,2220.000,-7.100,84,20,17,43,"InChI=1S/C51H100N22O11/c1-26(2)24-35(44(80)69-31(15-10-20-62-48(54)55)40(76)67-32(16-11-21-63-49(56)57)42(78)72-36(47(83)84)25-27(3)4)71-46(82)38(29(7)74)73-43(79)34(18-13-23-65-51(60)61)68-39(75)30(14-8-9-19-52)66-41(77)33(17-12-22-64-50(58)59)70-45(81)37(53)28(5)6/h26-38,74H,8-25,52-53H2,1-7H3,(H,66,77)(H,67,76)(H,68,75)(H,69,80)(H,70,81)(H,71,82)(H,72,78)(H,73,79)(H,83,84)(H4,54,55,62)(H4,56,57,63)(H4,58,59,64)(H4,60,61,65)/t29-,30+,31+,32+,33+,34+,35+,36+,37+,38+/m1/s1",C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C(C)C)N)O,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(C(C)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C(C)C)N,PBWMKSKSLNNGHP-GWMUGDFHSA-N,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-hydroxybutanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoic acid",1196.79,1196.79,0,1,0,10,10,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20151111,"AbaChemScene|Alfa Chemistry|BOC Sciences|Chemieliva Pharmaceutical Co., Ltd|Japan Chemical Substance Dictionary (Nikkaji)|MedChemexpress MCE",Chemical Vendors|Governmental Organizations|Legacy Depositors,NULL
168264808,CID 168264808,EGFR T790M/L858R-IN-2|HY-149824,497.600,C28H28FN7O,85.400,755.000,5.100,37,3,8,7,"InChI=1S/C28H28FN7O/c1-3-26(37)30-21-5-4-6-22(18-21)31-27-24-17-19(29)7-12-25(24)33-28(34-27)32-20-8-10-23(11-9-20)36-15-13-35(2)14-16-36/h3-12,17-18H,1,13-16H2,2H3,(H,30,37)(H2,31,32,33,34)",CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C=C(C=C4)F)C(=N3)NC5=CC(=CC=C5)NC(=O)C=C,CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C=C(C=C4)F)C(=N3)NC5=CC(=CC=C5)NC(=O)C=C,KDWNVZXLHSMELQ-UHFFFAOYSA-N,N-[3-[[6-fluoro-2-[4-(4-methylpiperazin-1-yl)anilino]quinazolin-4-yl]amino]phenyl]prop-2-enamide,497.234,497.234,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20230531,MedChemexpress MCE,Chemical Vendors,NULL
